data_2bbg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bbg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.505 2.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -138.39 163.04 32.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.1 151.49 42.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.22 -121.33 1.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.444 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.284 94.5 m -154.69 23.58 0.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.293 -1.122 . . . . 0.0 111.117 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -73.72 -13.86 61.04 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.259 -1.526 . . . . 0.0 113.332 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.813 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.1 m -120.97 24.25 10.27 Favored 'General case' 0 C--N 1.283 -2.297 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.46 77.5 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 118.708 -1.71 . . . . 0.0 109.029 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.356 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 16.6 pttm -87.84 52.87 2.59 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.534 1.159 . . . . 0.0 110.928 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 t -66.73 110.73 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.79 -22.84 34.28 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.24 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.2 mtmt -119.9 -145.69 0.37 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.663 -1.493 . . . . 0.0 109.147 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 17.4 m-85 -146.0 174.85 10.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.893 -1.754 . . . . 0.0 110.326 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.356 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.4 m -137.44 161.25 36.85 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.377 -1.452 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.999 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.775 . . . . 0.0 110.818 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 26.2 t . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 89.3 t -114.69 116.73 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 12.9 m -116.33 161.78 18.51 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.33 1.062 . . . . 0.0 113.157 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.726 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.6 m-85 -149.37 174.56 12.31 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -81.46 -40.72 22.89 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.837 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.2 113.85 19.62 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.083 -1.011 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.774 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.0 ptmm? -49.37 -35.05 17.61 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.29 86.98 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.126 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.735 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.18 -25.7 23.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 O-C-N 120.668 -1.27 . . . . 0.0 109.382 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.111 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 37.6 t -61.15 -67.35 0.41 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -54.53 -53.92 47.99 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.895 -1.128 . . . . 0.0 110.996 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -61.9 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.524 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.3 m-80 -60.26 -30.47 69.46 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 121.227 -0.921 . . . . 0.0 112.767 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.111 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 94.3 m . . . . . 0 N--CA 1.502 2.128 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.506 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.506 2.363 0 CA-C-O 121.51 0.671 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.0 p90 -138.19 162.89 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.05 150.81 42.63 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.411 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.95 -122.46 1.23 Allowed Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.54 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 92.3 m -154.79 24.11 0.45 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.369 -1.077 . . . . 0.0 110.818 -177.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.77 -13.33 60.93 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.299 -1.501 . . . . 0.0 113.294 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.907 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.9 m -121.28 24.75 9.86 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.431 -0.793 . . . . 0.0 109.367 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.86 77.52 Favored Glycine 0 C--N 1.29 -1.985 0 C-N-CA 118.701 -1.714 . . . . 0.0 109.058 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.319 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 9.2 pttm -88.08 54.32 3.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.561 1.172 . . . . 0.0 110.843 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.68 108.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.54 -22.65 36.69 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.022 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 41.5 mtmt -114.45 -147.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.821 -1.4 . . . . 0.0 108.943 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 25.4 m-85 -146.57 175.62 10.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.9 -1.75 . . . . 0.0 110.277 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.319 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.9 m -136.8 161.76 35.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.515 -1.366 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.9 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 18.2 t . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 120.638 0.256 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.4 t -114.45 111.48 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.699 -1.251 . . . . 0.0 108.434 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.2 m -116.13 161.64 18.62 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.29 1.043 . . . . 0.0 113.46 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.8 m-85 -150.12 175.75 11.46 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.8 p-10 -82.12 -41.82 19.95 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.92 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.71 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.11 115.51 20.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.964 -1.085 . . . . 0.0 108.739 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.89 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 9.4 ptmt -49.74 -35.3 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.8 -46.38 87.7 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.048 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.48 -25.79 25.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.0 109.332 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.043 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.2 t -60.35 -66.58 0.5 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.02 -54.17 48.06 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.927 -1.108 . . . . 0.0 110.785 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -61.61 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.576 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -61.02 -29.82 69.94 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.224 -0.922 . . . . 0.0 112.881 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.043 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.0 m . . . . . 0 N--CA 1.503 2.179 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.357 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 121.85 0.833 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -138.5 164.43 29.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.62 153.21 39.62 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.419 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.95 -122.18 1.23 Allowed Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.36 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.291 95.2 m -154.9 22.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 111.004 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -75.15 -10.16 59.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.316 -1.49 . . . . 0.0 113.713 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.6 m -124.5 25.32 7.64 Favored 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.245 -0.909 . . . . 0.0 109.707 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.24 77.43 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 118.593 -1.765 . . . . 0.0 109.167 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 4.2 pttt -87.83 51.67 2.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.505 1.145 . . . . 0.0 110.956 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.82 110.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 -22.04 39.46 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.11 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.3 mtmm -119.41 -145.53 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.865 -1.373 . . . . 0.0 109.005 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.541 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 26.5 m-85 -145.81 175.94 10.03 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 119.871 -1.768 . . . . 0.0 110.276 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 90.5 m -137.07 161.61 35.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.255 -1.528 . . . . 0.0 110.664 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.941 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.378 0 O-C-N 121.378 -0.826 . . . . 0.0 111.317 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 121.133 0.492 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.676 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 95.2 t -115.33 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.8 m -116.17 162.3 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.91 -1.119 . . . . 0.0 113.085 -176.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.737 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.7 m-85 -147.75 174.76 11.5 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.024 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.2 p-10 -82.04 -42.67 18.96 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.003 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.95 116.39 20.89 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.976 -1.077 . . . . 0.0 108.68 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.792 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.3 ptpt -49.19 -36.03 18.66 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.58 88.25 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.35 -26.36 25.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 O-C-N 120.704 -1.248 . . . . 0.0 109.435 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.146 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.4 t -60.98 -67.29 0.42 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -54.82 -53.42 55.47 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.825 -1.172 . . . . 0.0 110.875 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.31 -80.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 49.7 m-80 -61.16 -28.12 68.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.261 -0.899 . . . . 0.0 113.007 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.146 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.8 m . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.144 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.506 2.35 0 CA-C-O 121.633 0.73 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -136.6 165.16 26.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -122.73 149.89 43.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.309 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.54 -120.33 1.01 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.531 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.439 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.289 96.1 m -154.83 21.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -1.136 . . . . 0.0 111.334 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.331 -1.48 . . . . 0.0 113.541 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.092 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.8 m -123.19 25.59 8.37 Favored 'General case' 0 C--N 1.282 -2.354 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.68 17.23 79.11 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 118.784 -1.674 . . . . 0.0 109.412 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.599 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.14 53.17 2.73 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.541 1.162 . . . . 0.0 110.856 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.82 107.78 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.42 -21.06 45.87 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.067 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.717 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 15.2 mtmt -119.18 -144.14 0.36 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.917 -1.343 . . . . 0.0 109.128 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.7 m-85 -146.65 176.67 9.66 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 119.789 -1.819 . . . . 0.0 110.593 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.599 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 95.8 m -136.74 163.29 30.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.445 -1.41 . . . . 0.0 110.745 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.362 0 O-C-N 121.511 -0.743 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.762 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.6 t -114.96 118.11 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.82 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.5 m -116.16 161.69 18.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.493 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 83.7 m-85 -149.26 176.51 10.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.0 p-10 -81.93 -42.83 18.93 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.78 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.717 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.13 20.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.029 -1.045 . . . . 0.0 108.611 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.789 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.7 ptpt -49.94 -35.45 24.09 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.12 -46.16 89.04 Favored 'General case' 0 C--O 1.201 -1.497 0 O-C-N 121.307 -0.87 . . . . 0.0 109.12 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.717 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.79 -25.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 120.566 -1.334 . . . . 0.0 109.407 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.101 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.7 t -60.82 -67.45 0.4 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -55.02 -53.53 54.68 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.901 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.1 tmtm? -62.81 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.51 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.69 -28.46 68.64 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.262 -0.899 . . . . 0.0 112.92 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.101 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.7 m . . . . . 0 N--CA 1.502 2.171 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.368 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 1.26 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 5.5 t . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.27 170.76 15.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.993 -1.067 . . . . 0.0 110.668 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.24 152.16 40.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.988 . . . . 0.0 110.833 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.27 -122.78 1.25 Allowed Glycine 0 N--CA 1.485 1.951 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.294 91.5 m -155.77 26.75 0.38 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.32 -1.106 . . . . 0.0 110.57 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.43 -9.18 58.42 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.455 -1.403 . . . . 0.0 113.571 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.7 m -122.54 23.61 9.55 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.394 -0.816 . . . . 0.0 109.799 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.77 74.86 Favored Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.116 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 2.0 pttp -87.22 51.45 2.24 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.207 1.003 . . . . 0.0 111.944 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.02 114.68 3.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -24.55 22.46 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.323 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.663 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 6.7 mtmt -123.49 -146.1 0.35 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.515 -1.58 . . . . 0.0 109.554 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 54.6 m-85 -144.0 169.56 17.59 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 119.971 -1.705 . . . . 0.0 110.008 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.116 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 87.1 m -142.65 157.14 44.99 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.959 -1.713 . . . . 0.0 110.364 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.26 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 1.9 p . . . . . 0 C--N 1.304 -1.396 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.967 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.502 2.141 0 CA-C-O 121.037 0.446 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 70.8 t -114.31 115.58 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 22.9 m -116.24 164.04 15.1 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.342 1.068 . . . . 0.0 113.054 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.663 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 79.2 m-85 -147.88 170.29 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.61 -35.06 24.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 112.865 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.712 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.69 114.95 19.93 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.931 -1.106 . . . . 0.0 109.665 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.98 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -49.26 -35.22 17.1 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.56 -45.67 91.13 Favored 'General case' 0 C--O 1.197 -1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 109.085 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.712 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.4 mt -58.73 -26.15 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 O-C-N 120.466 -1.396 . . . . 0.0 109.052 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.98 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 14.7 t -59.49 -71.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -58.5 -51.1 71.28 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.028 -1.045 . . . . 0.0 111.158 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -60.78 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.643 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 48.7 m-80 -61.96 -33.08 73.63 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.902 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.7 m . . . . . 0 C--N 1.283 -2.316 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.35 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 121.597 0.713 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.5 p90 -137.9 165.47 26.43 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.87 152.31 40.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.33 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.33 -121.31 1.11 Allowed Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.472 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 97.0 m -154.88 23.16 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.308 -1.113 . . . . 0.0 110.948 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -74.13 -12.2 60.52 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.303 -1.498 . . . . 0.0 113.377 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.962 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.5 m -122.36 25.15 9.04 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 121.243 -0.911 . . . . 0.0 109.6 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.4 77.8 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 118.674 -1.727 . . . . 0.0 109.041 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.327 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.9 pttm -87.92 54.75 3.2 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.569 1.176 . . . . 0.0 110.768 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.49 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.15 -21.55 39.44 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.4 mtmp? -117.57 -145.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.712 -1.464 . . . . 0.0 109.252 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.5 m-85 -146.47 176.41 9.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 119.919 -1.738 . . . . 0.0 110.424 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.327 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 79.8 m -137.62 161.98 35.01 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.386 -1.446 . . . . 0.0 110.79 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.09 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.345 0 O-C-N 121.521 -0.737 . . . . 0.0 111.011 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 24.1 t . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 121.16 0.505 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.744 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.5 t -114.71 115.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.638 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.3 m -116.22 161.42 19.0 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.392 1.092 . . . . 0.0 113.469 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.727 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.2 m-85 -149.68 176.52 10.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.965 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.5 p30 -81.56 -42.46 20.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.141 -0.974 . . . . 0.0 111.85 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.715 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.28 116.11 20.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.093 -1.004 . . . . 0.0 108.603 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.838 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.0 ptpt -50.84 -34.55 28.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.7 -46.19 87.85 Favored 'General case' 0 C--O 1.199 -1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 108.868 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.715 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.6 -25.84 25.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 O-C-N 120.736 -1.227 . . . . 0.0 109.357 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.124 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -60.78 -67.59 0.39 Allowed 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -54.62 -53.79 50.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.908 -1.12 . . . . 0.0 110.93 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.609 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -62.47 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.609 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.89 -28.71 69.09 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.262 -0.899 . . . . 0.0 112.886 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.124 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.1 m . . . . . 0 N--CA 1.502 2.167 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.36 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.4 t . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 121.897 0.856 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 38.4 p90 -136.62 167.12 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -122.52 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.31 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.66 -121.47 1.12 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.442 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.289 87.0 m -154.63 21.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -1.138 . . . . 0.0 111.241 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -75.34 -12.97 60.38 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.2 -1.562 . . . . 0.0 113.617 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.122 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.3 m -122.72 25.59 8.63 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.4 79.74 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 118.904 -1.617 . . . . 0.0 109.578 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.644 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.04 53.43 2.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.469 1.128 . . . . 0.0 111.037 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.53 107.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.64 -20.84 47.84 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.181 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 29.9 mtmt -118.17 -143.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.879 -1.365 . . . . 0.0 109.121 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 18.2 m-85 -146.06 176.31 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.844 -1.785 . . . . 0.0 110.45 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.644 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 90.1 m -136.77 164.03 29.23 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.428 -1.42 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.946 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.543 -0.723 . . . . 0.0 110.991 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 121.21 0.529 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.824 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.92 116.51 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.873 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.36 161.64 18.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.037 -1.039 . . . . 0.0 113.302 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.8 m-85 -149.02 176.45 10.44 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.4 p30 -81.98 -43.31 18.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.254 -0.903 . . . . 0.0 111.879 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.71 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.02 116.42 20.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.094 -1.004 . . . . 0.0 108.492 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.794 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -49.82 -35.54 23.26 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.02 -46.52 87.99 Favored 'General case' 0 C--O 1.2 -1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.009 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.96 -25.75 26.8 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 O-C-N 120.773 -1.204 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.099 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.8 t -60.4 -65.88 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -54.96 -54.66 39.91 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.913 -1.117 . . . . 0.0 110.841 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 3.4 tmtm? -62.84 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -59.88 -27.86 67.06 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.287 -0.883 . . . . 0.0 112.871 -176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.099 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.2 m . . . . . 0 N--CA 1.504 2.255 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.285 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.506 2.362 0 CA-C-O 121.813 0.816 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.82 166.04 24.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.45 149.79 43.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.627 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -123.41 1.42 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.468 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 98.4 m -156.05 25.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.41 -1.053 . . . . 0.0 110.846 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -74.13 -8.8 57.47 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.373 -1.454 . . . . 0.0 113.562 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.766 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -125.77 27.02 6.52 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 121.33 -0.856 . . . . 0.0 109.726 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 15.34 76.92 Favored Glycine 0 C--N 1.291 -1.965 0 C-N-CA 118.508 -1.806 . . . . 0.0 108.723 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.258 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.41 53.21 2.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.351 1.072 . . . . 0.0 111.096 -178.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.19 109.58 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.4 -19.93 43.91 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.761 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 28.3 mtmt -118.6 -143.05 0.36 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.722 -1.458 . . . . 0.0 109.368 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.1 m-85 -145.79 173.75 11.83 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 119.976 -1.703 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.258 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 76.3 m -136.87 162.55 32.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.449 -1.407 . . . . 0.0 111.118 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.859 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.306 -1.308 0 O-C-N 121.458 -0.776 . . . . 0.0 110.846 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.504 2.247 0 CA-C-O 121.042 0.448 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.772 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 62.2 t -115.15 115.81 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.33 162.05 18.1 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.313 1.054 . . . . 0.0 113.091 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.759 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.9 m-85 -148.6 175.79 10.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.945 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.9 p-10 -81.87 -42.34 19.71 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.177 -0.952 . . . . 0.0 112.071 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.17 117.01 21.35 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.973 -1.079 . . . . 0.0 108.905 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.787 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -50.02 -35.89 26.62 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.8 -46.27 87.99 Favored 'General case' 0 C--O 1.2 -1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.059 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.07 -25.51 26.57 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 O-C-N 120.658 -1.276 . . . . 0.0 109.44 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.039 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 27.2 t -60.94 -66.52 0.52 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -55.92 -54.03 49.65 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.748 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtt? -61.77 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.61 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.0 m-80 -60.67 -30.09 69.69 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.253 -0.904 . . . . 0.0 112.699 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.039 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 62.9 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.239 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.504 2.261 0 CA-C-O 121.44 0.638 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.485 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 25.0 p90 -138.26 163.27 32.2 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.04 153.69 39.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.455 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.57 -121.17 1.11 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.313 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.446 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 99.1 m -154.63 20.54 0.47 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 111.089 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -74.84 -9.77 58.86 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.336 -1.478 . . . . 0.0 113.351 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.2 m -124.24 24.09 8.18 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.397 -0.815 . . . . 0.0 109.856 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.51 18.44 77.07 Favored Glycine 0 C--N 1.29 -1.989 0 C-N-CA 118.495 -1.812 . . . . 0.0 108.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.205 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 22.5 pttt -87.92 51.22 2.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.443 1.116 . . . . 0.0 111.031 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.68 109.65 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.68 -21.16 41.63 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.263 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.0 mtmm -122.02 -145.15 0.35 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.394 . . . . 0.0 109.075 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.498 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 22.7 m-85 -145.76 177.41 8.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.829 -1.795 . . . . 0.0 110.35 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.205 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.2 m -137.09 161.08 37.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.344 -1.473 . . . . 0.0 110.58 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.145 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.761 . . . . 0.0 111.301 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 19.4 t . . . . . 0 N--CA 1.505 2.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.66 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 95.6 t -115.07 118.79 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.038 -1.039 . . . . 0.0 108.449 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.707 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.12 161.87 18.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.853 -1.154 . . . . 0.0 113.334 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 85.0 m-85 -148.56 175.27 11.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.929 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.5 p-10 -81.98 -42.58 19.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.869 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 114.74 20.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 108.664 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.812 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.2 ptmm? -49.44 -35.29 18.94 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.25 87.77 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.12 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.733 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.15 -26.26 24.88 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 O-C-N 120.675 -1.266 . . . . 0.0 109.389 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.175 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 t -60.69 -66.02 0.6 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -55.5 -54.18 47.11 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.707 -1.246 . . . . 0.0 110.645 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.0 tmtm? -63.19 -79.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.503 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -60.88 -28.3 68.78 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.259 -0.901 . . . . 0.0 113.13 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.175 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.8 m . . . . . 0 C--N 1.286 -2.164 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.372 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.507 2.38 0 CA-C-O 121.618 0.723 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -137.94 165.01 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.97 152.15 41.16 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.458 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.87 -120.75 1.04 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.377 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.286 93.9 m -155.18 23.33 0.42 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.364 -1.08 . . . . 0.0 111.034 -177.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -73.93 -12.26 60.6 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.258 -1.526 . . . . 0.0 113.416 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.984 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -123.43 25.48 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.79 77.53 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 118.687 -1.721 . . . . 0.0 109.08 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.291 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 pttm -87.93 54.2 3.02 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.609 1.195 . . . . 0.0 110.801 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.71 108.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 -22.13 40.77 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.108 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.674 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 5.4 mtmp? -113.82 -147.42 0.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.908 -1.348 . . . . 0.0 108.768 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 21.2 m-85 -146.57 176.8 9.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.774 -1.829 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.291 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.5 m -137.48 162.14 34.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.491 -1.38 . . . . 0.0 111.072 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.865 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.1 p . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.621 -0.674 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 17.5 t . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 120.614 0.245 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.865 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 66.4 t -114.69 111.46 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.803 -1.186 . . . . 0.0 108.178 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.17 162.2 17.81 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.264 1.031 . . . . 0.0 113.367 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.674 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.2 m-85 -150.47 175.3 12.0 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.295 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.08 -41.26 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.885 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.721 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.72 115.54 21.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.092 -1.005 . . . . 0.0 109.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.795 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.5 ptpt -50.03 -35.08 23.52 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.52 -45.97 87.72 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 108.996 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.721 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.49 -25.63 24.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.005 0 O-C-N 120.621 -1.3 . . . . 0.0 109.336 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.844 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 25.5 t -61.55 -67.93 0.36 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.0 -53.03 60.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.766 -1.209 . . . . 0.0 110.696 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.1 tmtt? -61.85 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.62 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -61.63 -32.6 72.76 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.28 -0.888 . . . . 0.0 112.879 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.844 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 69.8 m . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.306 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.702 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 12.6 t . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.701 0.762 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.6 p90 -136.74 165.45 25.89 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -122.63 149.02 44.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.059 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.29 -119.66 0.96 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.449 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 93.9 m -155.14 20.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 111.599 -177.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -75.28 -12.26 60.24 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.133 -1.605 . . . . 0.0 113.546 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.061 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.5 m -123.0 25.29 8.62 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.58 17.49 79.1 Favored Glycine 0 C--N 1.29 -1.982 0 C-N-CA 118.823 -1.656 . . . . 0.0 109.396 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.672 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.4 pttt -87.34 51.7 2.3 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.45 1.119 . . . . 0.0 111.031 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.15 109.48 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.15 -21.95 39.73 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.213 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.754 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 38.4 mtmt -123.23 -142.2 0.32 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.418 . . . . 0.0 109.227 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 28' ' ' CYS . 9.8 m-85 -146.15 176.86 9.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.914 -1.741 . . . . 0.0 110.562 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.672 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 86.3 m -136.72 163.3 30.92 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.432 -1.417 . . . . 0.0 110.882 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.092 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.401 0 O-C-N 121.613 -0.679 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.786 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.84 121.29 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 11.2 m -116.27 160.99 19.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.029 -1.069 . . . . 0.0 113.493 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.754 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 77.5 m-85 -148.9 177.77 9.26 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.915 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.75 -43.75 17.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.699 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.12 116.42 21.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.014 -1.054 . . . . 0.0 108.338 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.862 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.41 -34.8 25.73 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.48 -46.31 89.16 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 108.948 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.68 -26.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.722 -1.236 . . . . 0.0 109.424 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.154 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -60.55 -67.4 0.4 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -55.0 -53.45 55.57 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.82 -1.175 . . . . 0.0 110.821 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.12 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.2 m-80 -60.69 -26.94 67.49 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.375 -0.828 . . . . 0.0 112.955 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.154 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.8 m . . . . . 0 N--CA 1.502 2.146 0 C-N-CA 118.689 -1.205 . . . . 0.0 111.046 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.507 2.405 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -138.68 166.97 22.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 109.4 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -122.95 151.88 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.898 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.88 -119.96 0.97 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.482 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 91.7 m -155.01 23.89 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.23 -1.159 . . . . 0.0 111.155 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -73.32 -14.08 61.23 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.235 -1.54 . . . . 0.0 113.201 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -122.36 24.51 9.31 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 17.93 77.18 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 118.637 -1.744 . . . . 0.0 108.979 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.271 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 10.7 pttm -88.12 51.67 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.407 1.098 . . . . 0.0 111.338 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -67.27 111.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.81 -24.45 29.54 Favored Glycine 0 N--CA 1.498 2.832 0 C-N-CA 119.239 -1.457 . . . . 0.0 109.856 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 12.9 mtmt -118.38 -146.81 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.78 -1.423 . . . . 0.0 108.838 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 15.9 m-85 -146.95 176.77 9.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 119.836 -1.79 . . . . 0.0 110.319 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.271 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.05 161.63 35.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.428 -1.42 . . . . 0.0 110.79 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.084 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 121.499 0.666 . . . . 0.0 110.423 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 120.657 0.265 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.907 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.5 t -114.58 112.96 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.797 -1.189 . . . . 0.0 108.096 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 16.8 m -116.13 161.61 18.67 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.417 1.103 . . . . 0.0 113.667 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.688 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.1 m-85 -149.92 176.94 10.3 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.009 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.98 -42.9 18.74 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.687 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.709 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.47 117.22 21.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.042 -1.036 . . . . 0.0 108.872 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.842 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -50.87 -35.71 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.96 87.8 Favored 'General case' 0 C--O 1.201 -1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 108.909 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.709 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.85 -25.92 26.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.936 0 O-C-N 120.736 -1.227 . . . . 0.0 109.29 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.11 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.2 t -60.18 -66.23 0.56 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.99 -54.48 42.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.907 -1.121 . . . . 0.0 110.881 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.26 -79.34 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.435 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.2 m-80 -59.82 -28.68 67.67 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.269 -0.895 . . . . 0.0 112.852 -176.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.11 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 118.611 -1.235 . . . . 0.0 111.412 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.505 2.286 0 CA-C-O 121.871 0.843 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -138.39 166.93 23.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.78 151.75 41.32 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.901 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.96 -119.76 0.95 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.546 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.289 98.1 m -155.38 23.99 0.41 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.152 -1.205 . . . . 0.0 111.334 -177.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.27 -14.36 61.31 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.213 -1.554 . . . . 0.0 113.33 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.875 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.0 m -121.5 24.37 9.9 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.52 77.07 Favored Glycine 0 C--N 1.29 -1.986 0 C-N-CA 118.535 -1.793 . . . . 0.0 108.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.289 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.4 pttm -87.59 52.07 2.39 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.474 1.131 . . . . 0.0 111.111 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t -66.88 111.36 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.76 31.14 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.009 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 40.7 mtmt -119.51 -146.32 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.415 . . . . 0.0 108.972 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -146.11 175.91 10.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 119.901 -1.749 . . . . 0.0 110.256 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 64.7 m -137.37 160.67 38.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.388 -1.445 . . . . 0.0 111.322 -178.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.943 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.309 0 O-C-N 121.681 -0.637 . . . . 0.0 110.676 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.0 t . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.794 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.54 114.71 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.796 -1.19 . . . . 0.0 108.751 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.5 m -116.0 161.36 18.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.157 0.979 . . . . 0.0 112.988 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.3 m-85 -149.55 174.69 12.24 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.086 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.5 p30 -81.75 -41.39 21.29 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.811 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.22 114.95 20.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.045 -1.034 . . . . 0.0 108.658 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -50.0 -34.7 21.97 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.93 -46.41 88.02 Favored 'General case' 0 C--O 1.199 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.023 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.3 -26.29 25.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 120.596 -1.315 . . . . 0.0 109.376 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.137 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -61.27 -67.67 0.38 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -55.03 -53.06 60.68 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.747 -1.221 . . . . 0.0 110.737 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -62.33 -79.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.559 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -60.85 -29.73 69.69 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.268 -0.895 . . . . 0.0 112.839 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.137 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.0 m . . . . . 0 C--N 1.287 -2.129 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.404 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.4 t . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 121.788 0.804 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 36.0 p90 -138.29 167.27 22.22 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.57 153.3 39.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.764 -1.21 . . . . 0.0 111.553 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.14 -120.68 1.07 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.142 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 99.4 m -154.97 20.3 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -1.121 . . . . 0.0 111.275 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -75.25 -10.59 59.6 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.279 -1.513 . . . . 0.0 113.712 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.024 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.3 m -123.82 25.19 8.13 Favored 'General case' 0 C--N 1.284 -2.28 0 O-C-N 121.275 -0.89 . . . . 0.0 109.803 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.64 17.88 78.3 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 118.711 -1.709 . . . . 0.0 109.19 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.268 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 21.2 pttt -88.22 51.11 2.11 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.463 1.125 . . . . 0.0 111.133 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.88 109.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.27 -21.03 42.82 Favored Glycine 0 N--CA 1.5 2.907 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.29 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.754 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.8 mtmt -123.75 -142.65 0.32 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.411 . . . . 0.0 109.187 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.541 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.6 m-85 -145.21 177.63 8.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.777 -1.827 . . . . 0.0 110.5 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.268 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 92.9 m -137.5 163.78 30.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.513 -1.367 . . . . 0.0 110.998 -178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.087 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.555 -0.716 . . . . 0.0 111.276 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 121.141 0.496 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.823 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.9 t -114.94 120.31 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 13.6 m -116.19 161.01 19.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.955 -1.09 . . . . 0.0 113.36 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.754 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 77.6 m-85 -148.84 177.89 9.15 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.029 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.12 -44.01 17.06 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -0.973 . . . . 0.0 111.689 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.92 116.27 20.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.014 -1.054 . . . . 0.0 108.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.815 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.29 -34.79 24.66 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.3 -46.42 88.62 Favored 'General case' 0 C--O 1.2 -1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.981 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.66 -26.14 26.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.796 -1.19 . . . . 0.0 109.444 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.136 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.6 t -60.42 -65.62 0.66 Allowed 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -55.87 -54.47 44.2 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.615 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.4 tmtm? -62.85 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.513 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.1 m-80 -60.51 -27.24 67.45 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.269 -0.894 . . . . 0.0 112.991 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.136 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.5 m . . . . . 0 N--CA 1.504 2.245 0 C-N-CA 118.575 -1.25 . . . . 0.0 111.244 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.506 2.349 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -138.16 166.53 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.95 149.56 44.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.21 -118.77 0.86 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.984 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.448 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 96.6 m -154.88 22.87 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 111.47 -177.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -73.48 -14.63 61.27 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.1 -1.625 . . . . 0.0 113.228 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.83 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 25.1 m -122.1 24.94 9.29 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.96 76.41 Favored Glycine 0 C--N 1.289 -2.064 0 C-N-CA 118.306 -1.902 . . . . 0.0 108.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.267 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 pttt -86.86 50.7 2.06 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.456 1.122 . . . . 0.0 110.871 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -67.47 110.76 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.41 -22.72 36.61 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.713 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 8.9 mttm -119.61 -147.61 0.4 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.759 -1.436 . . . . 0.0 108.806 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.1 m-85 -146.88 175.49 10.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.777 . . . . 0.0 110.256 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.267 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 80.1 m -137.66 160.99 37.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.307 -1.496 . . . . 0.0 111.559 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.307 -1.278 0 O-C-N 121.697 -0.627 . . . . 0.0 110.574 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 15.5 t . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 120.507 0.194 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.791 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.9 t -114.26 114.89 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.681 -1.262 . . . . 0.0 108.649 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 19.6 m -116.0 162.38 17.46 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.352 1.073 . . . . 0.0 113.45 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.713 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 80.6 m-85 -148.65 175.08 11.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.804 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.402 ' CB ' ' HD3' ' A' ' 16' ' ' LYS . 1.9 p-10 -82.06 -42.36 19.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.002 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.695 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.32 118.37 22.58 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.104 -0.997 . . . . 0.0 108.927 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.831 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.0 ptpt -51.04 -35.72 35.86 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.2 -45.99 89.64 Favored 'General case' 0 C--O 1.2 -1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.281 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.695 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -58.13 -26.36 29.1 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 O-C-N 120.651 -1.281 . . . . 0.0 109.418 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.105 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.5 t -60.9 -66.96 0.45 Allowed 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -55.2 -53.37 56.89 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.839 -1.163 . . . . 0.0 110.62 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.84 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -59.95 -29.09 68.17 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 121.302 -0.874 . . . . 0.0 112.705 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.105 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.0 m . . . . . 0 N--CA 1.503 2.198 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.3 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.509 2.484 0 CA-C-O 122.037 0.923 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -137.15 166.41 23.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -122.88 150.69 42.56 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.014 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.3 -120.06 0.99 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.291 97.1 m -155.51 24.19 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.258 -1.142 . . . . 0.0 111.141 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.95 -12.3 60.61 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.237 -1.54 . . . . 0.0 113.466 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.047 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.2 m -122.55 25.29 8.87 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-O 121.818 0.818 . . . . 0.0 109.57 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.79 78.4 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.671 -1.728 . . . . 0.0 109.222 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.612 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -87.06 56.5 4.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.64 1.21 . . . . 0.0 110.429 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.89 107.72 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.19 51.71 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.447 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 31.2 mtmt -116.59 -145.8 0.39 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.757 -1.437 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.4 m-85 -146.55 176.06 10.11 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.893 -1.754 . . . . 0.0 110.705 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.612 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 57.5 m -136.46 160.81 37.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.439 -1.413 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.065 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.506 2.35 0 CA-C-O 120.699 0.285 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.832 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.5 t -114.72 110.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.759 -1.213 . . . . 0.0 108.23 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.7 m -116.19 161.41 19.0 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.201 1.0 . . . . 0.0 113.435 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.3 m-85 -150.55 176.76 10.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.417 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 4.3 p-10 -82.04 -42.53 19.14 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.987 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.756 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.77 116.26 21.38 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.961 -1.087 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.805 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.5 ptpt -50.55 -34.88 27.24 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.22 -45.88 86.88 Favored 'General case' 0 C--O 1.2 -1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.759 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.51 -25.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 O-C-N 120.681 -1.262 . . . . 0.0 109.263 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.065 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.0 t -61.13 -68.48 0.31 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -54.06 -53.64 50.33 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.896 -1.127 . . . . 0.0 110.846 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.22 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.557 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.8 m-80 -62.21 -29.66 70.54 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.291 -0.881 . . . . 0.0 113.182 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.048 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 73.8 m . . . . . 0 N--CA 1.504 2.244 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.309 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.793 0.806 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.6 p90 -135.85 164.76 27.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.58 149.81 43.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.476 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.15 -122.3 1.27 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.286 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.462 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 97.4 m -155.95 25.82 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.19 . . . . 0.0 110.989 -177.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -73.47 -8.88 57.74 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.359 -1.463 . . . . 0.0 113.414 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.74 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.7 m -126.08 26.28 6.55 Favored 'General case' 0 C--N 1.282 -2.368 0 O-C-N 121.402 -0.812 . . . . 0.0 109.833 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.07 75.68 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 118.434 -1.841 . . . . 0.0 108.714 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.226 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.38 51.7 2.3 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.189 0.995 . . . . 0.0 111.465 -178.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.14 111.81 2.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.78 -22.41 33.84 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.6 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmt -120.19 -143.15 0.35 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.559 -1.553 . . . . 0.0 109.348 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.6 m-85 -145.56 174.1 11.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.013 -1.679 . . . . 0.0 110.172 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.226 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 88.1 m -136.85 162.47 33.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.403 -1.435 . . . . 0.0 111.003 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.907 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.6 -0.687 . . . . 0.0 110.957 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 121.053 0.454 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.745 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.09 116.28 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.19 -0.943 . . . . 0.0 108.462 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.3 m -116.21 161.84 18.36 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.057 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.723 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.3 m-85 -148.37 175.14 11.35 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.927 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.4 p-10 -81.97 -42.46 19.36 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.947 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.97 116.57 21.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.011 -1.055 . . . . 0.0 108.764 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.785 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.8 ptpt -49.59 -35.97 22.56 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.23 -46.16 89.22 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.127 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.94 -26.02 27.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 O-C-N 120.769 -1.207 . . . . 0.0 109.455 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.107 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 24.6 t -60.87 -66.29 0.56 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -55.75 -54.0 49.78 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.618 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.8 tmtm? -62.7 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -177.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.5 m-80 -60.6 -28.15 68.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.283 -0.886 . . . . 0.0 113.031 -176.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.107 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.8 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.216 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.835 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 9.4 t . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 121.869 0.842 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 32.8 p90 -135.06 166.4 23.13 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.03 149.23 43.81 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.321 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.469 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 150.65 -122.23 1.35 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 96.8 m -156.23 23.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -1.103 . . . . 0.0 111.117 -177.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.31 -7.53 54.2 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.3 -1.5 . . . . 0.0 113.801 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.7 m -125.95 27.03 6.45 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.46 15.62 77.36 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 118.595 -1.764 . . . . 0.0 108.819 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.287 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.98 50.95 2.08 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.163 0.982 . . . . 0.0 111.461 -178.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.46 110.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.09 -20.56 40.31 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.836 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.742 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 21.9 mtmt -124.08 -139.04 0.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.597 -1.531 . . . . 0.0 109.425 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.569 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -144.33 174.1 11.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 119.844 -1.785 . . . . 0.0 110.052 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.287 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 99.5 m -135.05 163.13 30.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.54 -1.35 . . . . 0.0 110.842 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.1 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.531 -0.731 . . . . 0.0 110.922 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.502 2.151 0 CA-C-O 121.075 0.464 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.829 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.7 t -115.17 118.88 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.226 -0.921 . . . . 0.0 108.835 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.8 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.8 m -116.27 161.15 19.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 113.464 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.742 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 78.3 m-85 -148.81 177.48 9.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.95 -43.82 17.58 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.222 -0.924 . . . . 0.0 111.867 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.712 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.24 116.43 21.11 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.996 -1.065 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.79 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.5 ptpt -50.01 -35.23 23.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.06 -46.44 88.23 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.167 -0.958 . . . . 0.0 108.88 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.712 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.62 -25.66 25.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 O-C-N 120.82 -1.175 . . . . 0.0 109.358 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.1 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.6 t -60.08 -65.64 0.65 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -55.29 -55.36 32.29 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.89 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.2 tmtm? -62.32 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -60.33 -28.11 67.88 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.298 -0.876 . . . . 0.0 113.037 -176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.094 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 55.7 m . . . . . 0 N--CA 1.503 2.215 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.295 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.5 t . . . . . 0 N--CA 1.505 2.302 0 CA-C-O 121.75 0.786 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 30.8 p90 -136.95 163.32 30.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -123.11 148.93 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.47 -119.64 0.94 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.67 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.286 98.1 m -154.67 21.58 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -1.139 . . . . 0.0 111.285 -177.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -74.63 -11.49 60.2 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.251 -1.531 . . . . 0.0 113.399 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.963 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -124.33 25.87 7.56 Favored 'General case' 0 C--N 1.283 -2.289 0 O-C-N 121.4 -0.812 . . . . 0.0 109.772 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.05 76.49 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 118.536 -1.792 . . . . 0.0 108.883 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.399 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 pttt -87.45 51.27 2.18 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.464 1.126 . . . . 0.0 110.788 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 109.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.12 -23.12 35.54 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.961 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.6 mtmt -119.08 -145.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.43 . . . . 0.0 108.936 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.5 m-85 -146.69 176.63 9.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.779 -1.826 . . . . 0.0 110.493 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.399 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 97.2 m -137.46 161.74 35.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.499 -1.376 . . . . 0.0 110.611 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.069 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.411 0 O-C-N 121.427 -0.795 . . . . 0.0 110.993 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.501 2.122 0 CA-C-O 120.986 0.422 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.717 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -114.93 117.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.22 161.8 18.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.898 -1.127 . . . . 0.0 113.865 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.709 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.1 m-85 -149.44 176.79 10.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.843 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.2 p30 -81.91 -42.83 18.96 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.786 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.724 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.26 116.28 21.05 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.06 -1.025 . . . . 0.0 108.716 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.0 ptmm? -50.27 -35.7 28.25 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.84 89.1 Favored 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.059 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.724 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.65 -25.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 O-C-N 120.716 -1.24 . . . . 0.0 109.408 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.113 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.1 t -60.66 -67.87 0.36 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -55.1 -53.59 53.98 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.925 -1.109 . . . . 0.0 110.863 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.4 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.16 -29.41 68.65 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.218 -0.926 . . . . 0.0 112.768 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.113 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m . . . . . 0 N--CA 1.502 2.144 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.229 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.506 2.349 0 CA-C-O 121.696 0.76 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 30.5 p90 -137.92 164.45 28.96 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -122.94 149.49 44.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.92 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.459 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.35 -119.92 0.96 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.881 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 97.2 m -155.1 21.84 0.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 111.415 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.79 -12.46 60.4 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.284 -1.51 . . . . 0.0 113.63 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.881 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -124.16 26.3 7.51 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.15 17.83 77.56 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 118.497 -1.811 . . . . 0.0 108.888 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.266 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 4.0 pttt -87.39 50.09 1.94 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.403 1.096 . . . . 0.0 110.9 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.64 109.91 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.54 -22.78 37.45 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.02 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.689 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 37.3 mtmt -119.81 -145.05 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.86 -1.377 . . . . 0.0 108.82 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.9 m-85 -146.38 175.71 10.33 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 119.849 -1.782 . . . . 0.0 110.483 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.266 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 88.4 m -138.79 162.2 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.453 -1.404 . . . . 0.0 110.816 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.862 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 110.882 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.617 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 91.5 t -114.91 118.02 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.5 m -116.31 162.06 18.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.986 -1.085 . . . . 0.0 113.182 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.689 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 87.7 m-85 -148.74 174.33 12.3 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -81.74 -41.42 21.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.764 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 115.49 20.54 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.047 -1.033 . . . . 0.0 108.636 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.78 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.4 ptpt -49.58 -35.74 21.71 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.84 89.92 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 121.395 -0.815 . . . . 0.0 109.201 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.727 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.82 -26.18 27.39 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.951 0 O-C-N 120.637 -1.289 . . . . 0.0 109.445 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.093 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.2 t -61.4 -68.91 0.27 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -54.86 -52.5 62.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.855 -1.153 . . . . 0.0 110.868 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.54 -79.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.555 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.1 m-80 -60.98 -29.22 69.55 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.197 -0.939 . . . . 0.0 112.812 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.093 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.9 m . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.254 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.506 2.372 0 CA-C-O 121.666 0.746 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 24.4 p90 -138.97 162.87 33.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -123.33 153.5 40.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.84 -1.162 . . . . 0.0 111.601 -177.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.76 -120.89 1.06 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.608 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.283 92.8 m -154.01 19.19 0.51 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -1.145 . . . . 0.0 111.238 -177.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.92 -12.89 60.79 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.313 -1.492 . . . . 0.0 113.199 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.945 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.0 m -122.71 23.92 9.31 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.363 -0.835 . . . . 0.0 109.569 178.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.36 77.77 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 118.556 -1.783 . . . . 0.0 109.111 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.393 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.2 pttm -87.2 51.78 2.33 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.509 1.147 . . . . 0.0 111.097 -178.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.49 108.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 -21.65 42.43 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.186 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.697 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.6 mtmm -121.0 -146.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.819 -1.401 . . . . 0.0 108.901 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.5 m-85 -146.67 177.38 9.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.808 -1.807 . . . . 0.0 110.666 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.393 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 96.8 m -138.14 161.37 36.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.513 -1.367 . . . . 0.0 110.656 -178.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.05 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.389 -0.82 . . . . 0.0 111.18 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.7 t . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.647 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 63.8 t -115.0 117.7 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.049 -1.032 . . . . 0.0 108.258 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 17.6 m -116.23 161.95 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.381 -176.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.1 m-85 -149.24 175.04 11.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.868 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.2 p30 -81.92 -42.12 19.93 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.218 -0.926 . . . . 0.0 111.865 178.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.36 115.3 20.65 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.064 -1.023 . . . . 0.0 108.85 179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.6 ptpt -49.77 -35.14 21.42 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.58 -46.48 86.86 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.945 176.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.39 -25.74 24.64 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 O-C-N 120.763 -1.21 . . . . 0.0 109.378 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.116 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 t -60.78 -66.1 0.58 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -55.44 -54.31 45.42 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.86 -1.15 . . . . 0.0 110.664 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtm? -62.26 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -59.93 -30.09 68.82 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.267 -0.896 . . . . 0.0 112.816 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.116 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 83.1 m . . . . . 0 N--CA 1.502 2.16 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.383 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.507 2.392 0 CA-C-O 121.892 0.853 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 30.4 p90 -136.09 168.9 18.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.63 145.59 48.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.694 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.94 -118.17 0.83 Allowed Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.605 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' THR 0.297 54.9 m -158.04 32.7 0.25 Allowed 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.251 -1.147 . . . . 0.0 110.276 -177.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -68.79 -7.96 38.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.084 -1.635 . . . . 0.0 112.529 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.7 m -120.49 23.67 10.73 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.966 0.889 . . . . 0.0 108.637 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.27 83.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.137 178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.087 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -93.78 71.62 4.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.842 1.306 . . . . 0.0 112.667 -178.681 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 9' ' ' THR . 33.6 t -64.27 116.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.599 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.85 -25.94 17.31 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.756 -1.687 . . . . 0.0 111.674 178.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.825 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 16.1 mttt -108.47 -146.33 0.4 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 120.371 2.085 . . . . 0.0 109.497 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.885 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 11.3 m-85 -146.4 169.37 19.01 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 119.437 -2.04 . . . . 0.0 111.487 -178.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.087 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 50.0 m -137.43 161.57 35.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.806 -1.809 . . . . 0.0 112.619 -178.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.078 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 121.366 0.603 . . . . 0.0 109.641 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 1.078 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 t -113.48 105.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.677 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 24.5 m -116.11 163.98 15.14 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.313 1.054 . . . . 0.0 113.545 -175.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.681 ' CG ' HG21 ' A' ' 34' ' ' ILE . 87.1 m-85 -150.08 176.65 10.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -82.54 -41.73 19.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.035 -1.041 . . . . 0.0 111.635 178.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.692 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.91 118.8 22.72 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.007 -1.058 . . . . 0.0 108.863 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.837 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.2 ptpt -50.65 -37.12 38.99 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.29 -45.27 91.73 Favored 'General case' 0 C--O 1.198 -1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 109.265 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.692 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.39 -26.06 29.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 120.659 -1.276 . . . . 0.0 109.31 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.971 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 5.2 t -61.85 -70.28 0.2 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -54.71 -51.48 65.44 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.958 -1.089 . . . . 0.0 110.585 178.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 1.6 tmtm? -62.3 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.47 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -61.45 -29.36 69.9 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.209 -0.932 . . . . 0.0 112.825 -177.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.971 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.8 m . . . . . 0 N--CA 1.505 2.307 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.08 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.793 0.806 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -137.55 164.6 28.33 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.17 149.27 44.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.746 -1.181 . . . . 0.0 110.801 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.99 -119.45 0.92 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.918 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 89.4 m -155.02 22.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -1.144 . . . . 0.0 111.514 -177.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -73.99 -12.61 60.69 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.185 -1.572 . . . . 0.0 113.333 -177.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.895 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -123.19 25.08 8.59 Favored 'General case' 0 C--N 1.281 -2.37 0 O-C-N 121.431 -0.793 . . . . 0.0 109.645 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.01 76.55 Favored Glycine 0 C--N 1.29 -2.018 0 C-N-CA 118.491 -1.814 . . . . 0.0 108.68 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.289 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 pttt -87.32 51.47 2.24 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.42 1.105 . . . . 0.0 110.927 -178.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.51 109.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.63 37.65 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 23.3 mtmt -118.52 -147.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.808 -1.407 . . . . 0.0 108.892 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.0 m-85 -147.3 176.51 9.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.852 -1.78 . . . . 0.0 110.232 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 81.5 m -136.4 162.23 33.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.515 -1.366 . . . . 0.0 111.341 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.987 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.305 -1.341 0 O-C-N 121.712 -0.617 . . . . 0.0 110.584 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 9.4 t . . . . . 0 N--CA 1.509 2.5 0 CA-C-O 120.446 0.165 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.855 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.23 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.63 -1.294 . . . . 0.0 108.595 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.4 m -116.03 162.01 18.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.315 1.055 . . . . 0.0 113.79 -176.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 79.1 m-85 -149.28 176.64 10.36 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.3 p-10 -82.22 -43.24 17.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.236 -0.915 . . . . 0.0 111.933 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.707 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.09 117.62 21.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.105 -0.997 . . . . 0.0 108.848 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.872 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 17.0 ptpt -50.26 -35.82 28.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.94 90.33 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.157 176.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.707 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.87 -26.01 27.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.717 -1.239 . . . . 0.0 109.333 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.152 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -60.56 -68.0 0.34 Allowed 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -54.85 -53.47 54.94 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.752 -1.217 . . . . 0.0 110.952 177.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.15 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.554 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.9 m-80 -60.32 -29.32 68.79 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 112.772 -176.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.152 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 71.0 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.272 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 121.868 0.842 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.5 165.73 24.84 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.45 149.77 43.39 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.67 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.97 -124.13 1.55 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.365 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 96.4 m -155.44 25.35 0.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.82 -177.826 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -74.05 -7.44 52.49 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.326 -1.484 . . . . 0.0 113.522 -176.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m -127.64 27.18 5.82 Favored 'General case' 0 C--N 1.284 -2.253 0 O-C-N 121.281 -0.887 . . . . 0.0 109.809 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.45 15.04 77.26 Favored Glycine 0 C--N 1.291 -1.933 0 C-N-CA 118.56 -1.781 . . . . 0.0 108.848 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.278 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.64 52.7 2.56 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.229 1.014 . . . . 0.0 111.298 -178.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.44 109.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.3 -20.63 44.2 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.801 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.735 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.8 mtmt -117.41 -143.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.709 -1.465 . . . . 0.0 109.169 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.8 m-85 -145.66 173.85 11.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 119.875 -1.766 . . . . 0.0 110.179 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.278 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -136.48 163.18 31.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.451 -1.406 . . . . 0.0 111.024 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.819 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.304 -1.403 0 O-C-N 121.529 -0.732 . . . . 0.0 110.799 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.504 2.236 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.819 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.0 t -115.14 115.51 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.37 161.99 18.22 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.304 1.049 . . . . 0.0 113.325 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.735 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.4 m-85 -148.74 175.82 10.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.048 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -82.36 -42.59 18.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.204 -0.935 . . . . 0.0 112.066 178.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.66 116.56 20.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.003 -1.06 . . . . 0.0 108.573 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.807 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 1.1 ptpp? -49.71 -35.85 23.29 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -46.15 89.12 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.094 176.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.16 -26.12 28.53 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.726 -1.234 . . . . 0.0 109.386 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.061 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -60.34 -65.82 0.62 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -56.45 -54.11 49.58 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.697 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -62.36 -79.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -177.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.546 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.75 -28.53 68.77 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.29 -0.881 . . . . 0.0 112.962 -176.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.061 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.2 m . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.251 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 121.646 0.736 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -137.3 166.97 22.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.84 153.03 40.14 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.113 -177.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.48 -121.28 1.11 Allowed Glycine 0 N--CA 1.487 2.082 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.484 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 92.3 m -155.19 22.32 0.43 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.339 -1.095 . . . . 0.0 111.057 -177.874 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -73.89 -13.41 60.9 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.316 -1.49 . . . . 0.0 113.355 -177.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.039 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -122.32 25.42 8.94 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 121.365 -0.834 . . . . 0.0 109.457 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.78 16.61 78.02 Favored Glycine 0 C--N 1.291 -1.947 0 C-N-CA 118.673 -1.727 . . . . 0.0 109.112 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.277 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pttm -88.03 52.94 2.59 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.483 1.135 . . . . 0.0 110.986 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.1 108.92 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.11 -22.38 39.56 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.997 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.691 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.6 mtmt -115.54 -146.36 0.4 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.743 -1.445 . . . . 0.0 108.83 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.6 m-85 -146.82 177.06 9.41 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 119.824 -1.798 . . . . 0.0 110.633 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.277 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.0 160.4 39.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.379 -1.45 . . . . 0.0 110.755 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.105 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.304 -1.393 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 9.6 t . . . . . 0 N--CA 1.509 2.496 0 CA-C-O 120.588 0.233 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.8 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 t -114.75 114.03 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.809 -1.182 . . . . 0.0 108.48 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.764 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.4 m -115.96 161.45 18.82 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.256 1.027 . . . . 0.0 113.218 -176.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.691 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 87.3 m-85 -149.9 176.49 10.7 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.265 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.5 p-10 -82.12 -42.15 19.52 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.238 -0.914 . . . . 0.0 111.833 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.42 114.99 20.54 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.043 -1.035 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 10.1 ptmt -50.21 -35.03 24.85 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.11 87.01 Favored 'General case' 0 C--O 1.2 -1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 108.879 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.733 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.16 -25.67 23.58 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 120.635 -1.291 . . . . 0.0 109.389 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.125 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 t -60.55 -66.88 0.46 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.01 -54.26 45.22 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.817 -1.177 . . . . 0.0 111.088 177.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.3 tmtm? -62.04 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.541 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -60.99 -30.31 70.2 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.185 -0.947 . . . . 0.0 112.818 -176.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.125 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 95.6 m . . . . . 0 C--N 1.286 -2.182 0 C-N-CA 118.696 -1.202 . . . . 0.0 111.338 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.504 2.258 0 CA-C-O 121.828 0.823 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -137.49 166.28 24.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.87 152.17 41.01 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.284 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.06 -120.16 0.99 Allowed Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.534 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 97.6 m -155.28 23.59 0.42 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 111.235 -177.817 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.45 -14.52 61.26 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 120.217 -1.552 . . . . 0.0 113.257 -177.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.907 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.2 m -121.66 25.07 9.48 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 121.361 -0.837 . . . . 0.0 109.475 177.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.17 17.26 77.22 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.283 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.7 pttm -87.69 53.08 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.582 1.182 . . . . 0.0 110.885 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.32 109.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.95 -22.94 36.36 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.912 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.0 mtmt -115.24 -148.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.859 -1.377 . . . . 0.0 108.668 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.4 m-85 -146.68 175.91 10.25 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 119.83 -1.794 . . . . 0.0 110.455 -179.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.283 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 63.0 m -137.16 160.94 37.53 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.359 -1.463 . . . . 0.0 111.369 -178.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.881 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.743 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.505 2.302 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.784 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.9 t -114.36 112.87 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.831 -1.168 . . . . 0.0 108.435 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.3 m -116.13 161.96 18.15 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.217 1.008 . . . . 0.0 113.0 -176.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.692 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.3 m-85 -149.62 174.08 12.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.14 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.63 -41.19 21.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 111.939 178.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.46 115.09 20.62 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.085 -1.009 . . . . 0.0 108.729 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.79 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.3 ptpt -49.92 -34.97 22.15 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.65 -46.2 87.66 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 176.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.6 -25.45 24.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 O-C-N 120.606 -1.309 . . . . 0.0 109.382 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.055 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 34.3 t -61.26 -66.66 0.5 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -55.04 -54.14 46.86 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.843 -1.161 . . . . 0.0 110.734 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.561 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.66 -79.09 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.561 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 51.1 m-80 -60.84 -31.13 70.57 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.278 -0.889 . . . . 0.0 112.869 -176.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.055 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 98.0 m . . . . . 0 N--CA 1.502 2.136 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.228 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.505 2.301 0 CA-C-O 121.703 0.763 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -137.04 163.42 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -123.09 149.45 44.46 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.939 -1.105 . . . . 0.0 111.084 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.46 -120.07 0.97 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.767 179.204 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 95.1 m -154.78 21.76 0.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.158 . . . . 0.0 111.283 -177.529 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.288 -1.507 . . . . 0.0 113.462 -177.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.92 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.8 m -124.26 25.66 7.68 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 178.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.64 17.62 76.66 Favored Glycine 0 C--N 1.29 -1.984 0 C-N-CA 118.38 -1.867 . . . . 0.0 108.694 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.299 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.8 pttt -87.68 51.2 2.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.547 1.165 . . . . 0.0 110.852 -178.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -67.23 108.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.21 -22.31 38.34 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.069 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.702 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmp? -119.0 -146.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.753 -1.439 . . . . 0.0 108.866 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.8 m-85 -146.77 176.15 10.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 119.856 -1.778 . . . . 0.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.299 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 92.8 m -137.29 161.89 35.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.389 -1.445 . . . . 0.0 110.802 -178.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.05 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.806 . . . . 0.0 111.123 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.686 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 83.4 t -114.94 117.6 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.1 m -116.22 161.86 18.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.895 -1.128 . . . . 0.0 113.474 -176.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.702 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.9 m-85 -148.64 175.17 11.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.845 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.8 -42.33 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.811 178.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.34 116.49 21.2 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.008 -1.058 . . . . 0.0 108.774 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.2 ptpt -50.23 -35.51 27.06 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.95 -46.16 88.7 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 109.047 176.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.72 -26.04 26.63 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.139 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.4 t -60.83 -67.58 0.39 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.78 -53.51 54.17 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.843 -1.161 . . . . 0.0 110.855 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -62.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.544 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.32 -0.863 . . . . 0.0 113.032 -176.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.139 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.4 m . . . . . 0 N--CA 1.503 2.18 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.353 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 39.2 t . . . . . 0 N--CA 1.509 2.478 0 CA-C-O 121.701 0.762 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.9 p90 -137.29 162.72 32.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.2 149.08 45.11 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.015 -1.053 . . . . 0.0 110.772 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.82 -121.84 1.16 Allowed Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.504 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.446 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 98.1 m -155.74 28.72 0.37 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.489 -1.007 . . . . 0.0 110.288 -177.861 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -71.36 -12.27 61.34 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.516 -1.365 . . . . 0.0 112.79 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -117.27 21.98 12.78 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.59 15.24 77.6 Favored Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -92.28 61.25 3.84 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.37 1.081 . . . . 0.0 112.428 -177.984 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.64 116.94 3.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.16 -23.74 22.46 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 118.866 -1.635 . . . . 0.0 111.641 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.0 mtmm -120.11 -149.72 0.44 Allowed 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 120.426 2.113 . . . . 0.0 110.222 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 12.9 m-85 -146.2 170.12 17.38 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 119.983 -1.698 . . . . 0.0 110.276 -179.276 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 55.5 m -133.86 163.91 28.45 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.197 -1.564 . . . . 0.0 111.199 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.055 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.491 0.663 . . . . 0.0 110.737 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 120.903 0.383 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.955 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 88.0 t -113.3 109.17 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 14.6 m -116.25 164.71 14.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -173.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' CG ' HG21 ' A' ' 34' ' ' ILE . 78.8 m-85 -150.59 176.8 10.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.64 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.55 -42.34 18.47 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.834 178.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 119.02 23.01 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.016 -1.053 . . . . 0.0 108.854 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.77 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -51.21 -36.6 42.36 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.71 -45.7 88.97 Favored 'General case' 0 C--O 1.201 -1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 176.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.55 -25.5 28.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 O-C-N 120.667 -1.271 . . . . 0.0 109.339 179.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.055 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 20.0 t -60.73 -66.8 0.47 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.76 -54.28 44.12 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.808 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -62.86 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -177.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.6 -28.81 68.79 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.323 -0.861 . . . . 0.0 113.058 -176.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.2 m . . . . . 0 N--CA 1.505 2.28 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.128 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.507 2.412 0 CA-C-O 121.731 0.777 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.98 167.29 21.79 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.05 152.42 41.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.699 -1.2 . . . . 0.0 111.206 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.92 -120.88 1.05 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.479 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 92.4 m -155.01 23.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.292 -1.122 . . . . 0.0 111.13 -177.775 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.71 -12.99 60.89 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 120.3 -1.5 . . . . 0.0 113.329 -177.001 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.93 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.7 m -123.0 24.96 8.76 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.346 -0.846 . . . . 0.0 109.542 177.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.14 17.39 77.26 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.605 -1.76 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.282 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 5.0 pttm -87.99 53.16 2.67 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.501 1.143 . . . . 0.0 110.972 -178.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -67.29 109.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.1 -23.31 34.95 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.916 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.7 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.4 mtmm -114.95 -147.68 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.852 -1.381 . . . . 0.0 108.761 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 19.2 m-85 -146.72 176.48 9.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.878 -1.764 . . . . 0.0 110.289 -179.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.282 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 59.9 m -137.13 161.84 35.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.301 -1.499 . . . . 0.0 111.283 -178.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.889 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.303 0 O-C-N 121.599 -0.688 . . . . 0.0 110.731 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 12.8 t . . . . . 0 N--CA 1.507 2.414 0 CA-C-O 120.561 0.219 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.849 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 59.4 t -114.49 113.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.724 -1.235 . . . . 0.0 108.366 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.603 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.12 162.5 17.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.029 . . . . 0.0 113.446 -176.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.7 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.4 m-85 -149.27 174.68 12.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 p-10 -82.2 -42.01 19.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.89 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.15 116.16 20.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.942 -1.099 . . . . 0.0 108.808 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.779 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.8 ptpt -49.94 -35.58 24.6 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.9 -46.31 88.19 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.033 176.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.718 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.73 -25.85 26.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 O-C-N 120.655 -1.278 . . . . 0.0 109.467 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.041 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.1 t -61.08 -66.66 0.5 Allowed 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -55.28 -53.82 51.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.878 -1.138 . . . . 0.0 110.551 177.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.1 tmtm? -62.46 -79.6 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.3 m-80 -60.37 -30.56 69.65 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.172 -0.955 . . . . 0.0 112.713 -176.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 70.7 m . . . . . 0 N--CA 1.503 2.179 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.1 t . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 121.938 0.875 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.8 p90 -137.57 166.54 23.66 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.54 152.91 39.89 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.285 -177.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.35 -121.62 1.15 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.354 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.437 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.286 93.7 m -154.7 22.63 0.46 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -1.109 . . . . 0.0 110.996 -177.764 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -74.46 -11.47 60.24 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.292 -1.505 . . . . 0.0 113.351 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.992 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -123.77 24.7 8.33 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 121.265 -0.897 . . . . 0.0 109.735 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.43 17.15 77.56 Favored Glycine 0 C--N 1.291 -1.966 0 C-N-CA 118.641 -1.743 . . . . 0.0 109.077 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -87.45 52.63 2.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.392 1.091 . . . . 0.0 111.01 -178.69 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.03 110.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.51 -21.32 41.39 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.712 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.5 mttt -120.87 -145.36 0.36 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.796 -1.414 . . . . 0.0 109.033 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.509 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 16.0 m-85 -146.1 177.65 8.81 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.778 -1.826 . . . . 0.0 110.494 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -137.45 162.01 34.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.389 -1.444 . . . . 0.0 110.874 -178.552 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.085 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.301 0 O-C-N 121.46 -0.775 . . . . 0.0 111.123 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 121.058 0.456 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.795 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.13 116.11 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.703 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.26 161.63 18.71 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.493 -176.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.712 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 79.9 m-85 -149.1 176.74 10.21 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.184 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.89 -43.62 17.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.236 -0.915 . . . . 0.0 111.796 178.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.707 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.44 21.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.947 -1.095 . . . . 0.0 108.498 179.295 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.7 ptpt -50.34 -35.2 26.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.16 -46.13 89.2 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 109.084 176.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.707 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.72 -26.27 27.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 O-C-N 120.719 -1.238 . . . . 0.0 109.454 179.228 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.117 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 t -61.28 -67.44 0.41 Allowed 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.08 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -55.23 -53.13 59.93 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.756 -1.215 . . . . 0.0 110.61 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -62.92 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.72 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.9 m-80 -61.08 -28.35 69.02 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 112.948 -176.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.117 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.1 m . . . . . 0 N--CA 1.503 2.219 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.118 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.014 0.435 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -83.63 118.86 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.224 -0.923 . . . . 0.0 110.238 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 156.0 9.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 mt -131.89 179.26 6.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.977 . . . . 0.0 109.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 t -145.38 150.65 36.94 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.735 -1.228 . . . . 0.0 110.426 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -138.39 163.04 32.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.1 151.49 42.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.22 -121.33 1.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.444 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.284 94.5 m -154.69 23.58 0.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.293 -1.122 . . . . 0.0 111.117 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -73.72 -13.86 61.04 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.259 -1.526 . . . . 0.0 113.332 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.813 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.1 m -120.97 24.25 10.27 Favored 'General case' 0 C--N 1.283 -2.297 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.46 77.5 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 118.708 -1.71 . . . . 0.0 109.029 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.356 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 16.6 pttm -87.84 52.87 2.59 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.534 1.159 . . . . 0.0 110.928 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 t -66.73 110.73 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.79 -22.84 34.28 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.24 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.2 mtmt -119.9 -145.69 0.37 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.663 -1.493 . . . . 0.0 109.147 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 17.4 m-85 -146.0 174.85 10.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.893 -1.754 . . . . 0.0 110.326 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.356 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.4 m -137.44 161.25 36.85 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.377 -1.452 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.999 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.46 127.85 32.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.775 . . . . 0.0 110.818 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -165.86 124.77 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.66 1.31 9.32 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.199 1.105 . . . . 0.0 111.317 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 HG21 ' HG2' ' A' ' 24' ' ' LYS . 5.8 tt -163.83 11.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.995 0.902 . . . . 0.0 111.257 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.24 11.53 84.87 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -87.92 -35.52 17.64 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.452 -1.028 . . . . 0.0 111.271 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' CYS . 47.8 m-85 -84.9 -41.1 16.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 111.742 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' TYR . 26.2 t 41.83 67.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.245 -0.909 . . . . 0.0 109.519 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 89.3 t -114.69 116.73 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 12.9 m -116.33 161.78 18.51 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.33 1.062 . . . . 0.0 113.157 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.726 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.6 m-85 -149.37 174.56 12.31 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -81.46 -40.72 22.89 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.837 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.2 113.85 19.62 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.083 -1.011 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.774 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.0 ptmm? -49.37 -35.05 17.61 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.29 86.98 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.126 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.735 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.18 -25.7 23.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 O-C-N 120.668 -1.27 . . . . 0.0 109.382 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.111 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 37.6 t -61.15 -67.35 0.41 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -54.53 -53.92 47.99 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.895 -1.128 . . . . 0.0 110.996 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -61.9 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.524 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.3 m-80 -60.26 -30.47 69.46 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 121.227 -0.921 . . . . 0.0 112.767 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.111 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 94.3 m -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.506 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 11.9 p . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.104 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.237 0.541 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -155.73 176.57 12.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.75 -168.23 39.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.14 178.04 7.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -1.004 . . . . 0.0 109.487 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 t -114.26 137.81 51.3 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.653 -1.279 . . . . 0.0 110.03 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.0 p90 -138.19 162.89 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.05 150.81 42.63 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.411 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.95 -122.46 1.23 Allowed Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.54 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 92.3 m -154.79 24.11 0.45 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.369 -1.077 . . . . 0.0 110.818 -177.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.77 -13.33 60.93 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.299 -1.501 . . . . 0.0 113.294 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.907 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.9 m -121.28 24.75 9.86 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.431 -0.793 . . . . 0.0 109.367 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.86 77.52 Favored Glycine 0 C--N 1.29 -1.985 0 C-N-CA 118.701 -1.714 . . . . 0.0 109.058 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.319 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 9.2 pttm -88.08 54.32 3.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.561 1.172 . . . . 0.0 110.843 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.68 108.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.54 -22.65 36.69 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.022 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 41.5 mtmt -114.45 -147.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.821 -1.4 . . . . 0.0 108.943 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 25.4 m-85 -146.57 175.62 10.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.9 -1.75 . . . . 0.0 110.277 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.319 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.9 m -136.8 161.76 35.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.515 -1.366 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.9 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -135.21 106.72 6.87 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -171.82 139.96 1.13 Allowed Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -78.2 -7.65 16.19 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.263 1.138 . . . . 0.0 109.765 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.587 HG21 ' HG2' ' A' ' 24' ' ' LYS . 7.8 tt -164.86 -169.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.5 13.09 57.11 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.04 -1.037 . . . . 0.0 111.256 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.587 ' HG2' HG21 ' A' ' 22' ' ' ILE . 13.8 ptmt -83.65 -44.24 14.75 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.715 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.459 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 46.1 m-85 -87.65 -50.79 6.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.956 -1.09 . . . . 0.0 110.782 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' TYR . 18.2 t 36.24 74.29 0.08 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.624 -0.672 . . . . 0.0 110.749 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.4 t -114.45 111.48 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.699 -1.251 . . . . 0.0 108.434 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.2 m -116.13 161.64 18.62 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.29 1.043 . . . . 0.0 113.46 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.8 m-85 -150.12 175.75 11.46 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.8 p-10 -82.12 -41.82 19.95 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.92 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.71 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.11 115.51 20.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.964 -1.085 . . . . 0.0 108.739 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.89 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 9.4 ptmt -49.74 -35.3 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.8 -46.38 87.7 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.048 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.48 -25.79 25.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.0 109.332 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.043 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.2 t -60.35 -66.58 0.5 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.02 -54.17 48.06 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.927 -1.108 . . . . 0.0 110.785 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -61.61 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.576 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -61.02 -29.82 69.94 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.224 -0.922 . . . . 0.0 112.881 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.043 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.0 m -50.96 -29.91 13.52 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.357 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.1 -1.0 . . . . 0.0 110.144 -179.733 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.254 0.549 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.39 155.66 34.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.27 158.76 11.29 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.698 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.8 mt -130.78 179.62 5.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 t -143.04 148.65 37.08 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.445 -1.409 . . . . 0.0 111.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -138.5 164.43 29.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.62 153.21 39.62 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.419 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.95 -122.18 1.23 Allowed Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.36 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.291 95.2 m -154.9 22.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 111.004 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -75.15 -10.16 59.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.316 -1.49 . . . . 0.0 113.713 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.6 m -124.5 25.32 7.64 Favored 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.245 -0.909 . . . . 0.0 109.707 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.24 77.43 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 118.593 -1.765 . . . . 0.0 109.167 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 4.2 pttt -87.83 51.67 2.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.505 1.145 . . . . 0.0 110.956 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.82 110.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 -22.04 39.46 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.11 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.3 mtmm -119.41 -145.53 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.865 -1.373 . . . . 0.0 109.005 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.541 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 26.5 m-85 -145.81 175.94 10.03 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 119.871 -1.768 . . . . 0.0 110.276 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 90.5 m -137.07 161.61 35.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.255 -1.528 . . . . 0.0 110.664 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.941 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.49 131.15 31.43 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.378 -0.826 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -164.01 129.93 2.2 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -78.38 -2.78 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.253 1.133 . . . . 0.0 111.241 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.426 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 7.5 tt -164.53 12.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.031 0.92 . . . . 0.0 111.24 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.84 12.22 84.06 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -88.25 -34.78 17.62 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.435 -1.038 . . . . 0.0 111.425 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.4 m-85 -86.55 -43.91 12.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.171 -0.956 . . . . 0.0 111.944 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 20.0 t 48.94 69.77 0.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.113 -0.992 . . . . 0.0 109.808 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.676 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 95.2 t -115.33 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.8 m -116.17 162.3 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.91 -1.119 . . . . 0.0 113.085 -176.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.737 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.7 m-85 -147.75 174.76 11.5 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.024 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.2 p-10 -82.04 -42.67 18.96 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.003 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.95 116.39 20.89 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.976 -1.077 . . . . 0.0 108.68 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.792 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.3 ptpt -49.19 -36.03 18.66 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.58 88.25 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.35 -26.36 25.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 O-C-N 120.704 -1.248 . . . . 0.0 109.435 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.146 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.4 t -60.98 -67.29 0.42 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -54.82 -53.42 55.47 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.825 -1.172 . . . . 0.0 110.875 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.31 -80.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 49.7 m-80 -61.16 -28.12 68.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.261 -0.899 . . . . 0.0 113.007 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.146 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.8 m -48.34 -32.37 7.38 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.084 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -155.54 -164.64 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.403 -0.811 . . . . 0.0 109.961 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.01 -148.12 12.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.657 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.99 179.72 5.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.964 . . . . 0.0 109.692 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 17.1 t -142.82 152.55 42.32 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.761 -1.212 . . . . 0.0 110.585 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -136.6 165.16 26.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -122.73 149.89 43.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.309 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.54 -120.33 1.01 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.531 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.439 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.289 96.1 m -154.83 21.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -1.136 . . . . 0.0 111.334 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.331 -1.48 . . . . 0.0 113.541 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.092 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.8 m -123.19 25.59 8.37 Favored 'General case' 0 C--N 1.282 -2.354 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.68 17.23 79.11 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 118.784 -1.674 . . . . 0.0 109.412 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.599 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.14 53.17 2.73 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.541 1.162 . . . . 0.0 110.856 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.82 107.78 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.42 -21.06 45.87 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.067 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.717 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 15.2 mtmt -119.18 -144.14 0.36 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.917 -1.343 . . . . 0.0 109.128 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.463 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.7 m-85 -146.65 176.67 9.66 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 119.789 -1.819 . . . . 0.0 110.593 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.599 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 95.8 m -136.74 163.29 30.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.445 -1.41 . . . . 0.0 110.745 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.9 125.15 29.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.511 -0.743 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 p -166.11 124.41 1.09 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -78.78 -1.44 11.6 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.105 1.055 . . . . 0.0 110.794 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 24' ' ' LYS . 4.7 tt -163.99 12.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.015 0.912 . . . . 0.0 110.909 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.63 13.49 83.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HD2' HG23 ' A' ' 22' ' ' ILE . 7.8 ptmt -86.41 -35.48 19.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.8 m-85 -85.21 -44.33 13.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.797 . . . . 0.0 111.585 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 54.1 t 44.65 64.15 1.45 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.762 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.6 t -114.96 118.11 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.82 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.5 m -116.16 161.69 18.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.493 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 83.7 m-85 -149.26 176.51 10.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.0 p-10 -81.93 -42.83 18.93 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.78 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.717 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.13 20.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.029 -1.045 . . . . 0.0 108.611 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.789 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.7 ptpt -49.94 -35.45 24.09 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.12 -46.16 89.04 Favored 'General case' 0 C--O 1.201 -1.497 0 O-C-N 121.307 -0.87 . . . . 0.0 109.12 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.717 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.79 -25.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 120.566 -1.334 . . . . 0.0 109.407 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.101 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.7 t -60.82 -67.45 0.4 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -55.02 -53.53 54.68 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.901 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.1 tmtm? -62.81 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.51 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.69 -28.46 68.64 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.262 -0.899 . . . . 0.0 112.92 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.101 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.7 m -49.23 -29.81 6.22 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.368 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.158 -179.773 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.281 0.562 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.01 -167.06 1.6 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.51 -135.69 1.94 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.102 -1.046 . . . . 0.0 110.912 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mt -133.11 178.83 6.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.522 -0.987 . . . . 0.0 109.716 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 1.26 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 5.5 t -148.05 149.67 32.52 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.27 170.76 15.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.993 -1.067 . . . . 0.0 110.668 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.24 152.16 40.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.988 . . . . 0.0 110.833 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.27 -122.78 1.25 Allowed Glycine 0 N--CA 1.485 1.951 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.294 91.5 m -155.77 26.75 0.38 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.32 -1.106 . . . . 0.0 110.57 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.43 -9.18 58.42 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.455 -1.403 . . . . 0.0 113.571 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.7 m -122.54 23.61 9.55 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.394 -0.816 . . . . 0.0 109.799 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.77 74.86 Favored Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.116 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 2.0 pttp -87.22 51.45 2.24 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.207 1.003 . . . . 0.0 111.944 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.02 114.68 3.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -24.55 22.46 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.323 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.663 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 6.7 mtmt -123.49 -146.1 0.35 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.515 -1.58 . . . . 0.0 109.554 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 54.6 m-85 -144.0 169.56 17.59 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 119.971 -1.705 . . . . 0.0 110.008 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.116 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 87.1 m -142.65 157.14 44.99 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.959 -1.713 . . . . 0.0 110.364 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.26 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 1.9 p -142.42 136.05 29.12 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.967 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -165.55 137.69 3.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -77.46 0.9 9.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.06 1.032 . . . . 0.0 111.231 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 HG22 ' HB3' ' A' ' 24' ' ' LYS . 5.9 tt -163.72 9.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.938 0.875 . . . . 0.0 111.287 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.02 11.52 84.71 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 16.4 ptmt -87.35 -36.56 17.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.439 -1.036 . . . . 0.0 111.548 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.453 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.7 m-85 -85.3 -36.58 20.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.631 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 t 44.9 75.46 0.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 70.8 t -114.31 115.58 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 22.9 m -116.24 164.04 15.1 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.342 1.068 . . . . 0.0 113.054 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.663 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 79.2 m-85 -147.88 170.29 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.61 -35.06 24.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 112.865 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.712 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.69 114.95 19.93 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.931 -1.106 . . . . 0.0 109.665 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.98 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -49.26 -35.22 17.1 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.56 -45.67 91.13 Favored 'General case' 0 C--O 1.197 -1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 109.085 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.712 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.4 mt -58.73 -26.15 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 O-C-N 120.466 -1.396 . . . . 0.0 109.052 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.98 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 14.7 t -59.49 -71.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -58.5 -51.1 71.28 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.028 -1.045 . . . . 0.0 111.158 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -60.78 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.643 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 48.7 m-80 -61.96 -33.08 73.63 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.902 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.7 m -51.45 -32.94 28.78 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.35 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 9.1 p . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.093 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.116 0.484 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 3.5 m-20 -83.73 -157.15 0.24 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.217 -0.927 . . . . 0.0 109.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.9 -130.11 2.06 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.067 -1.063 . . . . 0.0 110.565 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -131.59 179.54 5.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -1.043 . . . . 0.0 110.054 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.6 t -143.86 149.61 37.21 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.942 -1.099 . . . . 0.0 110.05 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.5 p90 -137.9 165.47 26.43 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.87 152.31 40.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.33 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.33 -121.31 1.11 Allowed Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.472 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 97.0 m -154.88 23.16 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.308 -1.113 . . . . 0.0 110.948 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -74.13 -12.2 60.52 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.303 -1.498 . . . . 0.0 113.377 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.962 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.5 m -122.36 25.15 9.04 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 121.243 -0.911 . . . . 0.0 109.6 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.4 77.8 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 118.674 -1.727 . . . . 0.0 109.041 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.327 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.9 pttm -87.92 54.75 3.2 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.569 1.176 . . . . 0.0 110.768 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.49 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.15 -21.55 39.44 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.727 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.4 mtmp? -117.57 -145.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.712 -1.464 . . . . 0.0 109.252 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.5 m-85 -146.47 176.41 9.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 119.919 -1.738 . . . . 0.0 110.424 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.327 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 79.8 m -137.62 161.98 35.01 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.386 -1.446 . . . . 0.0 110.79 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.09 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.36 123.79 26.03 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.521 -0.737 . . . . 0.0 111.011 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -166.9 126.31 1.11 Allowed Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.89 0.67 9.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.13 1.069 . . . . 0.0 111.223 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 24' ' ' LYS . 6.0 tt -163.98 12.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 122.043 0.925 . . . . 0.0 111.304 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.43 12.99 83.29 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.483 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -86.48 -38.07 17.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.529 -0.983 . . . . 0.0 111.141 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.1 m-85 -85.04 -39.48 17.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 111.539 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 24.1 t 41.81 68.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.744 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.5 t -114.71 115.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.638 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.3 m -116.22 161.42 19.0 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.392 1.092 . . . . 0.0 113.469 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.727 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.2 m-85 -149.68 176.52 10.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.965 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.5 p30 -81.56 -42.46 20.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.141 -0.974 . . . . 0.0 111.85 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.715 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.28 116.11 20.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.093 -1.004 . . . . 0.0 108.603 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.838 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.0 ptpt -50.84 -34.55 28.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.7 -46.19 87.85 Favored 'General case' 0 C--O 1.199 -1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 108.868 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.715 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.6 -25.84 25.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 O-C-N 120.736 -1.227 . . . . 0.0 109.357 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.124 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -60.78 -67.59 0.39 Allowed 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -54.62 -53.79 50.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.908 -1.12 . . . . 0.0 110.93 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.609 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -62.47 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.609 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.89 -28.71 69.09 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.262 -0.899 . . . . 0.0 112.886 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.124 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.1 m -50.06 -25.96 3.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.36 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.404 ' CG2' ' HA ' ' A' ' 2' ' ' ASP . 13.2 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.067 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.226 0.536 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -155.9 -176.88 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 109.809 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.24 -157.38 29.83 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.952 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.8 mt -131.48 179.99 5.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.71 -0.877 . . . . 0.0 109.376 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.4 t -138.7 150.56 46.3 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.59 -1.319 . . . . 0.0 111.079 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 38.4 p90 -136.62 167.12 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -122.52 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.31 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.66 -121.47 1.12 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.442 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.289 87.0 m -154.63 21.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -1.138 . . . . 0.0 111.241 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -75.34 -12.97 60.38 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.2 -1.562 . . . . 0.0 113.617 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.122 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.3 m -122.72 25.59 8.63 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.4 79.74 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 118.904 -1.617 . . . . 0.0 109.578 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.644 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.04 53.43 2.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.469 1.128 . . . . 0.0 111.037 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.53 107.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.64 -20.84 47.84 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.181 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 29.9 mtmt -118.17 -143.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.879 -1.365 . . . . 0.0 109.121 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 18.2 m-85 -146.06 176.31 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.844 -1.785 . . . . 0.0 110.45 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.644 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 90.1 m -136.77 164.03 29.23 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.428 -1.42 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.946 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.33 122.25 23.55 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.543 -0.723 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -166.45 125.57 1.13 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -79.44 -2.18 12.07 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.097 1.051 . . . . 0.0 110.813 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.436 HG23 ' CD ' ' A' ' 24' ' ' LYS . 5.3 tt -164.39 15.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.085 0.945 . . . . 0.0 110.876 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.78 83.72 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 14.3 ptmt -86.9 -33.86 19.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -1.024 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.8 m-85 -85.1 -40.83 16.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 111.253 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' TYR . 12.9 t 40.49 61.93 1.48 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.381 -0.824 . . . . 0.0 110.027 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.824 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.92 116.51 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.873 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.36 161.64 18.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.037 -1.039 . . . . 0.0 113.302 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.8 m-85 -149.02 176.45 10.44 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.4 p30 -81.98 -43.31 18.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.254 -0.903 . . . . 0.0 111.879 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.71 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.02 116.42 20.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.094 -1.004 . . . . 0.0 108.492 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.794 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -49.82 -35.54 23.26 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.02 -46.52 87.99 Favored 'General case' 0 C--O 1.2 -1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.009 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.96 -25.75 26.8 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 O-C-N 120.773 -1.204 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.099 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.8 t -60.4 -65.88 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -54.96 -54.66 39.91 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.913 -1.117 . . . . 0.0 110.841 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 3.4 tmtm? -62.84 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -59.88 -27.86 67.06 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.287 -0.883 . . . . 0.0 112.871 -176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.099 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.2 m -49.57 -28.13 5.29 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.285 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.1 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.3 t0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.166 0.508 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.72 -165.08 1.87 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.484 -0.76 . . . . 0.0 109.773 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.15 -150.54 17.41 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.987 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.76 180.0 5.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.903 . . . . 0.0 109.496 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.7 t -137.93 149.5 46.24 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.741 -1.225 . . . . 0.0 110.718 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.82 166.04 24.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.45 149.79 43.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.627 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.37 -123.41 1.42 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.468 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 98.4 m -156.05 25.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.41 -1.053 . . . . 0.0 110.846 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -74.13 -8.8 57.47 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.373 -1.454 . . . . 0.0 113.562 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.766 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -125.77 27.02 6.52 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 121.33 -0.856 . . . . 0.0 109.726 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 15.34 76.92 Favored Glycine 0 C--N 1.291 -1.965 0 C-N-CA 118.508 -1.806 . . . . 0.0 108.723 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.258 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.41 53.21 2.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.351 1.072 . . . . 0.0 111.096 -178.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.19 109.58 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.4 -19.93 43.91 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.761 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 28.3 mtmt -118.6 -143.05 0.36 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.722 -1.458 . . . . 0.0 109.368 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.1 m-85 -145.79 173.75 11.83 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 119.976 -1.703 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.258 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 76.3 m -136.87 162.55 32.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.449 -1.407 . . . . 0.0 111.118 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.859 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.03 122.59 23.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.458 -0.776 . . . . 0.0 110.846 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -166.28 126.29 1.21 Allowed Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.06 -1.53 11.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.169 1.089 . . . . 0.0 111.249 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG23 ' CD ' ' A' ' 24' ' ' LYS . 5.3 tt -164.13 13.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-O 121.93 0.872 . . . . 0.0 111.296 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.96 84.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 13.4 ptmt -87.07 -35.34 18.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -1.002 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.8 m-85 -85.14 -40.7 16.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 111.307 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 25' ' ' TYR . 38.2 t 41.67 66.42 0.7 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.456 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.772 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 62.2 t -115.15 115.81 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.33 162.05 18.1 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.313 1.054 . . . . 0.0 113.091 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.759 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.9 m-85 -148.6 175.79 10.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.945 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.9 p-10 -81.87 -42.34 19.71 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.177 -0.952 . . . . 0.0 112.071 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.17 117.01 21.35 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.973 -1.079 . . . . 0.0 108.905 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.787 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -50.02 -35.89 26.62 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.8 -46.27 87.99 Favored 'General case' 0 C--O 1.2 -1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.059 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.07 -25.51 26.57 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 O-C-N 120.658 -1.276 . . . . 0.0 109.44 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.039 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 27.2 t -60.94 -66.52 0.52 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -55.92 -54.03 49.65 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.748 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtt? -61.77 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.61 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.0 m-80 -60.67 -30.09 69.69 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.253 -0.904 . . . . 0.0 112.699 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.039 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 62.9 m -50.92 -26.98 6.6 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.239 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 22.1 p . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.165 -0.959 . . . . 0.0 110.089 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.063 0.458 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -82.93 -139.88 0.05 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.269 -0.894 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.23 -140.63 6.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.8 mt -132.94 179.19 6.33 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.334 -1.098 . . . . 0.0 110.274 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t -146.31 150.38 35.63 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.935 -1.103 . . . . 0.0 109.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.485 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 25.0 p90 -138.26 163.27 32.2 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.04 153.69 39.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.455 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.57 -121.17 1.11 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.313 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 99.1 m -154.63 20.54 0.47 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 111.089 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -74.84 -9.77 58.86 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.336 -1.478 . . . . 0.0 113.351 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.2 m -124.24 24.09 8.18 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.397 -0.815 . . . . 0.0 109.856 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.51 18.44 77.07 Favored Glycine 0 C--N 1.29 -1.989 0 C-N-CA 118.495 -1.812 . . . . 0.0 108.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.205 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 22.5 pttt -87.92 51.22 2.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.443 1.116 . . . . 0.0 111.031 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.68 109.65 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.68 -21.16 41.63 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.263 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.0 mtmm -122.02 -145.15 0.35 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.394 . . . . 0.0 109.075 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.498 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 22.7 m-85 -145.76 177.41 8.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.829 -1.795 . . . . 0.0 110.35 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.205 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.2 m -137.09 161.08 37.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.344 -1.473 . . . . 0.0 110.58 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.145 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.49 126.18 23.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.761 . . . . 0.0 111.301 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -167.28 127.15 1.12 Allowed Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -75.22 -60.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.141 1.074 . . . . 0.0 110.006 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 HG21 ' H ' ' A' ' 24' ' ' LYS . 9.6 tt -84.55 -0.46 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.888 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.9 13.41 83.66 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.49 ' H ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.79 -25.17 21.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.379 -1.071 . . . . 0.0 111.36 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' CYS . 46.0 m-85 -83.59 -37.1 23.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 111.772 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 19.4 t 41.57 70.41 0.27 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.66 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 95.6 t -115.07 118.79 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.038 -1.039 . . . . 0.0 108.449 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.707 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.12 161.87 18.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.853 -1.154 . . . . 0.0 113.334 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 85.0 m-85 -148.56 175.27 11.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.929 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.5 p-10 -81.98 -42.58 19.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.869 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 114.74 20.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 108.664 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.812 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.2 ptmm? -49.44 -35.29 18.94 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.25 87.77 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.12 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.733 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.15 -26.26 24.88 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 O-C-N 120.675 -1.266 . . . . 0.0 109.389 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.175 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 t -60.69 -66.02 0.6 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -55.5 -54.18 47.11 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.707 -1.246 . . . . 0.0 110.645 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.0 tmtm? -63.19 -79.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.503 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -60.88 -28.3 68.78 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.259 -0.901 . . . . 0.0 113.13 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.175 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.8 m -48.49 -27.93 3.01 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.372 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.103 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.47 172.69 17.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.107 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.63 -122.52 1.06 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 mt -132.7 179.1 6.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 110.033 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.3 t -122.96 137.95 54.81 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.783 -1.198 . . . . 0.0 110.044 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -137.94 165.01 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.97 152.15 41.16 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.458 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.87 -120.75 1.04 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.377 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.286 93.9 m -155.18 23.33 0.42 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.364 -1.08 . . . . 0.0 111.034 -177.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -73.93 -12.26 60.6 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.258 -1.526 . . . . 0.0 113.416 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.984 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -123.43 25.48 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.79 77.53 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 118.687 -1.721 . . . . 0.0 109.08 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.291 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 pttm -87.93 54.2 3.02 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.609 1.195 . . . . 0.0 110.801 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.71 108.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 -22.13 40.77 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.108 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.674 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 5.4 mtmp? -113.82 -147.42 0.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.908 -1.348 . . . . 0.0 108.768 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 21.2 m-85 -146.57 176.8 9.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.774 -1.829 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.291 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.5 m -137.48 162.14 34.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.491 -1.38 . . . . 0.0 111.072 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.865 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.1 p -136.14 108.27 7.22 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.621 -0.674 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -171.66 139.37 1.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -77.13 -7.71 17.3 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.306 1.161 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.586 HG21 ' HG2' ' A' ' 24' ' ' LYS . 8.6 tt -165.0 -169.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.73 13.92 54.16 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.13 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -83.83 -44.12 14.67 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.303 -1.116 . . . . 0.0 110.732 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.8 m-85 -88.05 -51.69 5.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.878 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 17.5 t 39.32 75.14 0.08 Allowed 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.595 -0.691 . . . . 0.0 110.922 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.865 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 66.4 t -114.69 111.46 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.803 -1.186 . . . . 0.0 108.178 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.17 162.2 17.81 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.264 1.031 . . . . 0.0 113.367 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.674 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.2 m-85 -150.47 175.3 12.0 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.295 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.08 -41.26 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.885 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.721 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.72 115.54 21.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.092 -1.005 . . . . 0.0 109.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.795 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.5 ptpt -50.03 -35.08 23.52 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.52 -45.97 87.72 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 108.996 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.721 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.49 -25.63 24.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.005 0 O-C-N 120.621 -1.3 . . . . 0.0 109.336 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.844 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 25.5 t -61.55 -67.93 0.36 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.0 -53.03 60.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.766 -1.209 . . . . 0.0 110.696 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.1 tmtt? -61.85 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.62 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -61.63 -32.6 72.76 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.28 -0.888 . . . . 0.0 112.879 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.844 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 69.8 m -52.22 -29.74 24.09 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.306 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 22.6 p . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.045 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.452 0.644 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.96 140.76 31.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.708 . . . . 0.0 109.979 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.99 178.61 38.97 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -132.22 179.14 6.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.945 . . . . 0.0 109.37 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.702 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 12.6 t -146.98 155.57 42.37 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.704 -1.247 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.6 p90 -136.74 165.45 25.89 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -122.63 149.02 44.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.059 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.29 -119.66 0.96 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.449 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 93.9 m -155.14 20.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 111.599 -177.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -75.28 -12.26 60.24 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.133 -1.605 . . . . 0.0 113.546 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.061 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.5 m -123.0 25.29 8.62 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.58 17.49 79.1 Favored Glycine 0 C--N 1.29 -1.982 0 C-N-CA 118.823 -1.656 . . . . 0.0 109.396 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.672 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.4 pttt -87.34 51.7 2.3 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.45 1.119 . . . . 0.0 111.031 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.15 109.48 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.15 -21.95 39.73 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.213 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.754 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 38.4 mtmt -123.23 -142.2 0.32 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.418 . . . . 0.0 109.227 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 28' ' ' CYS . 9.8 m-85 -146.15 176.86 9.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.914 -1.741 . . . . 0.0 110.562 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.672 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 86.3 m -136.72 163.3 30.92 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.432 -1.417 . . . . 0.0 110.882 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.092 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -130.92 127.53 38.67 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.613 -0.679 . . . . 0.0 110.875 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -165.68 116.43 0.84 Allowed Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.92 0.94 9.68 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.274 1.144 . . . . 0.0 110.469 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' A' ' 24' ' ' LYS . 7.2 tt -163.89 11.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 122.109 0.957 . . . . 0.0 110.771 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.03 12.98 83.63 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' CE ' ' CE2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -87.56 -34.99 18.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.471 -1.017 . . . . 0.0 111.266 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' CE2' ' CE ' ' A' ' 24' ' ' LYS . 47.7 m-85 -85.37 -46.02 11.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 111.948 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.6 t 42.5 60.34 2.41 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.143 -0.973 . . . . 0.0 109.154 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.786 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.84 121.29 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 11.2 m -116.27 160.99 19.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.029 -1.069 . . . . 0.0 113.493 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.754 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 77.5 m-85 -148.9 177.77 9.26 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.915 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.75 -43.75 17.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.699 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.12 116.42 21.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.014 -1.054 . . . . 0.0 108.338 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.862 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.41 -34.8 25.73 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.48 -46.31 89.16 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 108.948 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.68 -26.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.722 -1.236 . . . . 0.0 109.424 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.154 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -60.55 -67.4 0.4 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -55.0 -53.45 55.57 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.82 -1.175 . . . . 0.0 110.821 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.12 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.2 m-80 -60.69 -26.94 67.49 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.375 -0.828 . . . . 0.0 112.955 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.154 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.8 m -47.99 -34.5 9.41 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 118.689 -1.205 . . . . 0.0 111.046 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.207 -179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.237 0.541 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -155.24 -163.58 1.58 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.387 -0.821 . . . . 0.0 109.506 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.55 -113.67 0.29 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.379 -1.391 . . . . 0.0 111.868 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.85 179.9 6.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.965 . . . . 0.0 110.62 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.1 t -131.32 142.86 50.16 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.994 -1.066 . . . . 0.0 108.967 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -138.68 166.97 22.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 109.4 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -122.95 151.88 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.898 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.88 -119.96 0.97 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.482 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 91.7 m -155.01 23.89 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.23 -1.159 . . . . 0.0 111.155 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -73.32 -14.08 61.23 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.235 -1.54 . . . . 0.0 113.201 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -122.36 24.51 9.31 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 17.93 77.18 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 118.637 -1.744 . . . . 0.0 108.979 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.271 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 10.7 pttm -88.12 51.67 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.407 1.098 . . . . 0.0 111.338 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -67.27 111.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.81 -24.45 29.54 Favored Glycine 0 N--CA 1.498 2.832 0 C-N-CA 119.239 -1.457 . . . . 0.0 109.856 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 12.9 mtmt -118.38 -146.81 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.78 -1.423 . . . . 0.0 108.838 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 15.9 m-85 -146.95 176.77 9.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 119.836 -1.79 . . . . 0.0 110.319 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.271 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.05 161.63 35.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.428 -1.42 . . . . 0.0 110.79 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.084 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.31 108.13 8.54 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.499 0.666 . . . . 0.0 110.423 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 p -172.46 136.3 0.83 Allowed Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.8 -5.62 16.12 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.215 1.113 . . . . 0.0 109.682 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG21 ' HG2' ' A' ' 24' ' ' LYS . 7.9 tt -164.63 -169.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.31 14.91 52.83 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.925 -1.109 . . . . 0.0 111.064 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.588 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -84.07 -43.94 14.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.246 -1.15 . . . . 0.0 110.973 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 44.9 m-85 -87.75 -50.57 6.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.159 -0.963 . . . . 0.0 111.127 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' TYR . 31.9 t 37.84 72.85 0.11 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.636 -0.665 . . . . 0.0 110.721 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.907 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.5 t -114.58 112.96 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.797 -1.189 . . . . 0.0 108.096 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 16.8 m -116.13 161.61 18.67 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.417 1.103 . . . . 0.0 113.667 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.688 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.1 m-85 -149.92 176.94 10.3 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.009 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.98 -42.9 18.74 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.687 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.709 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.47 117.22 21.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.042 -1.036 . . . . 0.0 108.872 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.842 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -50.87 -35.71 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.96 87.8 Favored 'General case' 0 C--O 1.201 -1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 108.909 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.709 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.85 -25.92 26.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.936 0 O-C-N 120.736 -1.227 . . . . 0.0 109.29 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.11 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.2 t -60.18 -66.23 0.56 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.99 -54.48 42.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.907 -1.121 . . . . 0.0 110.881 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.26 -79.34 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.435 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.2 m-80 -59.82 -28.68 67.67 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.269 -0.895 . . . . 0.0 112.852 -176.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.11 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m -50.49 -25.58 4.18 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 118.611 -1.235 . . . . 0.0 111.412 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.129 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.156 0.503 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -155.3 139.3 16.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.53 -169.56 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.1 mt -131.8 179.79 5.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.592 -0.946 . . . . 0.0 109.46 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.5 t -134.1 136.07 43.65 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.687 -1.258 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -138.39 166.93 23.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.78 151.75 41.32 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.901 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.96 -119.76 0.95 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.546 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.289 98.1 m -155.38 23.99 0.41 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.152 -1.205 . . . . 0.0 111.334 -177.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.27 -14.36 61.31 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.213 -1.554 . . . . 0.0 113.33 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.875 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.0 m -121.5 24.37 9.9 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.52 77.07 Favored Glycine 0 C--N 1.29 -1.986 0 C-N-CA 118.535 -1.793 . . . . 0.0 108.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.289 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.4 pttm -87.59 52.07 2.39 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.474 1.131 . . . . 0.0 111.111 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t -66.88 111.36 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.76 31.14 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.009 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 40.7 mtmt -119.51 -146.32 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.415 . . . . 0.0 108.972 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -146.11 175.91 10.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 119.901 -1.749 . . . . 0.0 110.256 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 64.7 m -137.37 160.67 38.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.388 -1.445 . . . . 0.0 111.322 -178.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.943 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.43 110.13 7.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.681 -0.637 . . . . 0.0 110.676 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -171.17 137.7 1.11 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.03 -15.22 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.308 1.162 . . . . 0.0 109.823 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.611 HG21 ' HG2' ' A' ' 24' ' ' LYS . 6.8 tt -165.07 -166.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.41 10.5 54.75 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.819 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.617 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 12.8 ptmt -87.27 10.97 15.41 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -1.14 . . . . 0.0 110.676 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.3 m-85 -151.42 -53.99 0.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.488 ' C ' ' O ' ' A' ' 25' ' ' TYR . 10.0 t 34.91 75.19 0.06 Allowed 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.794 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.54 114.71 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.796 -1.19 . . . . 0.0 108.751 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.5 m -116.0 161.36 18.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.157 0.979 . . . . 0.0 112.988 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.3 m-85 -149.55 174.69 12.24 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.086 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.5 p30 -81.75 -41.39 21.29 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.811 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.22 114.95 20.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.045 -1.034 . . . . 0.0 108.658 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -50.0 -34.7 21.97 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.93 -46.41 88.02 Favored 'General case' 0 C--O 1.199 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.023 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.713 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.3 -26.29 25.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 120.596 -1.315 . . . . 0.0 109.376 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.137 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -61.27 -67.67 0.38 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -55.03 -53.06 60.68 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.747 -1.221 . . . . 0.0 110.737 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -62.33 -79.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.559 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -60.85 -29.73 69.69 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.268 -0.895 . . . . 0.0 112.839 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.137 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.0 m -50.42 -30.15 11.83 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.404 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.102 -179.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.225 0.536 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.53 -148.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.456 -0.778 . . . . 0.0 109.692 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.81 -153.15 22.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.763 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.93 179.67 5.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.588 -0.948 . . . . 0.0 109.689 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.4 t -142.76 153.95 43.78 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.686 -1.259 . . . . 0.0 110.576 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 36.0 p90 -138.29 167.27 22.22 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.57 153.3 39.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.764 -1.21 . . . . 0.0 111.553 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.14 -120.68 1.07 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.142 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 99.4 m -154.97 20.3 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -1.121 . . . . 0.0 111.275 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -75.25 -10.59 59.6 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.279 -1.513 . . . . 0.0 113.712 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.024 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.3 m -123.82 25.19 8.13 Favored 'General case' 0 C--N 1.284 -2.28 0 O-C-N 121.275 -0.89 . . . . 0.0 109.803 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.64 17.88 78.3 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 118.711 -1.709 . . . . 0.0 109.19 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.268 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 21.2 pttt -88.22 51.11 2.11 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.463 1.125 . . . . 0.0 111.133 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.88 109.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.27 -21.03 42.82 Favored Glycine 0 N--CA 1.5 2.907 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.29 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.754 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.8 mtmt -123.75 -142.65 0.32 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.411 . . . . 0.0 109.187 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.541 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.6 m-85 -145.21 177.63 8.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.777 -1.827 . . . . 0.0 110.5 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.268 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 92.9 m -137.5 163.78 30.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.513 -1.367 . . . . 0.0 110.998 -178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.087 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.1 123.71 27.72 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.555 -0.716 . . . . 0.0 111.276 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.2 p -166.72 119.33 0.79 Allowed Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.55 -8.18 15.94 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.204 1.107 . . . . 0.0 110.607 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.522 HG23 ' CD ' ' A' ' 24' ' ' LYS . 5.0 tt -164.67 20.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 122.129 0.966 . . . . 0.0 110.371 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.18 84.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -90.37 21.33 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.528 -0.983 . . . . 0.0 110.591 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.589 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.5 m-85 -148.9 -43.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.273 -0.892 . . . . 0.0 110.789 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' C ' ' O ' ' A' ' 25' ' ' TYR . 48.6 t 37.48 61.35 0.99 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.354 -0.841 . . . . 0.0 110.048 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.823 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.9 t -114.94 120.31 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 13.6 m -116.19 161.01 19.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.955 -1.09 . . . . 0.0 113.36 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.754 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 77.6 m-85 -148.84 177.89 9.15 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.029 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.12 -44.01 17.06 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -0.973 . . . . 0.0 111.689 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.92 116.27 20.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.014 -1.054 . . . . 0.0 108.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.815 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.29 -34.79 24.66 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.3 -46.42 88.62 Favored 'General case' 0 C--O 1.2 -1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.981 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.66 -26.14 26.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.796 -1.19 . . . . 0.0 109.444 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.136 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.6 t -60.42 -65.62 0.66 Allowed 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -55.87 -54.47 44.2 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.615 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.4 tmtm? -62.85 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.513 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.1 m-80 -60.51 -27.24 67.45 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.269 -0.894 . . . . 0.0 112.991 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.136 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.5 m -48.5 -29.61 4.34 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 118.575 -1.25 . . . . 0.0 111.244 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.177 -179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.346 0.593 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.27 -164.49 1.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 110.097 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.68 -154.79 25.51 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.96 179.9 5.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.575 -0.956 . . . . 0.0 109.768 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.8 t -135.14 136.65 42.05 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.803 -1.186 . . . . 0.0 110.048 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -138.16 166.53 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.95 149.56 44.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.21 -118.77 0.86 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.984 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.448 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 96.6 m -154.88 22.87 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 111.47 -177.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -73.48 -14.63 61.27 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.1 -1.625 . . . . 0.0 113.228 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.83 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 25.1 m -122.1 24.94 9.29 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.96 76.41 Favored Glycine 0 C--N 1.289 -2.064 0 C-N-CA 118.306 -1.902 . . . . 0.0 108.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.267 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 pttt -86.86 50.7 2.06 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.456 1.122 . . . . 0.0 110.871 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -67.47 110.76 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.41 -22.72 36.61 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.713 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 8.9 mttm -119.61 -147.61 0.4 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.759 -1.436 . . . . 0.0 108.806 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.1 m-85 -146.88 175.49 10.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.777 . . . . 0.0 110.256 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.267 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 80.1 m -137.66 160.99 37.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.307 -1.496 . . . . 0.0 111.559 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -137.1 110.62 7.99 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.697 -0.627 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.71 140.8 1.45 Allowed Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -76.45 -16.32 17.16 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.311 1.164 . . . . 0.0 109.731 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.615 HG21 ' HG2' ' A' ' 24' ' ' LYS . 6.6 tt -164.81 -165.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.608 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.4 9.29 58.78 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.881 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.615 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -87.86 12.91 11.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.275 -1.132 . . . . 0.0 110.983 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 43.6 m-85 -150.66 -54.58 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' TYR . 15.5 t 36.27 75.57 0.06 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.418 -0.801 . . . . 0.0 110.859 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.791 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.9 t -114.26 114.89 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.681 -1.262 . . . . 0.0 108.649 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 19.6 m -116.0 162.38 17.46 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.352 1.073 . . . . 0.0 113.45 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.713 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 80.6 m-85 -148.65 175.08 11.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.804 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.402 ' CB ' ' HD3' ' A' ' 16' ' ' LYS . 1.9 p-10 -82.06 -42.36 19.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.002 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.695 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.32 118.37 22.58 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.104 -0.997 . . . . 0.0 108.927 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.831 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.0 ptpt -51.04 -35.72 35.86 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.2 -45.99 89.64 Favored 'General case' 0 C--O 1.2 -1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.281 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.695 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -58.13 -26.36 29.1 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 O-C-N 120.651 -1.281 . . . . 0.0 109.418 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.105 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.5 t -60.9 -66.96 0.45 Allowed 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -55.2 -53.37 56.89 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.839 -1.163 . . . . 0.0 110.62 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.84 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -59.95 -29.09 68.17 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 121.302 -0.874 . . . . 0.0 112.705 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.105 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.0 m -50.68 -26.59 5.66 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.3 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.057 -179.771 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.011 0.434 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -83.69 119.5 24.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.44 167.75 27.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.911 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.1 mt -131.34 179.89 5.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.801 -0.823 . . . . 0.0 109.025 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.6 t -133.0 139.75 47.41 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.578 -1.327 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -137.15 166.41 23.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -122.88 150.69 42.56 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.014 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.3 -120.06 0.99 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.291 97.1 m -155.51 24.19 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.258 -1.142 . . . . 0.0 111.141 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.95 -12.3 60.61 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.237 -1.54 . . . . 0.0 113.466 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.047 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.2 m -122.55 25.29 8.87 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-O 121.818 0.818 . . . . 0.0 109.57 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.79 78.4 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.671 -1.728 . . . . 0.0 109.222 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.612 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -87.06 56.5 4.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.64 1.21 . . . . 0.0 110.429 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.89 107.72 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.19 51.71 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.447 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 31.2 mtmt -116.59 -145.8 0.39 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.757 -1.437 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.4 m-85 -146.55 176.06 10.11 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.893 -1.754 . . . . 0.0 110.705 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.612 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 57.5 m -136.46 160.81 37.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.439 -1.413 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.065 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.41 111.07 8.1 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -170.51 139.48 1.4 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.646 -0.659 . . . . 0.0 109.29 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.11 -5.13 14.3 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.237 1.125 . . . . 0.0 109.877 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.602 ' CG2' ' HG2' ' A' ' 24' ' ' LYS . 9.3 tt -164.83 -171.81 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.4 5.46 84.43 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.87 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.602 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 1.2 ptmt -86.81 -29.45 22.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.018 -1.284 . . . . 0.0 110.341 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.596 ' HD1' ' HG3' ' A' ' 24' ' ' LYS . 4.1 m-30 -86.25 -57.46 3.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' TYR . 33.6 t 35.32 72.98 0.09 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.73 -0.606 . . . . 0.0 111.122 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.832 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.5 t -114.72 110.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.759 -1.213 . . . . 0.0 108.23 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.7 m -116.19 161.41 19.0 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.201 1.0 . . . . 0.0 113.435 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.3 m-85 -150.55 176.76 10.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.417 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 4.3 p-10 -82.04 -42.53 19.14 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.987 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.756 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.77 116.26 21.38 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.961 -1.087 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.805 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.5 ptpt -50.55 -34.88 27.24 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.22 -45.88 86.88 Favored 'General case' 0 C--O 1.2 -1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.759 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.51 -25.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 O-C-N 120.681 -1.262 . . . . 0.0 109.263 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.065 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.0 t -61.13 -68.48 0.31 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -54.06 -53.64 50.33 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.896 -1.127 . . . . 0.0 110.846 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.22 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.557 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.8 m-80 -62.21 -29.66 70.54 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.291 -0.881 . . . . 0.0 113.182 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.048 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 73.8 m -49.99 -29.11 7.94 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.309 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.994 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.7 t0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.187 0.518 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -155.34 -157.59 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.478 -0.764 . . . . 0.0 109.72 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.81 -154.7 24.97 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.691 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 mt -131.17 179.87 5.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.956 . . . . 0.0 109.623 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.2 t -140.18 149.92 43.56 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.715 -1.241 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.6 p90 -135.85 164.76 27.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.58 149.81 43.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.476 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.15 -122.3 1.27 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.286 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.462 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 97.4 m -155.95 25.82 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.19 . . . . 0.0 110.989 -177.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -73.47 -8.88 57.74 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.359 -1.463 . . . . 0.0 113.414 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.74 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.7 m -126.08 26.28 6.55 Favored 'General case' 0 C--N 1.282 -2.368 0 O-C-N 121.402 -0.812 . . . . 0.0 109.833 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.07 75.68 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 118.434 -1.841 . . . . 0.0 108.714 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.226 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.38 51.7 2.3 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.189 0.995 . . . . 0.0 111.465 -178.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.14 111.81 2.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.78 -22.41 33.84 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.6 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmt -120.19 -143.15 0.35 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.559 -1.553 . . . . 0.0 109.348 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.6 m-85 -145.56 174.1 11.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.013 -1.679 . . . . 0.0 110.172 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.226 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 88.1 m -136.85 162.47 33.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.403 -1.435 . . . . 0.0 111.003 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.907 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -135.11 124.6 24.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.6 -0.687 . . . . 0.0 110.957 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -165.91 126.39 1.27 Allowed Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.35 -0.74 10.98 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.213 1.112 . . . . 0.0 111.209 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG23 ' CD ' ' A' ' 24' ' ' LYS . 5.7 tt -163.92 12.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 CA-C-O 121.968 0.89 . . . . 0.0 111.159 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.08 11.82 84.54 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -87.22 -35.22 18.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.441 -1.035 . . . . 0.0 111.169 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.6 m-85 -85.12 -39.89 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.885 . . . . 0.0 111.259 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 t 43.3 67.72 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.745 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.09 116.28 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.19 -0.943 . . . . 0.0 108.462 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.3 m -116.21 161.84 18.36 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.057 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.723 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.3 m-85 -148.37 175.14 11.35 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.927 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.4 p-10 -81.97 -42.46 19.36 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.947 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.97 116.57 21.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.011 -1.055 . . . . 0.0 108.764 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.785 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.8 ptpt -49.59 -35.97 22.56 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.23 -46.16 89.22 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.127 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.94 -26.02 27.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 O-C-N 120.769 -1.207 . . . . 0.0 109.455 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.107 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 24.6 t -60.87 -66.29 0.56 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -55.75 -54.0 49.78 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.618 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.8 tmtm? -62.7 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -177.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.5 m-80 -60.6 -28.15 68.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.283 -0.886 . . . . 0.0 113.031 -176.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.107 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.8 m -49.14 -28.88 4.71 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.216 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.088 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.133 0.492 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -156.37 -160.96 1.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.784 . . . . 0.0 109.888 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.48 -142.48 7.56 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.63 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.88 179.49 6.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -1.014 . . . . 0.0 109.842 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.835 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 9.4 t -144.26 156.83 44.45 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.79 -1.194 . . . . 0.0 110.489 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 32.8 p90 -135.06 166.4 23.13 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.03 149.23 43.81 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.321 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.469 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 150.65 -122.23 1.35 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 96.8 m -156.23 23.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -1.103 . . . . 0.0 111.117 -177.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.31 -7.53 54.2 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.3 -1.5 . . . . 0.0 113.801 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.7 m -125.95 27.03 6.45 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.46 15.62 77.36 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 118.595 -1.764 . . . . 0.0 108.819 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.287 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.98 50.95 2.08 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.163 0.982 . . . . 0.0 111.461 -178.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.46 110.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.09 -20.56 40.31 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.836 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.742 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 21.9 mtmt -124.08 -139.04 0.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.597 -1.531 . . . . 0.0 109.425 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.569 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -144.33 174.1 11.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 119.844 -1.785 . . . . 0.0 110.052 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.287 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 99.5 m -135.05 163.13 30.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.54 -1.35 . . . . 0.0 110.842 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.1 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -131.48 123.74 28.69 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.531 -0.731 . . . . 0.0 110.922 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -165.79 118.56 0.87 Allowed Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -78.57 0.25 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.271 1.143 . . . . 0.0 110.641 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 HG23 ' CD ' ' A' ' 24' ' ' LYS . 5.3 tt -163.94 13.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.065 0.936 . . . . 0.0 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.96 83.67 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 13.4 ptmt -88.18 -33.88 18.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.453 -1.027 . . . . 0.0 111.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.2 m-85 -85.08 -41.78 15.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 111.75 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 25' ' ' TYR . 6.3 t 42.83 60.07 2.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.138 -0.977 . . . . 0.0 109.819 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.829 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.7 t -115.17 118.88 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.226 -0.921 . . . . 0.0 108.835 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.8 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.8 m -116.27 161.15 19.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 113.464 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.742 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 78.3 m-85 -148.81 177.48 9.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.95 -43.82 17.58 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.222 -0.924 . . . . 0.0 111.867 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.712 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.24 116.43 21.11 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.996 -1.065 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.79 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.5 ptpt -50.01 -35.23 23.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.06 -46.44 88.23 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.167 -0.958 . . . . 0.0 108.88 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.712 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.62 -25.66 25.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 O-C-N 120.82 -1.175 . . . . 0.0 109.358 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.1 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.6 t -60.08 -65.64 0.65 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -55.29 -55.36 32.29 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.89 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.2 tmtm? -62.32 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -60.33 -28.11 67.88 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.298 -0.876 . . . . 0.0 113.037 -176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.094 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 55.7 m -48.88 -31.13 6.71 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.295 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.232 -179.801 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.135 0.493 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.03 142.33 19.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.492 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.85 39.43 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.89 179.25 6.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.623 -0.928 . . . . 0.0 109.288 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.5 t -145.25 154.72 42.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.607 -1.308 . . . . 0.0 110.871 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 30.8 p90 -136.95 163.32 30.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -123.11 148.93 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.186 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.47 -119.64 0.94 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.67 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.286 98.1 m -154.67 21.58 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -1.139 . . . . 0.0 111.285 -177.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -74.63 -11.49 60.2 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.251 -1.531 . . . . 0.0 113.399 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.963 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -124.33 25.87 7.56 Favored 'General case' 0 C--N 1.283 -2.289 0 O-C-N 121.4 -0.812 . . . . 0.0 109.772 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.05 76.49 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 118.536 -1.792 . . . . 0.0 108.883 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.399 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 pttt -87.45 51.27 2.18 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.464 1.126 . . . . 0.0 110.788 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 109.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.12 -23.12 35.54 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.961 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.709 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.6 mtmt -119.08 -145.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.43 . . . . 0.0 108.936 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.5 m-85 -146.69 176.63 9.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.779 -1.826 . . . . 0.0 110.493 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.399 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 97.2 m -137.46 161.74 35.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.499 -1.376 . . . . 0.0 110.611 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.069 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -130.96 125.81 34.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.427 -0.795 . . . . 0.0 110.993 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 p -166.3 124.87 1.09 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.87 0.04 10.05 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.28 1.147 . . . . 0.0 111.065 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 HG23 ' CD ' ' A' ' 24' ' ' LYS . 5.0 tt -163.49 12.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.007 0.908 . . . . 0.0 110.888 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.44 11.71 84.9 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -88.3 -33.11 18.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.48 -1.012 . . . . 0.0 111.594 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 51.2 m-85 -85.08 -38.07 19.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.925 . . . . 0.0 111.409 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.4 t 41.32 66.92 0.6 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.405 -0.809 . . . . 0.0 110.794 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.717 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -114.93 117.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.22 161.8 18.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.898 -1.127 . . . . 0.0 113.865 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.709 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.1 m-85 -149.44 176.79 10.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.843 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.2 p30 -81.91 -42.83 18.96 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.786 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.724 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.26 116.28 21.05 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.06 -1.025 . . . . 0.0 108.716 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.0 ptmm? -50.27 -35.7 28.25 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.84 89.1 Favored 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.059 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.724 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.65 -25.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 O-C-N 120.716 -1.24 . . . . 0.0 109.408 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.113 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.1 t -60.66 -67.87 0.36 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -55.1 -53.59 53.98 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.925 -1.109 . . . . 0.0 110.863 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.4 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.16 -29.41 68.65 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.218 -0.926 . . . . 0.0 112.768 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.113 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m -50.15 -28.25 7.07 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.229 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 12.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.226 0.536 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -155.52 -171.74 3.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.39 -158.75 31.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 mt -132.11 179.52 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.955 . . . . 0.0 109.58 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t -143.65 150.39 38.68 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.735 -1.228 . . . . 0.0 110.673 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 30.5 p90 -137.92 164.45 28.96 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -122.94 149.49 44.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.92 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.35 -119.92 0.96 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.881 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 97.2 m -155.1 21.84 0.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 111.415 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.79 -12.46 60.4 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.284 -1.51 . . . . 0.0 113.63 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.881 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -124.16 26.3 7.51 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.15 17.83 77.56 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 118.497 -1.811 . . . . 0.0 108.888 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.266 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 4.0 pttt -87.39 50.09 1.94 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.403 1.096 . . . . 0.0 110.9 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.64 109.91 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.54 -22.78 37.45 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.02 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.689 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 37.3 mtmt -119.81 -145.05 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.86 -1.377 . . . . 0.0 108.82 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.9 m-85 -146.38 175.71 10.33 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 119.849 -1.782 . . . . 0.0 110.483 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.266 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 88.4 m -138.79 162.2 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.453 -1.404 . . . . 0.0 110.816 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.862 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.75 127.92 33.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 110.882 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.5 p -165.92 123.98 1.09 Allowed Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.21 -1.05 11.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.205 1.108 . . . . 0.0 110.931 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.57 HG23 ' HD2' ' A' ' 24' ' ' LYS . 4.5 tt -163.66 11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 122.031 0.919 . . . . 0.0 111.031 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.92 11.88 85.11 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.57 ' HD2' HG23 ' A' ' 22' ' ' ILE . 10.3 ptmm? -86.81 -33.45 19.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -1.101 . . . . 0.0 110.8 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' CYS . 49.0 m-85 -85.38 -43.37 13.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 111.592 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 43.3 t 42.93 65.59 0.92 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.341 -0.85 . . . . 0.0 109.577 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.617 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 91.5 t -114.91 118.02 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.5 m -116.31 162.06 18.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.986 -1.085 . . . . 0.0 113.182 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.689 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 87.7 m-85 -148.74 174.33 12.3 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -81.74 -41.42 21.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.764 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 115.49 20.54 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.047 -1.033 . . . . 0.0 108.636 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.78 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.4 ptpt -49.58 -35.74 21.71 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.84 89.92 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 121.395 -0.815 . . . . 0.0 109.201 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.727 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.82 -26.18 27.39 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.951 0 O-C-N 120.637 -1.289 . . . . 0.0 109.445 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.093 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.2 t -61.4 -68.91 0.27 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -54.86 -52.5 62.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.855 -1.153 . . . . 0.0 110.868 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.54 -79.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.555 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.1 m-80 -60.98 -29.22 69.55 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.197 -0.939 . . . . 0.0 112.812 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.093 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.9 m -49.87 -31.2 11.52 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.254 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.139 -179.897 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.014 0.435 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -155.45 159.55 39.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -0.832 . . . . 0.0 110.378 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.49 170.92 31.07 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -131.76 179.4 6.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.946 . . . . 0.0 109.518 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 t -144.82 150.84 37.83 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.744 -1.222 . . . . 0.0 110.589 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 24.4 p90 -138.97 162.87 33.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -123.33 153.5 40.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.84 -1.162 . . . . 0.0 111.601 -177.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.76 -120.89 1.06 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.608 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.283 92.8 m -154.01 19.19 0.51 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -1.145 . . . . 0.0 111.238 -177.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.92 -12.89 60.79 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.313 -1.492 . . . . 0.0 113.199 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.945 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.0 m -122.71 23.92 9.31 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.363 -0.835 . . . . 0.0 109.569 178.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.36 77.77 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 118.556 -1.783 . . . . 0.0 109.111 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.393 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.2 pttm -87.2 51.78 2.33 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.509 1.147 . . . . 0.0 111.097 -178.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.49 108.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 -21.65 42.43 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.186 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.697 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.6 mtmm -121.0 -146.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.819 -1.401 . . . . 0.0 108.901 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.5 m-85 -146.67 177.38 9.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.808 -1.807 . . . . 0.0 110.666 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.393 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 96.8 m -138.14 161.37 36.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.513 -1.367 . . . . 0.0 110.656 -178.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.05 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -134.88 127.28 30.4 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.389 -0.82 . . . . 0.0 111.18 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -165.55 126.11 1.31 Allowed Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.54 -7.25 17.65 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.259 1.136 . . . . 0.0 111.308 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.478 HG23 ' CD ' ' A' ' 24' ' ' LYS . 6.2 tt -164.53 16.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.154 0.978 . . . . 0.0 110.932 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.88 9.76 85.11 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -90.4 20.78 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.422 -1.046 . . . . 0.0 110.76 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.7 m-85 -148.55 -40.63 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.0 110.613 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 24.7 t 40.81 71.66 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.382 -0.824 . . . . 0.0 110.572 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.647 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 63.8 t -115.0 117.7 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.049 -1.032 . . . . 0.0 108.258 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 17.6 m -116.23 161.95 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.381 -176.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.1 m-85 -149.24 175.04 11.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.868 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.2 p30 -81.92 -42.12 19.93 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.218 -0.926 . . . . 0.0 111.865 178.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.36 115.3 20.65 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.064 -1.023 . . . . 0.0 108.85 179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.6 ptpt -49.77 -35.14 21.42 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.58 -46.48 86.86 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.945 176.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.39 -25.74 24.64 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 O-C-N 120.763 -1.21 . . . . 0.0 109.378 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.116 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 t -60.78 -66.1 0.58 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -55.44 -54.31 45.42 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.86 -1.15 . . . . 0.0 110.664 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtm? -62.26 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -59.93 -30.09 68.82 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.267 -0.896 . . . . 0.0 112.816 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.116 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 83.1 m -50.86 -26.14 5.42 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.383 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 17.9 p . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -155.17 133.7 11.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.828 . . . . 0.0 110.764 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.67 -177.34 40.3 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 mt -132.69 179.74 5.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.942 . . . . 0.0 109.458 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.7 t -137.4 135.32 36.83 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.766 -1.209 . . . . 0.0 109.676 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 30.4 p90 -136.09 168.9 18.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.63 145.59 48.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.694 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.94 -118.17 0.83 Allowed Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.605 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' THR 0.297 54.9 m -158.04 32.7 0.25 Allowed 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.251 -1.147 . . . . 0.0 110.276 -177.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -68.79 -7.96 38.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.084 -1.635 . . . . 0.0 112.529 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.7 m -120.49 23.67 10.73 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.966 0.889 . . . . 0.0 108.637 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.27 83.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.137 178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.087 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -93.78 71.62 4.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.842 1.306 . . . . 0.0 112.667 -178.681 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 9' ' ' THR . 33.6 t -64.27 116.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.599 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.85 -25.94 17.31 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.756 -1.687 . . . . 0.0 111.674 178.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.825 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 16.1 mttt -108.47 -146.33 0.4 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 120.371 2.085 . . . . 0.0 109.497 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.885 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 11.3 m-85 -146.4 169.37 19.01 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 119.437 -2.04 . . . . 0.0 111.487 -178.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.087 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 50.0 m -137.43 161.57 35.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.806 -1.809 . . . . 0.0 112.619 -178.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.078 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -135.71 104.16 5.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.366 0.603 . . . . 0.0 109.641 179.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 p -169.99 141.49 1.79 Allowed Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -77.06 -8.73 17.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.291 1.153 . . . . 0.0 110.075 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 ' HG2' ' A' ' 24' ' ' LYS . 7.7 tt -165.36 -169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.37 12.95 57.39 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.266 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.61 ' HG2' HG21 ' A' ' 22' ' ' ILE . 21.0 ptmt -84.01 -43.14 15.46 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.159 -1.2 . . . . 0.0 110.73 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' N ' ' CG ' ' A' ' 24' ' ' LYS . 45.3 m-85 -86.76 -51.73 5.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 30.8 t 40.56 75.36 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.609 -0.682 . . . . 0.0 110.391 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 1.078 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 t -113.48 105.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.677 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 24.5 m -116.11 163.98 15.14 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.313 1.054 . . . . 0.0 113.545 -175.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.681 ' CG ' HG21 ' A' ' 34' ' ' ILE . 87.1 m-85 -150.08 176.65 10.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -82.54 -41.73 19.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.035 -1.041 . . . . 0.0 111.635 178.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.692 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.91 118.8 22.72 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.007 -1.058 . . . . 0.0 108.863 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.837 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.2 ptpt -50.65 -37.12 38.99 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.29 -45.27 91.73 Favored 'General case' 0 C--O 1.198 -1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 109.265 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.39 -26.06 29.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 120.659 -1.276 . . . . 0.0 109.31 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.971 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 5.2 t -61.85 -70.28 0.2 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -54.71 -51.48 65.44 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.958 -1.089 . . . . 0.0 110.585 178.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 1.6 tmtm? -62.3 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.47 ' ND2' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -61.45 -29.36 69.9 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.209 -0.932 . . . . 0.0 112.825 -177.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.971 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.8 m -50.44 -31.39 14.94 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.08 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.172 -179.848 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.072 0.463 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.87 -168.42 2.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.91 -135.96 3.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.36 179.79 5.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.445 -1.032 . . . . 0.0 109.652 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.61 140.82 49.5 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.772 -1.205 . . . . 0.0 110.141 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -137.55 164.6 28.33 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.17 149.27 44.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.746 -1.181 . . . . 0.0 110.801 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.99 -119.45 0.92 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.918 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 89.4 m -155.02 22.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -1.144 . . . . 0.0 111.514 -177.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -73.99 -12.61 60.69 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.185 -1.572 . . . . 0.0 113.333 -177.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.895 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -123.19 25.08 8.59 Favored 'General case' 0 C--N 1.281 -2.37 0 O-C-N 121.431 -0.793 . . . . 0.0 109.645 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.01 76.55 Favored Glycine 0 C--N 1.29 -2.018 0 C-N-CA 118.491 -1.814 . . . . 0.0 108.68 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.289 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 pttt -87.32 51.47 2.24 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.42 1.105 . . . . 0.0 110.927 -178.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.51 109.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.63 37.65 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 23.3 mtmt -118.52 -147.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.808 -1.407 . . . . 0.0 108.892 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.0 m-85 -147.3 176.51 9.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.852 -1.78 . . . . 0.0 110.232 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 81.5 m -136.4 162.23 33.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.515 -1.366 . . . . 0.0 111.341 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.987 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -136.71 109.83 7.76 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.712 -0.617 . . . . 0.0 110.584 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.61 136.99 1.2 Allowed Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -75.91 -12.63 19.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.316 1.166 . . . . 0.0 109.811 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 23' ' ' GLY . 7.1 tt -165.09 -166.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -84.16 7.46 71.39 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.345 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' HG2' HG21 ' A' ' 22' ' ' ILE . 35.0 pttt -88.58 17.13 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.123 -1.222 . . . . 0.0 111.396 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.3 m-85 -151.6 -54.79 0.14 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 177.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 9.4 t 36.8 75.64 0.06 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.445 -0.784 . . . . 0.0 110.993 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.855 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.23 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.63 -1.294 . . . . 0.0 108.595 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.4 m -116.03 162.01 18.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.315 1.055 . . . . 0.0 113.79 -176.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 79.1 m-85 -149.28 176.64 10.36 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.3 p-10 -82.22 -43.24 17.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.236 -0.915 . . . . 0.0 111.933 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.707 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.09 117.62 21.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.105 -0.997 . . . . 0.0 108.848 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.872 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 17.0 ptpt -50.26 -35.82 28.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.94 90.33 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.157 176.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.707 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.87 -26.01 27.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.717 -1.239 . . . . 0.0 109.333 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.152 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -60.56 -68.0 0.34 Allowed 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -54.85 -53.47 54.94 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.752 -1.217 . . . . 0.0 110.952 177.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.15 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.554 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.9 m-80 -60.32 -29.32 68.79 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 112.772 -176.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.152 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 71.0 m -50.17 -27.1 5.31 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.272 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.158 -179.69 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.402 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 10.4 p-10 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.421 0.629 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -83.97 111.82 19.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.602 -0.686 . . . . 0.0 110.235 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.83 168.37 27.89 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 mt -130.44 179.8 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.663 -0.904 . . . . 0.0 109.158 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 t -139.35 148.87 43.49 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.591 -1.318 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.5 165.73 24.84 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.45 149.77 43.39 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.67 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.97 -124.13 1.55 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.365 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 96.4 m -155.44 25.35 0.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.82 -177.826 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -74.05 -7.44 52.49 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.326 -1.484 . . . . 0.0 113.522 -176.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m -127.64 27.18 5.82 Favored 'General case' 0 C--N 1.284 -2.253 0 O-C-N 121.281 -0.887 . . . . 0.0 109.809 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.45 15.04 77.26 Favored Glycine 0 C--N 1.291 -1.933 0 C-N-CA 118.56 -1.781 . . . . 0.0 108.848 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.278 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.64 52.7 2.56 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.229 1.014 . . . . 0.0 111.298 -178.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.44 109.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.3 -20.63 44.2 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.801 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.735 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.8 mtmt -117.41 -143.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.709 -1.465 . . . . 0.0 109.169 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.8 m-85 -145.66 173.85 11.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 119.875 -1.766 . . . . 0.0 110.179 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.278 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -136.48 163.18 31.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.451 -1.406 . . . . 0.0 111.024 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.819 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -134.01 122.58 23.22 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.529 -0.732 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 p -165.69 124.86 1.17 Allowed Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.99 -1.83 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.257 1.135 . . . . 0.0 111.241 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 24' ' ' LYS . 4.5 tt -163.9 13.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 122.02 0.914 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 12.05 84.4 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 10.7 ptmt -87.96 -34.78 17.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.405 -1.056 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.4 m-85 -84.48 -39.0 19.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.283 -0.886 . . . . 0.0 111.332 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.8 t 41.39 65.46 0.83 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.374 -0.829 . . . . 0.0 110.461 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.819 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.0 t -115.14 115.51 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.37 161.99 18.22 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.304 1.049 . . . . 0.0 113.325 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.735 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 82.4 m-85 -148.74 175.82 10.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.048 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -82.36 -42.59 18.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.204 -0.935 . . . . 0.0 112.066 178.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.66 116.56 20.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.003 -1.06 . . . . 0.0 108.573 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.807 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 1.1 ptpp? -49.71 -35.85 23.29 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -46.15 89.12 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.094 176.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.16 -26.12 28.53 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.726 -1.234 . . . . 0.0 109.386 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.061 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -60.34 -65.82 0.62 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -56.45 -54.11 49.58 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.697 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -62.36 -79.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -177.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.546 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.75 -28.53 68.77 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.29 -0.881 . . . . 0.0 112.962 -176.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.061 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.2 m -49.37 -32.61 11.8 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.251 -178.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.2 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.096 0.474 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -155.45 159.11 39.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.279 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.01 -167.13 39.08 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mt -132.85 179.8 5.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.607 -0.937 . . . . 0.0 109.62 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -137.49 140.74 41.35 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.769 -1.207 . . . . 0.0 109.886 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -137.3 166.97 22.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.84 153.03 40.14 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.113 -177.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.48 -121.28 1.11 Allowed Glycine 0 N--CA 1.487 2.082 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.484 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 92.3 m -155.19 22.32 0.43 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.339 -1.095 . . . . 0.0 111.057 -177.874 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -73.89 -13.41 60.9 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.316 -1.49 . . . . 0.0 113.355 -177.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.039 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -122.32 25.42 8.94 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 121.365 -0.834 . . . . 0.0 109.457 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.78 16.61 78.02 Favored Glycine 0 C--N 1.291 -1.947 0 C-N-CA 118.673 -1.727 . . . . 0.0 109.112 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.277 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pttm -88.03 52.94 2.59 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.483 1.135 . . . . 0.0 110.986 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.1 108.92 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.11 -22.38 39.56 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.997 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.691 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.6 mtmt -115.54 -146.36 0.4 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.743 -1.445 . . . . 0.0 108.83 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.6 m-85 -146.82 177.06 9.41 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 119.824 -1.798 . . . . 0.0 110.633 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.277 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.0 160.4 39.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.379 -1.45 . . . . 0.0 110.755 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.105 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -137.26 112.44 9.14 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -170.72 137.63 1.21 Allowed Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.59 -14.78 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.293 1.154 . . . . 0.0 109.606 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.601 HG21 ' HG2' ' A' ' 24' ' ' LYS . 7.8 tt -164.89 -166.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.49 11.7 50.02 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.76 -1.209 . . . . 0.0 110.637 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.601 ' HG2' HG21 ' A' ' 22' ' ' ILE . 13.7 ptmt -88.2 12.82 12.78 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.364 -1.08 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.6 m-85 -151.04 -53.24 0.14 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 9.6 t 36.56 74.99 0.07 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.451 -0.781 . . . . 0.0 110.473 -178.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.8 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 t -114.75 114.03 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.809 -1.182 . . . . 0.0 108.48 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.764 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.4 m -115.96 161.45 18.82 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.256 1.027 . . . . 0.0 113.218 -176.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.691 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 87.3 m-85 -149.9 176.49 10.7 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.265 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.5 p-10 -82.12 -42.15 19.52 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.238 -0.914 . . . . 0.0 111.833 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.42 114.99 20.54 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.043 -1.035 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 10.1 ptmt -50.21 -35.03 24.85 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.11 87.01 Favored 'General case' 0 C--O 1.2 -1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 108.879 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.733 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.16 -25.67 23.58 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 120.635 -1.291 . . . . 0.0 109.389 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.125 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 t -60.55 -66.88 0.46 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.01 -54.26 45.22 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.817 -1.177 . . . . 0.0 111.088 177.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.3 tmtm? -62.04 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.541 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -60.99 -30.31 70.2 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.185 -0.947 . . . . 0.0 112.818 -176.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.125 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 95.6 m -51.15 -30.73 17.52 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 118.696 -1.202 . . . . 0.0 111.338 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.133 -0.979 . . . . 0.0 110.152 -179.97 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -83.44 145.72 28.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.043 -1.035 . . . . 0.0 110.154 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.25 -178.46 40.8 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -131.23 179.81 5.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.698 -0.884 . . . . 0.0 109.484 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.7 t -132.77 135.87 45.98 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.625 -1.297 . . . . 0.0 110.382 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -137.49 166.28 24.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.87 152.17 41.01 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.284 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.06 -120.16 0.99 Allowed Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.534 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.287 97.6 m -155.28 23.59 0.42 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 111.235 -177.817 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.45 -14.52 61.26 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 120.217 -1.552 . . . . 0.0 113.257 -177.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.907 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.2 m -121.66 25.07 9.48 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 121.361 -0.837 . . . . 0.0 109.475 177.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.17 17.26 77.22 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.283 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.7 pttm -87.69 53.08 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.582 1.182 . . . . 0.0 110.885 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.32 109.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.95 -22.94 36.36 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.912 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.0 mtmt -115.24 -148.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.859 -1.377 . . . . 0.0 108.668 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.4 m-85 -146.68 175.91 10.25 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 119.83 -1.794 . . . . 0.0 110.455 -179.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.283 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 63.0 m -137.16 160.94 37.53 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.359 -1.463 . . . . 0.0 111.369 -178.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.881 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.25 112.03 8.33 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.743 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.89 140.21 1.34 Allowed Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -76.98 -7.39 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.223 1.117 . . . . 0.0 110.059 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.563 HG21 ' HG2' ' A' ' 24' ' ' LYS . 8.8 tt -165.08 -170.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.548 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.11 13.1 58.33 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.245 -178.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -84.13 -43.82 14.63 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.159 -1.2 . . . . 0.0 110.908 -179.711 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.452 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.2 m-85 -87.51 -51.83 5.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.064 -1.023 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.6 t 39.53 75.48 0.08 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.363 -0.836 . . . . 0.0 110.23 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.784 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.9 t -114.36 112.87 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.831 -1.168 . . . . 0.0 108.435 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.3 m -116.13 161.96 18.15 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.217 1.008 . . . . 0.0 113.0 -176.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.692 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 86.3 m-85 -149.62 174.08 12.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.14 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.63 -41.19 21.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 111.939 178.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.46 115.09 20.62 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.085 -1.009 . . . . 0.0 108.729 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.79 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.3 ptpt -49.92 -34.97 22.15 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.65 -46.2 87.66 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 176.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.6 -25.45 24.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 O-C-N 120.606 -1.309 . . . . 0.0 109.382 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.055 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 34.3 t -61.26 -66.66 0.5 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -55.04 -54.14 46.86 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.843 -1.161 . . . . 0.0 110.734 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.561 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.66 -79.09 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.561 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 51.1 m-80 -60.84 -31.13 70.57 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.278 -0.889 . . . . 0.0 112.869 -176.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.055 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 98.0 m -51.47 -32.32 26.78 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.228 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 9.4 p . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.127 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.08 0.467 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.31 107.35 15.77 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.39 178.91 38.86 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -132.31 179.34 6.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.524 -0.986 . . . . 0.0 109.391 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 t -145.18 152.11 39.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.664 -1.272 . . . . 0.0 110.622 179.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -137.04 163.42 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -123.09 149.45 44.46 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.939 -1.105 . . . . 0.0 111.084 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.46 -120.07 0.97 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.767 179.204 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.288 95.1 m -154.78 21.76 0.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.158 . . . . 0.0 111.283 -177.529 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.288 -1.507 . . . . 0.0 113.462 -177.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.92 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.8 m -124.26 25.66 7.68 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 178.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.64 17.62 76.66 Favored Glycine 0 C--N 1.29 -1.984 0 C-N-CA 118.38 -1.867 . . . . 0.0 108.694 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.299 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.8 pttt -87.68 51.2 2.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.547 1.165 . . . . 0.0 110.852 -178.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -67.23 108.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.21 -22.31 38.34 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.069 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.702 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmp? -119.0 -146.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.753 -1.439 . . . . 0.0 108.866 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.8 m-85 -146.77 176.15 10.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 119.856 -1.778 . . . . 0.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.299 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 92.8 m -137.29 161.89 35.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.389 -1.445 . . . . 0.0 110.802 -178.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.05 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.44 127.18 30.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.806 . . . . 0.0 111.123 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 p -166.18 126.66 1.26 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.25 2.23 8.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.089 1.047 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 5.0 tt -163.5 8.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.02 0.914 . . . . 0.0 111.169 178.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.91 85.53 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 22' ' ' ILE . 14.3 ptmm? -87.82 -34.08 18.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -85.03 -40.06 17.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 0.0 111.231 -179.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.3 t 44.28 70.58 0.32 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.306 -0.871 . . . . 0.0 110.284 -179.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.686 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 83.4 t -114.94 117.6 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.1 m -116.22 161.86 18.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.895 -1.128 . . . . 0.0 113.474 -176.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.702 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 84.9 m-85 -148.64 175.17 11.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.845 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.8 -42.33 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.811 178.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.714 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.34 116.49 21.2 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.008 -1.058 . . . . 0.0 108.774 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.2 ptpt -50.23 -35.51 27.06 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.95 -46.16 88.7 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 109.047 176.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.72 -26.04 26.63 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.139 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.4 t -60.83 -67.58 0.39 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.78 -53.51 54.17 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.843 -1.161 . . . . 0.0 110.855 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -62.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.544 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.7 m-80 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.32 -0.863 . . . . 0.0 113.032 -176.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.139 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.4 m -48.97 -29.65 5.07 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.353 -178.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.198 -179.969 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.196 0.522 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.95 -161.79 0.53 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.63 -129.26 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.605 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mt -131.98 -179.95 5.72 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.615 -0.932 . . . . 0.0 110.064 -178.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 39.2 t -137.52 150.35 47.45 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.872 -1.142 . . . . 0.0 110.359 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.9 p90 -137.29 162.72 32.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.2 149.08 45.11 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.015 -1.053 . . . . 0.0 110.772 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.82 -121.84 1.16 Allowed Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.504 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 98.1 m -155.74 28.72 0.37 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.489 -1.007 . . . . 0.0 110.288 -177.861 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -71.36 -12.27 61.34 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.516 -1.365 . . . . 0.0 112.79 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -117.27 21.98 12.78 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.59 15.24 77.6 Favored Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -92.28 61.25 3.84 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.37 1.081 . . . . 0.0 112.428 -177.984 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.64 116.94 3.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.16 -23.74 22.46 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 118.866 -1.635 . . . . 0.0 111.641 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.0 mtmm -120.11 -149.72 0.44 Allowed 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 120.426 2.113 . . . . 0.0 110.222 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 12.9 m-85 -146.2 170.12 17.38 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 119.983 -1.698 . . . . 0.0 110.276 -179.276 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 55.5 m -133.86 163.91 28.45 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.197 -1.564 . . . . 0.0 111.199 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.055 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.81 117.7 18.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.491 0.663 . . . . 0.0 110.737 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 p -165.82 140.27 3.82 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -76.49 -1.91 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.097 1.051 . . . . 0.0 111.599 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 24' ' ' LYS . 5.9 tt -164.2 13.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-O 121.994 0.902 . . . . 0.0 111.392 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.9 11.88 84.35 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -85.49 -37.69 19.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.483 -1.01 . . . . 0.0 111.069 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.2 m-85 -84.83 -33.19 22.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.813 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.1 t 40.92 75.52 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.535 -0.728 . . . . 0.0 111.086 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.955 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 88.0 t -113.3 109.17 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 14.6 m -116.25 164.71 14.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -173.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' CG ' HG21 ' A' ' 34' ' ' ILE . 78.8 m-85 -150.59 176.8 10.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.64 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.55 -42.34 18.47 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.834 178.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 119.02 23.01 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.016 -1.053 . . . . 0.0 108.854 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.77 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -51.21 -36.6 42.36 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.71 -45.7 88.97 Favored 'General case' 0 C--O 1.201 -1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 176.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -58.55 -25.5 28.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 O-C-N 120.667 -1.271 . . . . 0.0 109.339 179.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.055 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 20.0 t -60.73 -66.8 0.47 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.76 -54.28 44.12 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.808 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -62.86 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -177.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.6 -28.81 68.79 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.323 -0.861 . . . . 0.0 113.058 -176.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.2 m -49.95 -26.25 4.03 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.128 -178.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 13.0 p . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.088 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 25' ' ' TYR . 10.2 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.04 0.448 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -82.12 -158.56 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.96 -129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.64 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 mt -132.79 179.9 5.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.496 -1.002 . . . . 0.0 109.951 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 t -133.66 138.04 45.68 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.847 -1.158 . . . . 0.0 110.031 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.98 167.29 21.79 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.05 152.42 41.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.699 -1.2 . . . . 0.0 111.206 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.92 -120.88 1.05 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.479 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.285 92.4 m -155.01 23.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.292 -1.122 . . . . 0.0 111.13 -177.775 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.71 -12.99 60.89 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 120.3 -1.5 . . . . 0.0 113.329 -177.001 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.93 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.7 m -123.0 24.96 8.76 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.346 -0.846 . . . . 0.0 109.542 177.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.14 17.39 77.26 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.605 -1.76 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.282 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 5.0 pttm -87.99 53.16 2.67 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.501 1.143 . . . . 0.0 110.972 -178.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -67.29 109.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.1 -23.31 34.95 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.916 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.7 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.4 mtmm -114.95 -147.68 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.852 -1.381 . . . . 0.0 108.761 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 19.2 m-85 -146.72 176.48 9.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.878 -1.764 . . . . 0.0 110.289 -179.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.282 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 59.9 m -137.13 161.84 35.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.301 -1.499 . . . . 0.0 111.283 -178.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.889 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.15 109.73 7.04 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.599 -0.688 . . . . 0.0 110.731 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.2 136.89 1.3 Allowed Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -75.46 -13.67 20.42 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.276 1.145 . . . . 0.0 109.738 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.569 HG21 ' HG2' ' A' ' 24' ' ' LYS . 7.5 tt -165.08 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.167 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -83.34 8.98 62.51 Favored Glycine 0 N--CA 1.501 2.997 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.085 -178.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HG2' HG21 ' A' ' 22' ' ' ILE . 6.8 ptmm? -88.45 15.27 8.12 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.169 -1.195 . . . . 0.0 111.132 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.7 m-85 -150.95 -53.96 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 110.447 178.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' TYR . 12.8 t 36.66 75.34 0.06 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.367 -0.833 . . . . 0.0 110.853 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.849 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 59.4 t -114.49 113.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.724 -1.235 . . . . 0.0 108.366 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.603 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.12 162.5 17.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.029 . . . . 0.0 113.446 -176.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.7 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 88.4 m-85 -149.27 174.68 12.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 p-10 -82.2 -42.01 19.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.89 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.15 116.16 20.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.942 -1.099 . . . . 0.0 108.808 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.779 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.8 ptpt -49.94 -35.58 24.6 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.9 -46.31 88.19 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.033 176.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.718 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.0 mt -57.73 -25.85 26.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 O-C-N 120.655 -1.278 . . . . 0.0 109.467 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.041 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.1 t -61.08 -66.66 0.5 Allowed 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -55.28 -53.82 51.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.878 -1.138 . . . . 0.0 110.551 177.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.1 tmtm? -62.46 -79.6 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.3 m-80 -60.37 -30.56 69.65 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.172 -0.955 . . . . 0.0 112.713 -176.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 70.7 m -50.99 -27.3 7.43 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.263 -178.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 17.8 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.048 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.56 133.16 34.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.0 110.159 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.37 144.18 4.0 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 mt -132.23 179.56 6.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.577 -0.955 . . . . 0.0 109.147 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.1 t -143.41 150.85 39.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.488 -1.383 . . . . 0.0 111.348 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.8 p90 -137.57 166.54 23.66 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.54 152.91 39.89 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.285 -177.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.35 -121.62 1.15 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.354 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.437 ' O ' ' CG2' ' A' ' 9' ' ' THR 0.286 93.7 m -154.7 22.63 0.46 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -1.109 . . . . 0.0 110.996 -177.764 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -74.46 -11.47 60.24 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.292 -1.505 . . . . 0.0 113.351 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.992 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -123.77 24.7 8.33 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 121.265 -0.897 . . . . 0.0 109.735 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.43 17.15 77.56 Favored Glycine 0 C--N 1.291 -1.966 0 C-N-CA 118.641 -1.743 . . . . 0.0 109.077 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -87.45 52.63 2.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.392 1.091 . . . . 0.0 111.01 -178.69 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.03 110.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.51 -21.32 41.39 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.712 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.5 mttt -120.87 -145.36 0.36 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.796 -1.414 . . . . 0.0 109.033 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.509 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 16.0 m-85 -146.1 177.65 8.81 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.778 -1.826 . . . . 0.0 110.494 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -137.45 162.01 34.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.389 -1.444 . . . . 0.0 110.874 -178.552 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.085 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -133.89 124.86 27.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.46 -0.775 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 p -165.84 128.33 1.48 Allowed Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -77.29 -2.02 12.21 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.181 1.095 . . . . 0.0 111.078 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 HG23 ' HD2' ' A' ' 24' ' ' LYS . 4.4 tt -163.42 12.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-O 121.992 0.901 . . . . 0.0 111.125 179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.33 84.53 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HD2' HG23 ' A' ' 22' ' ' ILE . 14.2 ptmm? -87.96 -33.67 18.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.367 -1.078 . . . . 0.0 111.244 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.427 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.1 m-85 -85.15 -39.05 18.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.283 -0.885 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.4 t 43.29 68.32 0.52 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.345 -0.847 . . . . 0.0 110.36 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.795 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.13 116.11 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.703 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.26 161.63 18.71 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.493 -176.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.712 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 79.9 m-85 -149.1 176.74 10.21 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.184 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.89 -43.62 17.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.236 -0.915 . . . . 0.0 111.796 178.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.707 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.44 21.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.947 -1.095 . . . . 0.0 108.498 179.295 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.7 ptpt -50.34 -35.2 26.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.16 -46.13 89.2 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 109.084 176.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.707 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.72 -26.27 27.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 O-C-N 120.719 -1.238 . . . . 0.0 109.454 179.228 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.117 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 t -61.28 -67.44 0.41 Allowed 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.08 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -55.23 -53.13 59.93 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.756 -1.215 . . . . 0.0 110.61 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -62.92 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.72 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.9 m-80 -61.08 -28.35 69.02 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 112.948 -176.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.117 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.1 m -48.92 -32.46 9.04 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.118 -178.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.124 -179.885 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.505 2.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -138.39 163.04 32.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.1 151.49 42.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.22 -121.33 1.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.444 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.284 94.5 m -154.69 23.58 0.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.293 -1.122 . . . . 0.0 111.117 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -73.72 -13.86 61.04 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.259 -1.526 . . . . 0.0 113.332 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.833 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.1 m -120.97 24.25 10.27 Favored 'General case' 0 C--N 1.283 -2.297 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.46 77.5 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 118.708 -1.71 . . . . 0.0 109.029 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.356 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 16.6 pttm -87.84 52.87 2.59 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.534 1.159 . . . . 0.0 110.928 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 9' ' ' THR . 35.1 t -66.73 110.73 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.79 -22.84 34.28 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.24 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.2 mtmt -119.9 -145.69 0.37 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.663 -1.493 . . . . 0.0 109.147 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 17.4 m-85 -146.0 174.85 10.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.893 -1.754 . . . . 0.0 110.326 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.356 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.4 m -137.44 161.25 36.85 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.377 -1.452 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.994 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.775 . . . . 0.0 110.818 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 26.2 t . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.773 HG12 ' CE1' ' A' ' 29' ' ' TYR . 89.3 t -114.69 116.73 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 12.9 m -116.33 161.78 18.51 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.33 1.062 . . . . 0.0 113.157 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.6 m-85 -149.37 174.56 12.31 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.1 p30 -81.46 -40.72 22.89 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.837 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.75 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.2 113.85 19.62 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.083 -1.011 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.0 ptmm? -49.37 -35.05 17.61 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.29 86.98 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.126 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.761 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.18 -25.7 23.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 O-C-N 120.668 -1.27 . . . . 0.0 109.382 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.111 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 37.6 t -61.15 -67.35 0.41 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -54.53 -53.92 47.99 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.895 -1.128 . . . . 0.0 110.996 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -61.9 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.543 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.8 m120 -60.26 -30.47 69.46 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 121.227 -0.921 . . . . 0.0 112.767 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.111 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 94.3 m . . . . . 0 N--CA 1.502 2.128 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.506 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.506 2.363 0 CA-C-O 121.51 0.671 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.0 p90 -138.19 162.89 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.05 150.81 42.63 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.411 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.95 -122.46 1.23 Allowed Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.54 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.669 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -154.79 24.11 0.45 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.369 -1.077 . . . . 0.0 110.818 -177.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.77 -13.33 60.93 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.299 -1.501 . . . . 0.0 113.294 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.933 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.9 m -121.28 24.75 9.86 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.431 -0.793 . . . . 0.0 109.367 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.86 77.52 Favored Glycine 0 C--N 1.29 -1.985 0 C-N-CA 118.701 -1.714 . . . . 0.0 109.058 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.319 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 9.2 pttm -88.08 54.32 3.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.561 1.172 . . . . 0.0 110.843 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.462 ' CG2' HG23 ' A' ' 9' ' ' THR . 40.2 t -66.68 108.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.54 -22.65 36.69 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.022 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.749 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 41.5 mtmt -114.45 -147.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.821 -1.4 . . . . 0.0 108.943 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 25.4 m-85 -146.57 175.62 10.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.9 -1.75 . . . . 0.0 110.277 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.319 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.9 m -136.8 161.76 35.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.515 -1.366 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.9 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 18.2 t . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 120.638 0.256 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.4 t -114.45 111.48 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.699 -1.251 . . . . 0.0 108.434 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.2 m -116.13 161.64 18.62 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.29 1.043 . . . . 0.0 113.46 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.8 m-85 -150.12 175.75 11.46 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.8 p-10 -82.12 -41.82 19.95 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.92 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.11 115.51 20.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.964 -1.085 . . . . 0.0 108.739 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.913 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 9.4 ptmt -49.74 -35.3 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.8 -46.38 87.7 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.048 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.48 -25.79 25.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.0 109.332 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.043 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.2 t -60.35 -66.58 0.5 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.02 -54.17 48.06 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.927 -1.108 . . . . 0.0 110.785 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -61.61 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -61.02 -29.82 69.94 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.224 -0.922 . . . . 0.0 112.881 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.043 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.0 m . . . . . 0 N--CA 1.503 2.179 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.357 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 121.85 0.833 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -138.5 164.43 29.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.62 153.21 39.62 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.419 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.95 -122.18 1.23 Allowed Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.36 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 95.2 m -154.9 22.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 111.004 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -75.15 -10.16 59.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.316 -1.49 . . . . 0.0 113.713 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.013 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.6 m -124.5 25.32 7.64 Favored 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.245 -0.909 . . . . 0.0 109.707 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.24 77.43 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 118.593 -1.765 . . . . 0.0 109.167 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 4.2 pttt -87.83 51.67 2.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.505 1.145 . . . . 0.0 110.956 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.82 110.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 -22.04 39.46 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.11 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.772 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.3 mtmm -119.41 -145.53 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.865 -1.373 . . . . 0.0 109.005 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 26.5 m-85 -145.81 175.94 10.03 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 119.871 -1.768 . . . . 0.0 110.276 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 90.5 m -137.07 161.61 35.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.255 -1.528 . . . . 0.0 110.664 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.932 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.378 0 O-C-N 121.378 -0.826 . . . . 0.0 111.317 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 121.133 0.492 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.2 t -115.33 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.8 m -116.17 162.3 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.91 -1.119 . . . . 0.0 113.085 -176.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.7 m-85 -147.75 174.76 11.5 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.024 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.2 p-10 -82.04 -42.67 18.96 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.003 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.95 116.39 20.89 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.976 -1.077 . . . . 0.0 108.68 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.3 ptpt -49.19 -36.03 18.66 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.58 88.25 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.35 -26.36 25.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 O-C-N 120.704 -1.248 . . . . 0.0 109.435 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.146 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.4 t -60.98 -67.29 0.42 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -54.82 -53.42 55.47 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.825 -1.172 . . . . 0.0 110.875 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.31 -80.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.6 m120 -61.16 -28.12 68.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.261 -0.899 . . . . 0.0 113.007 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.146 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.8 m . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.144 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.506 2.35 0 CA-C-O 121.633 0.73 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.508 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -136.6 165.16 26.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.73 149.89 43.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.309 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.54 -120.33 1.01 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.531 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.685 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 96.1 m -154.83 21.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -1.136 . . . . 0.0 111.334 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.331 -1.48 . . . . 0.0 113.541 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.112 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.8 m -123.19 25.59 8.37 Favored 'General case' 0 C--N 1.282 -2.354 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.68 17.23 79.11 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 118.784 -1.674 . . . . 0.0 109.412 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.608 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.14 53.17 2.73 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.541 1.162 . . . . 0.0 110.856 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.82 107.78 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.42 -21.06 45.87 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.067 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 15.2 mtmt -119.18 -144.14 0.36 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.917 -1.343 . . . . 0.0 109.128 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 14.7 m-85 -146.65 176.67 9.66 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 119.789 -1.819 . . . . 0.0 110.593 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.608 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 95.8 m -136.74 163.29 30.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.445 -1.41 . . . . 0.0 110.745 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.362 0 O-C-N 121.511 -0.743 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.762 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.6 t -114.96 118.11 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.82 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.5 m -116.16 161.69 18.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.493 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 83.7 m-85 -149.26 176.51 10.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.0 p-10 -81.93 -42.83 18.93 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.78 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.13 20.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.029 -1.045 . . . . 0.0 108.611 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.7 ptpt -49.94 -35.45 24.09 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.12 -46.16 89.04 Favored 'General case' 0 C--O 1.201 -1.497 0 O-C-N 121.307 -0.87 . . . . 0.0 109.12 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.79 -25.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 120.566 -1.334 . . . . 0.0 109.407 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.101 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.7 t -60.82 -67.45 0.4 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -55.02 -53.53 54.68 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.901 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.1 tmtm? -62.81 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.603 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.69 -28.46 68.64 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.262 -0.899 . . . . 0.0 112.92 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.101 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.7 m . . . . . 0 N--CA 1.502 2.171 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.368 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 1.27 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 5.5 t . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.27 170.76 15.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.993 -1.067 . . . . 0.0 110.668 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.24 152.16 40.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.988 . . . . 0.0 110.833 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.27 -122.78 1.25 Allowed Glycine 0 N--CA 1.485 1.951 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 9' ' ' THR 0.294 91.5 m -155.77 26.75 0.38 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.32 -1.106 . . . . 0.0 110.57 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.43 -9.18 58.42 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.455 -1.403 . . . . 0.0 113.571 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.7 m -122.54 23.61 9.55 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.394 -0.816 . . . . 0.0 109.799 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.77 74.86 Favored Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.116 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 2.0 pttp -87.22 51.45 2.24 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.207 1.003 . . . . 0.0 111.944 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.02 114.68 3.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -24.55 22.46 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.323 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.691 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 6.7 mtmt -123.49 -146.1 0.35 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.515 -1.58 . . . . 0.0 109.554 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 54.6 m-85 -144.0 169.56 17.59 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 119.971 -1.705 . . . . 0.0 110.008 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.116 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 87.1 m -142.65 157.14 44.99 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.959 -1.713 . . . . 0.0 110.364 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.27 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 1.9 p . . . . . 0 C--N 1.304 -1.396 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.967 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.502 2.141 0 CA-C-O 121.037 0.446 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.67 HG12 ' CE1' ' A' ' 29' ' ' TYR . 70.8 t -114.31 115.58 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 22.9 m -116.24 164.04 15.1 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.342 1.068 . . . . 0.0 113.054 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.692 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.2 m-85 -147.88 170.29 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.61 -35.06 24.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 112.865 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.69 114.95 19.93 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.931 -1.106 . . . . 0.0 109.665 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 1.007 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -49.26 -35.22 17.1 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.56 -45.67 91.13 Favored 'General case' 0 C--O 1.197 -1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 109.085 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.731 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.4 mt -58.73 -26.15 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 O-C-N 120.466 -1.396 . . . . 0.0 109.052 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.007 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 14.7 t -59.49 -71.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -58.5 -51.1 71.28 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.028 -1.045 . . . . 0.0 111.158 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.659 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -60.78 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.659 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.1 m120 -61.96 -33.08 73.63 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.902 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.7 m . . . . . 0 C--N 1.283 -2.316 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.35 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 121.597 0.713 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -137.9 165.47 26.43 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.87 152.31 40.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.33 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.33 -121.31 1.11 Allowed Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.472 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.0 m -154.88 23.16 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.308 -1.113 . . . . 0.0 110.948 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -74.13 -12.2 60.52 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.303 -1.498 . . . . 0.0 113.377 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.5 m -122.36 25.15 9.04 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 121.243 -0.911 . . . . 0.0 109.6 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.4 77.8 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 118.674 -1.727 . . . . 0.0 109.041 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.327 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.9 pttm -87.92 54.75 3.2 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.569 1.176 . . . . 0.0 110.768 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.49 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.15 -21.55 39.44 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.4 mtmp? -117.57 -145.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.712 -1.464 . . . . 0.0 109.252 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.5 m-85 -146.47 176.41 9.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 119.919 -1.738 . . . . 0.0 110.424 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.327 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 79.8 m -137.62 161.98 35.01 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.386 -1.446 . . . . 0.0 110.79 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.083 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.345 0 O-C-N 121.521 -0.737 . . . . 0.0 111.011 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.1 t . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 121.16 0.505 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.744 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.5 t -114.71 115.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.638 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.3 m -116.22 161.42 19.0 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.392 1.092 . . . . 0.0 113.469 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.779 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.2 m-85 -149.68 176.52 10.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.965 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.5 p30 -81.56 -42.46 20.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.141 -0.974 . . . . 0.0 111.85 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.73 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.28 116.11 20.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.093 -1.004 . . . . 0.0 108.603 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.855 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.0 ptpt -50.84 -34.55 28.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.7 -46.19 87.85 Favored 'General case' 0 C--O 1.199 -1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 108.868 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.779 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.84 25.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 O-C-N 120.736 -1.227 . . . . 0.0 109.357 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.124 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -60.78 -67.59 0.39 Allowed 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -54.62 -53.79 50.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.908 -1.12 . . . . 0.0 110.93 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -62.47 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.631 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.8 m120 -60.89 -28.71 69.09 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.262 -0.899 . . . . 0.0 112.886 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.124 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.1 m . . . . . 0 N--CA 1.502 2.167 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.36 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.4 t . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 121.897 0.856 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 38.4 p90 -136.62 167.12 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.52 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.31 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.66 -121.47 1.12 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.442 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.645 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 87.0 m -154.63 21.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -1.138 . . . . 0.0 111.241 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -75.34 -12.97 60.38 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.2 -1.562 . . . . 0.0 113.617 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.149 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.3 m -122.72 25.59 8.63 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.4 79.74 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 118.904 -1.617 . . . . 0.0 109.578 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.677 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.04 53.43 2.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.469 1.128 . . . . 0.0 111.037 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.53 107.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.64 -20.84 47.84 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.181 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 29.9 mtmt -118.17 -143.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.879 -1.365 . . . . 0.0 109.121 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.528 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 18.2 m-85 -146.06 176.31 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.844 -1.785 . . . . 0.0 110.45 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.677 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 90.1 m -136.77 164.03 29.23 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.428 -1.42 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.543 -0.723 . . . . 0.0 110.991 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 121.21 0.529 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.824 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.92 116.51 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.877 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 14.1 m -116.36 161.64 18.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.037 -1.039 . . . . 0.0 113.302 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.815 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.8 m-85 -149.02 176.45 10.44 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.4 p30 -81.98 -43.31 18.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.254 -0.903 . . . . 0.0 111.879 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.722 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.02 116.42 20.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.094 -1.004 . . . . 0.0 108.492 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -49.82 -35.54 23.26 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.02 -46.52 87.99 Favored 'General case' 0 C--O 1.2 -1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.009 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.815 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.96 -25.75 26.8 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 O-C-N 120.773 -1.204 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.099 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.8 t -60.4 -65.88 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -54.96 -54.66 39.91 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.913 -1.117 . . . . 0.0 110.841 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.4 tmtm? -62.84 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -59.88 -27.86 67.06 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.287 -0.883 . . . . 0.0 112.871 -176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.099 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.2 m . . . . . 0 N--CA 1.504 2.255 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.285 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.506 2.362 0 CA-C-O 121.813 0.816 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.82 166.04 24.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.45 149.79 43.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.627 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.404 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 153.37 -123.41 1.42 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.468 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 98.4 m -156.05 25.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.41 -1.053 . . . . 0.0 110.846 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -74.13 -8.8 57.47 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.373 -1.454 . . . . 0.0 113.562 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.788 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -125.77 27.02 6.52 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 121.33 -0.856 . . . . 0.0 109.726 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 15.34 76.92 Favored Glycine 0 C--N 1.291 -1.965 0 C-N-CA 118.508 -1.806 . . . . 0.0 108.723 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.258 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.41 53.21 2.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.351 1.072 . . . . 0.0 111.096 -178.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 9' ' ' THR . 44.4 t -67.19 109.58 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.4 -19.93 43.91 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.761 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 28.3 mtmt -118.6 -143.05 0.36 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.722 -1.458 . . . . 0.0 109.368 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.1 m-85 -145.79 173.75 11.83 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 119.976 -1.703 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.258 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 76.3 m -136.87 162.55 32.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.449 -1.407 . . . . 0.0 111.118 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.306 -1.308 0 O-C-N 121.458 -0.776 . . . . 0.0 110.846 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.504 2.247 0 CA-C-O 121.042 0.448 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.772 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 62.2 t -115.15 115.81 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.33 162.05 18.1 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.313 1.054 . . . . 0.0 113.091 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.807 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.6 175.79 10.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.945 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.9 p-10 -81.87 -42.34 19.71 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.177 -0.952 . . . . 0.0 112.071 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.17 117.01 21.35 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.973 -1.079 . . . . 0.0 108.905 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.808 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -50.02 -35.89 26.62 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.8 -46.27 87.99 Favored 'General case' 0 C--O 1.2 -1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.059 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.807 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.07 -25.51 26.57 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 O-C-N 120.658 -1.276 . . . . 0.0 109.44 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.039 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 27.2 t -60.94 -66.52 0.52 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -55.92 -54.03 49.65 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.748 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtt? -61.77 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.634 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.6 m120 -60.67 -30.09 69.69 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.253 -0.904 . . . . 0.0 112.699 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.039 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 62.9 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.239 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.504 2.261 0 CA-C-O 121.44 0.638 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.485 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 25.0 p90 -138.26 163.27 32.2 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.04 153.69 39.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.455 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.57 -121.17 1.11 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.313 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 99.1 m -154.63 20.54 0.47 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 111.089 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -74.84 -9.77 58.86 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.336 -1.478 . . . . 0.0 113.351 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.982 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.2 m -124.24 24.09 8.18 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.397 -0.815 . . . . 0.0 109.856 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.51 18.44 77.07 Favored Glycine 0 C--N 1.29 -1.989 0 C-N-CA 118.495 -1.812 . . . . 0.0 108.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.205 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 22.5 pttt -87.92 51.22 2.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.443 1.116 . . . . 0.0 111.031 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.68 109.65 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.68 -21.16 41.63 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.263 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.0 mtmm -122.02 -145.15 0.35 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.394 . . . . 0.0 109.075 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 22.7 m-85 -145.76 177.41 8.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.829 -1.795 . . . . 0.0 110.35 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.205 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.2 m -137.09 161.08 37.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.344 -1.473 . . . . 0.0 110.58 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.142 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.761 . . . . 0.0 111.301 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 19.4 t . . . . . 0 N--CA 1.505 2.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.6 t -115.07 118.79 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.038 -1.039 . . . . 0.0 108.449 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 15.9 m -116.12 161.87 18.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.853 -1.154 . . . . 0.0 113.334 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.784 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 85.0 m-85 -148.56 175.27 11.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.929 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.5 p-10 -81.98 -42.58 19.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.869 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.749 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 114.74 20.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 108.664 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.2 ptmm? -49.44 -35.29 18.94 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.25 87.77 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.12 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.778 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.15 -26.26 24.88 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 O-C-N 120.675 -1.266 . . . . 0.0 109.389 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.175 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 t -60.69 -66.02 0.6 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -55.5 -54.18 47.11 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.707 -1.246 . . . . 0.0 110.645 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.0 tmtm? -63.19 -79.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.88 -28.3 68.78 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.259 -0.901 . . . . 0.0 113.13 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.175 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.8 m . . . . . 0 C--N 1.286 -2.164 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.372 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.507 2.38 0 CA-C-O 121.618 0.723 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -137.94 165.01 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.97 152.15 41.16 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.458 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.87 -120.75 1.04 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.377 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.9 m -155.18 23.33 0.42 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.364 -1.08 . . . . 0.0 111.034 -177.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -73.93 -12.26 60.6 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.258 -1.526 . . . . 0.0 113.416 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.003 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -123.43 25.48 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.79 77.53 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 118.687 -1.721 . . . . 0.0 109.08 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.291 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 pttm -87.93 54.2 3.02 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.609 1.195 . . . . 0.0 110.801 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.71 108.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 -22.13 40.77 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.108 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 5.4 mtmp? -113.82 -147.42 0.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.908 -1.348 . . . . 0.0 108.768 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 21.2 m-85 -146.57 176.8 9.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.774 -1.829 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.291 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.5 m -137.48 162.14 34.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.491 -1.38 . . . . 0.0 111.072 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.865 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.1 p . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.621 -0.674 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 17.5 t . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 120.614 0.245 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.865 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 66.4 t -114.69 111.46 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.803 -1.186 . . . . 0.0 108.178 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.17 162.2 17.81 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.264 1.031 . . . . 0.0 113.367 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.777 ' CE1' HG12 ' A' ' 27' ' ' VAL . 84.2 m-85 -150.47 175.3 12.0 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.295 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.08 -41.26 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.885 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.72 115.54 21.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.092 -1.005 . . . . 0.0 109.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.818 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.5 ptpt -50.03 -35.08 23.52 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.52 -45.97 87.72 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 108.996 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.769 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.49 -25.63 24.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.005 0 O-C-N 120.621 -1.3 . . . . 0.0 109.336 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.844 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 25.5 t -61.55 -67.93 0.36 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.0 -53.03 60.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.766 -1.209 . . . . 0.0 110.696 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.1 tmtt? -61.85 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.639 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.9 m120 -61.63 -32.6 72.76 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.28 -0.888 . . . . 0.0 112.879 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.844 ' SG ' ' HA ' ' A' ' 35' ' ' CYS . 69.8 m . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.306 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.702 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 12.6 t . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.701 0.762 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.6 p90 -136.74 165.45 25.89 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.422 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 9.6 pt-20 -122.63 149.02 44.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.059 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.29 -119.66 0.96 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.449 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 93.9 m -155.14 20.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 111.599 -177.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -75.28 -12.26 60.24 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.133 -1.605 . . . . 0.0 113.546 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.084 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.5 m -123.0 25.29 8.62 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.58 17.49 79.1 Favored Glycine 0 C--N 1.29 -1.982 0 C-N-CA 118.823 -1.656 . . . . 0.0 109.396 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.68 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.4 pttt -87.34 51.7 2.3 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.45 1.119 . . . . 0.0 111.031 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.15 109.48 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.15 -21.95 39.73 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.213 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.791 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 38.4 mtmt -123.23 -142.2 0.32 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.418 . . . . 0.0 109.227 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 9.8 m-85 -146.15 176.86 9.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.914 -1.741 . . . . 0.0 110.562 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.68 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 86.3 m -136.72 163.3 30.92 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.432 -1.417 . . . . 0.0 110.882 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.088 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.401 0 O-C-N 121.613 -0.679 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.786 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.84 121.29 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 11.2 m -116.27 160.99 19.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.029 -1.069 . . . . 0.0 113.493 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.5 m-85 -148.9 177.77 9.26 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.915 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.75 -43.75 17.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.699 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.717 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.12 116.42 21.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.014 -1.054 . . . . 0.0 108.338 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.883 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.41 -34.8 25.73 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.48 -46.31 89.16 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 108.948 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.68 -26.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.722 -1.236 . . . . 0.0 109.424 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.154 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -60.55 -67.4 0.4 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -55.0 -53.45 55.57 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.82 -1.175 . . . . 0.0 110.821 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.12 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.69 -26.94 67.49 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.375 -0.828 . . . . 0.0 112.955 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.154 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.8 m . . . . . 0 N--CA 1.502 2.146 0 C-N-CA 118.689 -1.205 . . . . 0.0 111.046 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.507 2.405 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' HE1' ' HZ2' ' A' ' 13' ' ' LYS . 39.7 p90 -138.68 166.97 22.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 109.4 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -122.95 151.88 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.898 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.88 -119.96 0.97 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.482 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 91.7 m -155.01 23.89 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.23 -1.159 . . . . 0.0 111.155 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -73.32 -14.08 61.23 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.235 -1.54 . . . . 0.0 113.201 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -122.36 24.51 9.31 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 17.93 77.18 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 118.637 -1.744 . . . . 0.0 108.979 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.271 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 10.7 pttm -88.12 51.67 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.407 1.098 . . . . 0.0 111.338 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 9' ' ' THR . 38.2 t -67.27 111.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.81 -24.45 29.54 Favored Glycine 0 N--CA 1.498 2.832 0 C-N-CA 119.239 -1.457 . . . . 0.0 109.856 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 12.9 mtmt -118.38 -146.81 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.78 -1.423 . . . . 0.0 108.838 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 15.9 m-85 -146.95 176.77 9.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 119.836 -1.79 . . . . 0.0 110.319 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.271 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.05 161.63 35.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.428 -1.42 . . . . 0.0 110.79 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.08 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 121.499 0.666 . . . . 0.0 110.423 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 120.657 0.265 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.907 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.5 t -114.58 112.96 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.797 -1.189 . . . . 0.0 108.096 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 16.8 m -116.13 161.61 18.67 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.417 1.103 . . . . 0.0 113.667 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.801 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.1 m-85 -149.92 176.94 10.3 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.009 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.98 -42.9 18.74 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.687 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.47 117.22 21.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.042 -1.036 . . . . 0.0 108.872 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.867 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -50.87 -35.71 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.54 -45.96 87.8 Favored 'General case' 0 C--O 1.201 -1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 108.909 176.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.801 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.85 -25.92 26.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.936 0 O-C-N 120.736 -1.227 . . . . 0.0 109.29 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.11 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.2 t -60.18 -66.23 0.56 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.99 -54.48 42.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.907 -1.121 . . . . 0.0 110.881 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.26 -79.34 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -59.82 -28.68 67.67 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.269 -0.895 . . . . 0.0 112.852 -176.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.11 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 118.611 -1.235 . . . . 0.0 111.412 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.505 2.286 0 CA-C-O 121.871 0.843 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -138.39 166.93 23.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.78 151.75 41.32 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.901 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.96 -119.76 0.95 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.546 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 98.1 m -155.38 23.99 0.41 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.152 -1.205 . . . . 0.0 111.334 -177.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.27 -14.36 61.31 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.213 -1.554 . . . . 0.0 113.33 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.0 m -121.5 24.37 9.9 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.52 77.07 Favored Glycine 0 C--N 1.29 -1.986 0 C-N-CA 118.535 -1.793 . . . . 0.0 108.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.289 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.4 pttm -87.59 52.07 2.39 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.474 1.131 . . . . 0.0 111.111 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t -66.88 111.36 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.76 31.14 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.009 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 40.7 mtmt -119.51 -146.32 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.415 . . . . 0.0 108.972 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -146.11 175.91 10.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 119.901 -1.749 . . . . 0.0 110.256 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 64.7 m -137.37 160.67 38.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.388 -1.445 . . . . 0.0 111.322 -178.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.309 0 O-C-N 121.681 -0.637 . . . . 0.0 110.676 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.0 t . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.794 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.54 114.71 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.796 -1.19 . . . . 0.0 108.751 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.5 m -116.0 161.36 18.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.157 0.979 . . . . 0.0 112.988 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CE1' HG12 ' A' ' 27' ' ' VAL . 88.3 m-85 -149.55 174.69 12.24 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.086 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.75 -41.39 21.29 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.811 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.728 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.22 114.95 20.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.045 -1.034 . . . . 0.0 108.658 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.853 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -50.0 -34.7 21.97 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.93 -46.41 88.02 Favored 'General case' 0 C--O 1.199 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.023 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.3 -26.29 25.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 120.596 -1.315 . . . . 0.0 109.376 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.137 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -61.27 -67.67 0.38 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -55.03 -53.06 60.68 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.747 -1.221 . . . . 0.0 110.737 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -62.33 -79.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -60.85 -29.73 69.69 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.268 -0.895 . . . . 0.0 112.839 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.137 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.0 m . . . . . 0 C--N 1.287 -2.129 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.404 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.4 t . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 121.788 0.804 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 36.0 p90 -138.29 167.27 22.22 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.9 pt-20 -122.57 153.3 39.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.764 -1.21 . . . . 0.0 111.553 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.14 -120.68 1.07 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.142 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 99.4 m -154.97 20.3 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -1.121 . . . . 0.0 111.275 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -75.25 -10.59 59.6 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.279 -1.513 . . . . 0.0 113.712 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.051 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.3 m -123.82 25.19 8.13 Favored 'General case' 0 C--N 1.284 -2.28 0 O-C-N 121.275 -0.89 . . . . 0.0 109.803 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.64 17.88 78.3 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 118.711 -1.709 . . . . 0.0 109.19 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.268 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 21.2 pttt -88.22 51.11 2.11 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.463 1.125 . . . . 0.0 111.133 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.88 109.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.27 -21.03 42.82 Favored Glycine 0 N--CA 1.5 2.907 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.29 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.793 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.8 mtmt -123.75 -142.65 0.32 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.411 . . . . 0.0 109.187 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.6 m-85 -145.21 177.63 8.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.777 -1.827 . . . . 0.0 110.5 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.268 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 92.9 m -137.5 163.78 30.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.513 -1.367 . . . . 0.0 110.998 -178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.555 -0.716 . . . . 0.0 111.276 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 121.141 0.496 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.823 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.9 t -114.94 120.31 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 13.6 m -116.19 161.01 19.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.955 -1.09 . . . . 0.0 113.36 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.803 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.6 m-85 -148.84 177.89 9.15 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.029 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.12 -44.01 17.06 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -0.973 . . . . 0.0 111.689 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.92 116.27 20.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.014 -1.054 . . . . 0.0 108.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.29 -34.79 24.66 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.3 -46.42 88.62 Favored 'General case' 0 C--O 1.2 -1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.981 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.66 -26.14 26.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.796 -1.19 . . . . 0.0 109.444 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.136 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.6 t -60.42 -65.62 0.66 Allowed 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -55.87 -54.47 44.2 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.615 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.4 tmtm? -62.85 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.672 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.7 m120 -60.51 -27.24 67.45 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.269 -0.894 . . . . 0.0 112.991 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.136 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.5 m . . . . . 0 N--CA 1.504 2.245 0 C-N-CA 118.575 -1.25 . . . . 0.0 111.244 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.506 2.349 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -138.16 166.53 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.1 pt-20 -122.95 149.56 44.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.789 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.21 -118.77 0.86 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.984 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 96.6 m -154.88 22.87 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 111.47 -177.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -73.48 -14.63 61.27 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.1 -1.625 . . . . 0.0 113.228 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 25.1 m -122.1 24.94 9.29 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.96 76.41 Favored Glycine 0 C--N 1.289 -2.064 0 C-N-CA 118.306 -1.902 . . . . 0.0 108.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.301 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 pttt -86.86 50.7 2.06 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.456 1.122 . . . . 0.0 110.871 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -67.47 110.76 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.41 -22.72 36.61 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 8.9 mttm -119.61 -147.61 0.4 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.759 -1.436 . . . . 0.0 108.806 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.1 m-85 -146.88 175.49 10.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.777 . . . . 0.0 110.256 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.301 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 80.1 m -137.66 160.99 37.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.307 -1.496 . . . . 0.0 111.559 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.307 -1.278 0 O-C-N 121.697 -0.627 . . . . 0.0 110.574 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 15.5 t . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 120.507 0.194 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.791 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.9 t -114.26 114.89 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.681 -1.262 . . . . 0.0 108.649 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 19.6 m -116.0 162.38 17.46 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.352 1.073 . . . . 0.0 113.45 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.784 ' CG ' HG22 ' A' ' 34' ' ' ILE . 80.6 m-85 -148.65 175.08 11.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.804 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CB ' ' HD3' ' A' ' 16' ' ' LYS . 1.9 p-10 -82.06 -42.36 19.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.002 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.705 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.32 118.37 22.58 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.104 -0.997 . . . . 0.0 108.927 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.849 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.0 ptpt -51.04 -35.72 35.86 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.2 -45.99 89.64 Favored 'General case' 0 C--O 1.2 -1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.281 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.784 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -58.13 -26.36 29.1 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 O-C-N 120.651 -1.281 . . . . 0.0 109.418 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.105 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.5 t -60.9 -66.96 0.45 Allowed 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -55.2 -53.37 56.89 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.839 -1.163 . . . . 0.0 110.62 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.84 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -59.95 -29.09 68.17 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 121.302 -0.874 . . . . 0.0 112.705 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.105 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.0 m . . . . . 0 N--CA 1.503 2.198 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.3 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.509 2.484 0 CA-C-O 122.037 0.923 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -137.15 166.41 23.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -122.88 150.69 42.56 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.014 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.3 -120.06 0.99 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 97.1 m -155.51 24.19 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.258 -1.142 . . . . 0.0 111.141 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.95 -12.3 60.61 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.237 -1.54 . . . . 0.0 113.466 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.065 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.2 m -122.55 25.29 8.87 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-O 121.818 0.818 . . . . 0.0 109.57 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.79 78.4 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.671 -1.728 . . . . 0.0 109.222 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -87.06 56.5 4.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.64 1.21 . . . . 0.0 110.429 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.89 107.72 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.19 51.71 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.447 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.752 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 31.2 mtmt -116.59 -145.8 0.39 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.757 -1.437 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 16.4 m-85 -146.55 176.06 10.11 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.893 -1.754 . . . . 0.0 110.705 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.625 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 57.5 m -136.46 160.81 37.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.439 -1.413 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.066 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.506 2.35 0 CA-C-O 120.699 0.285 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.832 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.5 t -114.72 110.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.759 -1.213 . . . . 0.0 108.23 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.7 m -116.19 161.41 19.0 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.201 1.0 . . . . 0.0 113.435 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.771 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.3 m-85 -150.55 176.76 10.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.417 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 4.3 p-10 -82.04 -42.53 19.14 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.987 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.769 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.77 116.26 21.38 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.961 -1.087 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.5 ptpt -50.55 -34.88 27.24 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.22 -45.88 86.88 Favored 'General case' 0 C--O 1.2 -1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.759 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.769 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.51 -25.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 O-C-N 120.681 -1.262 . . . . 0.0 109.263 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.066 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.0 t -61.13 -68.48 0.31 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -54.06 -53.64 50.33 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.896 -1.127 . . . . 0.0 110.846 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.22 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.628 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -62.21 -29.66 70.54 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.291 -0.881 . . . . 0.0 113.182 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.048 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 73.8 m . . . . . 0 N--CA 1.504 2.244 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.309 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.793 0.806 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.6 p90 -135.85 164.76 27.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.58 149.81 43.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.476 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.15 -122.3 1.27 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.286 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.707 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.4 m -155.95 25.82 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.19 . . . . 0.0 110.989 -177.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -73.47 -8.88 57.74 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.359 -1.463 . . . . 0.0 113.414 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.7 m -126.08 26.28 6.55 Favored 'General case' 0 C--N 1.282 -2.368 0 O-C-N 121.402 -0.812 . . . . 0.0 109.833 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.07 75.68 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 118.434 -1.841 . . . . 0.0 108.714 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.226 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.38 51.7 2.3 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.189 0.995 . . . . 0.0 111.465 -178.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 9' ' ' THR . 40.2 t -67.14 111.81 2.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.78 -22.41 33.84 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.6 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmt -120.19 -143.15 0.35 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.559 -1.553 . . . . 0.0 109.348 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.56 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.6 m-85 -145.56 174.1 11.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.013 -1.679 . . . . 0.0 110.172 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.226 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 88.1 m -136.85 162.47 33.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.403 -1.435 . . . . 0.0 111.003 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.907 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.6 -0.687 . . . . 0.0 110.957 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 121.053 0.454 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.745 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.09 116.28 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.19 -0.943 . . . . 0.0 108.462 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.3 m -116.21 161.84 18.36 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.057 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.797 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.3 m-85 -148.37 175.14 11.35 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.927 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.4 p-10 -81.97 -42.46 19.36 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.947 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.97 116.57 21.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.011 -1.055 . . . . 0.0 108.764 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.8 ptpt -49.59 -35.97 22.56 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.23 -46.16 89.22 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.127 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.797 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.94 -26.02 27.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 O-C-N 120.769 -1.207 . . . . 0.0 109.455 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.107 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 24.6 t -60.87 -66.29 0.56 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -55.75 -54.0 49.78 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.618 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.8 tmtm? -62.7 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.631 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.6 -28.15 68.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.283 -0.886 . . . . 0.0 113.031 -176.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.107 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.8 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.216 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.835 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 9.4 t . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 121.869 0.842 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 32.8 p90 -135.06 166.4 23.13 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.03 149.23 43.81 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.321 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 150.65 -122.23 1.35 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.8 m -156.23 23.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -1.103 . . . . 0.0 111.117 -177.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.31 -7.53 54.2 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.3 -1.5 . . . . 0.0 113.801 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.997 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.7 m -125.95 27.03 6.45 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.46 15.62 77.36 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 118.595 -1.764 . . . . 0.0 108.819 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.287 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.98 50.95 2.08 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.163 0.982 . . . . 0.0 111.461 -178.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 9' ' ' THR . 39.3 t -67.46 110.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.09 -20.56 40.31 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.836 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 21.9 mtmt -124.08 -139.04 0.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.597 -1.531 . . . . 0.0 109.425 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.586 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -144.33 174.1 11.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 119.844 -1.785 . . . . 0.0 110.052 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.287 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 99.5 m -135.05 163.13 30.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.54 -1.35 . . . . 0.0 110.842 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.097 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.531 -0.731 . . . . 0.0 110.922 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.502 2.151 0 CA-C-O 121.075 0.464 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.829 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.7 t -115.17 118.88 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.226 -0.921 . . . . 0.0 108.835 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.8 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.8 m -116.27 161.15 19.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 113.464 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.802 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.3 m-85 -148.81 177.48 9.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.95 -43.82 17.58 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.222 -0.924 . . . . 0.0 111.867 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.24 116.43 21.11 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.996 -1.065 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.815 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.5 ptpt -50.01 -35.23 23.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.06 -46.44 88.23 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.167 -0.958 . . . . 0.0 108.88 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.802 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.62 -25.66 25.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 O-C-N 120.82 -1.175 . . . . 0.0 109.358 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.097 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.6 t -60.08 -65.64 0.65 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 5' ' ' CYS . 49.5 m-20 -55.29 -55.36 32.29 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.89 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.2 tmtm? -62.32 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.33 -28.11 67.88 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.298 -0.876 . . . . 0.0 113.037 -176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.094 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 55.7 m . . . . . 0 N--CA 1.503 2.215 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.295 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.5 t . . . . . 0 N--CA 1.505 2.302 0 CA-C-O 121.75 0.786 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 30.8 p90 -136.95 163.32 30.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.7 pt-20 -123.11 148.93 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.186 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.47 -119.64 0.94 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.67 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.689 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 98.1 m -154.67 21.58 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -1.139 . . . . 0.0 111.285 -177.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -74.63 -11.49 60.2 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.251 -1.531 . . . . 0.0 113.399 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -124.33 25.87 7.56 Favored 'General case' 0 C--N 1.283 -2.289 0 O-C-N 121.4 -0.812 . . . . 0.0 109.772 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.05 76.49 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 118.536 -1.792 . . . . 0.0 108.883 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.429 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 pttt -87.45 51.27 2.18 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.464 1.126 . . . . 0.0 110.788 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 109.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.12 -23.12 35.54 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.961 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.6 mtmt -119.08 -145.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.43 . . . . 0.0 108.936 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.5 m-85 -146.69 176.63 9.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.779 -1.826 . . . . 0.0 110.493 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.429 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 97.2 m -137.46 161.74 35.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.499 -1.376 . . . . 0.0 110.611 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.068 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.411 0 O-C-N 121.427 -0.795 . . . . 0.0 110.993 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.501 2.122 0 CA-C-O 120.986 0.422 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.717 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -114.93 117.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.22 161.8 18.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.898 -1.127 . . . . 0.0 113.865 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.1 m-85 -149.44 176.79 10.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.843 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.91 -42.83 18.96 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.786 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.736 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.26 116.28 21.05 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.06 -1.025 . . . . 0.0 108.716 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.0 ptmm? -50.27 -35.7 28.25 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.84 89.1 Favored 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.059 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.773 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.65 -25.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 O-C-N 120.716 -1.24 . . . . 0.0 109.408 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.113 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.1 t -60.66 -67.87 0.36 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -55.1 -53.59 53.98 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.925 -1.109 . . . . 0.0 110.863 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.4 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.597 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.16 -29.41 68.65 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.218 -0.926 . . . . 0.0 112.768 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.113 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m . . . . . 0 N--CA 1.502 2.144 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.229 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.506 2.349 0 CA-C-O 121.696 0.76 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 30.5 p90 -137.92 164.45 28.96 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 6.5 pt-20 -122.94 149.49 44.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.92 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.35 -119.92 0.96 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.881 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.701 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.2 m -155.1 21.84 0.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 111.415 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.79 -12.46 60.4 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.284 -1.51 . . . . 0.0 113.63 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.904 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -124.16 26.3 7.51 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.15 17.83 77.56 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 118.497 -1.811 . . . . 0.0 108.888 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.298 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 4.0 pttt -87.39 50.09 1.94 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.403 1.096 . . . . 0.0 110.9 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.64 109.91 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.54 -22.78 37.45 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.02 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 37.3 mtmt -119.81 -145.05 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.86 -1.377 . . . . 0.0 108.82 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.9 m-85 -146.38 175.71 10.33 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 119.849 -1.782 . . . . 0.0 110.483 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.298 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 88.4 m -138.79 162.2 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.453 -1.404 . . . . 0.0 110.816 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 110.882 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.742 HG12 ' CE1' ' A' ' 29' ' ' TYR . 91.5 t -114.91 118.02 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.5 m -116.31 162.06 18.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.986 -1.085 . . . . 0.0 113.182 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.7 m-85 -148.74 174.33 12.3 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -81.74 -41.42 21.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.764 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.741 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 115.49 20.54 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.047 -1.033 . . . . 0.0 108.636 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.4 ptpt -49.58 -35.74 21.71 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.407 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -45.84 89.92 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 121.395 -0.815 . . . . 0.0 109.201 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.82 -26.18 27.39 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.951 0 O-C-N 120.637 -1.289 . . . . 0.0 109.445 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.093 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.2 t -61.4 -68.91 0.27 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -54.86 -52.5 62.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.855 -1.153 . . . . 0.0 110.868 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.54 -79.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.7 m120 -60.98 -29.22 69.55 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.197 -0.939 . . . . 0.0 112.812 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.093 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.9 m . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.254 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.506 2.372 0 CA-C-O 121.666 0.746 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 24.4 p90 -138.97 162.87 33.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -123.33 153.5 40.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.84 -1.162 . . . . 0.0 111.601 -177.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.76 -120.89 1.06 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.608 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 9' ' ' THR 0.283 92.8 m -154.01 19.19 0.51 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -1.145 . . . . 0.0 111.238 -177.883 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.492 ' H ' ' HZ1' ' A' ' 13' ' ' LYS . 17.9 t30 -73.92 -12.89 60.79 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.313 -1.492 . . . . 0.0 113.199 -177.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.971 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.0 m -122.71 23.92 9.31 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.363 -0.835 . . . . 0.0 109.569 178.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.36 77.77 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 118.556 -1.783 . . . . 0.0 109.111 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.424 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.2 pttm -87.2 51.78 2.33 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.509 1.147 . . . . 0.0 111.097 -178.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.49 108.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 -21.65 42.43 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.186 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.729 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.6 mtmm -121.0 -146.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.819 -1.401 . . . . 0.0 108.901 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.5 m-85 -146.67 177.38 9.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.808 -1.807 . . . . 0.0 110.666 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.424 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 96.8 m -138.14 161.37 36.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.513 -1.367 . . . . 0.0 110.656 -178.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.389 -0.82 . . . . 0.0 111.18 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.7 t . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.724 HG12 ' CE1' ' A' ' 29' ' ' TYR . 63.8 t -115.0 117.7 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.049 -1.032 . . . . 0.0 108.258 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 17.6 m -116.23 161.95 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.381 -176.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.781 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.1 m-85 -149.24 175.04 11.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.868 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.92 -42.12 19.93 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.218 -0.926 . . . . 0.0 111.865 178.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.36 115.3 20.65 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.064 -1.023 . . . . 0.0 108.85 179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.6 ptpt -49.77 -35.14 21.42 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.58 -46.48 86.86 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.945 176.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.39 -25.74 24.64 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 O-C-N 120.763 -1.21 . . . . 0.0 109.378 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.116 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 t -60.78 -66.1 0.58 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -55.44 -54.31 45.42 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.86 -1.15 . . . . 0.0 110.664 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtm? -62.26 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -59.93 -30.09 68.82 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.267 -0.896 . . . . 0.0 112.816 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.116 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 83.1 m . . . . . 0 N--CA 1.502 2.16 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.383 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.507 2.392 0 CA-C-O 121.892 0.853 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 30.4 p90 -136.09 168.9 18.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.63 145.59 48.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.694 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.94 -118.17 0.83 Allowed Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.605 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.72 ' O ' HG22 ' A' ' 9' ' ' THR 0.297 54.9 m -158.04 32.7 0.25 Allowed 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.251 -1.147 . . . . 0.0 110.276 -177.618 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -68.79 -7.96 38.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.084 -1.635 . . . . 0.0 112.529 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.7 m -120.49 23.67 10.73 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.966 0.889 . . . . 0.0 108.637 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.27 83.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.137 178.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.087 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -93.78 71.62 4.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.842 1.306 . . . . 0.0 112.667 -178.681 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.6 t -64.27 116.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.599 177.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.85 -25.94 17.31 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.756 -1.687 . . . . 0.0 111.674 178.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.861 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 16.1 mttt -108.47 -146.33 0.4 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 120.371 2.085 . . . . 0.0 109.497 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.891 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 11.3 m-85 -146.4 169.37 19.01 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 119.437 -2.04 . . . . 0.0 111.487 -178.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.087 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 50.0 m -137.43 161.57 35.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.806 -1.809 . . . . 0.0 112.619 -178.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.078 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 121.366 0.603 . . . . 0.0 109.641 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.078 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 t -113.48 105.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.7 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 24.5 m -116.11 163.98 15.14 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.313 1.054 . . . . 0.0 113.545 -175.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.834 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.1 m-85 -150.08 176.65 10.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -82.54 -41.73 19.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.035 -1.041 . . . . 0.0 111.635 178.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.91 118.8 22.72 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.007 -1.058 . . . . 0.0 108.863 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.852 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.2 ptpt -50.65 -37.12 38.99 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.29 -45.27 91.73 Favored 'General case' 0 C--O 1.198 -1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 109.265 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.834 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.39 -26.06 29.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 120.659 -1.276 . . . . 0.0 109.31 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.971 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 5.2 t -61.85 -70.28 0.2 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -54.71 -51.48 65.44 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.958 -1.089 . . . . 0.0 110.585 178.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.6 tmtm? -62.3 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -61.45 -29.36 69.9 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.209 -0.932 . . . . 0.0 112.825 -177.005 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.971 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.8 m . . . . . 0 N--CA 1.505 2.307 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.08 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.793 0.806 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -137.55 164.6 28.33 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 8.0 pt-20 -123.17 149.27 44.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.746 -1.181 . . . . 0.0 110.801 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.99 -119.45 0.92 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.918 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.674 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 89.4 m -155.02 22.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -1.144 . . . . 0.0 111.514 -177.473 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -73.99 -12.61 60.69 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.185 -1.572 . . . . 0.0 113.333 -177.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -123.19 25.08 8.59 Favored 'General case' 0 C--N 1.281 -2.37 0 O-C-N 121.431 -0.793 . . . . 0.0 109.645 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.01 76.55 Favored Glycine 0 C--N 1.29 -2.018 0 C-N-CA 118.491 -1.814 . . . . 0.0 108.68 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.324 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 pttt -87.32 51.47 2.24 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.42 1.105 . . . . 0.0 110.927 -178.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.51 109.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.63 37.65 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.75 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 23.3 mtmt -118.52 -147.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.808 -1.407 . . . . 0.0 108.892 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.0 m-85 -147.3 176.51 9.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.852 -1.78 . . . . 0.0 110.232 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.324 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 81.5 m -136.4 162.23 33.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.515 -1.366 . . . . 0.0 111.341 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.985 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.305 -1.341 0 O-C-N 121.712 -0.617 . . . . 0.0 110.584 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.4 t . . . . . 0 N--CA 1.509 2.5 0 CA-C-O 120.446 0.165 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.855 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.23 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.63 -1.294 . . . . 0.0 108.595 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.4 m -116.03 162.01 18.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.315 1.055 . . . . 0.0 113.79 -176.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.799 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.1 m-85 -149.28 176.64 10.36 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.3 p-10 -82.22 -43.24 17.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.236 -0.915 . . . . 0.0 111.933 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.09 117.62 21.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.105 -0.997 . . . . 0.0 108.848 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.878 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 17.0 ptpt -50.26 -35.82 28.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.55 -45.94 90.33 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.157 176.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.87 -26.01 27.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.717 -1.239 . . . . 0.0 109.333 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.152 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -60.56 -68.0 0.34 Allowed 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -54.85 -53.47 54.94 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.752 -1.217 . . . . 0.0 110.952 177.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.15 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.893 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -60.32 -29.32 68.79 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 112.772 -176.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.152 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 71.0 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.272 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 121.868 0.842 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.5 165.73 24.84 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.45 149.77 43.39 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.67 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 152.97 -124.13 1.55 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.4 m -155.44 25.35 0.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.82 -177.826 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -74.05 -7.44 52.49 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.326 -1.484 . . . . 0.0 113.522 -176.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.831 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m -127.64 27.18 5.82 Favored 'General case' 0 C--N 1.284 -2.253 0 O-C-N 121.281 -0.887 . . . . 0.0 109.809 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.45 15.04 77.26 Favored Glycine 0 C--N 1.291 -1.933 0 C-N-CA 118.56 -1.781 . . . . 0.0 108.848 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.278 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.64 52.7 2.56 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.229 1.014 . . . . 0.0 111.298 -178.585 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 9' ' ' THR . 44.5 t -67.44 109.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.3 -20.63 44.2 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.801 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.771 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.8 mtmt -117.41 -143.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.709 -1.465 . . . . 0.0 109.169 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.555 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.8 m-85 -145.66 173.85 11.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 119.875 -1.766 . . . . 0.0 110.179 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.278 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -136.48 163.18 31.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.451 -1.406 . . . . 0.0 111.024 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.819 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.304 -1.403 0 O-C-N 121.529 -0.732 . . . . 0.0 110.799 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.504 2.236 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.819 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.0 t -115.14 115.51 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.37 161.99 18.22 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.304 1.049 . . . . 0.0 113.325 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.804 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.4 m-85 -148.74 175.82 10.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.048 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.412 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -82.36 -42.59 18.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.204 -0.935 . . . . 0.0 112.066 178.949 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.66 116.56 20.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.003 -1.06 . . . . 0.0 108.573 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.828 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 1.1 ptpp? -49.71 -35.85 23.29 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -46.15 89.12 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.094 176.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.804 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.16 -26.12 28.53 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.726 -1.234 . . . . 0.0 109.386 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.061 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -60.34 -65.82 0.62 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -56.45 -54.11 49.58 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.697 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -62.36 -79.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -177.646 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.75 -28.53 68.77 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.29 -0.881 . . . . 0.0 112.962 -176.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.061 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.2 m . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.251 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 121.646 0.736 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -137.3 166.97 22.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.84 153.03 40.14 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.113 -177.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.48 -121.28 1.11 Allowed Glycine 0 N--CA 1.487 2.082 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.484 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -155.19 22.32 0.43 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.339 -1.095 . . . . 0.0 111.057 -177.874 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -73.89 -13.41 60.9 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.316 -1.49 . . . . 0.0 113.355 -177.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.062 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -122.32 25.42 8.94 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 121.365 -0.834 . . . . 0.0 109.457 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.78 16.61 78.02 Favored Glycine 0 C--N 1.291 -1.947 0 C-N-CA 118.673 -1.727 . . . . 0.0 109.112 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.277 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pttm -88.03 52.94 2.59 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.483 1.135 . . . . 0.0 110.986 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 HG23 ' A' ' 9' ' ' THR . 38.8 t -67.1 108.92 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.375 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.11 -22.38 39.56 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.997 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.6 mtmt -115.54 -146.36 0.4 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.743 -1.445 . . . . 0.0 108.83 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.543 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.6 m-85 -146.82 177.06 9.41 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 119.824 -1.798 . . . . 0.0 110.633 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.277 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.0 160.4 39.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.379 -1.45 . . . . 0.0 110.755 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.104 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.304 -1.393 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.6 t . . . . . 0 N--CA 1.509 2.496 0 CA-C-O 120.588 0.233 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.8 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 t -114.75 114.03 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.809 -1.182 . . . . 0.0 108.48 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.764 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.4 m -115.96 161.45 18.82 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.256 1.027 . . . . 0.0 113.218 -176.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.782 ' CE1' HG12 ' A' ' 27' ' ' VAL . 87.3 m-85 -149.9 176.49 10.7 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.265 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.5 p-10 -82.12 -42.15 19.52 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.238 -0.914 . . . . 0.0 111.833 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.746 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.42 114.99 20.54 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.043 -1.035 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 10.1 ptmt -50.21 -35.03 24.85 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.11 87.01 Favored 'General case' 0 C--O 1.2 -1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 108.879 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.771 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.16 -25.67 23.58 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 120.635 -1.291 . . . . 0.0 109.389 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.125 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 t -60.55 -66.88 0.46 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.01 -54.26 45.22 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.817 -1.177 . . . . 0.0 111.088 177.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.3 tmtm? -62.04 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -60.99 -30.31 70.2 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.185 -0.947 . . . . 0.0 112.818 -176.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.125 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 95.6 m . . . . . 0 C--N 1.286 -2.182 0 C-N-CA 118.696 -1.202 . . . . 0.0 111.338 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.504 2.258 0 CA-C-O 121.828 0.823 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -137.49 166.28 24.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.87 152.17 41.01 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.284 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.06 -120.16 0.99 Allowed Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.534 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.6 m -155.28 23.59 0.42 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 111.235 -177.817 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.45 -14.52 61.26 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 120.217 -1.552 . . . . 0.0 113.257 -177.024 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.2 m -121.66 25.07 9.48 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 121.361 -0.837 . . . . 0.0 109.475 177.764 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.17 17.26 77.22 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.283 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.7 pttm -87.69 53.08 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.582 1.182 . . . . 0.0 110.885 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 9' ' ' THR . 25.8 t -67.32 109.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.316 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.95 -22.94 36.36 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.912 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.0 mtmt -115.24 -148.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.859 -1.377 . . . . 0.0 108.668 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.4 m-85 -146.68 175.91 10.25 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 119.83 -1.794 . . . . 0.0 110.455 -179.473 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.283 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 63.0 m -137.16 160.94 37.53 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.359 -1.463 . . . . 0.0 111.369 -178.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.879 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.743 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.505 2.302 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.784 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.9 t -114.36 112.87 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.831 -1.168 . . . . 0.0 108.435 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.3 m -116.13 161.96 18.15 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.217 1.008 . . . . 0.0 113.0 -176.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.3 m-85 -149.62 174.08 12.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.14 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.63 -41.19 21.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 111.939 178.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.46 115.09 20.62 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.085 -1.009 . . . . 0.0 108.729 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.81 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.3 ptpt -49.92 -34.97 22.15 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.65 -46.2 87.66 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 176.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.45 24.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 O-C-N 120.606 -1.309 . . . . 0.0 109.382 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.055 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 34.3 t -61.26 -66.66 0.5 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -55.04 -54.14 46.86 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.843 -1.161 . . . . 0.0 110.734 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.66 -79.09 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.1 m120 -60.84 -31.13 70.57 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.278 -0.889 . . . . 0.0 112.869 -176.856 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.055 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 98.0 m . . . . . 0 N--CA 1.502 2.136 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.228 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.505 2.301 0 CA-C-O 121.703 0.763 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -137.04 163.42 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.4 pt-20 -123.09 149.45 44.46 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.939 -1.105 . . . . 0.0 111.084 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.46 -120.07 0.97 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.767 179.204 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 95.1 m -154.78 21.76 0.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.158 . . . . 0.0 111.283 -177.529 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.288 -1.507 . . . . 0.0 113.462 -177.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.8 m -124.26 25.66 7.68 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 178.331 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.64 17.62 76.66 Favored Glycine 0 C--N 1.29 -1.984 0 C-N-CA 118.38 -1.867 . . . . 0.0 108.694 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.332 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.8 pttt -87.68 51.2 2.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.547 1.165 . . . . 0.0 110.852 -178.656 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -67.23 108.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.21 -22.31 38.34 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.069 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmp? -119.0 -146.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.753 -1.439 . . . . 0.0 108.866 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.8 m-85 -146.77 176.15 10.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 119.856 -1.778 . . . . 0.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.332 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 92.8 m -137.29 161.89 35.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.389 -1.445 . . . . 0.0 110.802 -178.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.041 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.806 . . . . 0.0 111.123 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 83.4 t -114.94 117.6 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.1 m -116.22 161.86 18.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.895 -1.128 . . . . 0.0 113.474 -176.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.796 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.64 175.17 11.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.845 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.3 p-10 -81.8 -42.33 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.811 178.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.34 116.49 21.2 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.008 -1.058 . . . . 0.0 108.774 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.2 ptpt -50.23 -35.51 27.06 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.95 -46.16 88.7 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 109.047 176.388 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.796 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.72 -26.04 26.63 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.139 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.4 t -60.83 -67.58 0.39 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.78 -53.51 54.17 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.843 -1.161 . . . . 0.0 110.855 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -62.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.77 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.605 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.32 -0.863 . . . . 0.0 113.032 -176.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.139 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.4 m . . . . . 0 N--CA 1.503 2.18 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.353 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 39.2 t . . . . . 0 N--CA 1.509 2.478 0 CA-C-O 121.701 0.762 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.9 p90 -137.29 162.72 32.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.2 149.08 45.11 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.015 -1.053 . . . . 0.0 110.772 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.82 -121.84 1.16 Allowed Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.504 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 98.1 m -155.74 28.72 0.37 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.489 -1.007 . . . . 0.0 110.288 -177.861 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -71.36 -12.27 61.34 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.516 -1.365 . . . . 0.0 112.79 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -117.27 21.98 12.78 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.59 15.24 77.6 Favored Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -92.28 61.25 3.84 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.37 1.081 . . . . 0.0 112.428 -177.984 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.524 HG23 HG23 ' A' ' 9' ' ' THR . 24.6 t -63.64 116.94 3.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.16 -23.74 22.46 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 118.866 -1.635 . . . . 0.0 111.641 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.0 mtmm -120.11 -149.72 0.44 Allowed 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 120.426 2.113 . . . . 0.0 110.222 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 12.9 m-85 -146.2 170.12 17.38 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 119.983 -1.698 . . . . 0.0 110.276 -179.276 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 55.5 m -133.86 163.91 28.45 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.197 -1.564 . . . . 0.0 111.199 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.053 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.491 0.663 . . . . 0.0 110.737 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 120.903 0.383 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.955 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 88.0 t -113.3 109.17 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 14.6 m -116.25 164.71 14.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -173.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.818 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.8 m-85 -150.59 176.8 10.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.64 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.55 -42.34 18.47 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.834 178.797 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 119.02 23.01 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.016 -1.053 . . . . 0.0 108.854 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -51.21 -36.6 42.36 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.71 -45.7 88.97 Favored 'General case' 0 C--O 1.201 -1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 176.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.818 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.55 -25.5 28.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 O-C-N 120.667 -1.271 . . . . 0.0 109.339 179.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.053 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 20.0 t -60.73 -66.8 0.47 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.76 -54.28 44.12 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.808 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -62.86 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -177.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.6 -28.81 68.79 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.323 -0.861 . . . . 0.0 113.058 -176.637 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.2 m . . . . . 0 N--CA 1.505 2.28 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.128 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.507 2.412 0 CA-C-O 121.731 0.777 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.98 167.29 21.79 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.05 152.42 41.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.699 -1.2 . . . . 0.0 111.206 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.92 -120.88 1.05 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.479 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.4 m -155.01 23.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.292 -1.122 . . . . 0.0 111.13 -177.775 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.71 -12.99 60.89 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 120.3 -1.5 . . . . 0.0 113.329 -177.001 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.7 m -123.0 24.96 8.76 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.346 -0.846 . . . . 0.0 109.542 177.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.14 17.39 77.26 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.605 -1.76 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.282 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 5.0 pttm -87.99 53.16 2.67 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.501 1.143 . . . . 0.0 110.972 -178.661 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.416 ' CG2' HG23 ' A' ' 9' ' ' THR . 49.2 t -67.29 109.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.3 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.1 -23.31 34.95 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.916 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.4 mtmm -114.95 -147.68 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.852 -1.381 . . . . 0.0 108.761 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.52 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 19.2 m-85 -146.72 176.48 9.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.878 -1.764 . . . . 0.0 110.289 -179.454 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.282 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 59.9 m -137.13 161.84 35.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.301 -1.499 . . . . 0.0 111.283 -178.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.882 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.303 0 O-C-N 121.599 -0.688 . . . . 0.0 110.731 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.436 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 12.8 t . . . . . 0 N--CA 1.507 2.414 0 CA-C-O 120.561 0.219 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.849 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 59.4 t -114.49 113.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.724 -1.235 . . . . 0.0 108.366 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.603 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.12 162.5 17.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.029 . . . . 0.0 113.446 -176.617 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.4 m-85 -149.27 174.68 12.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.7 p-10 -82.2 -42.01 19.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.89 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.729 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.15 116.16 20.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.942 -1.099 . . . . 0.0 108.808 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.8 ptpt -49.94 -35.58 24.6 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.9 -46.31 88.19 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.033 176.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.73 -25.85 26.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 O-C-N 120.655 -1.278 . . . . 0.0 109.467 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.041 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.1 t -61.08 -66.66 0.5 Allowed 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -55.28 -53.82 51.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.878 -1.138 . . . . 0.0 110.551 177.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.1 tmtm? -62.46 -79.6 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.613 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.37 -30.56 69.65 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.172 -0.955 . . . . 0.0 112.713 -176.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 70.7 m . . . . . 0 N--CA 1.503 2.179 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.1 t . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 121.938 0.875 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.8 p90 -137.57 166.54 23.66 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.54 152.91 39.89 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.285 -177.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.35 -121.62 1.15 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.354 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.7 m -154.7 22.63 0.46 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -1.109 . . . . 0.0 110.996 -177.764 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -74.46 -11.47 60.24 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.292 -1.505 . . . . 0.0 113.351 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.02 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -123.77 24.7 8.33 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 121.265 -0.897 . . . . 0.0 109.735 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.43 17.15 77.56 Favored Glycine 0 C--N 1.291 -1.966 0 C-N-CA 118.641 -1.743 . . . . 0.0 109.077 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.273 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -87.45 52.63 2.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.392 1.091 . . . . 0.0 111.01 -178.69 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.03 110.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.51 -21.32 41.39 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.5 mttt -120.87 -145.36 0.36 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.796 -1.414 . . . . 0.0 109.033 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 16.0 m-85 -146.1 177.65 8.81 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.778 -1.826 . . . . 0.0 110.494 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.273 ' SG ' ' HD2' ' A' ' 13' ' ' LYS . 70.8 m -137.45 162.01 34.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.389 -1.444 . . . . 0.0 110.874 -178.552 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.301 0 O-C-N 121.46 -0.775 . . . . 0.0 111.123 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 121.058 0.456 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.795 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.13 116.11 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.703 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.26 161.63 18.71 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.493 -176.498 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.789 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.9 m-85 -149.1 176.74 10.21 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.184 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.89 -43.62 17.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.236 -0.915 . . . . 0.0 111.796 178.713 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.44 21.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.947 -1.095 . . . . 0.0 108.498 179.295 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.7 ptpt -50.34 -35.2 26.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.16 -46.13 89.2 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 109.084 176.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.789 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.72 -26.27 27.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 O-C-N 120.719 -1.238 . . . . 0.0 109.454 179.228 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.117 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 t -61.28 -67.44 0.41 Allowed 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.08 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -55.23 -53.13 59.93 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.756 -1.215 . . . . 0.0 110.61 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -62.92 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.72 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.608 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -61.08 -28.35 69.02 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 112.948 -176.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.117 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.1 m . . . . . 0 N--CA 1.503 2.219 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.118 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.014 0.435 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -83.63 118.86 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.224 -0.923 . . . . 0.0 110.238 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 156.0 9.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 mt -131.89 179.26 6.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.977 . . . . 0.0 109.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 t -145.38 150.65 36.94 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.735 -1.228 . . . . 0.0 110.426 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -138.39 163.04 32.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.1 151.49 42.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.22 -121.33 1.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.444 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.284 94.5 m -154.69 23.58 0.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.293 -1.122 . . . . 0.0 111.117 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -73.72 -13.86 61.04 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.259 -1.526 . . . . 0.0 113.332 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.833 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.1 m -120.97 24.25 10.27 Favored 'General case' 0 C--N 1.283 -2.297 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.46 77.5 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 118.708 -1.71 . . . . 0.0 109.029 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.356 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 16.6 pttm -87.84 52.87 2.59 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.534 1.159 . . . . 0.0 110.928 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 9' ' ' THR . 35.1 t -66.73 110.73 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.79 -22.84 34.28 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.24 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.2 mtmt -119.9 -145.69 0.37 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.663 -1.493 . . . . 0.0 109.147 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 17.4 m-85 -146.0 174.85 10.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.893 -1.754 . . . . 0.0 110.326 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.356 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.4 m -137.44 161.25 36.85 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.377 -1.452 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.994 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.46 127.85 32.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.775 . . . . 0.0 110.818 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -165.86 124.77 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.66 1.31 9.32 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.199 1.105 . . . . 0.0 111.317 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.8 tt -163.83 11.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.995 0.902 . . . . 0.0 111.257 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.24 11.53 84.87 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.602 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -87.92 -35.52 17.64 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.452 -1.028 . . . . 0.0 111.271 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.446 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.8 m-85 -84.9 -41.1 16.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 111.742 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' TYR . 26.2 t 41.83 67.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.245 -0.909 . . . . 0.0 109.519 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.773 HG12 ' CE1' ' A' ' 29' ' ' TYR . 89.3 t -114.69 116.73 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 12.9 m -116.33 161.78 18.51 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.33 1.062 . . . . 0.0 113.157 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.6 m-85 -149.37 174.56 12.31 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.1 p30 -81.46 -40.72 22.89 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.837 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.75 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.2 113.85 19.62 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.083 -1.011 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.0 ptmm? -49.37 -35.05 17.61 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.29 86.98 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.126 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.761 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.18 -25.7 23.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 O-C-N 120.668 -1.27 . . . . 0.0 109.382 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.111 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 37.6 t -61.15 -67.35 0.41 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -54.53 -53.92 47.99 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.895 -1.128 . . . . 0.0 110.996 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -61.9 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.543 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.8 m120 -60.26 -30.47 69.46 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 121.227 -0.921 . . . . 0.0 112.767 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.111 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 94.3 m -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.506 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 11.9 p . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.104 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.237 0.541 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -155.73 176.57 12.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.75 -168.23 39.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.14 178.04 7.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -1.004 . . . . 0.0 109.487 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 t -114.26 137.81 51.3 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.653 -1.279 . . . . 0.0 110.03 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.0 p90 -138.19 162.89 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.05 150.81 42.63 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.411 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.95 -122.46 1.23 Allowed Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.54 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.669 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -154.79 24.11 0.45 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.369 -1.077 . . . . 0.0 110.818 -177.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.77 -13.33 60.93 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.299 -1.501 . . . . 0.0 113.294 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.933 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.9 m -121.28 24.75 9.86 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.431 -0.793 . . . . 0.0 109.367 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.86 77.52 Favored Glycine 0 C--N 1.29 -1.985 0 C-N-CA 118.701 -1.714 . . . . 0.0 109.058 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.319 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 9.2 pttm -88.08 54.32 3.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.561 1.172 . . . . 0.0 110.843 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' CG2' HG23 ' A' ' 9' ' ' THR . 40.2 t -66.68 108.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.54 -22.65 36.69 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.022 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.749 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 41.5 mtmt -114.45 -147.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.821 -1.4 . . . . 0.0 108.943 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 25.4 m-85 -146.57 175.62 10.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.9 -1.75 . . . . 0.0 110.277 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.319 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.9 m -136.8 161.76 35.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.515 -1.366 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.9 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -135.21 106.72 6.87 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -171.82 139.96 1.13 Allowed Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -78.2 -7.65 16.19 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.263 1.138 . . . . 0.0 109.765 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.827 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.8 tt -164.86 -169.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.5 13.09 57.11 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.04 -1.037 . . . . 0.0 111.256 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.827 ' H ' HG23 ' A' ' 22' ' ' ILE . 13.8 ptmt -83.65 -44.24 14.75 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.715 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 46.1 m-85 -87.65 -50.79 6.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.956 -1.09 . . . . 0.0 110.782 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' TYR . 18.2 t 36.24 74.29 0.08 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.624 -0.672 . . . . 0.0 110.749 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.4 t -114.45 111.48 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.699 -1.251 . . . . 0.0 108.434 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.2 m -116.13 161.64 18.62 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.29 1.043 . . . . 0.0 113.46 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.8 m-85 -150.12 175.75 11.46 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.8 p-10 -82.12 -41.82 19.95 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.92 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.11 115.51 20.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.964 -1.085 . . . . 0.0 108.739 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.913 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 9.4 ptmt -49.74 -35.3 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.8 -46.38 87.7 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.048 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.48 -25.79 25.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.0 109.332 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.043 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.2 t -60.35 -66.58 0.5 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.02 -54.17 48.06 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.927 -1.108 . . . . 0.0 110.785 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -61.61 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -61.02 -29.82 69.94 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.224 -0.922 . . . . 0.0 112.881 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.043 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.0 m -50.96 -29.91 13.52 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.357 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.1 -1.0 . . . . 0.0 110.144 -179.733 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.254 0.549 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.39 155.66 34.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.27 158.76 11.29 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.698 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.8 mt -130.78 179.62 5.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 t -143.04 148.65 37.08 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.445 -1.409 . . . . 0.0 111.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -138.5 164.43 29.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.62 153.21 39.62 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.419 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.95 -122.18 1.23 Allowed Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.36 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 95.2 m -154.9 22.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 111.004 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -75.15 -10.16 59.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.316 -1.49 . . . . 0.0 113.713 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.013 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.6 m -124.5 25.32 7.64 Favored 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.245 -0.909 . . . . 0.0 109.707 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.24 77.43 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 118.593 -1.765 . . . . 0.0 109.167 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 4.2 pttt -87.83 51.67 2.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.505 1.145 . . . . 0.0 110.956 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.82 110.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 -22.04 39.46 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.11 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.772 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.3 mtmm -119.41 -145.53 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.865 -1.373 . . . . 0.0 109.005 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 26.5 m-85 -145.81 175.94 10.03 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 119.871 -1.768 . . . . 0.0 110.276 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 90.5 m -137.07 161.61 35.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.255 -1.528 . . . . 0.0 110.664 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.932 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.49 131.15 31.43 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.378 -0.826 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -164.01 129.93 2.2 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -78.38 -2.78 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.253 1.133 . . . . 0.0 111.241 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.645 HG21 ' HD2' ' A' ' 24' ' ' LYS . 7.5 tt -164.53 12.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.031 0.92 . . . . 0.0 111.24 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.84 12.22 84.06 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.645 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -88.25 -34.78 17.62 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.435 -1.038 . . . . 0.0 111.425 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.4 m-85 -86.55 -43.91 12.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.171 -0.956 . . . . 0.0 111.944 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 20.0 t 48.94 69.77 0.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.113 -0.992 . . . . 0.0 109.808 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.2 t -115.33 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.8 m -116.17 162.3 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.91 -1.119 . . . . 0.0 113.085 -176.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.7 m-85 -147.75 174.76 11.5 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.024 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.2 p-10 -82.04 -42.67 18.96 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.003 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.95 116.39 20.89 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.976 -1.077 . . . . 0.0 108.68 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.3 ptpt -49.19 -36.03 18.66 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.58 88.25 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.35 -26.36 25.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 O-C-N 120.704 -1.248 . . . . 0.0 109.435 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.146 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.4 t -60.98 -67.29 0.42 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -54.82 -53.42 55.47 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.825 -1.172 . . . . 0.0 110.875 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.31 -80.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.6 m120 -61.16 -28.12 68.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.261 -0.899 . . . . 0.0 113.007 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.146 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.8 m -48.34 -32.37 7.38 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.084 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 40' ' ' THR . 3.6 t70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -155.54 -164.64 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.403 -0.811 . . . . 0.0 109.961 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.01 -148.12 12.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.657 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.99 179.72 5.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.964 . . . . 0.0 109.692 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 17.1 t -142.82 152.55 42.32 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.761 -1.212 . . . . 0.0 110.585 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.508 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -136.6 165.16 26.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.73 149.89 43.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.309 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.54 -120.33 1.01 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.531 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.685 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 96.1 m -154.83 21.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -1.136 . . . . 0.0 111.334 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.331 -1.48 . . . . 0.0 113.541 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.112 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.8 m -123.19 25.59 8.37 Favored 'General case' 0 C--N 1.282 -2.354 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.68 17.23 79.11 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 118.784 -1.674 . . . . 0.0 109.412 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.608 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.14 53.17 2.73 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.541 1.162 . . . . 0.0 110.856 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.82 107.78 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.42 -21.06 45.87 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.067 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 15.2 mtmt -119.18 -144.14 0.36 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.917 -1.343 . . . . 0.0 109.128 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 14.7 m-85 -146.65 176.67 9.66 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 119.789 -1.819 . . . . 0.0 110.593 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.608 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 95.8 m -136.74 163.29 30.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.445 -1.41 . . . . 0.0 110.745 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.9 125.15 29.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.511 -0.743 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 p -166.11 124.41 1.09 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -78.78 -1.44 11.6 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.105 1.055 . . . . 0.0 110.794 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 24' ' ' LYS . 4.7 tt -163.99 12.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.015 0.912 . . . . 0.0 110.909 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.63 13.49 83.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 7.8 ptmt -86.41 -35.48 19.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.8 m-85 -85.21 -44.33 13.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.797 . . . . 0.0 111.585 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 54.1 t 44.65 64.15 1.45 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.762 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.6 t -114.96 118.11 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.82 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.5 m -116.16 161.69 18.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.493 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 83.7 m-85 -149.26 176.51 10.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.0 p-10 -81.93 -42.83 18.93 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.78 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.13 20.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.029 -1.045 . . . . 0.0 108.611 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.7 ptpt -49.94 -35.45 24.09 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.12 -46.16 89.04 Favored 'General case' 0 C--O 1.201 -1.497 0 O-C-N 121.307 -0.87 . . . . 0.0 109.12 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.79 -25.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 120.566 -1.334 . . . . 0.0 109.407 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.101 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.7 t -60.82 -67.45 0.4 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -55.02 -53.53 54.68 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.901 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.1 tmtm? -62.81 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.603 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.69 -28.46 68.64 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.262 -0.899 . . . . 0.0 112.92 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.101 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.7 m -49.23 -29.81 6.22 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.368 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.522 HG21 ' O ' ' A' ' 1' ' ' ASP . 8.7 p . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.158 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.281 0.562 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.01 -167.06 1.6 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 40' ' ' THR . . . -169.51 -135.69 1.94 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.102 -1.046 . . . . 0.0 110.912 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mt -133.11 178.83 6.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.522 -0.987 . . . . 0.0 109.716 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 1.27 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 5.5 t -148.05 149.67 32.52 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.27 170.76 15.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.993 -1.067 . . . . 0.0 110.668 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.24 152.16 40.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.988 . . . . 0.0 110.833 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.27 -122.78 1.25 Allowed Glycine 0 N--CA 1.485 1.951 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 9' ' ' THR 0.294 91.5 m -155.77 26.75 0.38 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.32 -1.106 . . . . 0.0 110.57 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.43 -9.18 58.42 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.455 -1.403 . . . . 0.0 113.571 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.7 m -122.54 23.61 9.55 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.394 -0.816 . . . . 0.0 109.799 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.77 74.86 Favored Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.116 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 2.0 pttp -87.22 51.45 2.24 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.207 1.003 . . . . 0.0 111.944 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.02 114.68 3.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -24.55 22.46 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.323 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.691 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 6.7 mtmt -123.49 -146.1 0.35 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.515 -1.58 . . . . 0.0 109.554 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 54.6 m-85 -144.0 169.56 17.59 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 119.971 -1.705 . . . . 0.0 110.008 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.116 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 87.1 m -142.65 157.14 44.99 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.959 -1.713 . . . . 0.0 110.364 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.27 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 1.9 p -142.42 136.05 29.12 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.967 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -165.55 137.69 3.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -77.46 0.9 9.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.06 1.032 . . . . 0.0 111.231 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.626 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.9 tt -163.72 9.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.938 0.875 . . . . 0.0 111.287 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.02 11.52 84.71 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD2' HG21 ' A' ' 22' ' ' ILE . 16.4 ptmt -87.35 -36.56 17.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.439 -1.036 . . . . 0.0 111.548 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.7 m-85 -85.3 -36.58 20.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.631 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 t 44.9 75.46 0.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.67 HG12 ' CE1' ' A' ' 29' ' ' TYR . 70.8 t -114.31 115.58 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 22.9 m -116.24 164.04 15.1 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.342 1.068 . . . . 0.0 113.054 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.692 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.2 m-85 -147.88 170.29 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.61 -35.06 24.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 112.865 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.69 114.95 19.93 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.931 -1.106 . . . . 0.0 109.665 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 1.007 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -49.26 -35.22 17.1 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.56 -45.67 91.13 Favored 'General case' 0 C--O 1.197 -1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 109.085 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.731 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.4 mt -58.73 -26.15 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 O-C-N 120.466 -1.396 . . . . 0.0 109.052 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.007 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 14.7 t -59.49 -71.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -58.5 -51.1 71.28 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.028 -1.045 . . . . 0.0 111.158 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.659 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -60.78 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.659 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.1 m120 -61.96 -33.08 73.63 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.902 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.7 m -51.45 -32.94 28.78 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.35 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 9.1 p . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.093 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.116 0.484 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 40' ' ' THR . 3.5 m-20 -83.73 -157.15 0.24 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.217 -0.927 . . . . 0.0 109.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.9 -130.11 2.06 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.067 -1.063 . . . . 0.0 110.565 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -131.59 179.54 5.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -1.043 . . . . 0.0 110.054 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.6 t -143.86 149.61 37.21 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.942 -1.099 . . . . 0.0 110.05 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -137.9 165.47 26.43 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.87 152.31 40.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.33 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.33 -121.31 1.11 Allowed Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.472 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.0 m -154.88 23.16 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.308 -1.113 . . . . 0.0 110.948 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -74.13 -12.2 60.52 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.303 -1.498 . . . . 0.0 113.377 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.5 m -122.36 25.15 9.04 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 121.243 -0.911 . . . . 0.0 109.6 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.4 77.8 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 118.674 -1.727 . . . . 0.0 109.041 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.327 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.9 pttm -87.92 54.75 3.2 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.569 1.176 . . . . 0.0 110.768 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.49 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.15 -21.55 39.44 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.4 mtmp? -117.57 -145.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.712 -1.464 . . . . 0.0 109.252 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.5 m-85 -146.47 176.41 9.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 119.919 -1.738 . . . . 0.0 110.424 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.327 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 79.8 m -137.62 161.98 35.01 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.386 -1.446 . . . . 0.0 110.79 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.083 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.36 123.79 26.03 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.521 -0.737 . . . . 0.0 111.011 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -166.9 126.31 1.11 Allowed Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.89 0.67 9.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.13 1.069 . . . . 0.0 111.223 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 24' ' ' LYS . 6.0 tt -163.98 12.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 122.043 0.925 . . . . 0.0 111.304 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.43 12.99 83.29 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -86.48 -38.07 17.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.529 -0.983 . . . . 0.0 111.141 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.1 m-85 -85.04 -39.48 17.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 111.539 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.1 t 41.81 68.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.744 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.5 t -114.71 115.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.638 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.3 m -116.22 161.42 19.0 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.392 1.092 . . . . 0.0 113.469 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.779 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.2 m-85 -149.68 176.52 10.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.965 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.5 p30 -81.56 -42.46 20.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.141 -0.974 . . . . 0.0 111.85 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.73 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.28 116.11 20.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.093 -1.004 . . . . 0.0 108.603 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.855 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.0 ptpt -50.84 -34.55 28.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.7 -46.19 87.85 Favored 'General case' 0 C--O 1.199 -1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 108.868 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.779 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.84 25.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 O-C-N 120.736 -1.227 . . . . 0.0 109.357 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.124 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -60.78 -67.59 0.39 Allowed 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -54.62 -53.79 50.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.908 -1.12 . . . . 0.0 110.93 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -62.47 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.631 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.8 m120 -60.89 -28.71 69.09 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.262 -0.899 . . . . 0.0 112.886 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.124 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.1 m -50.06 -25.96 3.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.36 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 2' ' ' ASP . 13.2 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.067 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.226 0.536 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -155.9 -176.88 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 109.809 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.24 -157.38 29.83 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.952 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.8 mt -131.48 179.99 5.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.71 -0.877 . . . . 0.0 109.376 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.4 t -138.7 150.56 46.3 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.59 -1.319 . . . . 0.0 111.079 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 38.4 p90 -136.62 167.12 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.52 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.31 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.66 -121.47 1.12 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.442 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.645 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 87.0 m -154.63 21.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -1.138 . . . . 0.0 111.241 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -75.34 -12.97 60.38 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.2 -1.562 . . . . 0.0 113.617 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.149 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.3 m -122.72 25.59 8.63 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.4 79.74 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 118.904 -1.617 . . . . 0.0 109.578 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.677 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.04 53.43 2.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.469 1.128 . . . . 0.0 111.037 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.53 107.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.64 -20.84 47.84 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.181 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 29.9 mtmt -118.17 -143.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.879 -1.365 . . . . 0.0 109.121 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.528 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 18.2 m-85 -146.06 176.31 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.844 -1.785 . . . . 0.0 110.45 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.677 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 90.1 m -136.77 164.03 29.23 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.428 -1.42 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.33 122.25 23.55 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.543 -0.723 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -166.45 125.57 1.13 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -79.44 -2.18 12.07 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.097 1.051 . . . . 0.0 110.813 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 24' ' ' LYS . 5.3 tt -164.39 15.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.085 0.945 . . . . 0.0 110.876 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.78 83.72 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 14.3 ptmt -86.9 -33.86 19.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -1.024 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.8 m-85 -85.1 -40.83 16.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 111.253 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' TYR . 12.9 t 40.49 61.93 1.48 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.381 -0.824 . . . . 0.0 110.027 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.824 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.92 116.51 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.877 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 14.1 m -116.36 161.64 18.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.037 -1.039 . . . . 0.0 113.302 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.815 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.8 m-85 -149.02 176.45 10.44 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.4 p30 -81.98 -43.31 18.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.254 -0.903 . . . . 0.0 111.879 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.722 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.02 116.42 20.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.094 -1.004 . . . . 0.0 108.492 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -49.82 -35.54 23.26 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.02 -46.52 87.99 Favored 'General case' 0 C--O 1.2 -1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.009 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.815 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.96 -25.75 26.8 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 O-C-N 120.773 -1.204 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.099 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.8 t -60.4 -65.88 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -54.96 -54.66 39.91 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.913 -1.117 . . . . 0.0 110.841 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.488 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.4 tmtm? -62.84 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -59.88 -27.86 67.06 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.287 -0.883 . . . . 0.0 112.871 -176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.099 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.2 m -49.57 -28.13 5.29 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.285 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.1 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.3 t0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.166 0.508 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' A' ' 40' ' ' THR . 13.6 m-20 -155.72 -165.08 1.87 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.484 -0.76 . . . . 0.0 109.773 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.15 -150.54 17.41 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.987 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.76 180.0 5.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.903 . . . . 0.0 109.496 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.7 t -137.93 149.5 46.24 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.741 -1.225 . . . . 0.0 110.718 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.82 166.04 24.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.45 149.79 43.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.627 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.404 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 153.37 -123.41 1.42 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.468 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 98.4 m -156.05 25.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.41 -1.053 . . . . 0.0 110.846 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -74.13 -8.8 57.47 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.373 -1.454 . . . . 0.0 113.562 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.788 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -125.77 27.02 6.52 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 121.33 -0.856 . . . . 0.0 109.726 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 15.34 76.92 Favored Glycine 0 C--N 1.291 -1.965 0 C-N-CA 118.508 -1.806 . . . . 0.0 108.723 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.258 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.41 53.21 2.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.351 1.072 . . . . 0.0 111.096 -178.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 9' ' ' THR . 44.4 t -67.19 109.58 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.4 -19.93 43.91 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.761 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 28.3 mtmt -118.6 -143.05 0.36 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.722 -1.458 . . . . 0.0 109.368 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.1 m-85 -145.79 173.75 11.83 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 119.976 -1.703 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.258 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 76.3 m -136.87 162.55 32.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.449 -1.407 . . . . 0.0 111.118 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.03 122.59 23.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.458 -0.776 . . . . 0.0 110.846 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -166.28 126.29 1.21 Allowed Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.06 -1.53 11.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.169 1.089 . . . . 0.0 111.249 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.3 tt -164.13 13.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-O 121.93 0.872 . . . . 0.0 111.296 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.96 84.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.493 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 13.4 ptmt -87.07 -35.34 18.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -1.002 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.493 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.8 m-85 -85.14 -40.7 16.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 111.307 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 25' ' ' TYR . 38.2 t 41.67 66.42 0.7 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.456 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.772 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 62.2 t -115.15 115.81 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.33 162.05 18.1 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.313 1.054 . . . . 0.0 113.091 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.807 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.6 175.79 10.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.945 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.9 p-10 -81.87 -42.34 19.71 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.177 -0.952 . . . . 0.0 112.071 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.17 117.01 21.35 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.973 -1.079 . . . . 0.0 108.905 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.808 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -50.02 -35.89 26.62 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.8 -46.27 87.99 Favored 'General case' 0 C--O 1.2 -1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.059 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.807 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.07 -25.51 26.57 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 O-C-N 120.658 -1.276 . . . . 0.0 109.44 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.039 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 27.2 t -60.94 -66.52 0.52 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -55.92 -54.03 49.65 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.748 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtt? -61.77 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.634 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.6 m120 -60.67 -30.09 69.69 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.253 -0.904 . . . . 0.0 112.699 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.039 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 62.9 m -50.92 -26.98 6.6 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.239 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 2' ' ' ASP . 22.1 p . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.165 -0.959 . . . . 0.0 110.089 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.472 ' O ' HG22 ' A' ' 40' ' ' THR . 17.0 p-10 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.063 0.458 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -82.93 -139.88 0.05 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.269 -0.894 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.23 -140.63 6.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.8 mt -132.94 179.19 6.33 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.334 -1.098 . . . . 0.0 110.274 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t -146.31 150.38 35.63 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.935 -1.103 . . . . 0.0 109.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.485 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 25.0 p90 -138.26 163.27 32.2 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.04 153.69 39.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.455 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.57 -121.17 1.11 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.313 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 99.1 m -154.63 20.54 0.47 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 111.089 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -74.84 -9.77 58.86 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.336 -1.478 . . . . 0.0 113.351 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.982 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.2 m -124.24 24.09 8.18 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.397 -0.815 . . . . 0.0 109.856 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.51 18.44 77.07 Favored Glycine 0 C--N 1.29 -1.989 0 C-N-CA 118.495 -1.812 . . . . 0.0 108.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.205 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 22.5 pttt -87.92 51.22 2.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.443 1.116 . . . . 0.0 111.031 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.68 109.65 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.68 -21.16 41.63 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.263 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.0 mtmm -122.02 -145.15 0.35 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.394 . . . . 0.0 109.075 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 22.7 m-85 -145.76 177.41 8.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.829 -1.795 . . . . 0.0 110.35 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.205 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.2 m -137.09 161.08 37.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.344 -1.473 . . . . 0.0 110.58 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.142 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.49 126.18 23.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.761 . . . . 0.0 111.301 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -167.28 127.15 1.12 Allowed Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -75.22 -60.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.141 1.074 . . . . 0.0 110.006 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG21 ' HD2' ' A' ' 24' ' ' LYS . 9.6 tt -84.55 -0.46 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.888 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.9 13.41 83.66 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.79 -25.17 21.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.379 -1.071 . . . . 0.0 111.36 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' CYS . 46.0 m-85 -83.59 -37.1 23.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 111.772 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 19.4 t 41.57 70.41 0.27 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.6 t -115.07 118.79 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.038 -1.039 . . . . 0.0 108.449 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 15.9 m -116.12 161.87 18.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.853 -1.154 . . . . 0.0 113.334 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.784 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 85.0 m-85 -148.56 175.27 11.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.929 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.5 p-10 -81.98 -42.58 19.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.869 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.749 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 114.74 20.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 108.664 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.2 ptmm? -49.44 -35.29 18.94 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.25 87.77 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.12 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.778 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.15 -26.26 24.88 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 O-C-N 120.675 -1.266 . . . . 0.0 109.389 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.175 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 t -60.69 -66.02 0.6 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -55.5 -54.18 47.11 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.707 -1.246 . . . . 0.0 110.645 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.0 tmtm? -63.19 -79.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.88 -28.3 68.78 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.259 -0.901 . . . . 0.0 113.13 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.175 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.8 m -48.49 -27.93 3.01 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.372 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 1' ' ' ASP . 8.8 p . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.757 ' OD1' HG22 ' A' ' 40' ' ' THR . 11.6 m-20 -155.47 172.69 17.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.107 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.63 -122.52 1.06 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 mt -132.7 179.1 6.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 110.033 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.3 t -122.96 137.95 54.81 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.783 -1.198 . . . . 0.0 110.044 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -137.94 165.01 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.97 152.15 41.16 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.458 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.87 -120.75 1.04 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.377 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.9 m -155.18 23.33 0.42 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.364 -1.08 . . . . 0.0 111.034 -177.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -73.93 -12.26 60.6 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.258 -1.526 . . . . 0.0 113.416 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.003 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -123.43 25.48 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.79 77.53 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 118.687 -1.721 . . . . 0.0 109.08 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.291 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 pttm -87.93 54.2 3.02 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.609 1.195 . . . . 0.0 110.801 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.71 108.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 -22.13 40.77 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.108 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 5.4 mtmp? -113.82 -147.42 0.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.908 -1.348 . . . . 0.0 108.768 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 21.2 m-85 -146.57 176.8 9.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.774 -1.829 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.291 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.5 m -137.48 162.14 34.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.491 -1.38 . . . . 0.0 111.072 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.865 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.1 p -136.14 108.27 7.22 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.621 -0.674 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -171.66 139.37 1.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -77.13 -7.71 17.3 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.306 1.161 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.823 HG23 ' H ' ' A' ' 24' ' ' LYS . 8.6 tt -165.0 -169.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.563 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.73 13.92 54.16 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.13 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.823 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -83.83 -44.12 14.67 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.303 -1.116 . . . . 0.0 110.732 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.508 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.8 m-85 -88.05 -51.69 5.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.878 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 17.5 t 39.32 75.14 0.08 Allowed 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.595 -0.691 . . . . 0.0 110.922 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.865 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 66.4 t -114.69 111.46 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.803 -1.186 . . . . 0.0 108.178 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.17 162.2 17.81 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.264 1.031 . . . . 0.0 113.367 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.777 ' CE1' HG12 ' A' ' 27' ' ' VAL . 84.2 m-85 -150.47 175.3 12.0 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.295 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.08 -41.26 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.885 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.72 115.54 21.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.092 -1.005 . . . . 0.0 109.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.818 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.5 ptpt -50.03 -35.08 23.52 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.52 -45.97 87.72 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 108.996 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.769 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.49 -25.63 24.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.005 0 O-C-N 120.621 -1.3 . . . . 0.0 109.336 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.844 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 25.5 t -61.55 -67.93 0.36 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.0 -53.03 60.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.766 -1.209 . . . . 0.0 110.696 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.1 tmtt? -61.85 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.639 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.9 m120 -61.63 -32.6 72.76 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.28 -0.888 . . . . 0.0 112.879 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.844 ' SG ' ' HA ' ' A' ' 35' ' ' CYS . 69.8 m -52.22 -29.74 24.09 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.306 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.757 HG22 ' OD1' ' A' ' 2' ' ' ASP . 22.6 p . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.045 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.582 ' HB2' HG21 ' A' ' 40' ' ' THR . 7.1 p-10 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.452 0.644 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.96 140.76 31.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.708 . . . . 0.0 109.979 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.99 178.61 38.97 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -132.22 179.14 6.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.945 . . . . 0.0 109.37 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.702 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 12.6 t -146.98 155.57 42.37 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.704 -1.247 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.6 p90 -136.74 165.45 25.89 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 9.6 pt-20 -122.63 149.02 44.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.059 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.29 -119.66 0.96 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.449 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 93.9 m -155.14 20.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 111.599 -177.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -75.28 -12.26 60.24 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.133 -1.605 . . . . 0.0 113.546 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.084 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.5 m -123.0 25.29 8.62 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.58 17.49 79.1 Favored Glycine 0 C--N 1.29 -1.982 0 C-N-CA 118.823 -1.656 . . . . 0.0 109.396 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.68 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.4 pttt -87.34 51.7 2.3 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.45 1.119 . . . . 0.0 111.031 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.15 109.48 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.15 -21.95 39.73 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.213 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.791 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 38.4 mtmt -123.23 -142.2 0.32 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.418 . . . . 0.0 109.227 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 9.8 m-85 -146.15 176.86 9.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.914 -1.741 . . . . 0.0 110.562 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.68 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 86.3 m -136.72 163.3 30.92 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.432 -1.417 . . . . 0.0 110.882 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.088 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -130.92 127.53 38.67 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.613 -0.679 . . . . 0.0 110.875 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -165.68 116.43 0.84 Allowed Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.92 0.94 9.68 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.274 1.144 . . . . 0.0 110.469 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 24' ' ' LYS . 7.2 tt -163.89 11.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 122.109 0.957 . . . . 0.0 110.771 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.03 12.98 83.63 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -87.56 -34.99 18.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.471 -1.017 . . . . 0.0 111.266 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.464 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.7 m-85 -85.37 -46.02 11.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 111.948 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.6 t 42.5 60.34 2.41 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.143 -0.973 . . . . 0.0 109.154 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.786 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.84 121.29 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 11.2 m -116.27 160.99 19.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.029 -1.069 . . . . 0.0 113.493 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.5 m-85 -148.9 177.77 9.26 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.915 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.75 -43.75 17.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.699 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.717 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.12 116.42 21.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.014 -1.054 . . . . 0.0 108.338 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.883 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.41 -34.8 25.73 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.48 -46.31 89.16 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 108.948 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.68 -26.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.722 -1.236 . . . . 0.0 109.424 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.154 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -60.55 -67.4 0.4 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -55.0 -53.45 55.57 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.82 -1.175 . . . . 0.0 110.821 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.12 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.69 -26.94 67.49 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.375 -0.828 . . . . 0.0 112.955 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.154 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.8 m -47.99 -34.5 9.41 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 118.689 -1.205 . . . . 0.0 111.046 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.237 0.541 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.711 ' OD1' HG22 ' A' ' 40' ' ' THR . 39.8 m-20 -155.24 -163.58 1.58 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.387 -0.821 . . . . 0.0 109.506 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.55 -113.67 0.29 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.379 -1.391 . . . . 0.0 111.868 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.85 179.9 6.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.965 . . . . 0.0 110.62 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.1 t -131.32 142.86 50.16 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.994 -1.066 . . . . 0.0 108.967 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' HE1' ' HZ2' ' A' ' 13' ' ' LYS . 39.7 p90 -138.68 166.97 22.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 109.4 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -122.95 151.88 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.898 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.88 -119.96 0.97 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.482 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 91.7 m -155.01 23.89 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.23 -1.159 . . . . 0.0 111.155 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -73.32 -14.08 61.23 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.235 -1.54 . . . . 0.0 113.201 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -122.36 24.51 9.31 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 17.93 77.18 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 118.637 -1.744 . . . . 0.0 108.979 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.271 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 10.7 pttm -88.12 51.67 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.407 1.098 . . . . 0.0 111.338 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 9' ' ' THR . 38.2 t -67.27 111.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.81 -24.45 29.54 Favored Glycine 0 N--CA 1.498 2.832 0 C-N-CA 119.239 -1.457 . . . . 0.0 109.856 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 12.9 mtmt -118.38 -146.81 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.78 -1.423 . . . . 0.0 108.838 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 15.9 m-85 -146.95 176.77 9.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 119.836 -1.79 . . . . 0.0 110.319 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.271 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.05 161.63 35.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.428 -1.42 . . . . 0.0 110.79 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.08 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.31 108.13 8.54 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.499 0.666 . . . . 0.0 110.423 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 p -172.46 136.3 0.83 Allowed Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.8 -5.62 16.12 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.215 1.113 . . . . 0.0 109.682 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.816 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.9 tt -164.63 -169.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.31 14.91 52.83 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.925 -1.109 . . . . 0.0 111.064 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.816 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -84.07 -43.94 14.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.246 -1.15 . . . . 0.0 110.973 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 44.9 m-85 -87.75 -50.57 6.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.159 -0.963 . . . . 0.0 111.127 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' TYR . 31.9 t 37.84 72.85 0.11 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.636 -0.665 . . . . 0.0 110.721 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.907 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.5 t -114.58 112.96 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.797 -1.189 . . . . 0.0 108.096 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 16.8 m -116.13 161.61 18.67 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.417 1.103 . . . . 0.0 113.667 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.801 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.1 m-85 -149.92 176.94 10.3 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.009 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.98 -42.9 18.74 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.687 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.47 117.22 21.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.042 -1.036 . . . . 0.0 108.872 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.867 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -50.87 -35.71 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.54 -45.96 87.8 Favored 'General case' 0 C--O 1.201 -1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 108.909 176.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.801 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.85 -25.92 26.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.936 0 O-C-N 120.736 -1.227 . . . . 0.0 109.29 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.11 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.2 t -60.18 -66.23 0.56 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.99 -54.48 42.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.907 -1.121 . . . . 0.0 110.881 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.26 -79.34 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -59.82 -28.68 67.67 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.269 -0.895 . . . . 0.0 112.852 -176.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.11 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m -50.49 -25.58 4.18 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 118.611 -1.235 . . . . 0.0 111.412 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.711 HG22 ' OD1' ' A' ' 2' ' ' ASP . 14.2 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.156 0.503 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -155.3 139.3 16.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.53 -169.56 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.1 mt -131.8 179.79 5.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.592 -0.946 . . . . 0.0 109.46 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.5 t -134.1 136.07 43.65 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.687 -1.258 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -138.39 166.93 23.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.78 151.75 41.32 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.901 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.96 -119.76 0.95 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.546 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 98.1 m -155.38 23.99 0.41 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.152 -1.205 . . . . 0.0 111.334 -177.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.27 -14.36 61.31 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.213 -1.554 . . . . 0.0 113.33 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.0 m -121.5 24.37 9.9 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.52 77.07 Favored Glycine 0 C--N 1.29 -1.986 0 C-N-CA 118.535 -1.793 . . . . 0.0 108.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.289 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.4 pttm -87.59 52.07 2.39 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.474 1.131 . . . . 0.0 111.111 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t -66.88 111.36 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.76 31.14 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.009 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 40.7 mtmt -119.51 -146.32 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.415 . . . . 0.0 108.972 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -146.11 175.91 10.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 119.901 -1.749 . . . . 0.0 110.256 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 64.7 m -137.37 160.67 38.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.388 -1.445 . . . . 0.0 111.322 -178.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.43 110.13 7.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.681 -0.637 . . . . 0.0 110.676 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -171.17 137.7 1.11 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.03 -15.22 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.308 1.162 . . . . 0.0 109.823 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.797 HG23 ' H ' ' A' ' 24' ' ' LYS . 6.8 tt -165.07 -166.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.41 10.5 54.75 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.819 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.797 ' H ' HG23 ' A' ' 22' ' ' ILE . 12.8 ptmt -87.27 10.97 15.41 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -1.14 . . . . 0.0 110.676 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.653 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.3 m-85 -151.42 -53.99 0.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.488 ' C ' ' O ' ' A' ' 25' ' ' TYR . 10.0 t 34.91 75.19 0.06 Allowed 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.794 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.54 114.71 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.796 -1.19 . . . . 0.0 108.751 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.5 m -116.0 161.36 18.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.157 0.979 . . . . 0.0 112.988 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CE1' HG12 ' A' ' 27' ' ' VAL . 88.3 m-85 -149.55 174.69 12.24 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.086 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.75 -41.39 21.29 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.811 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.728 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.22 114.95 20.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.045 -1.034 . . . . 0.0 108.658 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.853 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -50.0 -34.7 21.97 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.93 -46.41 88.02 Favored 'General case' 0 C--O 1.199 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.023 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.3 -26.29 25.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 120.596 -1.315 . . . . 0.0 109.376 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.137 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -61.27 -67.67 0.38 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -55.03 -53.06 60.68 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.747 -1.221 . . . . 0.0 110.737 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -62.33 -79.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -60.85 -29.73 69.69 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.268 -0.895 . . . . 0.0 112.839 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.137 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.0 m -50.42 -30.15 11.83 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.404 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.102 -179.73 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.225 0.536 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.53 -148.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.456 -0.778 . . . . 0.0 109.692 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.81 -153.15 22.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.763 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.93 179.67 5.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.588 -0.948 . . . . 0.0 109.689 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.4 t -142.76 153.95 43.78 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.686 -1.259 . . . . 0.0 110.576 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 36.0 p90 -138.29 167.27 22.22 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.9 pt-20 -122.57 153.3 39.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.764 -1.21 . . . . 0.0 111.553 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.14 -120.68 1.07 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.142 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 99.4 m -154.97 20.3 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -1.121 . . . . 0.0 111.275 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -75.25 -10.59 59.6 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.279 -1.513 . . . . 0.0 113.712 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.051 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.3 m -123.82 25.19 8.13 Favored 'General case' 0 C--N 1.284 -2.28 0 O-C-N 121.275 -0.89 . . . . 0.0 109.803 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.64 17.88 78.3 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 118.711 -1.709 . . . . 0.0 109.19 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.268 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 21.2 pttt -88.22 51.11 2.11 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.463 1.125 . . . . 0.0 111.133 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.88 109.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.27 -21.03 42.82 Favored Glycine 0 N--CA 1.5 2.907 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.29 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.793 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.8 mtmt -123.75 -142.65 0.32 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.411 . . . . 0.0 109.187 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.6 m-85 -145.21 177.63 8.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.777 -1.827 . . . . 0.0 110.5 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.268 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 92.9 m -137.5 163.78 30.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.513 -1.367 . . . . 0.0 110.998 -178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.1 123.71 27.72 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.555 -0.716 . . . . 0.0 111.276 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.2 p -166.72 119.33 0.79 Allowed Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.55 -8.18 15.94 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.204 1.107 . . . . 0.0 110.607 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' A' ' 24' ' ' LYS . 5.0 tt -164.67 20.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 122.129 0.966 . . . . 0.0 110.371 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.18 84.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.625 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -90.37 21.33 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.528 -0.983 . . . . 0.0 110.591 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.625 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.5 m-85 -148.9 -43.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.273 -0.892 . . . . 0.0 110.789 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' C ' ' O ' ' A' ' 25' ' ' TYR . 48.6 t 37.48 61.35 0.99 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.354 -0.841 . . . . 0.0 110.048 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.823 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.9 t -114.94 120.31 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 13.6 m -116.19 161.01 19.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.955 -1.09 . . . . 0.0 113.36 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.803 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.6 m-85 -148.84 177.89 9.15 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.029 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.12 -44.01 17.06 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -0.973 . . . . 0.0 111.689 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.92 116.27 20.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.014 -1.054 . . . . 0.0 108.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.29 -34.79 24.66 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.3 -46.42 88.62 Favored 'General case' 0 C--O 1.2 -1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.981 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.66 -26.14 26.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.796 -1.19 . . . . 0.0 109.444 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.136 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.6 t -60.42 -65.62 0.66 Allowed 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -55.87 -54.47 44.2 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.615 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.4 tmtm? -62.85 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.672 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.7 m120 -60.51 -27.24 67.45 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.269 -0.894 . . . . 0.0 112.991 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.136 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.5 m -48.5 -29.61 4.34 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 118.575 -1.25 . . . . 0.0 111.244 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.177 -179.928 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.346 0.593 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.27 -164.49 1.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 110.097 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.68 -154.79 25.51 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.96 179.9 5.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.575 -0.956 . . . . 0.0 109.768 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.8 t -135.14 136.65 42.05 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.803 -1.186 . . . . 0.0 110.048 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -138.16 166.53 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.1 pt-20 -122.95 149.56 44.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.789 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.21 -118.77 0.86 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.984 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 96.6 m -154.88 22.87 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 111.47 -177.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -73.48 -14.63 61.27 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.1 -1.625 . . . . 0.0 113.228 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 25.1 m -122.1 24.94 9.29 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.96 76.41 Favored Glycine 0 C--N 1.289 -2.064 0 C-N-CA 118.306 -1.902 . . . . 0.0 108.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.301 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 pttt -86.86 50.7 2.06 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.456 1.122 . . . . 0.0 110.871 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -67.47 110.76 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.41 -22.72 36.61 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 8.9 mttm -119.61 -147.61 0.4 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.759 -1.436 . . . . 0.0 108.806 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.1 m-85 -146.88 175.49 10.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.777 . . . . 0.0 110.256 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.301 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 80.1 m -137.66 160.99 37.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.307 -1.496 . . . . 0.0 111.559 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -137.1 110.62 7.99 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.697 -0.627 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.71 140.8 1.45 Allowed Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -76.45 -16.32 17.16 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.311 1.164 . . . . 0.0 109.731 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.799 HG23 ' H ' ' A' ' 24' ' ' LYS . 6.6 tt -164.81 -165.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.4 9.29 58.78 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.881 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.799 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -87.86 12.91 11.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.275 -1.132 . . . . 0.0 110.983 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.62 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 43.6 m-85 -150.66 -54.58 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' TYR . 15.5 t 36.27 75.57 0.06 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.418 -0.801 . . . . 0.0 110.859 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.791 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.9 t -114.26 114.89 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.681 -1.262 . . . . 0.0 108.649 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 19.6 m -116.0 162.38 17.46 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.352 1.073 . . . . 0.0 113.45 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.784 ' CG ' HG22 ' A' ' 34' ' ' ILE . 80.6 m-85 -148.65 175.08 11.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.804 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CB ' ' HD3' ' A' ' 16' ' ' LYS . 1.9 p-10 -82.06 -42.36 19.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.002 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.705 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.32 118.37 22.58 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.104 -0.997 . . . . 0.0 108.927 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.849 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.0 ptpt -51.04 -35.72 35.86 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.2 -45.99 89.64 Favored 'General case' 0 C--O 1.2 -1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.281 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.784 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -58.13 -26.36 29.1 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 O-C-N 120.651 -1.281 . . . . 0.0 109.418 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.105 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.5 t -60.9 -66.96 0.45 Allowed 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -55.2 -53.37 56.89 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.839 -1.163 . . . . 0.0 110.62 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.84 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -59.95 -29.09 68.17 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 121.302 -0.874 . . . . 0.0 112.705 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.105 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.0 m -50.68 -26.59 5.66 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.3 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.057 -179.771 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.753 ' HA ' HG22 ' A' ' 40' ' ' THR . 2.8 p30 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.011 0.434 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -83.69 119.5 24.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.44 167.75 27.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.911 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.1 mt -131.34 179.89 5.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.801 -0.823 . . . . 0.0 109.025 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.6 t -133.0 139.75 47.41 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.578 -1.327 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -137.15 166.41 23.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -122.88 150.69 42.56 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.014 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.3 -120.06 0.99 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 97.1 m -155.51 24.19 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.258 -1.142 . . . . 0.0 111.141 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.95 -12.3 60.61 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.237 -1.54 . . . . 0.0 113.466 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.065 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.2 m -122.55 25.29 8.87 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-O 121.818 0.818 . . . . 0.0 109.57 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.79 78.4 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.671 -1.728 . . . . 0.0 109.222 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -87.06 56.5 4.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.64 1.21 . . . . 0.0 110.429 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.89 107.72 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.19 51.71 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.447 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.752 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 31.2 mtmt -116.59 -145.8 0.39 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.757 -1.437 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 16.4 m-85 -146.55 176.06 10.11 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.893 -1.754 . . . . 0.0 110.705 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.625 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 57.5 m -136.46 160.81 37.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.439 -1.413 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.066 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.41 111.07 8.1 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.405 ' HB3' ' N ' ' A' ' 26' ' ' CYS . 3.2 p -170.51 139.48 1.4 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.646 -0.659 . . . . 0.0 109.29 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.11 -5.13 14.3 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.237 1.125 . . . . 0.0 109.877 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.892 HG23 ' H ' ' A' ' 24' ' ' LYS . 9.3 tt -164.83 -171.81 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.4 5.46 84.43 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.87 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.892 ' H ' HG23 ' A' ' 22' ' ' ILE . 1.2 ptmt -86.81 -29.45 22.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.018 -1.284 . . . . 0.0 110.341 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.637 ' HD1' ' HG3' ' A' ' 24' ' ' LYS . 4.1 m-30 -86.25 -57.46 3.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' TYR . 33.6 t 35.32 72.98 0.09 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.73 -0.606 . . . . 0.0 111.122 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.832 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.5 t -114.72 110.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.759 -1.213 . . . . 0.0 108.23 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.7 m -116.19 161.41 19.0 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.201 1.0 . . . . 0.0 113.435 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.771 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.3 m-85 -150.55 176.76 10.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.417 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 4.3 p-10 -82.04 -42.53 19.14 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.987 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.769 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.77 116.26 21.38 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.961 -1.087 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.5 ptpt -50.55 -34.88 27.24 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.22 -45.88 86.88 Favored 'General case' 0 C--O 1.2 -1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.759 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.769 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.51 -25.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 O-C-N 120.681 -1.262 . . . . 0.0 109.263 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.066 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.0 t -61.13 -68.48 0.31 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -54.06 -53.64 50.33 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.896 -1.127 . . . . 0.0 110.846 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.22 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.628 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -62.21 -29.66 70.54 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.291 -0.881 . . . . 0.0 113.182 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.048 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 73.8 m -49.99 -29.11 7.94 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.309 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 1' ' ' ASP . 12.9 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.7 t0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.187 0.518 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -155.34 -157.59 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.478 -0.764 . . . . 0.0 109.72 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.81 -154.7 24.97 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.691 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 mt -131.17 179.87 5.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.956 . . . . 0.0 109.623 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.2 t -140.18 149.92 43.56 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.715 -1.241 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.6 p90 -135.85 164.76 27.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.58 149.81 43.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.476 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.15 -122.3 1.27 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.286 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.707 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.4 m -155.95 25.82 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.19 . . . . 0.0 110.989 -177.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -73.47 -8.88 57.74 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.359 -1.463 . . . . 0.0 113.414 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.7 m -126.08 26.28 6.55 Favored 'General case' 0 C--N 1.282 -2.368 0 O-C-N 121.402 -0.812 . . . . 0.0 109.833 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.07 75.68 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 118.434 -1.841 . . . . 0.0 108.714 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.226 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.38 51.7 2.3 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.189 0.995 . . . . 0.0 111.465 -178.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 9' ' ' THR . 40.2 t -67.14 111.81 2.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.78 -22.41 33.84 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.6 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmt -120.19 -143.15 0.35 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.559 -1.553 . . . . 0.0 109.348 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.56 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.6 m-85 -145.56 174.1 11.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.013 -1.679 . . . . 0.0 110.172 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.226 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 88.1 m -136.85 162.47 33.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.403 -1.435 . . . . 0.0 111.003 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.907 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -135.11 124.6 24.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.6 -0.687 . . . . 0.0 110.957 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -165.91 126.39 1.27 Allowed Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.35 -0.74 10.98 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.213 1.112 . . . . 0.0 111.209 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.557 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.7 tt -163.92 12.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 CA-C-O 121.968 0.89 . . . . 0.0 111.159 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.08 11.82 84.54 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.557 ' HD2' HG21 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -87.22 -35.22 18.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.441 -1.035 . . . . 0.0 111.169 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.6 m-85 -85.12 -39.89 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.885 . . . . 0.0 111.259 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 t 43.3 67.72 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.745 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.09 116.28 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.19 -0.943 . . . . 0.0 108.462 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.3 m -116.21 161.84 18.36 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.057 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.797 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.3 m-85 -148.37 175.14 11.35 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.927 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.4 p-10 -81.97 -42.46 19.36 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.947 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.97 116.57 21.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.011 -1.055 . . . . 0.0 108.764 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.8 ptpt -49.59 -35.97 22.56 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.23 -46.16 89.22 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.127 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.797 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.94 -26.02 27.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 O-C-N 120.769 -1.207 . . . . 0.0 109.455 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.107 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 24.6 t -60.87 -66.29 0.56 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -55.75 -54.0 49.78 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.618 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.8 tmtm? -62.7 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.631 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.6 -28.15 68.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.283 -0.886 . . . . 0.0 113.031 -176.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.107 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.8 m -49.14 -28.88 4.71 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.216 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.088 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.841 ' O ' HG21 ' A' ' 40' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.133 0.492 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -156.37 -160.96 1.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.784 . . . . 0.0 109.888 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.48 -142.48 7.56 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.63 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.88 179.49 6.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -1.014 . . . . 0.0 109.842 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.835 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 9.4 t -144.26 156.83 44.45 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.79 -1.194 . . . . 0.0 110.489 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 32.8 p90 -135.06 166.4 23.13 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.03 149.23 43.81 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.321 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 150.65 -122.23 1.35 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.8 m -156.23 23.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -1.103 . . . . 0.0 111.117 -177.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.31 -7.53 54.2 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.3 -1.5 . . . . 0.0 113.801 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.997 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.7 m -125.95 27.03 6.45 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.46 15.62 77.36 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 118.595 -1.764 . . . . 0.0 108.819 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.287 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.98 50.95 2.08 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.163 0.982 . . . . 0.0 111.461 -178.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 9' ' ' THR . 39.3 t -67.46 110.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.09 -20.56 40.31 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.836 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 21.9 mtmt -124.08 -139.04 0.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.597 -1.531 . . . . 0.0 109.425 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.586 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -144.33 174.1 11.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 119.844 -1.785 . . . . 0.0 110.052 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.287 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 99.5 m -135.05 163.13 30.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.54 -1.35 . . . . 0.0 110.842 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.097 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -131.48 123.74 28.69 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.531 -0.731 . . . . 0.0 110.922 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -165.79 118.56 0.87 Allowed Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -78.57 0.25 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.271 1.143 . . . . 0.0 110.641 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.534 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.3 tt -163.94 13.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.065 0.936 . . . . 0.0 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.96 83.67 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.534 ' HD2' HG21 ' A' ' 22' ' ' ILE . 13.4 ptmt -88.18 -33.88 18.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.453 -1.027 . . . . 0.0 111.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.2 m-85 -85.08 -41.78 15.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 111.75 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 25' ' ' TYR . 6.3 t 42.83 60.07 2.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.138 -0.977 . . . . 0.0 109.819 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.829 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.7 t -115.17 118.88 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.226 -0.921 . . . . 0.0 108.835 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.8 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.8 m -116.27 161.15 19.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 113.464 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.802 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.3 m-85 -148.81 177.48 9.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.95 -43.82 17.58 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.222 -0.924 . . . . 0.0 111.867 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.24 116.43 21.11 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.996 -1.065 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.815 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.5 ptpt -50.01 -35.23 23.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.06 -46.44 88.23 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.167 -0.958 . . . . 0.0 108.88 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.802 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.62 -25.66 25.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 O-C-N 120.82 -1.175 . . . . 0.0 109.358 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.097 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.6 t -60.08 -65.64 0.65 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 5' ' ' CYS . 49.5 m-20 -55.29 -55.36 32.29 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.89 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.2 tmtm? -62.32 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.33 -28.11 67.88 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.298 -0.876 . . . . 0.0 113.037 -176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.094 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 55.7 m -48.88 -31.13 6.71 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.295 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.841 HG21 ' O ' ' A' ' 1' ' ' ASP . 9.9 p . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.232 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.135 0.493 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.03 142.33 19.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.492 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.85 39.43 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.89 179.25 6.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.623 -0.928 . . . . 0.0 109.288 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.5 t -145.25 154.72 42.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.607 -1.308 . . . . 0.0 110.871 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 30.8 p90 -136.95 163.32 30.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.7 pt-20 -123.11 148.93 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.186 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.47 -119.64 0.94 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.67 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.689 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 98.1 m -154.67 21.58 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -1.139 . . . . 0.0 111.285 -177.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -74.63 -11.49 60.2 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.251 -1.531 . . . . 0.0 113.399 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -124.33 25.87 7.56 Favored 'General case' 0 C--N 1.283 -2.289 0 O-C-N 121.4 -0.812 . . . . 0.0 109.772 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.05 76.49 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 118.536 -1.792 . . . . 0.0 108.883 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.429 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 pttt -87.45 51.27 2.18 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.464 1.126 . . . . 0.0 110.788 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 109.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.12 -23.12 35.54 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.961 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.6 mtmt -119.08 -145.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.43 . . . . 0.0 108.936 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.5 m-85 -146.69 176.63 9.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.779 -1.826 . . . . 0.0 110.493 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.429 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 97.2 m -137.46 161.74 35.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.499 -1.376 . . . . 0.0 110.611 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.068 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -130.96 125.81 34.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.427 -0.795 . . . . 0.0 110.993 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 p -166.3 124.87 1.09 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.87 0.04 10.05 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.28 1.147 . . . . 0.0 111.065 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.0 tt -163.49 12.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.007 0.908 . . . . 0.0 110.888 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.44 11.71 84.9 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -88.3 -33.11 18.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.48 -1.012 . . . . 0.0 111.594 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 51.2 m-85 -85.08 -38.07 19.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.925 . . . . 0.0 111.409 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.4 t 41.32 66.92 0.6 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.405 -0.809 . . . . 0.0 110.794 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.717 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -114.93 117.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.22 161.8 18.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.898 -1.127 . . . . 0.0 113.865 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.1 m-85 -149.44 176.79 10.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.843 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.91 -42.83 18.96 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.786 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.736 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.26 116.28 21.05 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.06 -1.025 . . . . 0.0 108.716 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.0 ptmm? -50.27 -35.7 28.25 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.84 89.1 Favored 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.059 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.773 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.65 -25.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 O-C-N 120.716 -1.24 . . . . 0.0 109.408 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.113 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.1 t -60.66 -67.87 0.36 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -55.1 -53.59 53.98 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.925 -1.109 . . . . 0.0 110.863 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.4 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.597 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.16 -29.41 68.65 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.218 -0.926 . . . . 0.0 112.768 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.113 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m -50.15 -28.25 7.07 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.229 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 12.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.226 0.536 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' HA ' HG21 ' A' ' 40' ' ' THR . 6.9 m-20 -155.52 -171.74 3.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.39 -158.75 31.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 mt -132.11 179.52 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.955 . . . . 0.0 109.58 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t -143.65 150.39 38.68 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.735 -1.228 . . . . 0.0 110.673 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 30.5 p90 -137.92 164.45 28.96 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 6.5 pt-20 -122.94 149.49 44.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.92 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.35 -119.92 0.96 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.881 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.701 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.2 m -155.1 21.84 0.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 111.415 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.79 -12.46 60.4 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.284 -1.51 . . . . 0.0 113.63 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.904 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -124.16 26.3 7.51 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.15 17.83 77.56 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 118.497 -1.811 . . . . 0.0 108.888 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.298 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 4.0 pttt -87.39 50.09 1.94 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.403 1.096 . . . . 0.0 110.9 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.64 109.91 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.54 -22.78 37.45 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.02 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 37.3 mtmt -119.81 -145.05 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.86 -1.377 . . . . 0.0 108.82 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.9 m-85 -146.38 175.71 10.33 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 119.849 -1.782 . . . . 0.0 110.483 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.298 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 88.4 m -138.79 162.2 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.453 -1.404 . . . . 0.0 110.816 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.75 127.92 33.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 110.882 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.5 p -165.92 123.98 1.09 Allowed Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.21 -1.05 11.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.205 1.108 . . . . 0.0 110.931 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG21 ' HD2' ' A' ' 24' ' ' LYS . 4.5 tt -163.66 11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 122.031 0.919 . . . . 0.0 111.031 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.92 11.88 85.11 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HD2' HG21 ' A' ' 22' ' ' ILE . 10.3 ptmm? -86.81 -33.45 19.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -1.101 . . . . 0.0 110.8 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.0 m-85 -85.38 -43.37 13.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 111.592 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 43.3 t 42.93 65.59 0.92 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.341 -0.85 . . . . 0.0 109.577 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.742 HG12 ' CE1' ' A' ' 29' ' ' TYR . 91.5 t -114.91 118.02 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.5 m -116.31 162.06 18.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.986 -1.085 . . . . 0.0 113.182 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.7 m-85 -148.74 174.33 12.3 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -81.74 -41.42 21.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.764 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.741 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 115.49 20.54 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.047 -1.033 . . . . 0.0 108.636 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.4 ptpt -49.58 -35.74 21.71 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.407 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -45.84 89.92 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 121.395 -0.815 . . . . 0.0 109.201 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.82 -26.18 27.39 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.951 0 O-C-N 120.637 -1.289 . . . . 0.0 109.445 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.093 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.2 t -61.4 -68.91 0.27 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -54.86 -52.5 62.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.855 -1.153 . . . . 0.0 110.868 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.54 -79.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 14.7 m120 -60.98 -29.22 69.55 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.197 -0.939 . . . . 0.0 112.812 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.093 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.9 m -49.87 -31.2 11.52 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.254 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 2' ' ' ASP . 9.0 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.139 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.014 0.435 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -155.45 159.55 39.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -0.832 . . . . 0.0 110.378 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.49 170.92 31.07 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -131.76 179.4 6.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.946 . . . . 0.0 109.518 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 t -144.82 150.84 37.83 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.744 -1.222 . . . . 0.0 110.589 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 24.4 p90 -138.97 162.87 33.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -123.33 153.5 40.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.84 -1.162 . . . . 0.0 111.601 -177.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.76 -120.89 1.06 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.608 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 9' ' ' THR 0.283 92.8 m -154.01 19.19 0.51 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -1.145 . . . . 0.0 111.238 -177.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.492 ' H ' ' HZ1' ' A' ' 13' ' ' LYS . 17.9 t30 -73.92 -12.89 60.79 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.313 -1.492 . . . . 0.0 113.199 -177.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.971 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.0 m -122.71 23.92 9.31 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.363 -0.835 . . . . 0.0 109.569 178.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.36 77.77 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 118.556 -1.783 . . . . 0.0 109.111 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.424 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.2 pttm -87.2 51.78 2.33 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.509 1.147 . . . . 0.0 111.097 -178.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.49 108.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 -21.65 42.43 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.186 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.729 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.6 mtmm -121.0 -146.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.819 -1.401 . . . . 0.0 108.901 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.5 m-85 -146.67 177.38 9.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.808 -1.807 . . . . 0.0 110.666 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.424 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 96.8 m -138.14 161.37 36.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.513 -1.367 . . . . 0.0 110.656 -178.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -134.88 127.28 30.4 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.389 -0.82 . . . . 0.0 111.18 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -165.55 126.11 1.31 Allowed Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.54 -7.25 17.65 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.259 1.136 . . . . 0.0 111.308 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.463 HG21 ' HD2' ' A' ' 24' ' ' LYS . 6.2 tt -164.53 16.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.154 0.978 . . . . 0.0 110.932 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.88 9.76 85.11 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.617 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -90.4 20.78 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.422 -1.046 . . . . 0.0 110.76 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.7 m-85 -148.55 -40.63 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.0 110.613 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 24.7 t 40.81 71.66 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.382 -0.824 . . . . 0.0 110.572 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.724 HG12 ' CE1' ' A' ' 29' ' ' TYR . 63.8 t -115.0 117.7 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.049 -1.032 . . . . 0.0 108.258 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 17.6 m -116.23 161.95 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.381 -176.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.781 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.1 m-85 -149.24 175.04 11.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.868 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.92 -42.12 19.93 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.218 -0.926 . . . . 0.0 111.865 178.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.36 115.3 20.65 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.064 -1.023 . . . . 0.0 108.85 179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.6 ptpt -49.77 -35.14 21.42 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.58 -46.48 86.86 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.945 176.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.39 -25.74 24.64 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 O-C-N 120.763 -1.21 . . . . 0.0 109.378 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.116 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 t -60.78 -66.1 0.58 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -55.44 -54.31 45.42 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.86 -1.15 . . . . 0.0 110.664 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtm? -62.26 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -59.93 -30.09 68.82 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.267 -0.896 . . . . 0.0 112.816 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.116 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 83.1 m -50.86 -26.14 5.42 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.383 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 17.9 p . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -155.17 133.7 11.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.828 . . . . 0.0 110.764 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.67 -177.34 40.3 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 mt -132.69 179.74 5.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.942 . . . . 0.0 109.458 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.7 t -137.4 135.32 36.83 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.766 -1.209 . . . . 0.0 109.676 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 30.4 p90 -136.09 168.9 18.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.63 145.59 48.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.694 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.94 -118.17 0.83 Allowed Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.605 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.72 ' O ' HG22 ' A' ' 9' ' ' THR 0.297 54.9 m -158.04 32.7 0.25 Allowed 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.251 -1.147 . . . . 0.0 110.276 -177.618 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -68.79 -7.96 38.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.084 -1.635 . . . . 0.0 112.529 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.7 m -120.49 23.67 10.73 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.966 0.889 . . . . 0.0 108.637 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.27 83.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.137 178.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.087 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -93.78 71.62 4.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.842 1.306 . . . . 0.0 112.667 -178.681 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.6 t -64.27 116.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.599 177.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.85 -25.94 17.31 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.756 -1.687 . . . . 0.0 111.674 178.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.861 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 16.1 mttt -108.47 -146.33 0.4 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 120.371 2.085 . . . . 0.0 109.497 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.891 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 11.3 m-85 -146.4 169.37 19.01 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 119.437 -2.04 . . . . 0.0 111.487 -178.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.087 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 50.0 m -137.43 161.57 35.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.806 -1.809 . . . . 0.0 112.619 -178.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.078 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -135.71 104.16 5.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.366 0.603 . . . . 0.0 109.641 179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 p -169.99 141.49 1.79 Allowed Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -77.06 -8.73 17.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.291 1.153 . . . . 0.0 110.075 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.816 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.7 tt -165.36 -169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.37 12.95 57.39 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.266 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.816 ' H ' HG23 ' A' ' 22' ' ' ILE . 21.0 ptmt -84.01 -43.14 15.46 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.159 -1.2 . . . . 0.0 110.73 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.3 m-85 -86.76 -51.73 5.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 30.8 t 40.56 75.36 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.609 -0.682 . . . . 0.0 110.391 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.078 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 t -113.48 105.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.7 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 24.5 m -116.11 163.98 15.14 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.313 1.054 . . . . 0.0 113.545 -175.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.834 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.1 m-85 -150.08 176.65 10.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -82.54 -41.73 19.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.035 -1.041 . . . . 0.0 111.635 178.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.91 118.8 22.72 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.007 -1.058 . . . . 0.0 108.863 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.852 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.2 ptpt -50.65 -37.12 38.99 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.29 -45.27 91.73 Favored 'General case' 0 C--O 1.198 -1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 109.265 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.834 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.39 -26.06 29.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 120.659 -1.276 . . . . 0.0 109.31 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.971 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 5.2 t -61.85 -70.28 0.2 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -54.71 -51.48 65.44 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.958 -1.089 . . . . 0.0 110.585 178.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.6 tmtm? -62.3 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -61.45 -29.36 69.9 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.209 -0.932 . . . . 0.0 112.825 -177.005 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.971 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.8 m -50.44 -31.39 14.94 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.08 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.172 -179.848 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.072 0.463 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.87 -168.42 2.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.91 -135.96 3.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.36 179.79 5.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.445 -1.032 . . . . 0.0 109.652 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.61 140.82 49.5 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.772 -1.205 . . . . 0.0 110.141 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -137.55 164.6 28.33 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 8.0 pt-20 -123.17 149.27 44.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.746 -1.181 . . . . 0.0 110.801 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.99 -119.45 0.92 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.918 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.674 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 89.4 m -155.02 22.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -1.144 . . . . 0.0 111.514 -177.473 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -73.99 -12.61 60.69 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.185 -1.572 . . . . 0.0 113.333 -177.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -123.19 25.08 8.59 Favored 'General case' 0 C--N 1.281 -2.37 0 O-C-N 121.431 -0.793 . . . . 0.0 109.645 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.01 76.55 Favored Glycine 0 C--N 1.29 -2.018 0 C-N-CA 118.491 -1.814 . . . . 0.0 108.68 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.324 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 pttt -87.32 51.47 2.24 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.42 1.105 . . . . 0.0 110.927 -178.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.51 109.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.63 37.65 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.75 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 23.3 mtmt -118.52 -147.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.808 -1.407 . . . . 0.0 108.892 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.0 m-85 -147.3 176.51 9.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.852 -1.78 . . . . 0.0 110.232 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.324 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 81.5 m -136.4 162.23 33.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.515 -1.366 . . . . 0.0 111.341 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.985 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -136.71 109.83 7.76 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.712 -0.617 . . . . 0.0 110.584 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.61 136.99 1.2 Allowed Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -75.91 -12.63 19.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.316 1.166 . . . . 0.0 109.811 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.847 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.1 tt -165.09 -166.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.166 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.586 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -84.16 7.46 71.39 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.345 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.847 ' H ' HG23 ' A' ' 22' ' ' ILE . 35.0 pttt -88.58 17.13 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.123 -1.222 . . . . 0.0 111.396 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.3 m-85 -151.6 -54.79 0.14 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 177.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.4 t 36.8 75.64 0.06 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.445 -0.784 . . . . 0.0 110.993 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.855 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.23 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.63 -1.294 . . . . 0.0 108.595 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.4 m -116.03 162.01 18.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.315 1.055 . . . . 0.0 113.79 -176.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.799 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.1 m-85 -149.28 176.64 10.36 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.3 p-10 -82.22 -43.24 17.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.236 -0.915 . . . . 0.0 111.933 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.09 117.62 21.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.105 -0.997 . . . . 0.0 108.848 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.878 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 17.0 ptpt -50.26 -35.82 28.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.55 -45.94 90.33 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.157 176.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.87 -26.01 27.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.717 -1.239 . . . . 0.0 109.333 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.152 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -60.56 -68.0 0.34 Allowed 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -54.85 -53.47 54.94 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.752 -1.217 . . . . 0.0 110.952 177.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.15 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.893 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -60.32 -29.32 68.79 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 112.772 -176.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.152 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 71.0 m -50.17 -27.1 5.31 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.272 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.158 -179.69 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.782 ' HA ' HG21 ' A' ' 40' ' ' THR . 10.4 p-10 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.421 0.629 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -83.97 111.82 19.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.602 -0.686 . . . . 0.0 110.235 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.83 168.37 27.89 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 mt -130.44 179.8 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.663 -0.904 . . . . 0.0 109.158 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 t -139.35 148.87 43.49 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.591 -1.318 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.5 165.73 24.84 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.45 149.77 43.39 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.67 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.418 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 152.97 -124.13 1.55 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.4 m -155.44 25.35 0.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.82 -177.826 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -74.05 -7.44 52.49 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.326 -1.484 . . . . 0.0 113.522 -176.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.831 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m -127.64 27.18 5.82 Favored 'General case' 0 C--N 1.284 -2.253 0 O-C-N 121.281 -0.887 . . . . 0.0 109.809 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.45 15.04 77.26 Favored Glycine 0 C--N 1.291 -1.933 0 C-N-CA 118.56 -1.781 . . . . 0.0 108.848 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.278 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.64 52.7 2.56 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.229 1.014 . . . . 0.0 111.298 -178.585 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 9' ' ' THR . 44.5 t -67.44 109.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.3 -20.63 44.2 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.801 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.771 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.8 mtmt -117.41 -143.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.709 -1.465 . . . . 0.0 109.169 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.555 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.8 m-85 -145.66 173.85 11.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 119.875 -1.766 . . . . 0.0 110.179 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.278 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -136.48 163.18 31.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.451 -1.406 . . . . 0.0 111.024 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.819 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -134.01 122.58 23.22 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.529 -0.732 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 p -165.69 124.86 1.17 Allowed Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.99 -1.83 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.257 1.135 . . . . 0.0 111.241 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.487 HG21 ' HD2' ' A' ' 24' ' ' LYS . 4.5 tt -163.9 13.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 122.02 0.914 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 12.05 84.4 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 10.7 ptmt -87.96 -34.78 17.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.405 -1.056 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.501 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.4 m-85 -84.48 -39.0 19.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.283 -0.886 . . . . 0.0 111.332 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.8 t 41.39 65.46 0.83 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.374 -0.829 . . . . 0.0 110.461 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.819 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.0 t -115.14 115.51 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.37 161.99 18.22 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.304 1.049 . . . . 0.0 113.325 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.804 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.4 m-85 -148.74 175.82 10.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.048 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.412 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -82.36 -42.59 18.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.204 -0.935 . . . . 0.0 112.066 178.949 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.66 116.56 20.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.003 -1.06 . . . . 0.0 108.573 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.828 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 1.1 ptpp? -49.71 -35.85 23.29 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -46.15 89.12 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.094 176.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.804 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.16 -26.12 28.53 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.726 -1.234 . . . . 0.0 109.386 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.061 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -60.34 -65.82 0.62 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -56.45 -54.11 49.58 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.697 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -62.36 -79.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -177.646 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.75 -28.53 68.77 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.29 -0.881 . . . . 0.0 112.962 -176.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.061 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.2 m -49.37 -32.61 11.8 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.251 -178.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.782 HG21 ' HA ' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.2 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.096 0.474 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -155.45 159.11 39.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.279 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.01 -167.13 39.08 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mt -132.85 179.8 5.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.607 -0.937 . . . . 0.0 109.62 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -137.49 140.74 41.35 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.769 -1.207 . . . . 0.0 109.886 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -137.3 166.97 22.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.84 153.03 40.14 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.113 -177.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.48 -121.28 1.11 Allowed Glycine 0 N--CA 1.487 2.082 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.484 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -155.19 22.32 0.43 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.339 -1.095 . . . . 0.0 111.057 -177.874 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -73.89 -13.41 60.9 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.316 -1.49 . . . . 0.0 113.355 -177.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.062 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -122.32 25.42 8.94 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 121.365 -0.834 . . . . 0.0 109.457 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.78 16.61 78.02 Favored Glycine 0 C--N 1.291 -1.947 0 C-N-CA 118.673 -1.727 . . . . 0.0 109.112 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.277 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pttm -88.03 52.94 2.59 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.483 1.135 . . . . 0.0 110.986 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 HG23 ' A' ' 9' ' ' THR . 38.8 t -67.1 108.92 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.11 -22.38 39.56 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.997 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.6 mtmt -115.54 -146.36 0.4 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.743 -1.445 . . . . 0.0 108.83 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.543 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.6 m-85 -146.82 177.06 9.41 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 119.824 -1.798 . . . . 0.0 110.633 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.277 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.0 160.4 39.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.379 -1.45 . . . . 0.0 110.755 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.104 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -137.26 112.44 9.14 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -170.72 137.63 1.21 Allowed Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.59 -14.78 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.293 1.154 . . . . 0.0 109.606 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.765 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.8 tt -164.89 -166.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.49 11.7 50.02 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.76 -1.209 . . . . 0.0 110.637 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.765 ' H ' HG23 ' A' ' 22' ' ' ILE . 13.7 ptmt -88.2 12.82 12.78 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.364 -1.08 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.615 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.6 m-85 -151.04 -53.24 0.14 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.6 t 36.56 74.99 0.07 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.451 -0.781 . . . . 0.0 110.473 -178.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.8 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 t -114.75 114.03 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.809 -1.182 . . . . 0.0 108.48 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.764 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.4 m -115.96 161.45 18.82 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.256 1.027 . . . . 0.0 113.218 -176.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.782 ' CE1' HG12 ' A' ' 27' ' ' VAL . 87.3 m-85 -149.9 176.49 10.7 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.265 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.5 p-10 -82.12 -42.15 19.52 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.238 -0.914 . . . . 0.0 111.833 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.746 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.42 114.99 20.54 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.043 -1.035 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 10.1 ptmt -50.21 -35.03 24.85 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.11 87.01 Favored 'General case' 0 C--O 1.2 -1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 108.879 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.771 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.16 -25.67 23.58 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 120.635 -1.291 . . . . 0.0 109.389 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.125 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 t -60.55 -66.88 0.46 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.01 -54.26 45.22 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.817 -1.177 . . . . 0.0 111.088 177.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.3 tmtm? -62.04 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -60.99 -30.31 70.2 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.185 -0.947 . . . . 0.0 112.818 -176.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.125 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 95.6 m -51.15 -30.73 17.52 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 118.696 -1.202 . . . . 0.0 111.338 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.133 -0.979 . . . . 0.0 110.152 -179.97 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.666 ' O ' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -83.44 145.72 28.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.043 -1.035 . . . . 0.0 110.154 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.25 -178.46 40.8 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -131.23 179.81 5.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.698 -0.884 . . . . 0.0 109.484 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.7 t -132.77 135.87 45.98 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.625 -1.297 . . . . 0.0 110.382 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -137.49 166.28 24.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.87 152.17 41.01 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.284 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.06 -120.16 0.99 Allowed Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.534 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.6 m -155.28 23.59 0.42 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 111.235 -177.817 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.45 -14.52 61.26 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 120.217 -1.552 . . . . 0.0 113.257 -177.024 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.2 m -121.66 25.07 9.48 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 121.361 -0.837 . . . . 0.0 109.475 177.764 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.17 17.26 77.22 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.283 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.7 pttm -87.69 53.08 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.582 1.182 . . . . 0.0 110.885 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 9' ' ' THR . 25.8 t -67.32 109.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.316 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.95 -22.94 36.36 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.912 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.0 mtmt -115.24 -148.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.859 -1.377 . . . . 0.0 108.668 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.4 m-85 -146.68 175.91 10.25 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 119.83 -1.794 . . . . 0.0 110.455 -179.473 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.283 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 63.0 m -137.16 160.94 37.53 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.359 -1.463 . . . . 0.0 111.369 -178.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.879 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.25 112.03 8.33 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.743 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.89 140.21 1.34 Allowed Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -76.98 -7.39 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.223 1.117 . . . . 0.0 110.059 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.8 HG23 ' H ' ' A' ' 24' ' ' LYS . 8.8 tt -165.08 -170.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.11 13.1 58.33 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.245 -178.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.8 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -84.13 -43.82 14.63 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.159 -1.2 . . . . 0.0 110.908 -179.711 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.475 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.2 m-85 -87.51 -51.83 5.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.064 -1.023 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.6 t 39.53 75.48 0.08 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.363 -0.836 . . . . 0.0 110.23 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.784 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.9 t -114.36 112.87 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.831 -1.168 . . . . 0.0 108.435 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.3 m -116.13 161.96 18.15 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.217 1.008 . . . . 0.0 113.0 -176.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.3 m-85 -149.62 174.08 12.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.14 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.63 -41.19 21.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 111.939 178.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.46 115.09 20.62 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.085 -1.009 . . . . 0.0 108.729 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.81 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.3 ptpt -49.92 -34.97 22.15 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.65 -46.2 87.66 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 176.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.45 24.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 O-C-N 120.606 -1.309 . . . . 0.0 109.382 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.055 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 34.3 t -61.26 -66.66 0.5 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -55.04 -54.14 46.86 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.843 -1.161 . . . . 0.0 110.734 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.66 -79.09 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.1 m120 -60.84 -31.13 70.57 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.278 -0.889 . . . . 0.0 112.869 -176.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.055 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 98.0 m -51.47 -32.32 26.78 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.228 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.127 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.461 ' H2 ' HG21 ' A' ' 40' ' ' THR . 20.3 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.08 0.467 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.31 107.35 15.77 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.39 178.91 38.86 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -132.31 179.34 6.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.524 -0.986 . . . . 0.0 109.391 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 t -145.18 152.11 39.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.664 -1.272 . . . . 0.0 110.622 179.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -137.04 163.42 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.4 pt-20 -123.09 149.45 44.46 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.939 -1.105 . . . . 0.0 111.084 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.46 -120.07 0.97 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.767 179.204 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 95.1 m -154.78 21.76 0.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.158 . . . . 0.0 111.283 -177.529 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.288 -1.507 . . . . 0.0 113.462 -177.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.8 m -124.26 25.66 7.68 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 178.331 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.64 17.62 76.66 Favored Glycine 0 C--N 1.29 -1.984 0 C-N-CA 118.38 -1.867 . . . . 0.0 108.694 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.332 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.8 pttt -87.68 51.2 2.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.547 1.165 . . . . 0.0 110.852 -178.656 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -67.23 108.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.21 -22.31 38.34 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.069 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmp? -119.0 -146.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.753 -1.439 . . . . 0.0 108.866 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.8 m-85 -146.77 176.15 10.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 119.856 -1.778 . . . . 0.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.332 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 92.8 m -137.29 161.89 35.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.389 -1.445 . . . . 0.0 110.802 -178.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.041 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.44 127.18 30.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.806 . . . . 0.0 111.123 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 p -166.18 126.66 1.26 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.25 2.23 8.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.089 1.047 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.699 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.0 tt -163.5 8.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.02 0.914 . . . . 0.0 111.169 178.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.91 85.53 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.699 ' HD2' HG21 ' A' ' 22' ' ' ILE . 14.3 ptmm? -87.82 -34.08 18.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -85.03 -40.06 17.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 0.0 111.231 -179.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.3 t 44.28 70.58 0.32 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.306 -0.871 . . . . 0.0 110.284 -179.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 83.4 t -114.94 117.6 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.1 m -116.22 161.86 18.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.895 -1.128 . . . . 0.0 113.474 -176.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.796 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.64 175.17 11.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.845 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.3 p-10 -81.8 -42.33 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.811 178.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.34 116.49 21.2 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.008 -1.058 . . . . 0.0 108.774 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.2 ptpt -50.23 -35.51 27.06 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.95 -46.16 88.7 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 109.047 176.388 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.796 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.72 -26.04 26.63 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.139 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.4 t -60.83 -67.58 0.39 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.78 -53.51 54.17 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.843 -1.161 . . . . 0.0 110.855 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -62.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.77 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.605 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.32 -0.863 . . . . 0.0 113.032 -176.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.139 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.4 m -48.97 -29.65 5.07 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.353 -178.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.461 HG21 ' H2 ' ' A' ' 1' ' ' ASP . 8.7 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.196 0.522 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.95 -161.79 0.53 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.63 -129.26 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.605 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mt -131.98 -179.95 5.72 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.615 -0.932 . . . . 0.0 110.064 -178.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 39.2 t -137.52 150.35 47.45 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.872 -1.142 . . . . 0.0 110.359 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.9 p90 -137.29 162.72 32.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.2 149.08 45.11 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.015 -1.053 . . . . 0.0 110.772 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.82 -121.84 1.16 Allowed Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.504 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 98.1 m -155.74 28.72 0.37 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.489 -1.007 . . . . 0.0 110.288 -177.861 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -71.36 -12.27 61.34 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.516 -1.365 . . . . 0.0 112.79 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -117.27 21.98 12.78 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.59 15.24 77.6 Favored Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -92.28 61.25 3.84 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.37 1.081 . . . . 0.0 112.428 -177.984 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.524 HG23 HG23 ' A' ' 9' ' ' THR . 24.6 t -63.64 116.94 3.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.16 -23.74 22.46 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 118.866 -1.635 . . . . 0.0 111.641 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.0 mtmm -120.11 -149.72 0.44 Allowed 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 120.426 2.113 . . . . 0.0 110.222 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 12.9 m-85 -146.2 170.12 17.38 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 119.983 -1.698 . . . . 0.0 110.276 -179.276 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 55.5 m -133.86 163.91 28.45 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.197 -1.564 . . . . 0.0 111.199 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.053 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.81 117.7 18.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.491 0.663 . . . . 0.0 110.737 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 p -165.82 140.27 3.82 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -76.49 -1.91 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.097 1.051 . . . . 0.0 111.599 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 24' ' ' LYS . 5.9 tt -164.2 13.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-O 121.994 0.902 . . . . 0.0 111.392 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.9 11.88 84.35 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -85.49 -37.69 19.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.483 -1.01 . . . . 0.0 111.069 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.2 m-85 -84.83 -33.19 22.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.813 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.1 t 40.92 75.52 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.535 -0.728 . . . . 0.0 111.086 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.955 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 88.0 t -113.3 109.17 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 14.6 m -116.25 164.71 14.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -173.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.818 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.8 m-85 -150.59 176.8 10.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.64 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.55 -42.34 18.47 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.834 178.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 119.02 23.01 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.016 -1.053 . . . . 0.0 108.854 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -51.21 -36.6 42.36 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.71 -45.7 88.97 Favored 'General case' 0 C--O 1.201 -1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 176.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.818 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.55 -25.5 28.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 O-C-N 120.667 -1.271 . . . . 0.0 109.339 179.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.053 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 20.0 t -60.73 -66.8 0.47 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.76 -54.28 44.12 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.808 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -62.86 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -177.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.9 m120 -60.6 -28.81 68.79 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.323 -0.861 . . . . 0.0 113.058 -176.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.2 m -49.95 -26.25 4.03 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.128 -178.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.088 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 25' ' ' TYR . 10.2 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.04 0.448 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -82.12 -158.56 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.96 -129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.64 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 mt -132.79 179.9 5.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.496 -1.002 . . . . 0.0 109.951 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 t -133.66 138.04 45.68 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.847 -1.158 . . . . 0.0 110.031 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.98 167.29 21.79 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.05 152.42 41.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.699 -1.2 . . . . 0.0 111.206 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.92 -120.88 1.05 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.479 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.4 m -155.01 23.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.292 -1.122 . . . . 0.0 111.13 -177.775 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.71 -12.99 60.89 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 120.3 -1.5 . . . . 0.0 113.329 -177.001 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.7 m -123.0 24.96 8.76 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.346 -0.846 . . . . 0.0 109.542 177.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.14 17.39 77.26 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.605 -1.76 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.282 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 5.0 pttm -87.99 53.16 2.67 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.501 1.143 . . . . 0.0 110.972 -178.661 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' CG2' HG23 ' A' ' 9' ' ' THR . 49.2 t -67.29 109.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.3 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.1 -23.31 34.95 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.916 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.4 mtmm -114.95 -147.68 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.852 -1.381 . . . . 0.0 108.761 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.52 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 19.2 m-85 -146.72 176.48 9.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.878 -1.764 . . . . 0.0 110.289 -179.454 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.282 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 59.9 m -137.13 161.84 35.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.301 -1.499 . . . . 0.0 111.283 -178.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.882 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.15 109.73 7.04 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.599 -0.688 . . . . 0.0 110.731 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.2 136.89 1.3 Allowed Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -75.46 -13.67 20.42 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.276 1.145 . . . . 0.0 109.738 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.84 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.5 tt -165.08 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.167 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -83.34 8.98 62.51 Favored Glycine 0 N--CA 1.501 2.997 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.085 -178.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.84 ' H ' HG23 ' A' ' 22' ' ' ILE . 6.8 ptmm? -88.45 15.27 8.12 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.169 -1.195 . . . . 0.0 111.132 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.555 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.7 m-85 -150.95 -53.96 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 110.447 178.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' TYR . 12.8 t 36.66 75.34 0.06 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.367 -0.833 . . . . 0.0 110.853 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.849 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 59.4 t -114.49 113.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.724 -1.235 . . . . 0.0 108.366 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.603 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.12 162.5 17.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.029 . . . . 0.0 113.446 -176.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.4 m-85 -149.27 174.68 12.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.7 p-10 -82.2 -42.01 19.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.89 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.729 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.15 116.16 20.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.942 -1.099 . . . . 0.0 108.808 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.8 ptpt -49.94 -35.58 24.6 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.9 -46.31 88.19 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.033 176.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.73 -25.85 26.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 O-C-N 120.655 -1.278 . . . . 0.0 109.467 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.041 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.1 t -61.08 -66.66 0.5 Allowed 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -55.28 -53.82 51.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.878 -1.138 . . . . 0.0 110.551 177.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.1 tmtm? -62.46 -79.6 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.613 ' HB2' HG23 ' A' ' 34' ' ' ILE . 14.8 m120 -60.37 -30.56 69.65 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.172 -0.955 . . . . 0.0 112.713 -176.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 70.7 m -50.99 -27.3 7.43 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.263 -178.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.048 -179.775 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.56 133.16 34.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.0 110.159 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.37 144.18 4.0 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 mt -132.23 179.56 6.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.577 -0.955 . . . . 0.0 109.147 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.1 t -143.41 150.85 39.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.488 -1.383 . . . . 0.0 111.348 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.8 p90 -137.57 166.54 23.66 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.54 152.91 39.89 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.285 -177.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.35 -121.62 1.15 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.354 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.7 m -154.7 22.63 0.46 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -1.109 . . . . 0.0 110.996 -177.764 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -74.46 -11.47 60.24 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.292 -1.505 . . . . 0.0 113.351 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.02 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -123.77 24.7 8.33 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 121.265 -0.897 . . . . 0.0 109.735 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.43 17.15 77.56 Favored Glycine 0 C--N 1.291 -1.966 0 C-N-CA 118.641 -1.743 . . . . 0.0 109.077 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.273 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -87.45 52.63 2.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.392 1.091 . . . . 0.0 111.01 -178.69 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.03 110.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.51 -21.32 41.39 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.5 mttt -120.87 -145.36 0.36 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.796 -1.414 . . . . 0.0 109.033 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 16.0 m-85 -146.1 177.65 8.81 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.778 -1.826 . . . . 0.0 110.494 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.273 ' SG ' ' HD2' ' A' ' 13' ' ' LYS . 70.8 m -137.45 162.01 34.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.389 -1.444 . . . . 0.0 110.874 -178.552 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -133.89 124.86 27.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.46 -0.775 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 p -165.84 128.33 1.48 Allowed Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -77.29 -2.02 12.21 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.181 1.095 . . . . 0.0 111.078 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.505 HG21 ' HD2' ' A' ' 24' ' ' LYS . 4.4 tt -163.42 12.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-O 121.992 0.901 . . . . 0.0 111.125 179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.33 84.53 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.191 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD2' HG21 ' A' ' 22' ' ' ILE . 14.2 ptmm? -87.96 -33.67 18.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.367 -1.078 . . . . 0.0 111.244 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.1 m-85 -85.15 -39.05 18.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.283 -0.885 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.4 t 43.29 68.32 0.52 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.345 -0.847 . . . . 0.0 110.36 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.795 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.13 116.11 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.703 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.26 161.63 18.71 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.493 -176.498 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.789 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.9 m-85 -149.1 176.74 10.21 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.184 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.89 -43.62 17.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.236 -0.915 . . . . 0.0 111.796 178.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.44 21.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.947 -1.095 . . . . 0.0 108.498 179.295 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.7 ptpt -50.34 -35.2 26.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.16 -46.13 89.2 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 109.084 176.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.789 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.72 -26.27 27.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 O-C-N 120.719 -1.238 . . . . 0.0 109.454 179.228 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.117 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 t -61.28 -67.44 0.41 Allowed 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.08 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -55.23 -53.13 59.93 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.756 -1.215 . . . . 0.0 110.61 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -62.92 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.72 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.608 ' HB2' HG23 ' A' ' 34' ' ' ILE . 15.0 m120 -61.08 -28.35 69.02 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 112.948 -176.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.117 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.1 m -48.92 -32.46 9.04 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.118 -178.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.124 -179.885 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.505 2.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -138.39 163.04 32.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.1 151.49 42.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.22 -121.33 1.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.444 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.284 94.5 m -154.69 23.58 0.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.293 -1.122 . . . . 0.0 111.117 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -73.72 -13.86 61.04 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.259 -1.526 . . . . 0.0 113.332 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.833 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.1 m -120.97 24.25 10.27 Favored 'General case' 0 C--N 1.283 -2.297 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.46 77.5 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 118.708 -1.71 . . . . 0.0 109.029 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.356 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 16.6 pttm -87.84 52.87 2.59 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.534 1.159 . . . . 0.0 110.928 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 9' ' ' THR . 35.1 t -66.73 110.73 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.79 -22.84 34.28 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.24 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.2 mtmt -119.9 -145.69 0.37 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.663 -1.493 . . . . 0.0 109.147 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 17.4 m-85 -146.0 174.85 10.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.893 -1.754 . . . . 0.0 110.326 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.356 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.4 m -137.44 161.25 36.85 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.377 -1.452 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.994 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.775 . . . . 0.0 110.818 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 26.2 t . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.773 HG12 ' CE1' ' A' ' 29' ' ' TYR . 89.3 t -114.69 116.73 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 12.9 m -116.33 161.78 18.51 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.33 1.062 . . . . 0.0 113.157 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.6 m-85 -149.37 174.56 12.31 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.1 p30 -81.46 -40.72 22.89 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.837 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.75 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.2 113.85 19.62 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.083 -1.011 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.0 ptmm? -49.37 -35.05 17.61 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.29 86.98 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.126 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.761 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.18 -25.7 23.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 O-C-N 120.668 -1.27 . . . . 0.0 109.382 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.111 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 37.6 t -61.15 -67.35 0.41 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -54.53 -53.92 47.99 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.895 -1.128 . . . . 0.0 110.996 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -61.9 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.543 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.3 m-80 -60.26 -30.47 69.46 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 121.227 -0.921 . . . . 0.0 112.767 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.111 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 94.3 m . . . . . 0 N--CA 1.502 2.128 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.506 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.506 2.363 0 CA-C-O 121.51 0.671 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.0 p90 -138.19 162.89 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.05 150.81 42.63 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.411 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.95 -122.46 1.23 Allowed Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.54 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.669 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -154.79 24.11 0.45 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.369 -1.077 . . . . 0.0 110.818 -177.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.77 -13.33 60.93 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.299 -1.501 . . . . 0.0 113.294 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.933 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.9 m -121.28 24.75 9.86 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.431 -0.793 . . . . 0.0 109.367 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.86 77.52 Favored Glycine 0 C--N 1.29 -1.985 0 C-N-CA 118.701 -1.714 . . . . 0.0 109.058 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.319 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 9.2 pttm -88.08 54.32 3.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.561 1.172 . . . . 0.0 110.843 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.462 ' CG2' HG23 ' A' ' 9' ' ' THR . 40.2 t -66.68 108.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.54 -22.65 36.69 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.022 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.749 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 41.5 mtmt -114.45 -147.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.821 -1.4 . . . . 0.0 108.943 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 25.4 m-85 -146.57 175.62 10.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.9 -1.75 . . . . 0.0 110.277 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.319 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.9 m -136.8 161.76 35.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.515 -1.366 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.9 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 18.2 t . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 120.638 0.256 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.4 t -114.45 111.48 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.699 -1.251 . . . . 0.0 108.434 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.2 m -116.13 161.64 18.62 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.29 1.043 . . . . 0.0 113.46 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.8 m-85 -150.12 175.75 11.46 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.8 p-10 -82.12 -41.82 19.95 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.92 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.11 115.51 20.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.964 -1.085 . . . . 0.0 108.739 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.913 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 9.4 ptmt -49.74 -35.3 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.8 -46.38 87.7 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.048 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.48 -25.79 25.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.0 109.332 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.043 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.2 t -60.35 -66.58 0.5 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.02 -54.17 48.06 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.927 -1.108 . . . . 0.0 110.785 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -61.61 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -61.02 -29.82 69.94 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.224 -0.922 . . . . 0.0 112.881 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.043 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.0 m . . . . . 0 N--CA 1.503 2.179 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.357 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 121.85 0.833 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -138.5 164.43 29.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.62 153.21 39.62 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.419 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.95 -122.18 1.23 Allowed Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.36 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 95.2 m -154.9 22.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 111.004 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -75.15 -10.16 59.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.316 -1.49 . . . . 0.0 113.713 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.013 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.6 m -124.5 25.32 7.64 Favored 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.245 -0.909 . . . . 0.0 109.707 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.24 77.43 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 118.593 -1.765 . . . . 0.0 109.167 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 4.2 pttt -87.83 51.67 2.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.505 1.145 . . . . 0.0 110.956 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.82 110.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 -22.04 39.46 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.11 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.772 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.3 mtmm -119.41 -145.53 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.865 -1.373 . . . . 0.0 109.005 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 26.5 m-85 -145.81 175.94 10.03 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 119.871 -1.768 . . . . 0.0 110.276 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 90.5 m -137.07 161.61 35.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.255 -1.528 . . . . 0.0 110.664 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.932 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.378 0 O-C-N 121.378 -0.826 . . . . 0.0 111.317 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 121.133 0.492 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.2 t -115.33 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.8 m -116.17 162.3 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.91 -1.119 . . . . 0.0 113.085 -176.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.7 m-85 -147.75 174.76 11.5 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.024 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.2 p-10 -82.04 -42.67 18.96 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.003 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.95 116.39 20.89 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.976 -1.077 . . . . 0.0 108.68 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.3 ptpt -49.19 -36.03 18.66 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.58 88.25 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.35 -26.36 25.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 O-C-N 120.704 -1.248 . . . . 0.0 109.435 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.146 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.4 t -60.98 -67.29 0.42 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -54.82 -53.42 55.47 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.825 -1.172 . . . . 0.0 110.875 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.31 -80.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 34' ' ' ILE . 49.7 m-80 -61.16 -28.12 68.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.261 -0.899 . . . . 0.0 113.007 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.146 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.8 m . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.144 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 17.1 t . . . . . 0 N--CA 1.506 2.35 0 CA-C-O 121.633 0.73 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.508 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -136.6 165.16 26.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.73 149.89 43.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.309 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.54 -120.33 1.01 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.531 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.685 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 96.1 m -154.83 21.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -1.136 . . . . 0.0 111.334 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.331 -1.48 . . . . 0.0 113.541 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.112 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.8 m -123.19 25.59 8.37 Favored 'General case' 0 C--N 1.282 -2.354 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.68 17.23 79.11 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 118.784 -1.674 . . . . 0.0 109.412 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.608 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.14 53.17 2.73 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.541 1.162 . . . . 0.0 110.856 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.82 107.78 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.42 -21.06 45.87 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.067 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 15.2 mtmt -119.18 -144.14 0.36 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.917 -1.343 . . . . 0.0 109.128 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 14.7 m-85 -146.65 176.67 9.66 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 119.789 -1.819 . . . . 0.0 110.593 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.608 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 95.8 m -136.74 163.29 30.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.445 -1.41 . . . . 0.0 110.745 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.362 0 O-C-N 121.511 -0.743 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 121.246 0.546 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.762 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.6 t -114.96 118.11 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.82 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.5 m -116.16 161.69 18.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.493 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 83.7 m-85 -149.26 176.51 10.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.0 p-10 -81.93 -42.83 18.93 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.78 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.13 20.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.029 -1.045 . . . . 0.0 108.611 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.7 ptpt -49.94 -35.45 24.09 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.12 -46.16 89.04 Favored 'General case' 0 C--O 1.201 -1.497 0 O-C-N 121.307 -0.87 . . . . 0.0 109.12 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.79 -25.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 120.566 -1.334 . . . . 0.0 109.407 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.101 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.7 t -60.82 -67.45 0.4 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -55.02 -53.53 54.68 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.901 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.1 tmtm? -62.81 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.603 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.69 -28.46 68.64 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.262 -0.899 . . . . 0.0 112.92 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.101 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.7 m . . . . . 0 N--CA 1.502 2.171 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.368 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 1.27 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 5.5 t . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.27 170.76 15.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.993 -1.067 . . . . 0.0 110.668 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.24 152.16 40.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.988 . . . . 0.0 110.833 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.27 -122.78 1.25 Allowed Glycine 0 N--CA 1.485 1.951 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 9' ' ' THR 0.294 91.5 m -155.77 26.75 0.38 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.32 -1.106 . . . . 0.0 110.57 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.43 -9.18 58.42 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.455 -1.403 . . . . 0.0 113.571 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.7 m -122.54 23.61 9.55 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.394 -0.816 . . . . 0.0 109.799 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.77 74.86 Favored Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.116 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 2.0 pttp -87.22 51.45 2.24 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.207 1.003 . . . . 0.0 111.944 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.02 114.68 3.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -24.55 22.46 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.323 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.691 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 6.7 mtmt -123.49 -146.1 0.35 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.515 -1.58 . . . . 0.0 109.554 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 54.6 m-85 -144.0 169.56 17.59 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 119.971 -1.705 . . . . 0.0 110.008 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.116 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 87.1 m -142.65 157.14 44.99 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.959 -1.713 . . . . 0.0 110.364 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.27 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 1.9 p . . . . . 0 C--N 1.304 -1.396 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.967 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.502 2.141 0 CA-C-O 121.037 0.446 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.67 HG12 ' CE1' ' A' ' 29' ' ' TYR . 70.8 t -114.31 115.58 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 22.9 m -116.24 164.04 15.1 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.342 1.068 . . . . 0.0 113.054 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.692 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.2 m-85 -147.88 170.29 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.61 -35.06 24.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 112.865 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.69 114.95 19.93 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.931 -1.106 . . . . 0.0 109.665 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 1.007 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -49.26 -35.22 17.1 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.56 -45.67 91.13 Favored 'General case' 0 C--O 1.197 -1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 109.085 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.731 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.4 mt -58.73 -26.15 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 O-C-N 120.466 -1.396 . . . . 0.0 109.052 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.007 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 14.7 t -59.49 -71.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -58.5 -51.1 71.28 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.028 -1.045 . . . . 0.0 111.158 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.659 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -60.78 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.659 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 48.7 m-80 -61.96 -33.08 73.63 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.902 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.7 m . . . . . 0 C--N 1.283 -2.316 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.35 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 121.597 0.713 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -137.9 165.47 26.43 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.87 152.31 40.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.33 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.33 -121.31 1.11 Allowed Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.472 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.0 m -154.88 23.16 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.308 -1.113 . . . . 0.0 110.948 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -74.13 -12.2 60.52 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.303 -1.498 . . . . 0.0 113.377 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.5 m -122.36 25.15 9.04 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 121.243 -0.911 . . . . 0.0 109.6 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.4 77.8 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 118.674 -1.727 . . . . 0.0 109.041 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.327 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.9 pttm -87.92 54.75 3.2 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.569 1.176 . . . . 0.0 110.768 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.49 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.15 -21.55 39.44 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.4 mtmp? -117.57 -145.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.712 -1.464 . . . . 0.0 109.252 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.5 m-85 -146.47 176.41 9.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 119.919 -1.738 . . . . 0.0 110.424 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.327 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 79.8 m -137.62 161.98 35.01 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.386 -1.446 . . . . 0.0 110.79 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.083 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.345 0 O-C-N 121.521 -0.737 . . . . 0.0 111.011 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.1 t . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 121.16 0.505 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.744 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.5 t -114.71 115.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.638 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.3 m -116.22 161.42 19.0 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.392 1.092 . . . . 0.0 113.469 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.779 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.2 m-85 -149.68 176.52 10.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.965 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.5 p30 -81.56 -42.46 20.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.141 -0.974 . . . . 0.0 111.85 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.73 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.28 116.11 20.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.093 -1.004 . . . . 0.0 108.603 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.855 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.0 ptpt -50.84 -34.55 28.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.7 -46.19 87.85 Favored 'General case' 0 C--O 1.199 -1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 108.868 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.779 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.84 25.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 O-C-N 120.736 -1.227 . . . . 0.0 109.357 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.124 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -60.78 -67.59 0.39 Allowed 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -54.62 -53.79 50.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.908 -1.12 . . . . 0.0 110.93 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -62.47 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.631 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.89 -28.71 69.09 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.262 -0.899 . . . . 0.0 112.886 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.124 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.1 m . . . . . 0 N--CA 1.502 2.167 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.36 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.4 t . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 121.897 0.856 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 38.4 p90 -136.62 167.12 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.52 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.31 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.66 -121.47 1.12 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.442 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.645 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 87.0 m -154.63 21.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -1.138 . . . . 0.0 111.241 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -75.34 -12.97 60.38 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.2 -1.562 . . . . 0.0 113.617 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.149 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.3 m -122.72 25.59 8.63 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.4 79.74 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 118.904 -1.617 . . . . 0.0 109.578 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.677 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.04 53.43 2.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.469 1.128 . . . . 0.0 111.037 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.53 107.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.64 -20.84 47.84 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.181 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 29.9 mtmt -118.17 -143.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.879 -1.365 . . . . 0.0 109.121 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.528 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 18.2 m-85 -146.06 176.31 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.844 -1.785 . . . . 0.0 110.45 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.677 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 90.1 m -136.77 164.03 29.23 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.428 -1.42 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.543 -0.723 . . . . 0.0 110.991 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 121.21 0.529 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.824 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.92 116.51 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.877 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 14.1 m -116.36 161.64 18.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.037 -1.039 . . . . 0.0 113.302 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.815 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.8 m-85 -149.02 176.45 10.44 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.4 p30 -81.98 -43.31 18.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.254 -0.903 . . . . 0.0 111.879 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.722 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.02 116.42 20.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.094 -1.004 . . . . 0.0 108.492 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -49.82 -35.54 23.26 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.02 -46.52 87.99 Favored 'General case' 0 C--O 1.2 -1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.009 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.815 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.96 -25.75 26.8 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 O-C-N 120.773 -1.204 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.099 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.8 t -60.4 -65.88 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -54.96 -54.66 39.91 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.913 -1.117 . . . . 0.0 110.841 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.4 tmtm? -62.84 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -59.88 -27.86 67.06 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.287 -0.883 . . . . 0.0 112.871 -176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.099 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.2 m . . . . . 0 N--CA 1.504 2.255 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.285 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.506 2.362 0 CA-C-O 121.813 0.816 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.82 166.04 24.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.45 149.79 43.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.627 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.404 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 153.37 -123.41 1.42 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.468 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 98.4 m -156.05 25.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.41 -1.053 . . . . 0.0 110.846 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -74.13 -8.8 57.47 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.373 -1.454 . . . . 0.0 113.562 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.788 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -125.77 27.02 6.52 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 121.33 -0.856 . . . . 0.0 109.726 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 15.34 76.92 Favored Glycine 0 C--N 1.291 -1.965 0 C-N-CA 118.508 -1.806 . . . . 0.0 108.723 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.258 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.41 53.21 2.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.351 1.072 . . . . 0.0 111.096 -178.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 9' ' ' THR . 44.4 t -67.19 109.58 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.4 -19.93 43.91 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.761 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 28.3 mtmt -118.6 -143.05 0.36 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.722 -1.458 . . . . 0.0 109.368 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.1 m-85 -145.79 173.75 11.83 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 119.976 -1.703 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.258 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 76.3 m -136.87 162.55 32.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.449 -1.407 . . . . 0.0 111.118 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.306 -1.308 0 O-C-N 121.458 -0.776 . . . . 0.0 110.846 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.504 2.247 0 CA-C-O 121.042 0.448 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.772 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 62.2 t -115.15 115.81 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.33 162.05 18.1 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.313 1.054 . . . . 0.0 113.091 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.807 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.6 175.79 10.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.945 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.9 p-10 -81.87 -42.34 19.71 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.177 -0.952 . . . . 0.0 112.071 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.17 117.01 21.35 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.973 -1.079 . . . . 0.0 108.905 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.808 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -50.02 -35.89 26.62 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.8 -46.27 87.99 Favored 'General case' 0 C--O 1.2 -1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.059 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.807 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.07 -25.51 26.57 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 O-C-N 120.658 -1.276 . . . . 0.0 109.44 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.039 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 27.2 t -60.94 -66.52 0.52 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -55.92 -54.03 49.65 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.748 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtt? -61.77 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.634 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.0 m-80 -60.67 -30.09 69.69 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.253 -0.904 . . . . 0.0 112.699 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.039 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 62.9 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.239 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.504 2.261 0 CA-C-O 121.44 0.638 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.485 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 25.0 p90 -138.26 163.27 32.2 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.04 153.69 39.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.455 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.57 -121.17 1.11 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.313 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 99.1 m -154.63 20.54 0.47 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 111.089 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -74.84 -9.77 58.86 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.336 -1.478 . . . . 0.0 113.351 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.982 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.2 m -124.24 24.09 8.18 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.397 -0.815 . . . . 0.0 109.856 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.51 18.44 77.07 Favored Glycine 0 C--N 1.29 -1.989 0 C-N-CA 118.495 -1.812 . . . . 0.0 108.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.205 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 22.5 pttt -87.92 51.22 2.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.443 1.116 . . . . 0.0 111.031 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.68 109.65 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.68 -21.16 41.63 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.263 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.0 mtmm -122.02 -145.15 0.35 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.394 . . . . 0.0 109.075 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 22.7 m-85 -145.76 177.41 8.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.829 -1.795 . . . . 0.0 110.35 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.205 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.2 m -137.09 161.08 37.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.344 -1.473 . . . . 0.0 110.58 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.142 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.761 . . . . 0.0 111.301 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 19.4 t . . . . . 0 N--CA 1.505 2.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.6 t -115.07 118.79 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.038 -1.039 . . . . 0.0 108.449 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 15.9 m -116.12 161.87 18.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.853 -1.154 . . . . 0.0 113.334 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.784 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 85.0 m-85 -148.56 175.27 11.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.929 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.5 p-10 -81.98 -42.58 19.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.869 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.749 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 114.74 20.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 108.664 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.2 ptmm? -49.44 -35.29 18.94 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.25 87.77 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.12 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.778 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.15 -26.26 24.88 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 O-C-N 120.675 -1.266 . . . . 0.0 109.389 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.175 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 t -60.69 -66.02 0.6 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -55.5 -54.18 47.11 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.707 -1.246 . . . . 0.0 110.645 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.0 tmtm? -63.19 -79.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.6 m-80 -60.88 -28.3 68.78 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.259 -0.901 . . . . 0.0 113.13 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.175 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.8 m . . . . . 0 C--N 1.286 -2.164 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.372 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.507 2.38 0 CA-C-O 121.618 0.723 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -137.94 165.01 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.97 152.15 41.16 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.458 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.87 -120.75 1.04 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.377 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.9 m -155.18 23.33 0.42 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.364 -1.08 . . . . 0.0 111.034 -177.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -73.93 -12.26 60.6 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.258 -1.526 . . . . 0.0 113.416 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.003 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -123.43 25.48 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.79 77.53 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 118.687 -1.721 . . . . 0.0 109.08 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.291 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 pttm -87.93 54.2 3.02 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.609 1.195 . . . . 0.0 110.801 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.71 108.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 -22.13 40.77 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.108 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 5.4 mtmp? -113.82 -147.42 0.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.908 -1.348 . . . . 0.0 108.768 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 21.2 m-85 -146.57 176.8 9.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.774 -1.829 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.291 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.5 m -137.48 162.14 34.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.491 -1.38 . . . . 0.0 111.072 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.865 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.1 p . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.621 -0.674 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 17.5 t . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 120.614 0.245 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.865 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 66.4 t -114.69 111.46 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.803 -1.186 . . . . 0.0 108.178 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.17 162.2 17.81 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.264 1.031 . . . . 0.0 113.367 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.777 ' CE1' HG12 ' A' ' 27' ' ' VAL . 84.2 m-85 -150.47 175.3 12.0 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.295 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.08 -41.26 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.885 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.72 115.54 21.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.092 -1.005 . . . . 0.0 109.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.818 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.5 ptpt -50.03 -35.08 23.52 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.52 -45.97 87.72 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 108.996 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.769 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.49 -25.63 24.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.005 0 O-C-N 120.621 -1.3 . . . . 0.0 109.336 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.844 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 25.5 t -61.55 -67.93 0.36 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.0 -53.03 60.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.766 -1.209 . . . . 0.0 110.696 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.1 tmtt? -61.85 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.639 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -61.63 -32.6 72.76 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.28 -0.888 . . . . 0.0 112.879 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.844 ' SG ' ' HA ' ' A' ' 35' ' ' CYS . 69.8 m . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.306 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.702 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 12.6 t . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.701 0.762 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.6 p90 -136.74 165.45 25.89 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.422 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 9.6 pt-20 -122.63 149.02 44.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.059 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.29 -119.66 0.96 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.449 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 93.9 m -155.14 20.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 111.599 -177.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -75.28 -12.26 60.24 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.133 -1.605 . . . . 0.0 113.546 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.084 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.5 m -123.0 25.29 8.62 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.58 17.49 79.1 Favored Glycine 0 C--N 1.29 -1.982 0 C-N-CA 118.823 -1.656 . . . . 0.0 109.396 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.68 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.4 pttt -87.34 51.7 2.3 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.45 1.119 . . . . 0.0 111.031 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.15 109.48 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.15 -21.95 39.73 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.213 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.791 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 38.4 mtmt -123.23 -142.2 0.32 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.418 . . . . 0.0 109.227 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 9.8 m-85 -146.15 176.86 9.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.914 -1.741 . . . . 0.0 110.562 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.68 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 86.3 m -136.72 163.3 30.92 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.432 -1.417 . . . . 0.0 110.882 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.088 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.401 0 O-C-N 121.613 -0.679 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.786 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.84 121.29 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 11.2 m -116.27 160.99 19.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.029 -1.069 . . . . 0.0 113.493 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.5 m-85 -148.9 177.77 9.26 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.915 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.75 -43.75 17.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.699 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.717 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.12 116.42 21.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.014 -1.054 . . . . 0.0 108.338 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.883 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.41 -34.8 25.73 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.48 -46.31 89.16 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 108.948 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.68 -26.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.722 -1.236 . . . . 0.0 109.424 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.154 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -60.55 -67.4 0.4 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -55.0 -53.45 55.57 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.82 -1.175 . . . . 0.0 110.821 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.12 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.2 m-80 -60.69 -26.94 67.49 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.375 -0.828 . . . . 0.0 112.955 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.154 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.8 m . . . . . 0 N--CA 1.502 2.146 0 C-N-CA 118.689 -1.205 . . . . 0.0 111.046 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.507 2.405 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' HE1' ' HZ2' ' A' ' 13' ' ' LYS . 39.7 p90 -138.68 166.97 22.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 109.4 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -122.95 151.88 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.898 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.88 -119.96 0.97 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.482 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 91.7 m -155.01 23.89 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.23 -1.159 . . . . 0.0 111.155 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -73.32 -14.08 61.23 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.235 -1.54 . . . . 0.0 113.201 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -122.36 24.51 9.31 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 17.93 77.18 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 118.637 -1.744 . . . . 0.0 108.979 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.271 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 10.7 pttm -88.12 51.67 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.407 1.098 . . . . 0.0 111.338 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 9' ' ' THR . 38.2 t -67.27 111.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.81 -24.45 29.54 Favored Glycine 0 N--CA 1.498 2.832 0 C-N-CA 119.239 -1.457 . . . . 0.0 109.856 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 12.9 mtmt -118.38 -146.81 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.78 -1.423 . . . . 0.0 108.838 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 15.9 m-85 -146.95 176.77 9.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 119.836 -1.79 . . . . 0.0 110.319 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.271 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.05 161.63 35.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.428 -1.42 . . . . 0.0 110.79 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.08 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 121.499 0.666 . . . . 0.0 110.423 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 120.657 0.265 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.907 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.5 t -114.58 112.96 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.797 -1.189 . . . . 0.0 108.096 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 16.8 m -116.13 161.61 18.67 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.417 1.103 . . . . 0.0 113.667 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.801 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.1 m-85 -149.92 176.94 10.3 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.009 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.98 -42.9 18.74 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.687 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.47 117.22 21.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.042 -1.036 . . . . 0.0 108.872 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.867 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -50.87 -35.71 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.54 -45.96 87.8 Favored 'General case' 0 C--O 1.201 -1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 108.909 176.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.801 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.85 -25.92 26.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.936 0 O-C-N 120.736 -1.227 . . . . 0.0 109.29 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.11 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.2 t -60.18 -66.23 0.56 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.99 -54.48 42.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.907 -1.121 . . . . 0.0 110.881 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.26 -79.34 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.2 m-80 -59.82 -28.68 67.67 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.269 -0.895 . . . . 0.0 112.852 -176.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.11 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 118.611 -1.235 . . . . 0.0 111.412 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.505 2.286 0 CA-C-O 121.871 0.843 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -138.39 166.93 23.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.78 151.75 41.32 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.901 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.96 -119.76 0.95 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.546 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 98.1 m -155.38 23.99 0.41 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.152 -1.205 . . . . 0.0 111.334 -177.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.27 -14.36 61.31 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.213 -1.554 . . . . 0.0 113.33 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.0 m -121.5 24.37 9.9 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.52 77.07 Favored Glycine 0 C--N 1.29 -1.986 0 C-N-CA 118.535 -1.793 . . . . 0.0 108.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.289 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.4 pttm -87.59 52.07 2.39 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.474 1.131 . . . . 0.0 111.111 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t -66.88 111.36 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.76 31.14 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.009 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 40.7 mtmt -119.51 -146.32 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.415 . . . . 0.0 108.972 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -146.11 175.91 10.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 119.901 -1.749 . . . . 0.0 110.256 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 64.7 m -137.37 160.67 38.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.388 -1.445 . . . . 0.0 111.322 -178.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.309 0 O-C-N 121.681 -0.637 . . . . 0.0 110.676 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.0 t . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.794 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.54 114.71 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.796 -1.19 . . . . 0.0 108.751 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.5 m -116.0 161.36 18.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.157 0.979 . . . . 0.0 112.988 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CE1' HG12 ' A' ' 27' ' ' VAL . 88.3 m-85 -149.55 174.69 12.24 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.086 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.75 -41.39 21.29 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.811 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.728 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.22 114.95 20.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.045 -1.034 . . . . 0.0 108.658 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.853 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -50.0 -34.7 21.97 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.93 -46.41 88.02 Favored 'General case' 0 C--O 1.199 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.023 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.3 -26.29 25.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 120.596 -1.315 . . . . 0.0 109.376 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.137 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -61.27 -67.67 0.38 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -55.03 -53.06 60.68 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.747 -1.221 . . . . 0.0 110.737 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -62.33 -79.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -60.85 -29.73 69.69 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.268 -0.895 . . . . 0.0 112.839 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.137 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.0 m . . . . . 0 C--N 1.287 -2.129 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.404 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.4 t . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 121.788 0.804 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 36.0 p90 -138.29 167.27 22.22 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.9 pt-20 -122.57 153.3 39.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.764 -1.21 . . . . 0.0 111.553 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.14 -120.68 1.07 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.142 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 99.4 m -154.97 20.3 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -1.121 . . . . 0.0 111.275 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -75.25 -10.59 59.6 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.279 -1.513 . . . . 0.0 113.712 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.051 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.3 m -123.82 25.19 8.13 Favored 'General case' 0 C--N 1.284 -2.28 0 O-C-N 121.275 -0.89 . . . . 0.0 109.803 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.64 17.88 78.3 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 118.711 -1.709 . . . . 0.0 109.19 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.268 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 21.2 pttt -88.22 51.11 2.11 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.463 1.125 . . . . 0.0 111.133 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.88 109.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.27 -21.03 42.82 Favored Glycine 0 N--CA 1.5 2.907 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.29 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.793 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.8 mtmt -123.75 -142.65 0.32 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.411 . . . . 0.0 109.187 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.6 m-85 -145.21 177.63 8.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.777 -1.827 . . . . 0.0 110.5 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.268 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 92.9 m -137.5 163.78 30.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.513 -1.367 . . . . 0.0 110.998 -178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.555 -0.716 . . . . 0.0 111.276 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 121.141 0.496 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.823 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.9 t -114.94 120.31 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 13.6 m -116.19 161.01 19.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.955 -1.09 . . . . 0.0 113.36 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.803 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.6 m-85 -148.84 177.89 9.15 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.029 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.12 -44.01 17.06 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -0.973 . . . . 0.0 111.689 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.92 116.27 20.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.014 -1.054 . . . . 0.0 108.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.29 -34.79 24.66 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.3 -46.42 88.62 Favored 'General case' 0 C--O 1.2 -1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.981 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.66 -26.14 26.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.796 -1.19 . . . . 0.0 109.444 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.136 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.6 t -60.42 -65.62 0.66 Allowed 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -55.87 -54.47 44.2 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.615 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.4 tmtm? -62.85 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.672 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.1 m-80 -60.51 -27.24 67.45 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.269 -0.894 . . . . 0.0 112.991 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.136 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.5 m . . . . . 0 N--CA 1.504 2.245 0 C-N-CA 118.575 -1.25 . . . . 0.0 111.244 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.506 2.349 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -138.16 166.53 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.1 pt-20 -122.95 149.56 44.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.789 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.21 -118.77 0.86 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.984 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 96.6 m -154.88 22.87 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 111.47 -177.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -73.48 -14.63 61.27 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.1 -1.625 . . . . 0.0 113.228 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 25.1 m -122.1 24.94 9.29 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.96 76.41 Favored Glycine 0 C--N 1.289 -2.064 0 C-N-CA 118.306 -1.902 . . . . 0.0 108.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.301 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 pttt -86.86 50.7 2.06 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.456 1.122 . . . . 0.0 110.871 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -67.47 110.76 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.41 -22.72 36.61 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 8.9 mttm -119.61 -147.61 0.4 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.759 -1.436 . . . . 0.0 108.806 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.1 m-85 -146.88 175.49 10.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.777 . . . . 0.0 110.256 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.301 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 80.1 m -137.66 160.99 37.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.307 -1.496 . . . . 0.0 111.559 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.307 -1.278 0 O-C-N 121.697 -0.627 . . . . 0.0 110.574 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 15.5 t . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 120.507 0.194 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.791 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.9 t -114.26 114.89 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.681 -1.262 . . . . 0.0 108.649 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 19.6 m -116.0 162.38 17.46 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.352 1.073 . . . . 0.0 113.45 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.784 ' CG ' HG22 ' A' ' 34' ' ' ILE . 80.6 m-85 -148.65 175.08 11.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.804 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CB ' ' HD3' ' A' ' 16' ' ' LYS . 1.9 p-10 -82.06 -42.36 19.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.002 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.705 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.32 118.37 22.58 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.104 -0.997 . . . . 0.0 108.927 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.849 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.0 ptpt -51.04 -35.72 35.86 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.2 -45.99 89.64 Favored 'General case' 0 C--O 1.2 -1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.281 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.784 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -58.13 -26.36 29.1 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 O-C-N 120.651 -1.281 . . . . 0.0 109.418 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.105 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.5 t -60.9 -66.96 0.45 Allowed 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -55.2 -53.37 56.89 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.839 -1.163 . . . . 0.0 110.62 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.84 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -59.95 -29.09 68.17 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 121.302 -0.874 . . . . 0.0 112.705 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.105 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.0 m . . . . . 0 N--CA 1.503 2.198 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.3 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.509 2.484 0 CA-C-O 122.037 0.923 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -137.15 166.41 23.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -122.88 150.69 42.56 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.014 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.3 -120.06 0.99 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 97.1 m -155.51 24.19 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.258 -1.142 . . . . 0.0 111.141 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.95 -12.3 60.61 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.237 -1.54 . . . . 0.0 113.466 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.065 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.2 m -122.55 25.29 8.87 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-O 121.818 0.818 . . . . 0.0 109.57 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.79 78.4 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.671 -1.728 . . . . 0.0 109.222 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -87.06 56.5 4.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.64 1.21 . . . . 0.0 110.429 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.89 107.72 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.19 51.71 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.447 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.752 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 31.2 mtmt -116.59 -145.8 0.39 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.757 -1.437 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 16.4 m-85 -146.55 176.06 10.11 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.893 -1.754 . . . . 0.0 110.705 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.625 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 57.5 m -136.46 160.81 37.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.439 -1.413 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.066 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.506 2.35 0 CA-C-O 120.699 0.285 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.832 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.5 t -114.72 110.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.759 -1.213 . . . . 0.0 108.23 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.7 m -116.19 161.41 19.0 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.201 1.0 . . . . 0.0 113.435 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.771 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.3 m-85 -150.55 176.76 10.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.417 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 4.3 p-10 -82.04 -42.53 19.14 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.987 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.769 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.77 116.26 21.38 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.961 -1.087 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.5 ptpt -50.55 -34.88 27.24 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.22 -45.88 86.88 Favored 'General case' 0 C--O 1.2 -1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.759 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.769 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.51 -25.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 O-C-N 120.681 -1.262 . . . . 0.0 109.263 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.066 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.0 t -61.13 -68.48 0.31 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -54.06 -53.64 50.33 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.896 -1.127 . . . . 0.0 110.846 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.22 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.628 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.8 m-80 -62.21 -29.66 70.54 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.291 -0.881 . . . . 0.0 113.182 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.048 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 73.8 m . . . . . 0 N--CA 1.504 2.244 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.309 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.793 0.806 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.6 p90 -135.85 164.76 27.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.58 149.81 43.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.476 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.15 -122.3 1.27 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.286 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.707 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.4 m -155.95 25.82 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.19 . . . . 0.0 110.989 -177.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -73.47 -8.88 57.74 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.359 -1.463 . . . . 0.0 113.414 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.7 m -126.08 26.28 6.55 Favored 'General case' 0 C--N 1.282 -2.368 0 O-C-N 121.402 -0.812 . . . . 0.0 109.833 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.07 75.68 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 118.434 -1.841 . . . . 0.0 108.714 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.226 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.38 51.7 2.3 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.189 0.995 . . . . 0.0 111.465 -178.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 9' ' ' THR . 40.2 t -67.14 111.81 2.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.78 -22.41 33.84 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.6 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmt -120.19 -143.15 0.35 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.559 -1.553 . . . . 0.0 109.348 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.56 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.6 m-85 -145.56 174.1 11.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.013 -1.679 . . . . 0.0 110.172 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.226 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 88.1 m -136.85 162.47 33.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.403 -1.435 . . . . 0.0 111.003 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.907 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.6 -0.687 . . . . 0.0 110.957 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 121.053 0.454 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.745 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.09 116.28 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.19 -0.943 . . . . 0.0 108.462 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.3 m -116.21 161.84 18.36 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.057 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.797 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.3 m-85 -148.37 175.14 11.35 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.927 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.4 p-10 -81.97 -42.46 19.36 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.947 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.97 116.57 21.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.011 -1.055 . . . . 0.0 108.764 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.8 ptpt -49.59 -35.97 22.56 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.23 -46.16 89.22 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.127 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.797 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.94 -26.02 27.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 O-C-N 120.769 -1.207 . . . . 0.0 109.455 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.107 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 24.6 t -60.87 -66.29 0.56 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -55.75 -54.0 49.78 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.618 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.8 tmtm? -62.7 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.631 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.5 m-80 -60.6 -28.15 68.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.283 -0.886 . . . . 0.0 113.031 -176.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.107 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.8 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.216 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.835 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 9.4 t . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 121.869 0.842 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 32.8 p90 -135.06 166.4 23.13 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.03 149.23 43.81 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.321 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 150.65 -122.23 1.35 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.8 m -156.23 23.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -1.103 . . . . 0.0 111.117 -177.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.31 -7.53 54.2 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.3 -1.5 . . . . 0.0 113.801 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.997 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.7 m -125.95 27.03 6.45 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.46 15.62 77.36 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 118.595 -1.764 . . . . 0.0 108.819 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.287 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.98 50.95 2.08 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.163 0.982 . . . . 0.0 111.461 -178.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 9' ' ' THR . 39.3 t -67.46 110.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.09 -20.56 40.31 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.836 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 21.9 mtmt -124.08 -139.04 0.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.597 -1.531 . . . . 0.0 109.425 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.586 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -144.33 174.1 11.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 119.844 -1.785 . . . . 0.0 110.052 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.287 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 99.5 m -135.05 163.13 30.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.54 -1.35 . . . . 0.0 110.842 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.097 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.531 -0.731 . . . . 0.0 110.922 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.502 2.151 0 CA-C-O 121.075 0.464 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.829 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.7 t -115.17 118.88 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.226 -0.921 . . . . 0.0 108.835 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.8 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.8 m -116.27 161.15 19.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 113.464 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.802 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.3 m-85 -148.81 177.48 9.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.95 -43.82 17.58 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.222 -0.924 . . . . 0.0 111.867 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.24 116.43 21.11 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.996 -1.065 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.815 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.5 ptpt -50.01 -35.23 23.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.06 -46.44 88.23 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.167 -0.958 . . . . 0.0 108.88 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.802 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.62 -25.66 25.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 O-C-N 120.82 -1.175 . . . . 0.0 109.358 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.097 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.6 t -60.08 -65.64 0.65 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 5' ' ' CYS . 49.5 m-20 -55.29 -55.36 32.29 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.89 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.2 tmtm? -62.32 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.6 m-80 -60.33 -28.11 67.88 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.298 -0.876 . . . . 0.0 113.037 -176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.094 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 55.7 m . . . . . 0 N--CA 1.503 2.215 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.295 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.5 t . . . . . 0 N--CA 1.505 2.302 0 CA-C-O 121.75 0.786 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 30.8 p90 -136.95 163.32 30.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.7 pt-20 -123.11 148.93 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.186 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.47 -119.64 0.94 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.67 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.689 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 98.1 m -154.67 21.58 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -1.139 . . . . 0.0 111.285 -177.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -74.63 -11.49 60.2 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.251 -1.531 . . . . 0.0 113.399 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -124.33 25.87 7.56 Favored 'General case' 0 C--N 1.283 -2.289 0 O-C-N 121.4 -0.812 . . . . 0.0 109.772 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.05 76.49 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 118.536 -1.792 . . . . 0.0 108.883 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.429 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 pttt -87.45 51.27 2.18 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.464 1.126 . . . . 0.0 110.788 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 109.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.12 -23.12 35.54 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.961 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.6 mtmt -119.08 -145.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.43 . . . . 0.0 108.936 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.5 m-85 -146.69 176.63 9.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.779 -1.826 . . . . 0.0 110.493 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.429 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 97.2 m -137.46 161.74 35.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.499 -1.376 . . . . 0.0 110.611 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.068 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.411 0 O-C-N 121.427 -0.795 . . . . 0.0 110.993 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.501 2.122 0 CA-C-O 120.986 0.422 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.717 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -114.93 117.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.22 161.8 18.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.898 -1.127 . . . . 0.0 113.865 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.1 m-85 -149.44 176.79 10.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.843 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.91 -42.83 18.96 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.786 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.736 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.26 116.28 21.05 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.06 -1.025 . . . . 0.0 108.716 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.0 ptmm? -50.27 -35.7 28.25 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.84 89.1 Favored 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.059 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.773 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.65 -25.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 O-C-N 120.716 -1.24 . . . . 0.0 109.408 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.113 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.1 t -60.66 -67.87 0.36 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -55.1 -53.59 53.98 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.925 -1.109 . . . . 0.0 110.863 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.4 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.597 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.16 -29.41 68.65 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.218 -0.926 . . . . 0.0 112.768 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.113 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m . . . . . 0 N--CA 1.502 2.144 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.229 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.506 2.349 0 CA-C-O 121.696 0.76 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 30.5 p90 -137.92 164.45 28.96 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 6.5 pt-20 -122.94 149.49 44.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.92 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.35 -119.92 0.96 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.881 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.701 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.2 m -155.1 21.84 0.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 111.415 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.79 -12.46 60.4 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.284 -1.51 . . . . 0.0 113.63 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.904 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -124.16 26.3 7.51 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.15 17.83 77.56 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 118.497 -1.811 . . . . 0.0 108.888 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.298 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 4.0 pttt -87.39 50.09 1.94 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.403 1.096 . . . . 0.0 110.9 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.64 109.91 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.54 -22.78 37.45 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.02 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 37.3 mtmt -119.81 -145.05 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.86 -1.377 . . . . 0.0 108.82 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.9 m-85 -146.38 175.71 10.33 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 119.849 -1.782 . . . . 0.0 110.483 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.298 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 88.4 m -138.79 162.2 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.453 -1.404 . . . . 0.0 110.816 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 110.882 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.742 HG12 ' CE1' ' A' ' 29' ' ' TYR . 91.5 t -114.91 118.02 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.5 m -116.31 162.06 18.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.986 -1.085 . . . . 0.0 113.182 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.7 m-85 -148.74 174.33 12.3 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -81.74 -41.42 21.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.764 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.741 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 115.49 20.54 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.047 -1.033 . . . . 0.0 108.636 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.4 ptpt -49.58 -35.74 21.71 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.407 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -45.84 89.92 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 121.395 -0.815 . . . . 0.0 109.201 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.82 -26.18 27.39 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.951 0 O-C-N 120.637 -1.289 . . . . 0.0 109.445 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.093 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.2 t -61.4 -68.91 0.27 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -54.86 -52.5 62.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.855 -1.153 . . . . 0.0 110.868 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.54 -79.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.1 m-80 -60.98 -29.22 69.55 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.197 -0.939 . . . . 0.0 112.812 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.093 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.9 m . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.254 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.506 2.372 0 CA-C-O 121.666 0.746 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 24.4 p90 -138.97 162.87 33.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -123.33 153.5 40.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.84 -1.162 . . . . 0.0 111.601 -177.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.76 -120.89 1.06 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.608 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 9' ' ' THR 0.283 92.8 m -154.01 19.19 0.51 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -1.145 . . . . 0.0 111.238 -177.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.492 ' H ' ' HZ1' ' A' ' 13' ' ' LYS . 17.9 t30 -73.92 -12.89 60.79 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.313 -1.492 . . . . 0.0 113.199 -177.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.971 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.0 m -122.71 23.92 9.31 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.363 -0.835 . . . . 0.0 109.569 178.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.36 77.77 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 118.556 -1.783 . . . . 0.0 109.111 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.424 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.2 pttm -87.2 51.78 2.33 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.509 1.147 . . . . 0.0 111.097 -178.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.49 108.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 -21.65 42.43 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.186 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.729 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.6 mtmm -121.0 -146.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.819 -1.401 . . . . 0.0 108.901 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.5 m-85 -146.67 177.38 9.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.808 -1.807 . . . . 0.0 110.666 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.424 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 96.8 m -138.14 161.37 36.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.513 -1.367 . . . . 0.0 110.656 -178.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.389 -0.82 . . . . 0.0 111.18 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.7 t . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.724 HG12 ' CE1' ' A' ' 29' ' ' TYR . 63.8 t -115.0 117.7 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.049 -1.032 . . . . 0.0 108.258 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 17.6 m -116.23 161.95 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.381 -176.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.781 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.1 m-85 -149.24 175.04 11.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.868 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.92 -42.12 19.93 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.218 -0.926 . . . . 0.0 111.865 178.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.36 115.3 20.65 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.064 -1.023 . . . . 0.0 108.85 179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.6 ptpt -49.77 -35.14 21.42 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.58 -46.48 86.86 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.945 176.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.39 -25.74 24.64 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 O-C-N 120.763 -1.21 . . . . 0.0 109.378 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.116 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 t -60.78 -66.1 0.58 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -55.44 -54.31 45.42 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.86 -1.15 . . . . 0.0 110.664 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtm? -62.26 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -59.93 -30.09 68.82 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.267 -0.896 . . . . 0.0 112.816 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.116 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 83.1 m . . . . . 0 N--CA 1.502 2.16 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.383 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.507 2.392 0 CA-C-O 121.892 0.853 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 30.4 p90 -136.09 168.9 18.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.63 145.59 48.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.694 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.94 -118.17 0.83 Allowed Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.605 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.72 ' O ' HG22 ' A' ' 9' ' ' THR 0.297 54.9 m -158.04 32.7 0.25 Allowed 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.251 -1.147 . . . . 0.0 110.276 -177.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -68.79 -7.96 38.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.084 -1.635 . . . . 0.0 112.529 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.7 m -120.49 23.67 10.73 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.966 0.889 . . . . 0.0 108.637 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.27 83.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.137 178.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.087 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -93.78 71.62 4.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.842 1.306 . . . . 0.0 112.667 -178.681 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.6 t -64.27 116.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.599 177.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.85 -25.94 17.31 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.756 -1.687 . . . . 0.0 111.674 178.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.861 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 16.1 mttt -108.47 -146.33 0.4 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 120.371 2.085 . . . . 0.0 109.497 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.891 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 11.3 m-85 -146.4 169.37 19.01 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 119.437 -2.04 . . . . 0.0 111.487 -178.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.087 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 50.0 m -137.43 161.57 35.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.806 -1.809 . . . . 0.0 112.619 -178.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.078 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.308 -1.237 0 CA-C-O 121.366 0.603 . . . . 0.0 109.641 179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.078 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 t -113.48 105.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.7 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 24.5 m -116.11 163.98 15.14 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.313 1.054 . . . . 0.0 113.545 -175.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.834 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.1 m-85 -150.08 176.65 10.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -82.54 -41.73 19.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.035 -1.041 . . . . 0.0 111.635 178.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.91 118.8 22.72 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.007 -1.058 . . . . 0.0 108.863 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.852 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.2 ptpt -50.65 -37.12 38.99 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.29 -45.27 91.73 Favored 'General case' 0 C--O 1.198 -1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 109.265 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.834 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.39 -26.06 29.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 120.659 -1.276 . . . . 0.0 109.31 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.971 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 5.2 t -61.85 -70.28 0.2 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -54.71 -51.48 65.44 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.958 -1.089 . . . . 0.0 110.585 178.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.6 tmtm? -62.3 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.6 m-80 -61.45 -29.36 69.9 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.209 -0.932 . . . . 0.0 112.825 -177.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.971 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.8 m . . . . . 0 N--CA 1.505 2.307 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.08 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.793 0.806 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -137.55 164.6 28.33 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 8.0 pt-20 -123.17 149.27 44.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.746 -1.181 . . . . 0.0 110.801 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.99 -119.45 0.92 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.918 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.674 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 89.4 m -155.02 22.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -1.144 . . . . 0.0 111.514 -177.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -73.99 -12.61 60.69 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.185 -1.572 . . . . 0.0 113.333 -177.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -123.19 25.08 8.59 Favored 'General case' 0 C--N 1.281 -2.37 0 O-C-N 121.431 -0.793 . . . . 0.0 109.645 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.01 76.55 Favored Glycine 0 C--N 1.29 -2.018 0 C-N-CA 118.491 -1.814 . . . . 0.0 108.68 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.324 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 pttt -87.32 51.47 2.24 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.42 1.105 . . . . 0.0 110.927 -178.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.51 109.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.63 37.65 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.75 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 23.3 mtmt -118.52 -147.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.808 -1.407 . . . . 0.0 108.892 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.0 m-85 -147.3 176.51 9.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.852 -1.78 . . . . 0.0 110.232 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.324 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 81.5 m -136.4 162.23 33.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.515 -1.366 . . . . 0.0 111.341 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.985 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.305 -1.341 0 O-C-N 121.712 -0.617 . . . . 0.0 110.584 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.4 t . . . . . 0 N--CA 1.509 2.5 0 CA-C-O 120.446 0.165 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.855 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.23 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.63 -1.294 . . . . 0.0 108.595 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.4 m -116.03 162.01 18.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.315 1.055 . . . . 0.0 113.79 -176.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.799 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.1 m-85 -149.28 176.64 10.36 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.3 p-10 -82.22 -43.24 17.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.236 -0.915 . . . . 0.0 111.933 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.09 117.62 21.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.105 -0.997 . . . . 0.0 108.848 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.878 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 17.0 ptpt -50.26 -35.82 28.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.55 -45.94 90.33 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.157 176.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.87 -26.01 27.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.717 -1.239 . . . . 0.0 109.333 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.152 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -60.56 -68.0 0.34 Allowed 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -54.85 -53.47 54.94 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.752 -1.217 . . . . 0.0 110.952 177.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.15 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.9 m-80 -60.32 -29.32 68.79 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 112.772 -176.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.152 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 71.0 m . . . . . 0 N--CA 1.504 2.236 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.272 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 121.868 0.842 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.5 165.73 24.84 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.45 149.77 43.39 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.67 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 152.97 -124.13 1.55 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.4 m -155.44 25.35 0.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.82 -177.826 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -74.05 -7.44 52.49 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.326 -1.484 . . . . 0.0 113.522 -176.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.831 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m -127.64 27.18 5.82 Favored 'General case' 0 C--N 1.284 -2.253 0 O-C-N 121.281 -0.887 . . . . 0.0 109.809 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.45 15.04 77.26 Favored Glycine 0 C--N 1.291 -1.933 0 C-N-CA 118.56 -1.781 . . . . 0.0 108.848 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.278 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.64 52.7 2.56 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.229 1.014 . . . . 0.0 111.298 -178.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 9' ' ' THR . 44.5 t -67.44 109.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.3 -20.63 44.2 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.801 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.771 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.8 mtmt -117.41 -143.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.709 -1.465 . . . . 0.0 109.169 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.555 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.8 m-85 -145.66 173.85 11.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 119.875 -1.766 . . . . 0.0 110.179 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.278 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -136.48 163.18 31.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.451 -1.406 . . . . 0.0 111.024 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.819 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p . . . . . 0 C--N 1.304 -1.403 0 O-C-N 121.529 -0.732 . . . . 0.0 110.799 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.504 2.236 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.819 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.0 t -115.14 115.51 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.37 161.99 18.22 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.304 1.049 . . . . 0.0 113.325 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.804 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.4 m-85 -148.74 175.82 10.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.048 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.412 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -82.36 -42.59 18.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.204 -0.935 . . . . 0.0 112.066 178.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.66 116.56 20.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.003 -1.06 . . . . 0.0 108.573 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.828 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 1.1 ptpp? -49.71 -35.85 23.29 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -46.15 89.12 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.094 176.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.804 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.16 -26.12 28.53 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.726 -1.234 . . . . 0.0 109.386 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.061 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -60.34 -65.82 0.62 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -56.45 -54.11 49.58 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.697 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -62.36 -79.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -177.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.75 -28.53 68.77 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.29 -0.881 . . . . 0.0 112.962 -176.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.061 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.2 m . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.251 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 121.646 0.736 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -137.3 166.97 22.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.84 153.03 40.14 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.113 -177.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.48 -121.28 1.11 Allowed Glycine 0 N--CA 1.487 2.082 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.484 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -155.19 22.32 0.43 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.339 -1.095 . . . . 0.0 111.057 -177.874 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -73.89 -13.41 60.9 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.316 -1.49 . . . . 0.0 113.355 -177.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.062 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -122.32 25.42 8.94 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 121.365 -0.834 . . . . 0.0 109.457 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.78 16.61 78.02 Favored Glycine 0 C--N 1.291 -1.947 0 C-N-CA 118.673 -1.727 . . . . 0.0 109.112 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.277 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pttm -88.03 52.94 2.59 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.483 1.135 . . . . 0.0 110.986 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 HG23 ' A' ' 9' ' ' THR . 38.8 t -67.1 108.92 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.11 -22.38 39.56 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.997 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.6 mtmt -115.54 -146.36 0.4 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.743 -1.445 . . . . 0.0 108.83 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.543 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.6 m-85 -146.82 177.06 9.41 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 119.824 -1.798 . . . . 0.0 110.633 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.277 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.0 160.4 39.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.379 -1.45 . . . . 0.0 110.755 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.104 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.304 -1.393 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.6 t . . . . . 0 N--CA 1.509 2.496 0 CA-C-O 120.588 0.233 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.8 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 t -114.75 114.03 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.809 -1.182 . . . . 0.0 108.48 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.764 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.4 m -115.96 161.45 18.82 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.256 1.027 . . . . 0.0 113.218 -176.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.782 ' CE1' HG12 ' A' ' 27' ' ' VAL . 87.3 m-85 -149.9 176.49 10.7 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.265 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.5 p-10 -82.12 -42.15 19.52 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.238 -0.914 . . . . 0.0 111.833 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.746 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.42 114.99 20.54 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.043 -1.035 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 10.1 ptmt -50.21 -35.03 24.85 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.11 87.01 Favored 'General case' 0 C--O 1.2 -1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 108.879 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.771 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.16 -25.67 23.58 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 120.635 -1.291 . . . . 0.0 109.389 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.125 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 t -60.55 -66.88 0.46 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.01 -54.26 45.22 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.817 -1.177 . . . . 0.0 111.088 177.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.3 tmtm? -62.04 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -60.99 -30.31 70.2 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.185 -0.947 . . . . 0.0 112.818 -176.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.125 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 95.6 m . . . . . 0 C--N 1.286 -2.182 0 C-N-CA 118.696 -1.202 . . . . 0.0 111.338 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.504 2.258 0 CA-C-O 121.828 0.823 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -137.49 166.28 24.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.87 152.17 41.01 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.284 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.06 -120.16 0.99 Allowed Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.534 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.6 m -155.28 23.59 0.42 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 111.235 -177.817 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.45 -14.52 61.26 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 120.217 -1.552 . . . . 0.0 113.257 -177.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.2 m -121.66 25.07 9.48 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 121.361 -0.837 . . . . 0.0 109.475 177.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.17 17.26 77.22 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.283 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.7 pttm -87.69 53.08 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.582 1.182 . . . . 0.0 110.885 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 9' ' ' THR . 25.8 t -67.32 109.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.95 -22.94 36.36 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.912 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.0 mtmt -115.24 -148.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.859 -1.377 . . . . 0.0 108.668 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.4 m-85 -146.68 175.91 10.25 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 119.83 -1.794 . . . . 0.0 110.455 -179.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.283 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 63.0 m -137.16 160.94 37.53 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.359 -1.463 . . . . 0.0 111.369 -178.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.879 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.743 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.505 2.302 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.784 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.9 t -114.36 112.87 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.831 -1.168 . . . . 0.0 108.435 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.3 m -116.13 161.96 18.15 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.217 1.008 . . . . 0.0 113.0 -176.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.3 m-85 -149.62 174.08 12.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.14 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.63 -41.19 21.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 111.939 178.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.46 115.09 20.62 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.085 -1.009 . . . . 0.0 108.729 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.81 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.3 ptpt -49.92 -34.97 22.15 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.65 -46.2 87.66 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 176.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.45 24.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 O-C-N 120.606 -1.309 . . . . 0.0 109.382 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.055 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 34.3 t -61.26 -66.66 0.5 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -55.04 -54.14 46.86 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.843 -1.161 . . . . 0.0 110.734 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.66 -79.09 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 51.1 m-80 -60.84 -31.13 70.57 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.278 -0.889 . . . . 0.0 112.869 -176.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.055 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 98.0 m . . . . . 0 N--CA 1.502 2.136 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.228 -178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.505 2.301 0 CA-C-O 121.703 0.763 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -137.04 163.42 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.4 pt-20 -123.09 149.45 44.46 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.939 -1.105 . . . . 0.0 111.084 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.46 -120.07 0.97 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.767 179.204 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 95.1 m -154.78 21.76 0.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.158 . . . . 0.0 111.283 -177.529 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.288 -1.507 . . . . 0.0 113.462 -177.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.8 m -124.26 25.66 7.68 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 178.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.64 17.62 76.66 Favored Glycine 0 C--N 1.29 -1.984 0 C-N-CA 118.38 -1.867 . . . . 0.0 108.694 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.332 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.8 pttt -87.68 51.2 2.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.547 1.165 . . . . 0.0 110.852 -178.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -67.23 108.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.21 -22.31 38.34 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.069 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmp? -119.0 -146.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.753 -1.439 . . . . 0.0 108.866 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.8 m-85 -146.77 176.15 10.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 119.856 -1.778 . . . . 0.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.332 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 92.8 m -137.29 161.89 35.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.389 -1.445 . . . . 0.0 110.802 -178.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.041 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.806 . . . . 0.0 111.123 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 121.116 0.484 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 83.4 t -114.94 117.6 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.1 m -116.22 161.86 18.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.895 -1.128 . . . . 0.0 113.474 -176.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.796 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.64 175.17 11.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.845 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.3 p-10 -81.8 -42.33 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.811 178.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.34 116.49 21.2 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.008 -1.058 . . . . 0.0 108.774 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.2 ptpt -50.23 -35.51 27.06 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.95 -46.16 88.7 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 109.047 176.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.796 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.72 -26.04 26.63 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.139 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.4 t -60.83 -67.58 0.39 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.78 -53.51 54.17 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.843 -1.161 . . . . 0.0 110.855 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -62.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.605 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.32 -0.863 . . . . 0.0 113.032 -176.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.139 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.4 m . . . . . 0 N--CA 1.503 2.18 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.353 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 39.2 t . . . . . 0 N--CA 1.509 2.478 0 CA-C-O 121.701 0.762 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.9 p90 -137.29 162.72 32.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.2 149.08 45.11 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.015 -1.053 . . . . 0.0 110.772 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.82 -121.84 1.16 Allowed Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.504 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 98.1 m -155.74 28.72 0.37 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.489 -1.007 . . . . 0.0 110.288 -177.861 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -71.36 -12.27 61.34 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.516 -1.365 . . . . 0.0 112.79 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -117.27 21.98 12.78 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.59 15.24 77.6 Favored Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -92.28 61.25 3.84 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.37 1.081 . . . . 0.0 112.428 -177.984 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.524 HG23 HG23 ' A' ' 9' ' ' THR . 24.6 t -63.64 116.94 3.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.16 -23.74 22.46 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 118.866 -1.635 . . . . 0.0 111.641 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.0 mtmm -120.11 -149.72 0.44 Allowed 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 120.426 2.113 . . . . 0.0 110.222 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 12.9 m-85 -146.2 170.12 17.38 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 119.983 -1.698 . . . . 0.0 110.276 -179.276 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 55.5 m -133.86 163.91 28.45 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.197 -1.564 . . . . 0.0 111.199 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.053 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.491 0.663 . . . . 0.0 110.737 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 120.903 0.383 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.955 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 88.0 t -113.3 109.17 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 14.6 m -116.25 164.71 14.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -173.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.818 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.8 m-85 -150.59 176.8 10.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.64 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.55 -42.34 18.47 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.834 178.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 119.02 23.01 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.016 -1.053 . . . . 0.0 108.854 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -51.21 -36.6 42.36 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.71 -45.7 88.97 Favored 'General case' 0 C--O 1.201 -1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 176.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.818 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.55 -25.5 28.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 O-C-N 120.667 -1.271 . . . . 0.0 109.339 179.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.053 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 20.0 t -60.73 -66.8 0.47 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.76 -54.28 44.12 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.808 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -62.86 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -177.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.6 -28.81 68.79 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.323 -0.861 . . . . 0.0 113.058 -176.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.2 m . . . . . 0 N--CA 1.505 2.28 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.128 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.507 2.412 0 CA-C-O 121.731 0.777 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.98 167.29 21.79 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.05 152.42 41.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.699 -1.2 . . . . 0.0 111.206 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.92 -120.88 1.05 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.479 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.4 m -155.01 23.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.292 -1.122 . . . . 0.0 111.13 -177.775 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.71 -12.99 60.89 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 120.3 -1.5 . . . . 0.0 113.329 -177.001 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.7 m -123.0 24.96 8.76 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.346 -0.846 . . . . 0.0 109.542 177.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.14 17.39 77.26 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.605 -1.76 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.282 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 5.0 pttm -87.99 53.16 2.67 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.501 1.143 . . . . 0.0 110.972 -178.661 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.416 ' CG2' HG23 ' A' ' 9' ' ' THR . 49.2 t -67.29 109.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.3 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.1 -23.31 34.95 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.916 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.4 mtmm -114.95 -147.68 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.852 -1.381 . . . . 0.0 108.761 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.52 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 19.2 m-85 -146.72 176.48 9.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.878 -1.764 . . . . 0.0 110.289 -179.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.282 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 59.9 m -137.13 161.84 35.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.301 -1.499 . . . . 0.0 111.283 -178.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.882 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.303 0 O-C-N 121.599 -0.688 . . . . 0.0 110.731 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.436 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 12.8 t . . . . . 0 N--CA 1.507 2.414 0 CA-C-O 120.561 0.219 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.849 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 59.4 t -114.49 113.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.724 -1.235 . . . . 0.0 108.366 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.603 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.12 162.5 17.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.029 . . . . 0.0 113.446 -176.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.4 m-85 -149.27 174.68 12.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.7 p-10 -82.2 -42.01 19.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.89 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.729 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.15 116.16 20.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.942 -1.099 . . . . 0.0 108.808 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.8 ptpt -49.94 -35.58 24.6 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.9 -46.31 88.19 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.033 176.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.73 -25.85 26.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 O-C-N 120.655 -1.278 . . . . 0.0 109.467 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.041 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.1 t -61.08 -66.66 0.5 Allowed 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -55.28 -53.82 51.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.878 -1.138 . . . . 0.0 110.551 177.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.1 tmtm? -62.46 -79.6 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.613 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.3 m-80 -60.37 -30.56 69.65 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.172 -0.955 . . . . 0.0 112.713 -176.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 70.7 m . . . . . 0 N--CA 1.503 2.179 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.1 t . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 121.938 0.875 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.8 p90 -137.57 166.54 23.66 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.54 152.91 39.89 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.285 -177.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.35 -121.62 1.15 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.354 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.7 m -154.7 22.63 0.46 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -1.109 . . . . 0.0 110.996 -177.764 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -74.46 -11.47 60.24 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.292 -1.505 . . . . 0.0 113.351 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.02 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -123.77 24.7 8.33 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 121.265 -0.897 . . . . 0.0 109.735 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.43 17.15 77.56 Favored Glycine 0 C--N 1.291 -1.966 0 C-N-CA 118.641 -1.743 . . . . 0.0 109.077 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.273 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -87.45 52.63 2.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.392 1.091 . . . . 0.0 111.01 -178.69 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.03 110.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.51 -21.32 41.39 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.5 mttt -120.87 -145.36 0.36 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.796 -1.414 . . . . 0.0 109.033 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 16.0 m-85 -146.1 177.65 8.81 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.778 -1.826 . . . . 0.0 110.494 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.273 ' SG ' ' HD2' ' A' ' 13' ' ' LYS . 70.8 m -137.45 162.01 34.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.389 -1.444 . . . . 0.0 110.874 -178.552 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p . . . . . 0 C--N 1.306 -1.301 0 O-C-N 121.46 -0.775 . . . . 0.0 111.123 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 121.058 0.456 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.795 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.13 116.11 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.703 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.26 161.63 18.71 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.493 -176.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.789 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.9 m-85 -149.1 176.74 10.21 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.184 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.89 -43.62 17.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.236 -0.915 . . . . 0.0 111.796 178.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.44 21.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.947 -1.095 . . . . 0.0 108.498 179.295 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.7 ptpt -50.34 -35.2 26.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.16 -46.13 89.2 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 109.084 176.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.789 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.72 -26.27 27.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 O-C-N 120.719 -1.238 . . . . 0.0 109.454 179.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.117 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 t -61.28 -67.44 0.41 Allowed 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.08 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -55.23 -53.13 59.93 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.756 -1.215 . . . . 0.0 110.61 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -62.92 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.72 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.608 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.9 m-80 -61.08 -28.35 69.02 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 112.948 -176.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.117 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.1 m . . . . . 0 N--CA 1.503 2.219 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.118 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.014 0.435 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -83.63 118.86 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.224 -0.923 . . . . 0.0 110.238 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 156.0 9.09 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 mt -131.89 179.26 6.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.977 . . . . 0.0 109.45 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 t -145.38 150.65 36.94 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.735 -1.228 . . . . 0.0 110.426 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -138.39 163.04 32.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.1 151.49 42.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.22 -121.33 1.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.444 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.284 94.5 m -154.69 23.58 0.45 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.293 -1.122 . . . . 0.0 111.117 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -73.72 -13.86 61.04 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.259 -1.526 . . . . 0.0 113.332 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.833 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.1 m -120.97 24.25 10.27 Favored 'General case' 0 C--N 1.283 -2.297 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.46 77.5 Favored Glycine 0 C--N 1.29 -1.991 0 C-N-CA 118.708 -1.71 . . . . 0.0 109.029 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.356 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 16.6 pttm -87.84 52.87 2.59 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.534 1.159 . . . . 0.0 110.928 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 9' ' ' THR . 35.1 t -66.73 110.73 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.79 -22.84 34.28 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.24 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.2 mtmt -119.9 -145.69 0.37 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.663 -1.493 . . . . 0.0 109.147 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 17.4 m-85 -146.0 174.85 10.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.893 -1.754 . . . . 0.0 110.326 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.356 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.4 m -137.44 161.25 36.85 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.377 -1.452 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.994 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.46 127.85 32.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.459 -0.775 . . . . 0.0 110.818 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -165.86 124.77 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.66 1.31 9.32 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.199 1.105 . . . . 0.0 111.317 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.8 tt -163.83 11.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.995 0.902 . . . . 0.0 111.257 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.24 11.53 84.87 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.602 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -87.92 -35.52 17.64 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.452 -1.028 . . . . 0.0 111.271 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.446 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.8 m-85 -84.9 -41.1 16.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 111.742 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' TYR . 26.2 t 41.83 67.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.245 -0.909 . . . . 0.0 109.519 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.773 HG12 ' CE1' ' A' ' 29' ' ' TYR . 89.3 t -114.69 116.73 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 12.9 m -116.33 161.78 18.51 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.33 1.062 . . . . 0.0 113.157 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.6 m-85 -149.37 174.56 12.31 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.837 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.1 p30 -81.46 -40.72 22.89 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.837 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.75 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.2 113.85 19.62 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.083 -1.011 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.0 ptmm? -49.37 -35.05 17.61 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.29 86.98 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.126 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.761 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.18 -25.7 23.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 O-C-N 120.668 -1.27 . . . . 0.0 109.382 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.111 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 37.6 t -61.15 -67.35 0.41 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -54.53 -53.92 47.99 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.895 -1.128 . . . . 0.0 110.996 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -61.9 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.543 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.3 m-80 -60.26 -30.47 69.46 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 121.227 -0.921 . . . . 0.0 112.767 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.111 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 94.3 m -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.506 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 11.9 p . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.104 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.237 0.541 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -155.73 176.57 12.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 110.301 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.75 -168.23 39.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.14 178.04 7.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -1.004 . . . . 0.0 109.487 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 t -114.26 137.81 51.3 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.653 -1.279 . . . . 0.0 110.03 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.0 p90 -138.19 162.89 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.05 150.81 42.63 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.411 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.95 -122.46 1.23 Allowed Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.54 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.669 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -154.79 24.11 0.45 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.369 -1.077 . . . . 0.0 110.818 -177.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.77 -13.33 60.93 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.299 -1.501 . . . . 0.0 113.294 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.933 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.9 m -121.28 24.75 9.86 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.431 -0.793 . . . . 0.0 109.367 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.86 77.52 Favored Glycine 0 C--N 1.29 -1.985 0 C-N-CA 118.701 -1.714 . . . . 0.0 109.058 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.319 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 9.2 pttm -88.08 54.32 3.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.561 1.172 . . . . 0.0 110.843 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' CG2' HG23 ' A' ' 9' ' ' THR . 40.2 t -66.68 108.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.54 -22.65 36.69 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.022 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.749 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 41.5 mtmt -114.45 -147.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.821 -1.4 . . . . 0.0 108.943 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 25.4 m-85 -146.57 175.62 10.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.9 -1.75 . . . . 0.0 110.277 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.319 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.9 m -136.8 161.76 35.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.515 -1.366 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.9 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -135.21 106.72 6.87 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 110.246 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -171.82 139.96 1.13 Allowed Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -78.2 -7.65 16.19 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.263 1.138 . . . . 0.0 109.765 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.827 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.8 tt -164.86 -169.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.5 13.09 57.11 Favored Glycine 0 N--CA 1.502 3.09 0 O-C-N 121.04 -1.037 . . . . 0.0 111.256 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.827 ' H ' HG23 ' A' ' 22' ' ' ILE . 13.8 ptmt -83.65 -44.24 14.75 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.169 -1.195 . . . . 0.0 110.715 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 46.1 m-85 -87.65 -50.79 6.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.956 -1.09 . . . . 0.0 110.782 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' TYR . 18.2 t 36.24 74.29 0.08 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.624 -0.672 . . . . 0.0 110.749 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.4 t -114.45 111.48 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.699 -1.251 . . . . 0.0 108.434 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.2 m -116.13 161.64 18.62 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.29 1.043 . . . . 0.0 113.46 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.8 m-85 -150.12 175.75 11.46 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.8 p-10 -82.12 -41.82 19.95 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.92 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.11 115.51 20.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.964 -1.085 . . . . 0.0 108.739 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.913 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 9.4 ptmt -49.74 -35.3 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.8 -46.38 87.7 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.048 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.48 -25.79 25.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.0 109.332 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.043 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.2 t -60.35 -66.58 0.5 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.02 -54.17 48.06 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.927 -1.108 . . . . 0.0 110.785 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -61.61 -79.19 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -61.02 -29.82 69.94 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.224 -0.922 . . . . 0.0 112.881 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.043 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.0 m -50.96 -29.91 13.52 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.357 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.1 -1.0 . . . . 0.0 110.144 -179.733 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.254 0.549 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.39 155.66 34.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.27 158.76 11.29 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.698 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.8 mt -130.78 179.62 5.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 t -143.04 148.65 37.08 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.445 -1.409 . . . . 0.0 111.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -138.5 164.43 29.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.62 153.21 39.62 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.419 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.95 -122.18 1.23 Allowed Glycine 0 N--CA 1.486 2.006 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.36 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 95.2 m -154.9 22.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 111.004 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -75.15 -10.16 59.21 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.316 -1.49 . . . . 0.0 113.713 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.013 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.6 m -124.5 25.32 7.64 Favored 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.245 -0.909 . . . . 0.0 109.707 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.24 77.43 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 118.593 -1.765 . . . . 0.0 109.167 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.26 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 4.2 pttt -87.83 51.67 2.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.505 1.145 . . . . 0.0 110.956 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.82 110.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 -22.04 39.46 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.11 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.772 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.3 mtmm -119.41 -145.53 0.37 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.865 -1.373 . . . . 0.0 109.005 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 26.5 m-85 -145.81 175.94 10.03 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 119.871 -1.768 . . . . 0.0 110.276 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.26 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 90.5 m -137.07 161.61 35.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.255 -1.528 . . . . 0.0 110.664 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.932 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.49 131.15 31.43 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.378 -0.826 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -164.01 129.93 2.2 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -78.38 -2.78 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.253 1.133 . . . . 0.0 111.241 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.645 HG21 ' HD2' ' A' ' 24' ' ' LYS . 7.5 tt -164.53 12.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.031 0.92 . . . . 0.0 111.24 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.84 12.22 84.06 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.645 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -88.25 -34.78 17.62 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.435 -1.038 . . . . 0.0 111.425 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.4 m-85 -86.55 -43.91 12.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.171 -0.956 . . . . 0.0 111.944 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 20.0 t 48.94 69.77 0.54 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.113 -0.992 . . . . 0.0 109.808 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.2 t -115.33 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.8 m -116.17 162.3 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.91 -1.119 . . . . 0.0 113.085 -176.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.7 m-85 -147.75 174.76 11.5 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.024 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.2 p-10 -82.04 -42.67 18.96 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.003 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.95 116.39 20.89 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.976 -1.077 . . . . 0.0 108.68 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.809 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.3 ptpt -49.19 -36.03 18.66 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.58 88.25 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.35 -26.36 25.94 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 O-C-N 120.704 -1.248 . . . . 0.0 109.435 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.146 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 31.4 t -60.98 -67.29 0.42 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -54.82 -53.42 55.47 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.825 -1.172 . . . . 0.0 110.875 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.31 -80.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 34' ' ' ILE . 49.7 m-80 -61.16 -28.12 68.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.261 -0.899 . . . . 0.0 113.007 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.146 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.8 m -48.34 -32.37 7.38 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.084 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 40' ' ' THR . 3.6 t70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -155.54 -164.64 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.403 -0.811 . . . . 0.0 109.961 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.01 -148.12 12.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.657 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.99 179.72 5.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.964 . . . . 0.0 109.692 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 17.1 t -142.82 152.55 42.32 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.761 -1.212 . . . . 0.0 110.585 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.508 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -136.6 165.16 26.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.73 149.89 43.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.309 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.54 -120.33 1.01 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.531 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.685 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 96.1 m -154.83 21.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -1.136 . . . . 0.0 111.334 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.331 -1.48 . . . . 0.0 113.541 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.112 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.8 m -123.19 25.59 8.37 Favored 'General case' 0 C--N 1.282 -2.354 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.68 17.23 79.11 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 118.784 -1.674 . . . . 0.0 109.412 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.608 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.14 53.17 2.73 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.541 1.162 . . . . 0.0 110.856 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.82 107.78 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.42 -21.06 45.87 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.067 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 15.2 mtmt -119.18 -144.14 0.36 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.917 -1.343 . . . . 0.0 109.128 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 14.7 m-85 -146.65 176.67 9.66 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 119.789 -1.819 . . . . 0.0 110.593 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.608 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 95.8 m -136.74 163.29 30.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.445 -1.41 . . . . 0.0 110.745 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.9 125.15 29.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.511 -0.743 . . . . 0.0 111.03 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 p -166.11 124.41 1.09 Allowed Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -78.78 -1.44 11.6 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.105 1.055 . . . . 0.0 110.794 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 24' ' ' LYS . 4.7 tt -163.99 12.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.015 0.912 . . . . 0.0 110.909 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.63 13.49 83.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 7.8 ptmt -86.41 -35.48 19.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.8 m-85 -85.21 -44.33 13.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.797 . . . . 0.0 111.585 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 54.1 t 44.65 64.15 1.45 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.762 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.6 t -114.96 118.11 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.82 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.5 m -116.16 161.69 18.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.493 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 83.7 m-85 -149.26 176.51 10.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.0 p-10 -81.93 -42.83 18.93 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.78 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.13 20.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.029 -1.045 . . . . 0.0 108.611 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.7 ptpt -49.94 -35.45 24.09 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.12 -46.16 89.04 Favored 'General case' 0 C--O 1.201 -1.497 0 O-C-N 121.307 -0.87 . . . . 0.0 109.12 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.79 -25.97 26.71 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 120.566 -1.334 . . . . 0.0 109.407 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.101 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.7 t -60.82 -67.45 0.4 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -55.02 -53.53 54.68 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.901 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.1 tmtm? -62.81 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.603 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.69 -28.46 68.64 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.262 -0.899 . . . . 0.0 112.92 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.101 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.7 m -49.23 -29.81 6.22 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.368 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.522 HG21 ' O ' ' A' ' 1' ' ' ASP . 8.7 p . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.158 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.281 0.562 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.01 -167.06 1.6 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 40' ' ' THR . . . -169.51 -135.69 1.94 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.102 -1.046 . . . . 0.0 110.912 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mt -133.11 178.83 6.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.522 -0.987 . . . . 0.0 109.716 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 1.27 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 5.5 t -148.05 149.67 32.52 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.27 170.76 15.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.993 -1.067 . . . . 0.0 110.668 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.24 152.16 40.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.988 . . . . 0.0 110.833 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.27 -122.78 1.25 Allowed Glycine 0 N--CA 1.485 1.951 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.631 ' O ' HG22 ' A' ' 9' ' ' THR 0.294 91.5 m -155.77 26.75 0.38 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.32 -1.106 . . . . 0.0 110.57 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.43 -9.18 58.42 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.455 -1.403 . . . . 0.0 113.571 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.7 m -122.54 23.61 9.55 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.394 -0.816 . . . . 0.0 109.799 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.77 74.86 Favored Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.116 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 2.0 pttp -87.22 51.45 2.24 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.207 1.003 . . . . 0.0 111.944 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.02 114.68 3.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.25 -24.55 22.46 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.323 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.691 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 6.7 mtmt -123.49 -146.1 0.35 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.515 -1.58 . . . . 0.0 109.554 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 54.6 m-85 -144.0 169.56 17.59 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 119.971 -1.705 . . . . 0.0 110.008 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.116 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 87.1 m -142.65 157.14 44.99 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.959 -1.713 . . . . 0.0 110.364 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.27 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 1.9 p -142.42 136.05 29.12 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.967 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -165.55 137.69 3.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -77.46 0.9 9.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.06 1.032 . . . . 0.0 111.231 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.626 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.9 tt -163.72 9.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.938 0.875 . . . . 0.0 111.287 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.02 11.52 84.71 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD2' HG21 ' A' ' 22' ' ' ILE . 16.4 ptmt -87.35 -36.56 17.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.439 -1.036 . . . . 0.0 111.548 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.7 m-85 -85.3 -36.58 20.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.631 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 t 44.9 75.46 0.1 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.67 HG12 ' CE1' ' A' ' 29' ' ' TYR . 70.8 t -114.31 115.58 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 22.9 m -116.24 164.04 15.1 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.342 1.068 . . . . 0.0 113.054 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.692 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.2 m-85 -147.88 170.29 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -83.61 -35.06 24.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.033 -1.042 . . . . 0.0 112.865 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.69 114.95 19.93 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.931 -1.106 . . . . 0.0 109.665 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 1.007 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -49.26 -35.22 17.1 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.56 -45.67 91.13 Favored 'General case' 0 C--O 1.197 -1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 109.085 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.731 HG13 ' HB2' ' A' ' 31' ' ' SER . 3.4 mt -58.73 -26.15 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 O-C-N 120.466 -1.396 . . . . 0.0 109.052 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.007 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 14.7 t -59.49 -71.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -58.5 -51.1 71.28 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.028 -1.045 . . . . 0.0 111.158 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.659 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -60.78 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.659 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 48.7 m-80 -61.96 -33.08 73.63 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.902 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.7 m -51.45 -32.94 28.78 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.35 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 9.1 p . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.093 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.116 0.484 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 40' ' ' THR . 3.5 m-20 -83.73 -157.15 0.24 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.217 -0.927 . . . . 0.0 109.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.9 -130.11 2.06 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.067 -1.063 . . . . 0.0 110.565 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -131.59 179.54 5.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -1.043 . . . . 0.0 110.054 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.6 t -143.86 149.61 37.21 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.942 -1.099 . . . . 0.0 110.05 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -137.9 165.47 26.43 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.87 152.31 40.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.33 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.33 -121.31 1.11 Allowed Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.472 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.0 m -154.88 23.16 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.308 -1.113 . . . . 0.0 110.948 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -74.13 -12.2 60.52 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.303 -1.498 . . . . 0.0 113.377 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.5 m -122.36 25.15 9.04 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 121.243 -0.911 . . . . 0.0 109.6 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.4 77.8 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 118.674 -1.727 . . . . 0.0 109.041 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.327 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.9 pttm -87.92 54.75 3.2 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.569 1.176 . . . . 0.0 110.768 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.49 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.15 -21.55 39.44 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.4 mtmp? -117.57 -145.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.712 -1.464 . . . . 0.0 109.252 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.5 m-85 -146.47 176.41 9.82 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 119.919 -1.738 . . . . 0.0 110.424 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.327 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 79.8 m -137.62 161.98 35.01 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.386 -1.446 . . . . 0.0 110.79 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.083 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.36 123.79 26.03 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.521 -0.737 . . . . 0.0 111.011 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -166.9 126.31 1.11 Allowed Pre-proline 0 N--CA 1.498 1.973 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.89 0.67 9.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.13 1.069 . . . . 0.0 111.223 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 24' ' ' LYS . 6.0 tt -163.98 12.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 122.043 0.925 . . . . 0.0 111.304 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.43 12.99 83.29 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -86.48 -38.07 17.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.529 -0.983 . . . . 0.0 111.141 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.1 m-85 -85.04 -39.48 17.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 111.539 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 24.1 t 41.81 68.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.744 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.5 t -114.71 115.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.638 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.3 m -116.22 161.42 19.0 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.392 1.092 . . . . 0.0 113.469 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.779 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.2 m-85 -149.68 176.52 10.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.965 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.5 p30 -81.56 -42.46 20.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.141 -0.974 . . . . 0.0 111.85 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.73 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.28 116.11 20.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.093 -1.004 . . . . 0.0 108.603 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.855 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.0 ptpt -50.84 -34.55 28.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.7 -46.19 87.85 Favored 'General case' 0 C--O 1.199 -1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 108.868 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.779 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.84 25.66 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 O-C-N 120.736 -1.227 . . . . 0.0 109.357 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.124 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -60.78 -67.59 0.39 Allowed 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -54.62 -53.79 50.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.908 -1.12 . . . . 0.0 110.93 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -62.47 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.631 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.4 m-80 -60.89 -28.71 69.09 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.262 -0.899 . . . . 0.0 112.886 -176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.124 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 67.1 m -50.06 -25.96 3.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.36 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 2' ' ' ASP . 13.2 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.067 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.226 0.536 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -155.9 -176.88 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 109.809 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.24 -157.38 29.83 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.952 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.8 mt -131.48 179.99 5.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.71 -0.877 . . . . 0.0 109.376 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.4 t -138.7 150.56 46.3 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.59 -1.319 . . . . 0.0 111.079 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 38.4 p90 -136.62 167.12 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 8.5 pt-20 -122.52 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.31 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HZ1' ' A' ' 13' ' ' LYS . . . 154.66 -121.47 1.12 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.442 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.645 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 87.0 m -154.63 21.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -1.138 . . . . 0.0 111.241 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -75.34 -12.97 60.38 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.2 -1.562 . . . . 0.0 113.617 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.149 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.3 m -122.72 25.59 8.63 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.4 79.74 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 118.904 -1.617 . . . . 0.0 109.578 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.677 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.3 pttt -87.04 53.43 2.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.469 1.128 . . . . 0.0 111.037 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.53 107.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.64 -20.84 47.84 Favored Glycine 0 N--CA 1.501 2.994 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.181 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 29.9 mtmt -118.17 -143.8 0.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.879 -1.365 . . . . 0.0 109.121 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.528 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 18.2 m-85 -146.06 176.31 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.844 -1.785 . . . . 0.0 110.45 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.677 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 90.1 m -136.77 164.03 29.23 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.428 -1.42 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.33 122.25 23.55 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.543 -0.723 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -166.45 125.57 1.13 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -79.44 -2.18 12.07 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.097 1.051 . . . . 0.0 110.813 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 24' ' ' LYS . 5.3 tt -164.39 15.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.085 0.945 . . . . 0.0 110.876 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.78 83.72 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 14.3 ptmt -86.9 -33.86 19.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -1.024 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.8 m-85 -85.1 -40.83 16.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 111.253 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' TYR . 12.9 t 40.49 61.93 1.48 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.381 -0.824 . . . . 0.0 110.027 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.824 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.92 116.51 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.877 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 14.1 m -116.36 161.64 18.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.037 -1.039 . . . . 0.0 113.302 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.815 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.8 m-85 -149.02 176.45 10.44 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.4 p30 -81.98 -43.31 18.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.254 -0.903 . . . . 0.0 111.879 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.722 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.02 116.42 20.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.094 -1.004 . . . . 0.0 108.492 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.811 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -49.82 -35.54 23.26 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.02 -46.52 87.99 Favored 'General case' 0 C--O 1.2 -1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.009 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.815 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.96 -25.75 26.8 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.977 0 O-C-N 120.773 -1.204 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.099 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.8 t -60.4 -65.88 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -54.96 -54.66 39.91 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.913 -1.117 . . . . 0.0 110.841 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.488 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.4 tmtm? -62.84 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -59.88 -27.86 67.06 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 121.287 -0.883 . . . . 0.0 112.871 -176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.099 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.2 m -49.57 -28.13 5.29 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.285 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.1 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.3 t0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.166 0.508 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' A' ' 40' ' ' THR . 13.6 m-20 -155.72 -165.08 1.87 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.484 -0.76 . . . . 0.0 109.773 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.15 -150.54 17.41 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.987 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.76 180.0 5.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.665 -0.903 . . . . 0.0 109.496 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.7 t -137.93 149.5 46.24 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.741 -1.225 . . . . 0.0 110.718 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.82 166.04 24.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.45 149.79 43.37 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.627 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.404 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 153.37 -123.41 1.42 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.468 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 98.4 m -156.05 25.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.41 -1.053 . . . . 0.0 110.846 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -74.13 -8.8 57.47 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.373 -1.454 . . . . 0.0 113.562 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.788 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -125.77 27.02 6.52 Favored 'General case' 0 C--N 1.282 -2.334 0 O-C-N 121.33 -0.856 . . . . 0.0 109.726 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 15.34 76.92 Favored Glycine 0 C--N 1.291 -1.965 0 C-N-CA 118.508 -1.806 . . . . 0.0 108.723 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.258 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.41 53.21 2.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.351 1.072 . . . . 0.0 111.096 -178.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 9' ' ' THR . 44.4 t -67.19 109.58 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.4 -19.93 43.91 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.761 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 28.3 mtmt -118.6 -143.05 0.36 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.722 -1.458 . . . . 0.0 109.368 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.1 m-85 -145.79 173.75 11.83 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 119.976 -1.703 . . . . 0.0 110.02 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.258 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 76.3 m -136.87 162.55 32.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.449 -1.407 . . . . 0.0 111.118 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.03 122.59 23.22 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.458 -0.776 . . . . 0.0 110.846 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -166.28 126.29 1.21 Allowed Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.06 -1.53 11.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.169 1.089 . . . . 0.0 111.249 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.3 tt -164.13 13.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-O 121.93 0.872 . . . . 0.0 111.296 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.96 84.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.493 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 13.4 ptmt -87.07 -35.34 18.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -1.002 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.493 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.8 m-85 -85.14 -40.7 16.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 111.307 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 25' ' ' TYR . 38.2 t 41.67 66.42 0.7 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.456 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.772 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 62.2 t -115.15 115.81 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.33 162.05 18.1 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.313 1.054 . . . . 0.0 113.091 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.807 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.6 175.79 10.88 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.945 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.9 p-10 -81.87 -42.34 19.71 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.177 -0.952 . . . . 0.0 112.071 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.17 117.01 21.35 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.973 -1.079 . . . . 0.0 108.905 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.808 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.9 ptpt -50.02 -35.89 26.62 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.8 -46.27 87.99 Favored 'General case' 0 C--O 1.2 -1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.059 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.807 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.07 -25.51 26.57 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 O-C-N 120.658 -1.276 . . . . 0.0 109.44 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.039 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 27.2 t -60.94 -66.52 0.52 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -55.92 -54.03 49.65 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.748 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtt? -61.77 -78.81 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.634 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.0 m-80 -60.67 -30.09 69.69 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.253 -0.904 . . . . 0.0 112.699 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.039 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 62.9 m -50.92 -26.98 6.6 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.239 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.543 HG22 ' HA ' ' A' ' 2' ' ' ASP . 22.1 p . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.165 -0.959 . . . . 0.0 110.089 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.472 ' O ' HG22 ' A' ' 40' ' ' THR . 17.0 p-10 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.063 0.458 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -82.93 -139.88 0.05 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.269 -0.894 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.23 -140.63 6.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.8 mt -132.94 179.19 6.33 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.334 -1.098 . . . . 0.0 110.274 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t -146.31 150.38 35.63 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.935 -1.103 . . . . 0.0 109.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.485 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 25.0 p90 -138.26 163.27 32.2 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.04 153.69 39.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.455 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.57 -121.17 1.11 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.313 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 99.1 m -154.63 20.54 0.47 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -1.081 . . . . 0.0 111.089 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -74.84 -9.77 58.86 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.336 -1.478 . . . . 0.0 113.351 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.982 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.2 m -124.24 24.09 8.18 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.397 -0.815 . . . . 0.0 109.856 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.51 18.44 77.07 Favored Glycine 0 C--N 1.29 -1.989 0 C-N-CA 118.495 -1.812 . . . . 0.0 108.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.205 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 22.5 pttt -87.92 51.22 2.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.443 1.116 . . . . 0.0 111.031 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.68 109.65 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.68 -21.16 41.63 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.263 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.0 mtmm -122.02 -145.15 0.35 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.394 . . . . 0.0 109.075 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 22.7 m-85 -145.76 177.41 8.92 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.829 -1.795 . . . . 0.0 110.35 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.205 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 96.2 m -137.09 161.08 37.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.344 -1.473 . . . . 0.0 110.58 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.142 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.49 126.18 23.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.761 . . . . 0.0 111.301 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -167.28 127.15 1.12 Allowed Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -75.22 -60.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.141 1.074 . . . . 0.0 110.006 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG21 ' HD2' ' A' ' 24' ' ' LYS . 9.6 tt -84.55 -0.46 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.888 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.9 13.41 83.66 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.79 -25.17 21.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.379 -1.071 . . . . 0.0 111.36 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' CYS . 46.0 m-85 -83.59 -37.1 23.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 111.772 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 19.4 t 41.57 70.41 0.27 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.258 -0.901 . . . . 0.0 110.321 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 95.6 t -115.07 118.79 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.038 -1.039 . . . . 0.0 108.449 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 15.9 m -116.12 161.87 18.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.853 -1.154 . . . . 0.0 113.334 -176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.784 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 85.0 m-85 -148.56 175.27 11.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.929 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 2.5 p-10 -81.98 -42.58 19.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.869 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.749 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 114.74 20.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 108.664 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.832 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 6.2 ptmm? -49.44 -35.29 18.94 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.25 87.77 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.12 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.778 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.15 -26.26 24.88 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 O-C-N 120.675 -1.266 . . . . 0.0 109.389 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.175 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 t -60.69 -66.02 0.6 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -55.5 -54.18 47.11 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.707 -1.246 . . . . 0.0 110.645 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.0 tmtm? -63.19 -79.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.6 m-80 -60.88 -28.3 68.78 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.259 -0.901 . . . . 0.0 113.13 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.175 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.8 m -48.49 -27.93 3.01 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.372 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 1' ' ' ASP . 8.8 p . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.757 ' OD1' HG22 ' A' ' 40' ' ' THR . 11.6 m-20 -155.47 172.69 17.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.107 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.63 -122.52 1.06 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 mt -132.7 179.1 6.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -1.015 . . . . 0.0 110.033 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.3 t -122.96 137.95 54.81 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.783 -1.198 . . . . 0.0 110.044 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -137.94 165.01 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -122.97 152.15 41.16 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.458 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.87 -120.75 1.04 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.377 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.9 m -155.18 23.33 0.42 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.364 -1.08 . . . . 0.0 111.034 -177.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -73.93 -12.26 60.6 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.258 -1.526 . . . . 0.0 113.416 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.003 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.8 m -123.43 25.48 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.48 16.79 77.53 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 118.687 -1.721 . . . . 0.0 109.08 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.291 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 pttm -87.93 54.2 3.02 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.609 1.195 . . . . 0.0 110.801 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.71 108.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.94 -22.13 40.77 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.108 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 5.4 mtmp? -113.82 -147.42 0.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.908 -1.348 . . . . 0.0 108.768 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 21.2 m-85 -146.57 176.8 9.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.774 -1.829 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.291 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 57.5 m -137.48 162.14 34.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.491 -1.38 . . . . 0.0 111.072 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.865 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.1 p -136.14 108.27 7.22 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.621 -0.674 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -171.66 139.37 1.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -77.13 -7.71 17.3 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.306 1.161 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.823 HG23 ' H ' ' A' ' 24' ' ' LYS . 8.6 tt -165.0 -169.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.563 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.73 13.92 54.16 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.13 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.823 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -83.83 -44.12 14.67 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.303 -1.116 . . . . 0.0 110.732 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.508 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.8 m-85 -88.05 -51.69 5.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.878 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 17.5 t 39.32 75.14 0.08 Allowed 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.595 -0.691 . . . . 0.0 110.922 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.865 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 66.4 t -114.69 111.46 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.803 -1.186 . . . . 0.0 108.178 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.17 162.2 17.81 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.264 1.031 . . . . 0.0 113.367 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.777 ' CE1' HG12 ' A' ' 27' ' ' VAL . 84.2 m-85 -150.47 175.3 12.0 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.295 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.08 -41.26 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.885 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.72 115.54 21.01 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.092 -1.005 . . . . 0.0 109.099 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.818 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 12.5 ptpt -50.03 -35.08 23.52 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.52 -45.97 87.72 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.335 -0.853 . . . . 0.0 108.996 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.769 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.49 -25.63 24.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.005 0 O-C-N 120.621 -1.3 . . . . 0.0 109.336 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.844 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 25.5 t -61.55 -67.93 0.36 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.0 -53.03 60.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.766 -1.209 . . . . 0.0 110.696 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.1 tmtt? -61.85 -79.47 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.639 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.6 m-80 -61.63 -32.6 72.76 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.28 -0.888 . . . . 0.0 112.879 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.844 ' SG ' ' HA ' ' A' ' 35' ' ' CYS . 69.8 m -52.22 -29.74 24.09 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.306 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.757 HG22 ' OD1' ' A' ' 2' ' ' ASP . 22.6 p . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.045 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.582 ' HB2' HG21 ' A' ' 40' ' ' THR . 7.1 p-10 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.452 0.644 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.96 140.76 31.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.708 . . . . 0.0 109.979 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.99 178.61 38.97 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -132.22 179.14 6.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.945 . . . . 0.0 109.37 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.702 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 12.6 t -146.98 155.57 42.37 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.704 -1.247 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.6 p90 -136.74 165.45 25.89 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 9.6 pt-20 -122.63 149.02 44.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.059 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.29 -119.66 0.96 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.449 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 93.9 m -155.14 20.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 111.599 -177.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -75.28 -12.26 60.24 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.133 -1.605 . . . . 0.0 113.546 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.084 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.5 m -123.0 25.29 8.62 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.58 17.49 79.1 Favored Glycine 0 C--N 1.29 -1.982 0 C-N-CA 118.823 -1.656 . . . . 0.0 109.396 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.68 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 1.4 pttt -87.34 51.7 2.3 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.45 1.119 . . . . 0.0 111.031 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.15 109.48 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.15 -21.95 39.73 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.213 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.791 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 38.4 mtmt -123.23 -142.2 0.32 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.418 . . . . 0.0 109.227 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 9.8 m-85 -146.15 176.86 9.42 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.914 -1.741 . . . . 0.0 110.562 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.68 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 86.3 m -136.72 163.3 30.92 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.432 -1.417 . . . . 0.0 110.882 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.088 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -130.92 127.53 38.67 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.613 -0.679 . . . . 0.0 110.875 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -165.68 116.43 0.84 Allowed Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.92 0.94 9.68 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.274 1.144 . . . . 0.0 110.469 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 24' ' ' LYS . 7.2 tt -163.89 11.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 122.109 0.957 . . . . 0.0 110.771 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.03 12.98 83.63 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -87.56 -34.99 18.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.471 -1.017 . . . . 0.0 111.266 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.464 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 47.7 m-85 -85.37 -46.02 11.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 111.948 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.6 t 42.5 60.34 2.41 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.143 -0.973 . . . . 0.0 109.154 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.786 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.84 121.29 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 11.2 m -116.27 160.99 19.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.029 -1.069 . . . . 0.0 113.493 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.5 m-85 -148.9 177.77 9.26 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.915 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.75 -43.75 17.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.699 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.717 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.12 116.42 21.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.014 -1.054 . . . . 0.0 108.338 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.883 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.41 -34.8 25.73 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.48 -46.31 89.16 Favored 'General case' 0 C--O 1.201 -1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 108.948 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.68 -26.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.722 -1.236 . . . . 0.0 109.424 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.154 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -60.55 -67.4 0.4 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -55.0 -53.45 55.57 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.82 -1.175 . . . . 0.0 110.821 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.5 tmtm? -63.12 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.2 m-80 -60.69 -26.94 67.49 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.375 -0.828 . . . . 0.0 112.955 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.154 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.8 m -47.99 -34.5 9.41 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 118.689 -1.205 . . . . 0.0 111.046 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.237 0.541 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.711 ' OD1' HG22 ' A' ' 40' ' ' THR . 39.8 m-20 -155.24 -163.58 1.58 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.387 -0.821 . . . . 0.0 109.506 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.55 -113.67 0.29 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.379 -1.391 . . . . 0.0 111.868 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.85 179.9 6.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.559 -0.965 . . . . 0.0 110.62 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.1 t -131.32 142.86 50.16 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.994 -1.066 . . . . 0.0 108.967 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' HE1' ' HZ2' ' A' ' 13' ' ' LYS . 39.7 p90 -138.68 166.97 22.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 109.4 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -122.95 151.88 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.898 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.88 -119.96 0.97 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.482 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 91.7 m -155.01 23.89 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.23 -1.159 . . . . 0.0 111.155 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -73.32 -14.08 61.23 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.235 -1.54 . . . . 0.0 113.201 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -122.36 24.51 9.31 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 17.93 77.18 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 118.637 -1.744 . . . . 0.0 108.979 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.271 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 10.7 pttm -88.12 51.67 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.407 1.098 . . . . 0.0 111.338 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 9' ' ' THR . 38.2 t -67.27 111.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.81 -24.45 29.54 Favored Glycine 0 N--CA 1.498 2.832 0 C-N-CA 119.239 -1.457 . . . . 0.0 109.856 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 12.9 mtmt -118.38 -146.81 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.78 -1.423 . . . . 0.0 108.838 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 15.9 m-85 -146.95 176.77 9.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 119.836 -1.79 . . . . 0.0 110.319 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.271 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.05 161.63 35.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.428 -1.42 . . . . 0.0 110.79 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.08 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.31 108.13 8.54 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.499 0.666 . . . . 0.0 110.423 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 p -172.46 136.3 0.83 Allowed Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.8 -5.62 16.12 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.215 1.113 . . . . 0.0 109.682 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.816 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.9 tt -164.63 -169.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.31 14.91 52.83 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.925 -1.109 . . . . 0.0 111.064 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.816 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -84.07 -43.94 14.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.246 -1.15 . . . . 0.0 110.973 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 44.9 m-85 -87.75 -50.57 6.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.159 -0.963 . . . . 0.0 111.127 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' TYR . 31.9 t 37.84 72.85 0.11 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.636 -0.665 . . . . 0.0 110.721 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.907 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.5 t -114.58 112.96 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.797 -1.189 . . . . 0.0 108.096 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 16.8 m -116.13 161.61 18.67 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.417 1.103 . . . . 0.0 113.667 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.801 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.1 m-85 -149.92 176.94 10.3 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.009 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.98 -42.9 18.74 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.687 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.47 117.22 21.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.042 -1.036 . . . . 0.0 108.872 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.867 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -50.87 -35.71 34.16 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.54 -45.96 87.8 Favored 'General case' 0 C--O 1.201 -1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 108.909 176.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.801 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.85 -25.92 26.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.936 0 O-C-N 120.736 -1.227 . . . . 0.0 109.29 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.11 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.2 t -60.18 -66.23 0.56 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.99 -54.48 42.34 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.907 -1.121 . . . . 0.0 110.881 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.26 -79.34 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.647 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.2 m-80 -59.82 -28.68 67.67 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.269 -0.895 . . . . 0.0 112.852 -176.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.11 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m -50.49 -25.58 4.18 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 118.611 -1.235 . . . . 0.0 111.412 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.711 HG22 ' OD1' ' A' ' 2' ' ' ASP . 14.2 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.156 0.503 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -155.3 139.3 16.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.53 -169.56 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.1 mt -131.8 179.79 5.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.592 -0.946 . . . . 0.0 109.46 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.5 t -134.1 136.07 43.65 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.687 -1.258 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -138.39 166.93 23.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.78 151.75 41.32 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.901 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.96 -119.76 0.95 Allowed Glycine 0 N--CA 1.488 2.102 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.546 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.289 98.1 m -155.38 23.99 0.41 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.152 -1.205 . . . . 0.0 111.334 -177.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -73.27 -14.36 61.31 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.213 -1.554 . . . . 0.0 113.33 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.894 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 27.0 m -121.5 24.37 9.9 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.52 77.07 Favored Glycine 0 C--N 1.29 -1.986 0 C-N-CA 118.535 -1.793 . . . . 0.0 108.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.289 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.4 pttm -87.59 52.07 2.39 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.474 1.131 . . . . 0.0 111.111 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t -66.88 111.36 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.76 31.14 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.009 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 40.7 mtmt -119.51 -146.32 0.38 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.415 . . . . 0.0 108.972 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -146.11 175.91 10.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 119.901 -1.749 . . . . 0.0 110.256 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.289 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 64.7 m -137.37 160.67 38.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.388 -1.445 . . . . 0.0 111.322 -178.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.939 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.43 110.13 7.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.681 -0.637 . . . . 0.0 110.676 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -171.17 137.7 1.11 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.03 -15.22 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.308 1.162 . . . . 0.0 109.823 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.797 HG23 ' H ' ' A' ' 24' ' ' LYS . 6.8 tt -165.07 -166.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.41 10.5 54.75 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.819 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.797 ' H ' HG23 ' A' ' 22' ' ' ILE . 12.8 ptmt -87.27 10.97 15.41 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -1.14 . . . . 0.0 110.676 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.653 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.3 m-85 -151.42 -53.99 0.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.488 ' C ' ' O ' ' A' ' 25' ' ' TYR . 10.0 t 34.91 75.19 0.06 Allowed 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.794 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.1 t -114.54 114.71 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.796 -1.19 . . . . 0.0 108.751 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.5 m -116.0 161.36 18.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.157 0.979 . . . . 0.0 112.988 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CE1' HG12 ' A' ' 27' ' ' VAL . 88.3 m-85 -149.55 174.69 12.24 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.086 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.75 -41.39 21.29 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.811 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.728 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.22 114.95 20.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.045 -1.034 . . . . 0.0 108.658 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.853 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.5 ptpp? -50.0 -34.7 21.97 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.93 -46.41 88.02 Favored 'General case' 0 C--O 1.199 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.023 176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.3 -26.29 25.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 120.596 -1.315 . . . . 0.0 109.376 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.137 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -61.27 -67.67 0.38 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -55.03 -53.06 60.68 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.747 -1.221 . . . . 0.0 110.737 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -62.33 -79.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -177.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -60.85 -29.73 69.69 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.268 -0.895 . . . . 0.0 112.839 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.137 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 91.0 m -50.42 -30.15 11.83 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.404 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.102 -179.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.225 0.536 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.53 -148.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.456 -0.778 . . . . 0.0 109.692 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.81 -153.15 22.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.763 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.93 179.67 5.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.588 -0.948 . . . . 0.0 109.689 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.4 t -142.76 153.95 43.78 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.686 -1.259 . . . . 0.0 110.576 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 36.0 p90 -138.29 167.27 22.22 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.9 pt-20 -122.57 153.3 39.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.764 -1.21 . . . . 0.0 111.553 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 153.14 -120.68 1.07 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.142 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 99.4 m -154.97 20.3 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -1.121 . . . . 0.0 111.275 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -75.25 -10.59 59.6 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.279 -1.513 . . . . 0.0 113.712 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.051 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.3 m -123.82 25.19 8.13 Favored 'General case' 0 C--N 1.284 -2.28 0 O-C-N 121.275 -0.89 . . . . 0.0 109.803 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.64 17.88 78.3 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 118.711 -1.709 . . . . 0.0 109.19 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.268 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 21.2 pttt -88.22 51.11 2.11 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.463 1.125 . . . . 0.0 111.133 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.88 109.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.27 -21.03 42.82 Favored Glycine 0 N--CA 1.5 2.907 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.29 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.793 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 7.8 mtmt -123.75 -142.65 0.32 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.411 . . . . 0.0 109.187 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 13.6 m-85 -145.21 177.63 8.66 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 119.777 -1.827 . . . . 0.0 110.5 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.268 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 92.9 m -137.5 163.78 30.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.513 -1.367 . . . . 0.0 110.998 -178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.1 123.71 27.72 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.555 -0.716 . . . . 0.0 111.276 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.2 p -166.72 119.33 0.79 Allowed Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.55 -8.18 15.94 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.204 1.107 . . . . 0.0 110.607 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' A' ' 24' ' ' LYS . 5.0 tt -164.67 20.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 122.129 0.966 . . . . 0.0 110.371 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.18 84.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.625 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -90.37 21.33 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.528 -0.983 . . . . 0.0 110.591 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.625 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.5 m-85 -148.9 -43.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.273 -0.892 . . . . 0.0 110.789 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' C ' ' O ' ' A' ' 25' ' ' TYR . 48.6 t 37.48 61.35 0.99 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.354 -0.841 . . . . 0.0 110.048 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.823 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.9 t -114.94 120.31 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.804 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 13.6 m -116.19 161.01 19.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.955 -1.09 . . . . 0.0 113.36 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.803 ' CG ' HG22 ' A' ' 34' ' ' ILE . 77.6 m-85 -148.84 177.89 9.15 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.029 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.4 p-10 -82.12 -44.01 17.06 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -0.973 . . . . 0.0 111.689 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.727 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.92 116.27 20.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.014 -1.054 . . . . 0.0 108.319 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.6 ptpp? -50.29 -34.79 24.66 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.3 -46.42 88.62 Favored 'General case' 0 C--O 1.2 -1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.981 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.66 -26.14 26.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.796 -1.19 . . . . 0.0 109.444 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.136 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 14.6 t -60.42 -65.62 0.66 Allowed 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -55.87 -54.47 44.2 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.615 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.4 tmtm? -62.85 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.672 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.1 m-80 -60.51 -27.24 67.45 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.269 -0.894 . . . . 0.0 112.991 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.136 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 52.5 m -48.5 -29.61 4.34 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 118.575 -1.25 . . . . 0.0 111.244 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.177 -179.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.346 0.593 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.27 -164.49 1.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 110.097 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.68 -154.79 25.51 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.96 179.9 5.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.575 -0.956 . . . . 0.0 109.768 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.8 t -135.14 136.65 42.05 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.803 -1.186 . . . . 0.0 110.048 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -138.16 166.53 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.1 pt-20 -122.95 149.56 44.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.789 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.21 -118.77 0.86 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.984 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 96.6 m -154.88 22.87 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 111.47 -177.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -73.48 -14.63 61.27 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.1 -1.625 . . . . 0.0 113.228 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.854 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 25.1 m -122.1 24.94 9.29 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.79 18.96 76.41 Favored Glycine 0 C--N 1.289 -2.064 0 C-N-CA 118.306 -1.902 . . . . 0.0 108.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.301 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 pttt -86.86 50.7 2.06 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.456 1.122 . . . . 0.0 110.871 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -67.47 110.76 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.41 -22.72 36.61 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 8.9 mttm -119.61 -147.61 0.4 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.759 -1.436 . . . . 0.0 108.806 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.1 m-85 -146.88 175.49 10.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.777 . . . . 0.0 110.256 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.301 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 80.1 m -137.66 160.99 37.68 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.307 -1.496 . . . . 0.0 111.559 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -137.1 110.62 7.99 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.697 -0.627 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.71 140.8 1.45 Allowed Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -76.45 -16.32 17.16 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.311 1.164 . . . . 0.0 109.731 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.799 HG23 ' H ' ' A' ' 24' ' ' LYS . 6.6 tt -164.81 -165.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.4 9.29 58.78 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.881 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.799 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -87.86 12.91 11.88 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.275 -1.132 . . . . 0.0 110.983 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.62 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 43.6 m-85 -150.66 -54.58 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' TYR . 15.5 t 36.27 75.57 0.06 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.418 -0.801 . . . . 0.0 110.859 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.791 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 72.9 t -114.26 114.89 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.681 -1.262 . . . . 0.0 108.649 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 19.6 m -116.0 162.38 17.46 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.352 1.073 . . . . 0.0 113.45 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.784 ' CG ' HG22 ' A' ' 34' ' ' ILE . 80.6 m-85 -148.65 175.08 11.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.804 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CB ' ' HD3' ' A' ' 16' ' ' LYS . 1.9 p-10 -82.06 -42.36 19.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.002 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.705 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.32 118.37 22.58 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.104 -0.997 . . . . 0.0 108.927 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.849 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.0 ptpt -51.04 -35.72 35.86 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.2 -45.99 89.64 Favored 'General case' 0 C--O 1.2 -1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.281 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.784 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -58.13 -26.36 29.1 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 O-C-N 120.651 -1.281 . . . . 0.0 109.418 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.105 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 9.5 t -60.9 -66.96 0.45 Allowed 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -55.2 -53.37 56.89 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.839 -1.163 . . . . 0.0 110.62 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.84 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -59.95 -29.09 68.17 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 121.302 -0.874 . . . . 0.0 112.705 -176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.105 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 68.0 m -50.68 -26.59 5.66 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.3 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.057 -179.771 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.753 ' HA ' HG22 ' A' ' 40' ' ' THR . 2.8 p30 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.011 0.434 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -83.69 119.5 24.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.44 167.75 27.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.911 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.1 mt -131.34 179.89 5.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.801 -0.823 . . . . 0.0 109.025 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.6 t -133.0 139.75 47.41 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.578 -1.327 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -137.15 166.41 23.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -122.88 150.69 42.56 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.014 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.3 -120.06 0.99 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.291 97.1 m -155.51 24.19 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.258 -1.142 . . . . 0.0 111.141 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.95 -12.3 60.61 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.237 -1.54 . . . . 0.0 113.466 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.065 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.2 m -122.55 25.29 8.87 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-O 121.818 0.818 . . . . 0.0 109.57 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.79 78.4 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.671 -1.728 . . . . 0.0 109.222 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -87.06 56.5 4.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.64 1.21 . . . . 0.0 110.429 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.89 107.72 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.48 -19.19 51.71 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.447 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.752 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 31.2 mtmt -116.59 -145.8 0.39 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.757 -1.437 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 16.4 m-85 -146.55 176.06 10.11 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.893 -1.754 . . . . 0.0 110.705 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.625 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 57.5 m -136.46 160.81 37.63 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.439 -1.413 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.066 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -137.41 111.07 8.1 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.405 ' HB3' ' N ' ' A' ' 26' ' ' CYS . 3.2 p -170.51 139.48 1.4 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.646 -0.659 . . . . 0.0 109.29 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.11 -5.13 14.3 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.237 1.125 . . . . 0.0 109.877 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.892 HG23 ' H ' ' A' ' 24' ' ' LYS . 9.3 tt -164.83 -171.81 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.4 5.46 84.43 Favored Glycine 0 N--CA 1.503 3.123 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.87 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.892 ' H ' HG23 ' A' ' 22' ' ' ILE . 1.2 ptmt -86.81 -29.45 22.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.018 -1.284 . . . . 0.0 110.341 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.637 ' HD1' ' HG3' ' A' ' 24' ' ' LYS . 4.1 m-30 -86.25 -57.46 3.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.193 -0.942 . . . . 0.0 110.156 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' TYR . 33.6 t 35.32 72.98 0.09 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.73 -0.606 . . . . 0.0 111.122 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.832 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 60.5 t -114.72 110.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.759 -1.213 . . . . 0.0 108.23 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.7 m -116.19 161.41 19.0 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.201 1.0 . . . . 0.0 113.435 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.771 ' CE1' HG12 ' A' ' 27' ' ' VAL . 86.3 m-85 -150.55 176.76 10.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.417 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 4.3 p-10 -82.04 -42.53 19.14 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.521 -0.871 . . . . 0.0 111.987 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.769 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.77 116.26 21.38 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.961 -1.087 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 5.5 ptpt -50.55 -34.88 27.24 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.22 -45.88 86.88 Favored 'General case' 0 C--O 1.2 -1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.759 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.769 HG13 ' HB2' ' A' ' 31' ' ' SER . 2.9 mt -57.51 -25.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.99 0 O-C-N 120.681 -1.262 . . . . 0.0 109.263 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.066 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.0 t -61.13 -68.48 0.31 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -54.06 -53.64 50.33 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.896 -1.127 . . . . 0.0 110.846 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -62.22 -80.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -177.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.628 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.8 m-80 -62.21 -29.66 70.54 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.291 -0.881 . . . . 0.0 113.182 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.048 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 73.8 m -49.99 -29.11 7.94 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.309 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.753 HG22 ' HA ' ' A' ' 1' ' ' ASP . 12.9 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.7 t0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.187 0.518 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -155.34 -157.59 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.478 -0.764 . . . . 0.0 109.72 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.81 -154.7 24.97 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.691 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 mt -131.17 179.87 5.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.574 -0.956 . . . . 0.0 109.623 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.2 t -140.18 149.92 43.56 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.715 -1.241 . . . . 0.0 110.566 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.6 p90 -135.85 164.76 27.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -122.58 149.81 43.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.476 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.15 -122.3 1.27 Allowed Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.286 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.707 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.4 m -155.95 25.82 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.19 . . . . 0.0 110.989 -177.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -73.47 -8.88 57.74 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 120.359 -1.463 . . . . 0.0 113.414 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.7 m -126.08 26.28 6.55 Favored 'General case' 0 C--N 1.282 -2.368 0 O-C-N 121.402 -0.812 . . . . 0.0 109.833 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.07 75.68 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 118.434 -1.841 . . . . 0.0 108.714 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.226 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.38 51.7 2.3 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.189 0.995 . . . . 0.0 111.465 -178.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 9' ' ' THR . 40.2 t -67.14 111.81 2.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.78 -22.41 33.84 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.6 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.767 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmt -120.19 -143.15 0.35 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.559 -1.553 . . . . 0.0 109.348 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.56 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.6 m-85 -145.56 174.1 11.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.013 -1.679 . . . . 0.0 110.172 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.226 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 88.1 m -136.85 162.47 33.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.403 -1.435 . . . . 0.0 111.003 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.907 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -135.11 124.6 24.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.6 -0.687 . . . . 0.0 110.957 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -165.91 126.39 1.27 Allowed Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.35 -0.74 10.98 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.213 1.112 . . . . 0.0 111.209 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.557 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.7 tt -163.92 12.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 CA-C-O 121.968 0.89 . . . . 0.0 111.159 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.08 11.82 84.54 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.557 ' HD2' HG21 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -87.22 -35.22 18.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.441 -1.035 . . . . 0.0 111.169 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 48.6 m-85 -85.12 -39.89 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.885 . . . . 0.0 111.259 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 t 43.3 67.72 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.25 -0.906 . . . . 0.0 110.149 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.745 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.09 116.28 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.19 -0.943 . . . . 0.0 108.462 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.3 m -116.21 161.84 18.36 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.057 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.797 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.3 m-85 -148.37 175.14 11.35 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.927 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.4 p-10 -81.97 -42.46 19.36 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.947 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -80.97 116.57 21.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.011 -1.055 . . . . 0.0 108.764 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.8 ptpt -49.59 -35.97 22.56 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.23 -46.16 89.22 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.127 176.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.797 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.94 -26.02 27.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 O-C-N 120.769 -1.207 . . . . 0.0 109.455 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.107 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 24.6 t -60.87 -66.29 0.56 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -55.75 -54.0 49.78 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.618 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.8 tmtm? -62.7 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.631 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.5 m-80 -60.6 -28.15 68.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.283 -0.886 . . . . 0.0 113.031 -176.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.107 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 57.8 m -49.14 -28.88 4.71 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.216 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.088 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.841 ' O ' HG21 ' A' ' 40' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.133 0.492 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -156.37 -160.96 1.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.784 . . . . 0.0 109.888 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.48 -142.48 7.56 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.63 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.88 179.49 6.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.477 -1.014 . . . . 0.0 109.842 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.835 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 9.4 t -144.26 156.83 44.45 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.79 -1.194 . . . . 0.0 110.489 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 32.8 p90 -135.06 166.4 23.13 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -122.03 149.23 43.81 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.321 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 150.65 -122.23 1.35 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.688 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.8 m -156.23 23.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -1.103 . . . . 0.0 111.117 -177.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.31 -7.53 54.2 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.3 -1.5 . . . . 0.0 113.801 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.997 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.7 m -125.95 27.03 6.45 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 121.196 -0.94 . . . . 0.0 109.725 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.46 15.62 77.36 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 118.595 -1.764 . . . . 0.0 108.819 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.287 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.98 50.95 2.08 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.163 0.982 . . . . 0.0 111.461 -178.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 9' ' ' THR . 39.3 t -67.46 110.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.09 -20.56 40.31 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.836 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 21.9 mtmt -124.08 -139.04 0.3 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.597 -1.531 . . . . 0.0 109.425 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.586 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.1 m-85 -144.33 174.1 11.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 119.844 -1.785 . . . . 0.0 110.052 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.287 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 99.5 m -135.05 163.13 30.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.54 -1.35 . . . . 0.0 110.842 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.097 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -131.48 123.74 28.69 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.531 -0.731 . . . . 0.0 110.922 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -165.79 118.56 0.87 Allowed Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -78.57 0.25 10.11 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.271 1.143 . . . . 0.0 110.641 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.534 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.3 tt -163.94 13.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.065 0.936 . . . . 0.0 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.09 12.96 83.67 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.534 ' HD2' HG21 ' A' ' 22' ' ' ILE . 13.4 ptmt -88.18 -33.88 18.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.453 -1.027 . . . . 0.0 111.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.2 m-85 -85.08 -41.78 15.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 111.75 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 25' ' ' TYR . 6.3 t 42.83 60.07 2.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.138 -0.977 . . . . 0.0 109.819 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.829 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.7 t -115.17 118.88 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.226 -0.921 . . . . 0.0 108.835 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.8 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 13.8 m -116.27 161.15 19.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 113.464 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.802 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.3 m-85 -148.81 177.48 9.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.95 -43.82 17.58 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.222 -0.924 . . . . 0.0 111.867 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.24 116.43 21.11 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.996 -1.065 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.815 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 13.5 ptpt -50.01 -35.23 23.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.06 -46.44 88.23 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.167 -0.958 . . . . 0.0 108.88 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.802 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.62 -25.66 25.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 O-C-N 120.82 -1.175 . . . . 0.0 109.358 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.097 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 30.6 t -60.08 -65.64 0.65 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 5' ' ' CYS . 49.5 m-20 -55.29 -55.36 32.29 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.89 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 2.2 tmtm? -62.32 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.6 m-80 -60.33 -28.11 67.88 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.298 -0.876 . . . . 0.0 113.037 -176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.094 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 55.7 m -48.88 -31.13 6.71 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.295 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.841 HG21 ' O ' ' A' ' 1' ' ' ASP . 9.9 p . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.232 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.135 0.493 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.03 142.33 19.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.492 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.85 39.43 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.89 179.25 6.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.623 -0.928 . . . . 0.0 109.288 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 15.5 t -145.25 154.72 42.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.607 -1.308 . . . . 0.0 110.871 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 30.8 p90 -136.95 163.32 30.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.567 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.7 pt-20 -123.11 148.93 45.14 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.186 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.47 -119.64 0.94 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.67 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.689 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 98.1 m -154.67 21.58 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -1.139 . . . . 0.0 111.285 -177.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -74.63 -11.49 60.2 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.251 -1.531 . . . . 0.0 113.399 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m -124.33 25.87 7.56 Favored 'General case' 0 C--N 1.283 -2.289 0 O-C-N 121.4 -0.812 . . . . 0.0 109.772 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.05 76.49 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 118.536 -1.792 . . . . 0.0 108.883 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.429 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 pttt -87.45 51.27 2.18 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.464 1.126 . . . . 0.0 110.788 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 109.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.12 -23.12 35.54 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.961 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.6 mtmt -119.08 -145.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.769 -1.43 . . . . 0.0 108.936 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.5 m-85 -146.69 176.63 9.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.779 -1.826 . . . . 0.0 110.493 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.429 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 97.2 m -137.46 161.74 35.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.499 -1.376 . . . . 0.0 110.611 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.068 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -130.96 125.81 34.38 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.427 -0.795 . . . . 0.0 110.993 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 p -166.3 124.87 1.09 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.87 0.04 10.05 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.28 1.147 . . . . 0.0 111.065 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.0 tt -163.49 12.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.007 0.908 . . . . 0.0 110.888 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.44 11.71 84.9 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HD2' HG21 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -88.3 -33.11 18.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.48 -1.012 . . . . 0.0 111.594 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 51.2 m-85 -85.08 -38.07 19.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.925 . . . . 0.0 111.409 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.4 t 41.32 66.92 0.6 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.405 -0.809 . . . . 0.0 110.794 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.717 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -114.93 117.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 14.1 m -116.22 161.8 18.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.898 -1.127 . . . . 0.0 113.865 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.773 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.1 m-85 -149.44 176.79 10.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.843 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.91 -42.83 18.96 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.786 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.736 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.26 116.28 21.05 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.06 -1.025 . . . . 0.0 108.716 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 3.0 ptmm? -50.27 -35.7 28.25 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -45.84 89.1 Favored 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.059 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.773 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.65 -25.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 O-C-N 120.716 -1.24 . . . . 0.0 109.408 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.113 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.1 t -60.66 -67.87 0.36 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -55.1 -53.59 53.98 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.925 -1.109 . . . . 0.0 110.863 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HD2' ' ND2' ' A' ' 38' ' ' ASN . 2.8 tmtm? -62.4 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.597 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.16 -29.41 68.65 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.218 -0.926 . . . . 0.0 112.768 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.113 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 66.7 m -50.15 -28.25 7.07 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.229 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 12.9 p . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.226 0.536 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' HA ' HG21 ' A' ' 40' ' ' THR . 6.9 m-20 -155.52 -171.74 3.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.39 -158.75 31.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 mt -132.11 179.52 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.955 . . . . 0.0 109.58 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t -143.65 150.39 38.68 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.735 -1.228 . . . . 0.0 110.673 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 30.5 p90 -137.92 164.45 28.96 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 6.5 pt-20 -122.94 149.49 44.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.92 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.35 -119.92 0.96 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.881 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.701 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 97.2 m -155.1 21.84 0.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 111.415 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.79 -12.46 60.4 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.284 -1.51 . . . . 0.0 113.63 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.904 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -124.16 26.3 7.51 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.15 17.83 77.56 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 118.497 -1.811 . . . . 0.0 108.888 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.298 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 4.0 pttt -87.39 50.09 1.94 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.403 1.096 . . . . 0.0 110.9 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.64 109.91 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.54 -22.78 37.45 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.02 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 37.3 mtmt -119.81 -145.05 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.86 -1.377 . . . . 0.0 108.82 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 16.9 m-85 -146.38 175.71 10.33 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 119.849 -1.782 . . . . 0.0 110.483 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.298 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 88.4 m -138.79 162.2 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.453 -1.404 . . . . 0.0 110.816 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -133.75 127.92 33.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 110.882 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.5 p -165.92 123.98 1.09 Allowed Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.21 -1.05 11.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.205 1.108 . . . . 0.0 110.931 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG21 ' HD2' ' A' ' 24' ' ' LYS . 4.5 tt -163.66 11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 122.031 0.919 . . . . 0.0 111.031 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.92 11.88 85.11 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HD2' HG21 ' A' ' 22' ' ' ILE . 10.3 ptmm? -86.81 -33.45 19.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -1.101 . . . . 0.0 110.8 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.0 m-85 -85.38 -43.37 13.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 111.592 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 43.3 t 42.93 65.59 0.92 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.341 -0.85 . . . . 0.0 109.577 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.742 HG12 ' CE1' ' A' ' 29' ' ' TYR . 91.5 t -114.91 118.02 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.5 m -116.31 162.06 18.07 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.986 -1.085 . . . . 0.0 113.182 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.7 m-85 -148.74 174.33 12.3 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -81.74 -41.42 21.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.764 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.741 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 115.49 20.54 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.047 -1.033 . . . . 0.0 108.636 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.799 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.4 ptpt -49.58 -35.74 21.71 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.407 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -45.84 89.92 Favored 'General case' 0 C--O 1.198 -1.629 0 O-C-N 121.395 -0.815 . . . . 0.0 109.201 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.82 -26.18 27.39 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.951 0 O-C-N 120.637 -1.289 . . . . 0.0 109.445 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.093 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.2 t -61.4 -68.91 0.27 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -54.86 -52.5 62.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.855 -1.153 . . . . 0.0 110.868 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.54 -79.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -177.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 50.1 m-80 -60.98 -29.22 69.55 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.197 -0.939 . . . . 0.0 112.812 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.093 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.9 m -49.87 -31.2 11.52 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.254 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 2' ' ' ASP . 9.0 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.139 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.014 0.435 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -155.45 159.55 39.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -0.832 . . . . 0.0 110.378 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.49 170.92 31.07 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -131.76 179.4 6.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.946 . . . . 0.0 109.518 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 t -144.82 150.84 37.83 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.744 -1.222 . . . . 0.0 110.589 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 24.4 p90 -138.97 162.87 33.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -123.33 153.5 40.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.84 -1.162 . . . . 0.0 111.601 -177.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.76 -120.89 1.06 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.608 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 9' ' ' THR 0.283 92.8 m -154.01 19.19 0.51 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -1.145 . . . . 0.0 111.238 -177.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.492 ' H ' ' HZ1' ' A' ' 13' ' ' LYS . 17.9 t30 -73.92 -12.89 60.79 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.313 -1.492 . . . . 0.0 113.199 -177.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.971 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.0 m -122.71 23.92 9.31 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.363 -0.835 . . . . 0.0 109.569 178.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.36 77.77 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 118.556 -1.783 . . . . 0.0 109.111 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.424 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.2 pttm -87.2 51.78 2.33 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.509 1.147 . . . . 0.0 111.097 -178.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -67.49 108.91 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 -21.65 42.43 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.186 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.729 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.6 mtmm -121.0 -146.74 0.38 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.819 -1.401 . . . . 0.0 108.901 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.5 m-85 -146.67 177.38 9.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.808 -1.807 . . . . 0.0 110.666 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.424 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 96.8 m -138.14 161.37 36.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.513 -1.367 . . . . 0.0 110.656 -178.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.044 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -134.88 127.28 30.4 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.389 -0.82 . . . . 0.0 111.18 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -165.55 126.11 1.31 Allowed Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.54 -7.25 17.65 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.259 1.136 . . . . 0.0 111.308 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.463 HG21 ' HD2' ' A' ' 24' ' ' LYS . 6.2 tt -164.53 16.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.154 0.978 . . . . 0.0 110.932 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.88 9.76 85.11 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.617 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -90.4 20.78 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.422 -1.046 . . . . 0.0 110.76 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.7 m-85 -148.55 -40.63 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.0 110.613 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 24.7 t 40.81 71.66 0.19 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.382 -0.824 . . . . 0.0 110.572 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.724 HG12 ' CE1' ' A' ' 29' ' ' TYR . 63.8 t -115.0 117.7 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.049 -1.032 . . . . 0.0 108.258 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 17.6 m -116.23 161.95 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.381 -176.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.781 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.1 m-85 -149.24 175.04 11.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.868 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 p30 -81.92 -42.12 19.93 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.218 -0.926 . . . . 0.0 111.865 178.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.36 115.3 20.65 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.064 -1.023 . . . . 0.0 108.85 179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.806 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.6 ptpt -49.77 -35.14 21.42 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.58 -46.48 86.86 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.945 176.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.781 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.39 -25.74 24.64 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 O-C-N 120.763 -1.21 . . . . 0.0 109.378 179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.116 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 t -60.78 -66.1 0.58 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -55.44 -54.31 45.42 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.86 -1.15 . . . . 0.0 110.664 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.2 tmtm? -62.26 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -59.93 -30.09 68.82 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.267 -0.896 . . . . 0.0 112.816 -176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.116 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 83.1 m -50.86 -26.14 5.42 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.383 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 37' ' ' LYS . 17.9 p . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -155.17 133.7 11.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.828 . . . . 0.0 110.764 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.67 -177.34 40.3 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.6 mt -132.69 179.74 5.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.599 -0.942 . . . . 0.0 109.458 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.7 t -137.4 135.32 36.83 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.766 -1.209 . . . . 0.0 109.676 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 30.4 p90 -136.09 168.9 18.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.63 145.59 48.22 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.694 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.94 -118.17 0.83 Allowed Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.605 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.72 ' O ' HG22 ' A' ' 9' ' ' THR 0.297 54.9 m -158.04 32.7 0.25 Allowed 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.251 -1.147 . . . . 0.0 110.276 -177.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -68.79 -7.96 38.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.084 -1.635 . . . . 0.0 112.529 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.7 m -120.49 23.67 10.73 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.966 0.889 . . . . 0.0 108.637 176.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.27 83.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.137 178.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.087 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -93.78 71.62 4.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.842 1.306 . . . . 0.0 112.667 -178.681 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.6 t -64.27 116.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.599 177.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.85 -25.94 17.31 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.756 -1.687 . . . . 0.0 111.674 178.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.861 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 16.1 mttt -108.47 -146.33 0.4 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 120.371 2.085 . . . . 0.0 109.497 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.891 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 11.3 m-85 -146.4 169.37 19.01 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 119.437 -2.04 . . . . 0.0 111.487 -178.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.087 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 50.0 m -137.43 161.57 35.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.806 -1.809 . . . . 0.0 112.619 -178.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.078 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -135.71 104.16 5.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.366 0.603 . . . . 0.0 109.641 179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 p -169.99 141.49 1.79 Allowed Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -77.06 -8.73 17.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.291 1.153 . . . . 0.0 110.075 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.816 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.7 tt -165.36 -169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -85.37 12.95 57.39 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.266 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.816 ' H ' HG23 ' A' ' 22' ' ' ILE . 21.0 ptmt -84.01 -43.14 15.46 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.159 -1.2 . . . . 0.0 110.73 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.3 m-85 -86.76 -51.73 5.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' TYR . 30.8 t 40.56 75.36 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.609 -0.682 . . . . 0.0 110.391 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.078 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 61.9 t -113.48 105.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.7 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 24.5 m -116.11 163.98 15.14 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.313 1.054 . . . . 0.0 113.545 -175.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.834 ' CG ' HG22 ' A' ' 34' ' ' ILE . 87.1 m-85 -150.08 176.65 10.61 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -82.54 -41.73 19.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.035 -1.041 . . . . 0.0 111.635 178.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.713 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.91 118.8 22.72 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.007 -1.058 . . . . 0.0 108.863 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.852 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.2 ptpt -50.65 -37.12 38.99 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.29 -45.27 91.73 Favored 'General case' 0 C--O 1.198 -1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 109.265 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.834 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.39 -26.06 29.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 120.659 -1.276 . . . . 0.0 109.31 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.971 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 5.2 t -61.85 -70.28 0.2 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -54.71 -51.48 65.44 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.958 -1.089 . . . . 0.0 110.585 178.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.6 tmtm? -62.3 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.6 m-80 -61.45 -29.36 69.9 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.209 -0.932 . . . . 0.0 112.825 -177.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.971 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.8 m -50.44 -31.39 14.94 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.08 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.172 -179.848 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.072 0.463 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.87 -168.42 2.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.233 -0.917 . . . . 0.0 110.007 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.91 -135.96 3.95 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.36 179.79 5.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.445 -1.032 . . . . 0.0 109.652 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.61 140.82 49.5 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.772 -1.205 . . . . 0.0 110.141 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 35.2 p90 -137.55 164.6 28.33 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 8.0 pt-20 -123.17 149.27 44.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.746 -1.181 . . . . 0.0 110.801 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.99 -119.45 0.92 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.918 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.674 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 89.4 m -155.02 22.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -1.144 . . . . 0.0 111.514 -177.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -73.99 -12.61 60.69 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.185 -1.572 . . . . 0.0 113.333 -177.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -123.19 25.08 8.59 Favored 'General case' 0 C--N 1.281 -2.37 0 O-C-N 121.431 -0.793 . . . . 0.0 109.645 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.01 76.55 Favored Glycine 0 C--N 1.29 -2.018 0 C-N-CA 118.491 -1.814 . . . . 0.0 108.68 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.324 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 pttt -87.32 51.47 2.24 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.42 1.105 . . . . 0.0 110.927 -178.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.51 109.9 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.63 37.65 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.75 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 23.3 mtmt -118.52 -147.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.808 -1.407 . . . . 0.0 108.892 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 14.0 m-85 -147.3 176.51 9.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.852 -1.78 . . . . 0.0 110.232 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.324 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 81.5 m -136.4 162.23 33.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.515 -1.366 . . . . 0.0 111.341 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.985 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -136.71 109.83 7.76 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.712 -0.617 . . . . 0.0 110.584 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.61 136.99 1.2 Allowed Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -75.91 -12.63 19.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.316 1.166 . . . . 0.0 109.811 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.847 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.1 tt -165.09 -166.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.586 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -84.16 7.46 71.39 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.345 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.847 ' H ' HG23 ' A' ' 22' ' ' ILE . 35.0 pttt -88.58 17.13 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.123 -1.222 . . . . 0.0 111.396 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.3 m-85 -151.6 -54.79 0.14 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 177.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.4 t 36.8 75.64 0.06 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.445 -0.784 . . . . 0.0 110.993 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.855 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.9 t -114.23 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.63 -1.294 . . . . 0.0 108.595 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.4 m -116.03 162.01 18.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.315 1.055 . . . . 0.0 113.79 -176.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.799 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.1 m-85 -149.28 176.64 10.36 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.3 p-10 -82.22 -43.24 17.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.236 -0.915 . . . . 0.0 111.933 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.09 117.62 21.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.105 -0.997 . . . . 0.0 108.848 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.878 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 17.0 ptpt -50.26 -35.82 28.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.55 -45.94 90.33 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.157 176.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.87 -26.01 27.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 O-C-N 120.717 -1.239 . . . . 0.0 109.333 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.152 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -60.56 -68.0 0.34 Allowed 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -54.85 -53.47 54.94 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.752 -1.217 . . . . 0.0 110.952 177.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -62.15 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -177.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.9 m-80 -60.32 -29.32 68.79 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.246 -0.909 . . . . 0.0 112.772 -176.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.152 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 71.0 m -50.17 -27.1 5.31 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.272 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.158 -179.69 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.782 ' HA ' HG21 ' A' ' 40' ' ' THR . 10.4 p-10 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.421 0.629 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -83.97 111.82 19.62 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.602 -0.686 . . . . 0.0 110.235 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.83 168.37 27.89 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 mt -130.44 179.8 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.663 -0.904 . . . . 0.0 109.158 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 t -139.35 148.87 43.49 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.591 -1.318 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 31.6 p90 -135.5 165.73 24.84 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.45 149.77 43.39 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.67 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.418 ' H ' ' NZ ' ' A' ' 13' ' ' LYS . . . 152.97 -124.13 1.55 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.365 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 96.4 m -155.44 25.35 0.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.82 -177.826 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -74.05 -7.44 52.49 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 120.326 -1.484 . . . . 0.0 113.522 -176.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.831 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m -127.64 27.18 5.82 Favored 'General case' 0 C--N 1.284 -2.253 0 O-C-N 121.281 -0.887 . . . . 0.0 109.809 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.45 15.04 77.26 Favored Glycine 0 C--N 1.291 -1.933 0 C-N-CA 118.56 -1.781 . . . . 0.0 108.848 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.278 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.64 52.7 2.56 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.229 1.014 . . . . 0.0 111.298 -178.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 9' ' ' THR . 44.5 t -67.44 109.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.3 -20.63 44.2 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.801 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.771 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.8 mtmt -117.41 -143.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.709 -1.465 . . . . 0.0 109.169 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.555 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 24.8 m-85 -145.66 173.85 11.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 119.875 -1.766 . . . . 0.0 110.179 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.278 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 70.8 m -136.48 163.18 31.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.451 -1.406 . . . . 0.0 111.024 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.819 ' SG ' ' O ' ' A' ' 27' ' ' VAL . 2.0 p -134.01 122.58 23.22 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.529 -0.732 . . . . 0.0 110.799 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 p -165.69 124.86 1.17 Allowed Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.99 -1.83 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.257 1.135 . . . . 0.0 111.241 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.487 HG21 ' HD2' ' A' ' 24' ' ' LYS . 4.5 tt -163.9 13.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-O 122.02 0.914 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 12.05 84.4 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 10.7 ptmt -87.96 -34.78 17.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.405 -1.056 . . . . 0.0 111.214 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.501 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.4 m-85 -84.48 -39.0 19.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.283 -0.886 . . . . 0.0 111.332 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 25' ' ' TYR . 42.8 t 41.39 65.46 0.83 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.374 -0.829 . . . . 0.0 110.461 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.819 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.0 t -115.14 115.51 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.9 m -116.37 161.99 18.22 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.304 1.049 . . . . 0.0 113.325 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.804 ' CG ' HG22 ' A' ' 34' ' ' ILE . 82.4 m-85 -148.74 175.82 10.9 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.048 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.412 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -82.36 -42.59 18.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.204 -0.935 . . . . 0.0 112.066 178.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -80.66 116.56 20.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.003 -1.06 . . . . 0.0 108.573 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.828 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 1.1 ptpp? -49.71 -35.85 23.29 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.15 -46.15 89.12 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.094 176.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.804 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.16 -26.12 28.53 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 O-C-N 120.726 -1.234 . . . . 0.0 109.386 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.061 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 13.4 t -60.34 -65.82 0.62 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -56.45 -54.11 49.58 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.697 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -62.36 -79.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -177.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.635 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.75 -28.53 68.77 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.29 -0.881 . . . . 0.0 112.962 -176.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.061 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 53.2 m -49.37 -32.61 11.8 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.469 -1.292 . . . . 0.0 111.251 -178.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.782 HG21 ' HA ' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.2 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.096 0.474 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -155.45 159.11 39.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.279 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.01 -167.13 39.08 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mt -132.85 179.8 5.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.607 -0.937 . . . . 0.0 109.62 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -137.49 140.74 41.35 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.769 -1.207 . . . . 0.0 109.886 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -137.3 166.97 22.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.84 153.03 40.14 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.113 -177.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.48 -121.28 1.11 Allowed Glycine 0 N--CA 1.487 2.082 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.484 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.3 m -155.19 22.32 0.43 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.339 -1.095 . . . . 0.0 111.057 -177.874 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -73.89 -13.41 60.9 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.316 -1.49 . . . . 0.0 113.355 -177.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.062 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -122.32 25.42 8.94 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 121.365 -0.834 . . . . 0.0 109.457 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.78 16.61 78.02 Favored Glycine 0 C--N 1.291 -1.947 0 C-N-CA 118.673 -1.727 . . . . 0.0 109.112 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.277 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pttm -88.03 52.94 2.59 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.483 1.135 . . . . 0.0 110.986 -178.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 HG23 ' A' ' 9' ' ' THR . 38.8 t -67.1 108.92 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.11 -22.38 39.56 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.997 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 36.6 mtmt -115.54 -146.36 0.4 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.743 -1.445 . . . . 0.0 108.83 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.543 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.6 m-85 -146.82 177.06 9.41 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 119.824 -1.798 . . . . 0.0 110.633 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.277 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 62.1 m -137.0 160.4 39.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.379 -1.45 . . . . 0.0 110.755 -178.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.104 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -137.26 112.44 9.14 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 p -170.72 137.63 1.21 Allowed Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.59 -14.78 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.293 1.154 . . . . 0.0 109.606 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.765 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.8 tt -164.89 -166.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -82.49 11.7 50.02 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.76 -1.209 . . . . 0.0 110.637 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.765 ' H ' HG23 ' A' ' 22' ' ' ILE . 13.7 ptmt -88.2 12.82 12.78 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.364 -1.08 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.615 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.6 m-85 -151.04 -53.24 0.14 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.114 -0.991 . . . . 0.0 110.783 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 9.6 t 36.56 74.99 0.07 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.451 -0.781 . . . . 0.0 110.473 -178.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.8 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.4 t -114.75 114.03 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.809 -1.182 . . . . 0.0 108.48 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.764 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 17.4 m -115.96 161.45 18.82 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.256 1.027 . . . . 0.0 113.218 -176.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.782 ' CE1' HG12 ' A' ' 27' ' ' VAL . 87.3 m-85 -149.9 176.49 10.7 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.265 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.5 p-10 -82.12 -42.15 19.52 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.238 -0.914 . . . . 0.0 111.833 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.746 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.42 114.99 20.54 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.043 -1.035 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.839 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 10.1 ptmt -50.21 -35.03 24.85 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.11 87.01 Favored 'General case' 0 C--O 1.2 -1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 108.879 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.771 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.16 -25.67 23.58 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 120.635 -1.291 . . . . 0.0 109.389 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.125 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 18.2 t -60.55 -66.88 0.46 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.01 -54.26 45.22 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.817 -1.177 . . . . 0.0 111.088 177.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.3 tmtm? -62.04 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -177.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -60.99 -30.31 70.2 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.185 -0.947 . . . . 0.0 112.818 -176.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.125 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 95.6 m -51.15 -30.73 17.52 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 118.696 -1.202 . . . . 0.0 111.338 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.133 -0.979 . . . . 0.0 110.152 -179.97 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.666 ' O ' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -83.44 145.72 28.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.043 -1.035 . . . . 0.0 110.154 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.25 -178.46 40.8 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -131.23 179.81 5.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.698 -0.884 . . . . 0.0 109.484 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.7 t -132.77 135.87 45.98 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.625 -1.297 . . . . 0.0 110.382 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -137.49 166.28 24.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.87 152.17 41.01 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.284 -177.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.06 -120.16 0.99 Allowed Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.534 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 9' ' ' THR 0.287 97.6 m -155.28 23.59 0.42 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 111.235 -177.817 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -73.45 -14.52 61.26 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 120.217 -1.552 . . . . 0.0 113.257 -177.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.2 m -121.66 25.07 9.48 Favored 'General case' 0 C--N 1.283 -2.319 0 O-C-N 121.361 -0.837 . . . . 0.0 109.475 177.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.17 17.26 77.22 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.283 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 6.7 pttm -87.69 53.08 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.582 1.182 . . . . 0.0 110.885 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 HG23 ' A' ' 9' ' ' THR . 25.8 t -67.32 109.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.95 -22.94 36.36 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.912 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 9.0 mtmt -115.24 -148.26 0.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.859 -1.377 . . . . 0.0 108.668 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.512 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 18.4 m-85 -146.68 175.91 10.25 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 119.83 -1.794 . . . . 0.0 110.455 -179.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.283 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 63.0 m -137.16 160.94 37.53 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.359 -1.463 . . . . 0.0 111.369 -178.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.879 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.25 112.03 8.33 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.743 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.89 140.21 1.34 Allowed Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -76.98 -7.39 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.223 1.117 . . . . 0.0 110.059 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.8 HG23 ' H ' ' A' ' 24' ' ' LYS . 8.8 tt -165.08 -170.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -86.11 13.1 58.33 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.245 -178.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.8 ' H ' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -84.13 -43.82 14.63 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.159 -1.2 . . . . 0.0 110.908 -179.711 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.475 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 45.2 m-85 -87.51 -51.83 5.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.064 -1.023 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.6 t 39.53 75.48 0.08 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.363 -0.836 . . . . 0.0 110.23 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.784 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 57.9 t -114.36 112.87 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.831 -1.168 . . . . 0.0 108.435 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.578 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 18.3 m -116.13 161.96 18.15 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.217 1.008 . . . . 0.0 113.0 -176.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.785 ' CG ' HG22 ' A' ' 34' ' ' ILE . 86.3 m-85 -149.62 174.08 12.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.14 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 3.1 p-10 -81.63 -41.19 21.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 111.939 178.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.733 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.46 115.09 20.62 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.085 -1.009 . . . . 0.0 108.729 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.81 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 15.3 ptpt -49.92 -34.97 22.15 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.65 -46.2 87.66 Favored 'General case' 0 C--O 1.2 -1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 108.951 176.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.6 -25.45 24.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 O-C-N 120.606 -1.309 . . . . 0.0 109.382 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.055 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 34.3 t -61.26 -66.66 0.5 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -55.04 -54.14 46.86 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.843 -1.161 . . . . 0.0 110.734 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.66 -79.09 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' ILE . 51.1 m-80 -60.84 -31.13 70.57 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.278 -0.889 . . . . 0.0 112.869 -176.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.055 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 98.0 m -51.47 -32.32 26.78 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.228 -178.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 1' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.127 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.461 ' H2 ' HG21 ' A' ' 40' ' ' THR . 20.3 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.08 0.467 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.31 107.35 15.77 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.39 178.91 38.86 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -132.31 179.34 6.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.524 -0.986 . . . . 0.0 109.391 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 t -145.18 152.11 39.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.664 -1.272 . . . . 0.0 110.622 179.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 29.5 p90 -137.04 163.42 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 7.4 pt-20 -123.09 149.45 44.46 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.939 -1.105 . . . . 0.0 111.084 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' HE3' ' A' ' 13' ' ' LYS . . . 155.46 -120.07 0.97 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.767 179.204 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.288 95.1 m -154.78 21.76 0.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.158 . . . . 0.0 111.283 -177.529 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 120.288 -1.507 . . . . 0.0 113.462 -177.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.946 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.8 m -124.26 25.66 7.68 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 178.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.64 17.62 76.66 Favored Glycine 0 C--N 1.29 -1.984 0 C-N-CA 118.38 -1.867 . . . . 0.0 108.694 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.332 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.8 pttt -87.68 51.2 2.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.547 1.165 . . . . 0.0 110.852 -178.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -67.23 108.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.21 -22.31 38.34 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.069 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 3.6 mtmp? -119.0 -146.08 0.38 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.753 -1.439 . . . . 0.0 108.866 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 16' ' ' LYS . 14.8 m-85 -146.77 176.15 10.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 119.856 -1.778 . . . . 0.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.332 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 92.8 m -137.29 161.89 35.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.389 -1.445 . . . . 0.0 110.802 -178.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.041 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -134.44 127.18 30.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.806 . . . . 0.0 111.123 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 p -166.18 126.66 1.26 Allowed Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.25 2.23 8.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.089 1.047 . . . . 0.0 111.275 -179.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.699 HG21 ' HD2' ' A' ' 24' ' ' LYS . 5.0 tt -163.5 8.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.02 0.914 . . . . 0.0 111.169 178.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.91 85.53 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.699 ' HD2' HG21 ' A' ' 22' ' ' ILE . 14.3 ptmm? -87.82 -34.08 18.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -85.03 -40.06 17.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 0.0 111.231 -179.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 28.3 t 44.28 70.58 0.32 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.306 -0.871 . . . . 0.0 110.284 -179.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.709 HG12 ' CE1' ' A' ' 29' ' ' TYR . 83.4 t -114.94 117.6 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 16.1 m -116.22 161.86 18.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.895 -1.128 . . . . 0.0 113.474 -176.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.796 ' CG ' HG22 ' A' ' 34' ' ' ILE . 84.9 m-85 -148.64 175.17 11.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.845 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 2.3 p-10 -81.8 -42.33 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.811 178.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.731 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.34 116.49 21.2 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.008 -1.058 . . . . 0.0 108.774 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.82 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 16.2 ptpt -50.23 -35.51 27.06 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.95 -46.16 88.7 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 109.047 176.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.796 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.72 -26.04 26.63 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.139 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 21.4 t -60.83 -67.58 0.39 Allowed 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -54.78 -53.51 54.17 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.843 -1.161 . . . . 0.0 110.855 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -62.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -177.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.605 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.7 m-80 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.32 -0.863 . . . . 0.0 113.032 -176.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.139 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 64.4 m -48.97 -29.65 5.07 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.353 -178.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.461 HG21 ' H2 ' ' A' ' 1' ' ' ASP . 8.7 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.196 0.522 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.95 -161.79 0.53 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.63 -129.26 1.08 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.605 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mt -131.98 -179.95 5.72 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.615 -0.932 . . . . 0.0 110.064 -178.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 39.2 t -137.52 150.35 47.45 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.872 -1.142 . . . . 0.0 110.359 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 18' ' ' CYS . 29.9 p90 -137.29 162.72 32.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.2 149.08 45.11 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.015 -1.053 . . . . 0.0 110.772 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.82 -121.84 1.16 Allowed Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.504 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 98.1 m -155.74 28.72 0.37 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.489 -1.007 . . . . 0.0 110.288 -177.861 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -71.36 -12.27 61.34 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.516 -1.365 . . . . 0.0 112.79 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -117.27 21.98 12.78 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.59 15.24 77.6 Favored Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -92.28 61.25 3.84 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.37 1.081 . . . . 0.0 112.428 -177.984 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.524 HG23 HG23 ' A' ' 9' ' ' THR . 24.6 t -63.64 116.94 3.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.16 -23.74 22.46 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 118.866 -1.635 . . . . 0.0 111.641 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 11.0 mtmm -120.11 -149.72 0.44 Allowed 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 120.426 2.113 . . . . 0.0 110.222 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 12.9 m-85 -146.2 170.12 17.38 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 119.983 -1.698 . . . . 0.0 110.276 -179.276 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 55.5 m -133.86 163.91 28.45 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.197 -1.564 . . . . 0.0 111.199 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.053 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.0 p -132.81 117.7 18.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.491 0.663 . . . . 0.0 110.737 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 p -165.82 140.27 3.82 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -76.49 -1.91 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.097 1.051 . . . . 0.0 111.599 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 24' ' ' LYS . 5.9 tt -164.2 13.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-O 121.994 0.902 . . . . 0.0 111.392 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.9 11.88 84.35 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -85.49 -37.69 19.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.483 -1.01 . . . . 0.0 111.069 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 49.2 m-85 -84.83 -33.19 22.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.813 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.1 t 40.92 75.52 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.535 -0.728 . . . . 0.0 111.086 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.955 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 88.0 t -113.3 109.17 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' C ' ' CD1' ' A' ' 29' ' ' TYR . 14.6 m -116.25 164.71 14.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -173.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.818 ' CG ' HG22 ' A' ' 34' ' ' ILE . 78.8 m-85 -150.59 176.8 10.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.64 179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.55 -42.34 18.47 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.834 178.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.723 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.2 m -81.06 119.02 23.01 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.016 -1.053 . . . . 0.0 108.854 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -51.21 -36.6 42.36 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.71 -45.7 88.97 Favored 'General case' 0 C--O 1.201 -1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 176.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.818 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -58.55 -25.5 28.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 O-C-N 120.667 -1.271 . . . . 0.0 109.339 179.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.053 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 20.0 t -60.73 -66.8 0.47 Allowed 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.76 -54.28 44.12 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.808 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 1.9 tmtm? -62.86 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -177.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.4 m-80 -60.6 -28.81 68.79 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 121.323 -0.861 . . . . 0.0 113.058 -176.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 59.2 m -49.95 -26.25 4.03 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 118.511 -1.276 . . . . 0.0 111.128 -178.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.088 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 25' ' ' TYR . 10.2 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.04 0.448 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -82.12 -158.56 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.959 . . . . 0.0 109.618 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.96 -129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.64 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 mt -132.79 179.9 5.88 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.496 -1.002 . . . . 0.0 109.951 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 t -133.66 138.04 45.68 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.847 -1.158 . . . . 0.0 110.031 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.98 167.29 21.79 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.05 152.42 41.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.699 -1.2 . . . . 0.0 111.206 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.92 -120.88 1.05 Allowed Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.479 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 9' ' ' THR 0.285 92.4 m -155.01 23.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.292 -1.122 . . . . 0.0 111.13 -177.775 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -73.71 -12.99 60.89 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 120.3 -1.5 . . . . 0.0 113.329 -177.001 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 31.7 m -123.0 24.96 8.76 Favored 'General case' 0 C--N 1.284 -2.282 0 O-C-N 121.346 -0.846 . . . . 0.0 109.542 177.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.14 17.39 77.26 Favored Glycine 0 C--N 1.29 -2.025 0 C-N-CA 118.605 -1.76 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.282 ' CD ' ' SG ' ' A' ' 18' ' ' CYS . 5.0 pttm -87.99 53.16 2.67 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.501 1.143 . . . . 0.0 110.972 -178.661 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' CG2' HG23 ' A' ' 9' ' ' THR . 49.2 t -67.29 109.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.3 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.1 -23.31 34.95 Favored Glycine 0 N--CA 1.499 2.888 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.916 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 16.4 mtmm -114.95 -147.68 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.852 -1.381 . . . . 0.0 108.761 178.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.52 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 19.2 m-85 -146.72 176.48 9.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.878 -1.764 . . . . 0.0 110.289 -179.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.282 ' SG ' ' CD ' ' A' ' 13' ' ' LYS . 59.9 m -137.13 161.84 35.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.301 -1.499 . . . . 0.0 111.283 -178.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.882 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -138.15 109.73 7.04 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.599 -0.688 . . . . 0.0 110.731 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -170.2 136.89 1.3 Allowed Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -75.46 -13.67 20.42 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.276 1.145 . . . . 0.0 109.738 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.84 HG23 ' H ' ' A' ' 24' ' ' LYS . 7.5 tt -165.08 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.167 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 22' ' ' ILE . . . -83.34 8.98 62.51 Favored Glycine 0 N--CA 1.501 2.997 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.085 -178.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.84 ' H ' HG23 ' A' ' 22' ' ' ILE . 6.8 ptmm? -88.45 15.27 8.12 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.169 -1.195 . . . . 0.0 111.132 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.555 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 42.7 m-85 -150.95 -53.96 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 110.447 178.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' TYR . 12.8 t 36.66 75.34 0.06 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.367 -0.833 . . . . 0.0 110.853 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.849 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 59.4 t -114.49 113.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.724 -1.235 . . . . 0.0 108.366 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.603 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 19.6 m -116.12 162.5 17.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.029 . . . . 0.0 113.446 -176.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.8 ' CG ' HG22 ' A' ' 34' ' ' ILE . 88.4 m-85 -149.27 174.68 12.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' HA ' ' CG ' ' A' ' 16' ' ' LYS . 1.7 p-10 -82.2 -42.01 19.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.89 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.729 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.15 116.16 20.92 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.942 -1.099 . . . . 0.0 108.808 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.797 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.8 ptpt -49.94 -35.58 24.6 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -58.9 -46.31 88.19 Favored 'General case' 0 C--O 1.2 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.033 176.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' CG ' ' A' ' 29' ' ' TYR . 3.0 mt -57.73 -25.85 26.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 O-C-N 120.655 -1.278 . . . . 0.0 109.467 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.041 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.1 t -61.08 -66.66 0.5 Allowed 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -55.28 -53.82 51.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.878 -1.138 . . . . 0.0 110.551 177.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 3.1 tmtm? -62.46 -79.6 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.613 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.3 m-80 -60.37 -30.56 69.65 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.172 -0.955 . . . . 0.0 112.713 -176.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.041 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 70.7 m -50.99 -27.3 7.43 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.263 -178.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.048 -179.775 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.56 133.16 34.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.0 110.159 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.37 144.18 4.0 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 mt -132.23 179.56 6.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.577 -0.955 . . . . 0.0 109.147 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 18' ' ' CYS . 13.1 t -143.41 150.85 39.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.488 -1.383 . . . . 0.0 111.348 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.412 ' CE1' ' NZ ' ' A' ' 13' ' ' LYS . 37.8 p90 -137.57 166.54 23.66 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.54 152.91 39.89 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.285 -177.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' H ' ' HE2' ' A' ' 13' ' ' LYS . . . 154.35 -121.62 1.15 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.354 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 9' ' ' THR 0.286 93.7 m -154.7 22.63 0.46 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -1.109 . . . . 0.0 110.996 -177.764 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -74.46 -11.47 60.24 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.292 -1.505 . . . . 0.0 113.351 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.02 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.9 m -123.77 24.7 8.33 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 121.265 -0.897 . . . . 0.0 109.735 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.43 17.15 77.56 Favored Glycine 0 C--N 1.291 -1.966 0 C-N-CA 118.641 -1.743 . . . . 0.0 109.077 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.273 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -87.45 52.63 2.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.392 1.091 . . . . 0.0 111.01 -178.69 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.03 110.06 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.51 -21.32 41.39 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 17.5 mttt -120.87 -145.36 0.36 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.796 -1.414 . . . . 0.0 109.033 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 16.0 m-85 -146.1 177.65 8.81 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.778 -1.826 . . . . 0.0 110.494 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.273 ' SG ' ' HD2' ' A' ' 13' ' ' LYS . 70.8 m -137.45 162.01 34.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.389 -1.444 . . . . 0.0 110.874 -178.552 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.082 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -133.89 124.86 27.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.46 -0.775 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 p -165.84 128.33 1.48 Allowed Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -77.29 -2.02 12.21 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.181 1.095 . . . . 0.0 111.078 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.505 HG21 ' HD2' ' A' ' 24' ' ' LYS . 4.4 tt -163.42 12.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-O 121.992 0.901 . . . . 0.0 111.125 179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.33 84.53 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD2' HG21 ' A' ' 22' ' ' ILE . 14.2 ptmm? -87.96 -33.67 18.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.367 -1.078 . . . . 0.0 111.244 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 50.1 m-85 -85.15 -39.05 18.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.283 -0.885 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.4 t 43.29 68.32 0.52 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.345 -0.847 . . . . 0.0 110.36 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.795 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 58.6 t -115.13 116.11 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.703 ' SG ' ' CB ' ' A' ' 11' ' ' CYS . 15.9 m -116.26 161.63 18.71 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.493 -176.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.789 ' CG ' HG22 ' A' ' 34' ' ' ILE . 79.9 m-85 -149.1 176.74 10.21 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.184 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 3.7 p-10 -81.89 -43.62 17.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.236 -0.915 . . . . 0.0 111.796 178.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.718 ' HB2' HG13 ' A' ' 34' ' ' ILE . 2.3 m -81.14 116.44 21.05 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.947 -1.095 . . . . 0.0 108.498 179.295 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.803 ' O ' ' HB3' ' A' ' 35' ' ' CYS . 14.7 ptpt -50.34 -35.2 26.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 32' ' ' LYS . . . -59.16 -46.13 89.2 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.346 -0.846 . . . . 0.0 109.084 176.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.789 HG22 ' CG ' ' A' ' 29' ' ' TYR . 2.9 mt -57.72 -26.27 27.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 O-C-N 120.719 -1.238 . . . . 0.0 109.454 179.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.117 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 23.6 t -61.28 -67.44 0.41 Allowed 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.08 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -55.23 -53.13 59.93 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.756 -1.215 . . . . 0.0 110.61 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' HD2' ' N ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -62.92 -80.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -177.72 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.608 ' HB2' HG23 ' A' ' 34' ' ' ILE . 50.9 m-80 -61.08 -28.35 69.02 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 112.948 -176.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.117 ' SG ' ' O ' ' A' ' 35' ' ' CYS . 60.1 m -48.92 -32.46 9.04 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.118 -178.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.124 -179.885 . . . . . . . . 0 0 . 1 stop_ save_